CN1145641A - 通过随机片段化和重装配进行的dna诱变 - Google Patents
通过随机片段化和重装配进行的dna诱变 Download PDFInfo
- Publication number
- CN1145641A CN1145641A CN95191679A CN95191679A CN1145641A CN 1145641 A CN1145641 A CN 1145641A CN 95191679 A CN95191679 A CN 95191679A CN 95191679 A CN95191679 A CN 95191679A CN 1145641 A CN1145641 A CN 1145641A
- Authority
- CN
- China
- Prior art keywords
- sequence
- fragment
- polynucleotide
- double
- heterozygosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43595—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from coelenteratae, e.g. medusae
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/545—IL-1
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
- C12N15/1027—Mutagenizing nucleic acids by DNA shuffling, e.g. RSR, STEP, RPR
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2468—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
- C12N9/2471—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
- C12N9/86—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides, e.g. penicillinase (3.5.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01023—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
- C12Y305/02—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in cyclic amides (3.5.2)
- C12Y305/02006—Beta-lactamase (3.5.2.6)
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
- C40B40/08—Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
- C40B50/06—Biochemical methods, e.g. using enzymes or whole viable microorganisms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
Abstract
描述了随机片段化后重装配DNA的方法,及其在体外、或体内用于核酸序列突变的应用。具体地讲,描述了生产编码突变蛋白质的核酸片段或多聚核苷酸的方法。本发明也涉及突变、杂合和选择的循环的方法,该方法使蛋白质在体内或体外发生定向分子进化。
Description
发明背景
发明领域
本发明涉及生产多核苷酸的方法,所说多核苷酸提供所需的表型和/或编码一种具有可选择的有利的预定特性的蛋白质。一方面,该方法可用于生产和选择编码突变蛋白质的核酸片段。
相关领域的描述
一种生物大分子例如蛋白质,DNA等的活性序列的复杂性已被称为其信息内容(“ IC”;5-9)。一种蛋白质的信息内容定义为活性蛋白对氨基酸的抗性,可以从用于描述一个具有相同功能的相关序列族所需要的不可变氨基酸(bits)的基本数目计数出(9,10)。对随机诱变敏感的蛋白质具有高信息内容。在1974年,制定该定义时,蛋白质的多样性仅表现为分类上的多样性。
分子生物学的发展例如分子文库已使我们可以鉴别更大量的可变碱基,甚至可以从随机文库中选择功能序列。大多数残基可以是变化的,但是通常不都是在同时发生变化,取决于上下文中的补体变化。所以一个含100个氨基酸的蛋白质不仅可能含有2000种不同的突变,而且可能有20100种的突变组合。
信息密度是单位序列长度上的信息含量。酶的活性位点倾向有高的信息密度。相反,酶的可变的连接点有低的信息密度(8)。
在模式文库中目前广泛应用的制造变异蛋白质的方法是易于产生错误的聚合酶链反应(11,12,19)和盒基因诱变(8,20,21,22,40,41,42),其中用合成的诱变寡核苷酸替代有待最佳化的特定区域。在两种情况下,在原始序列中一些位点周围产生了‘突变云’(4)。
易于产生错误的PCR使用了低精确性的多聚化条件以在一个长序列内导入低水平的随机点突变。利用易于产生错误的PCR对未知序列的片段的混合物进行诱变。但是,计算机模拟显示单独进行点诱变经常由于太慢而不能发生为连续序列演化所需要的模块变化。公开的易于产生错误的PCR方案不允许大于0.5-1.0kb的DNA片段进行增殖,从而限制了其在实际中的应用。此外易于产生错误的重复的循环导致中性突变积聚,这种积聚例如产生一个免疫源蛋白质。
在寡核苷酸定位诱变中,用合成的诱变寡核苷酸取代一个短序列。这种方法不会产生远缘突变的组合,因此不是组合的。相对于巨大的序列长度而言有限的文库大小是指使蛋白质最佳化不可避免地要进行许多个周期的选择。用合成的寡核苷酸进行诱变需要在每次选择周期之后对单个克隆进行测序,随后划分到族,任意地选择单一的族,将它减少到共有序列基元,重新合成该序列基元并重新插入到单个基因中,随后进行另一次选择。该方法构成了统计学上的峡口,该方法劳动强度大并且对于许多个周期的诱变是不实用的。
因此易于产生错误的PCR和寡核苷酸定位诱变适用于对序列进行精细调整的单个周期,当用于多个周期时很快受限制。
利用易于产生错误的PCR对未知序列的片段的混合物进行诱变(11,12)。但是公开的易于产生错误的PCR方案(11,12)遭受了聚合酶的低加工性能。因此,该方案不能导致一个平均大小的基因产生随机诱变。这种无能限制了易于产生错误的PCR的实用性。
易于产生错误的PCR另一个严重的限制是具有序列信息内容的反向突变的生长速率。对于一定的信息内容,文库大小,和诱变速率,反向突变到正向突变的平衡从统计学上阻碍了对进一步改善的选择性(统计学限度)。
最后易于产生错误的重复的循环导致中性突变积聚,这种积聚产生例如免疫原性但是没有结合亲和力。
因此易于产生错误的PCR由于太慢而不能发生为连续序列演化所需要的模块变化(1,2)。
在盒诱变中,通常用(部分)随机化的序列替代单链模板的序列模块。因此从统计学上说可以获得的最大信息内容受到随机序列数(即文库大小)的限制。该方法构成了统计学上的峡口,消除了通常不是最好的其它序列族,但是它具有更长周期的潜力。
此外,用合成的寡核苷酸进行诱变需要在每次选择周期之后对单个克隆进行测序(20),因此,该方法劳动强度大并且对于许多个周期的诱变是不实用的。
易于产生错误的聚合酶链反应和盒基因诱变最适合于并且被广泛地用于对相对低信息内容区域进行精细加工。一种明显例外的情况是利用易于产生错误的PCR进行许多个周期的扩增和选择可以从随机文库中选择一种RNA连接酶核糖酶(13)。
用于设计重组线性生物学序列例如蛋白质,RNA和DNA的手段并不象已经研制的手段那样有力量已逐渐显而易见。基于在越来越大的文库内研究越来越多的序列而寻找越来越好的突变体,以及增加诱变扩增和选择的循环数是必要的。但是正如上文中讨论的,当用于重复循环时广泛使用的现存的诱变方法有明显的限制。
通过天然的选择和有性的再生产大多数生物体发生演变。有性再生产可确保所选定的个体的后代的基因进行混合和组合。在有丝分裂期间,来自亲代的同源染色体沿其长度方向以互相并列和交叉部分的方式排列,因此交换了遗传材料。DNA进行这样的交换或混合使生物体可以快速地演化(1,2)。在有性重组中,由于在同源环境中所插入的序列具有实用性,因而一旦插入到新的序列中该插入的序列可能仍具有基本信息内容。
Marton等人(27)描述了在体外利用PCR监测具有直接重复序列的质粒中发生的重组。Marton等人公开了由于DNA的断裂或缺口而在PCR期间出现重组。这样产生重组分子。Meyerhans等人(23)也公开了在体外PCR期间DNA重组的出现。
术语应用分子演变(“AME”)是指为特定的有用目的应用演变的设计的规则系统。而对于多核苷酸(3,11-14),肽和蛋白质(噬菌体(15-17),lacI(18)和多核糖体已经报道了许多不同的AME的模式文库,在这些模式文库中已经使用随机交叉重组随意地制备重组文库。
从理论上说,在一个100个氨基酸的蛋白质中存在2000个不同的单突变。一个含100个氨基酸的蛋白质可能有20100种的突变组合,该数目太大以致于不能用常规方法彻底地开发。研制一种使所有的这些可能的突变组合产生和对此筛选的系统是有利的。
Winter和其合作者(43,44)已经利用一个体外位点特异性重组系统将用于在噬菌体系统中表达的轻链抗体基因与重链抗体基因进行组合。但是,它们的系统依赖于重组的特定位点并且因而受到限制。Hayashi等人(48)报道了通过重叠延伸和PCR而在单链抗体中(scFv)发生的抗体CDR区域的同步诱变。
Caren等人(45)描述了利用体内随机重组而产生大批量的多位点突变的方法。但是这些方法需要两个不同的质粒文库发生重组,每个文库具有不同的选择性标记。因此这种方法仅限制在相当于所存在的选择性标记数目的有限数的重组,并且这些方法还伴随着使连接到选定的序列上的标记基因数目呈线性增加。
Calogero等人(46)和Galizzi等人(47)报道了在位于质粒上的两个同源但被截短的昆虫毒素基因进行体内重组可产生杂合基因。Radman等人(49)报道了在错配修复酶缺陷的缩主细胞中实质上错配的DNA序列进行体内重组,导致形成杂合分子。
研制一种生产突变蛋白的方法是有利的,利用该方法可以研制易于研究的突变核酸序列的大文库。本文描述的发明涉及点诱变的重复循环的使用,核酸混合以及对高度复杂线性序列例如通过随机重组的蛋白质的体外特定的分子演化的选择。
因此,研制一种用于生产突变DNA,RNA和蛋白质的大量文库以及为所需目的选择特定的突变体的方法是有利的。本文描述的发明涉及诱变的重复循环的使用,体内重组以及对高度复杂线性序列例如通过随机重组的蛋白质,DNA,RNA的体外特定的分子演化的选择。
根据下面的描述和参考附图,本发明的进一步的优点是显而易见的。
发明概述
本发明涉及用于制备选定的多核苷酸序列或选定的多核苷酸序列群体的方法,通常所说的序列是被扩增的和/或克隆的多核苷酸形式,从而选定的多核苷酸序列具有用于选择所需要的表型特性(例如,编码多肽,促进被连接的多核苷酸的转录,结合蛋白质等等)。鉴别具有所需结构或功能特性例如结合到预定的生物大分子(例如受体)上的多肽的方法涉及从多肽的大文库中筛选单个的文库成员,该成员具有该多肽的氨基酸所授予的所需的结构和功能特性。
本发明提供了用于生产适合于亲和作用筛选或表型筛选的目的多肽或目的抗体的文库的方法。该方法包括(1)获得第一批大量的选定的文库成员,含有目的多肽或目的抗体和编码所说目的多肽或目的抗体的相关多核苷酸,以及获得所说相关多核苷酸或其复制本,其中所说的相关多核苷酸含有实际上相同序列的一个区域,在所说多核苷酸或复制本中非强制性地引入突变,和(2)在适合于PCR扩增的条件下通常随机地将所说相关多核苷酸或复制本合并和分裂以形成其片段,进行PCR扩增和非强制性地诱变,从而使所说片段同源重组以形成一个重组多核苷酸杂合池(shuffling pool),从而在第一批大量选定的文库成员中不存在所说杂合池的重组多核苷酸的基本片段(例如,大于10%),所说杂合池组成了适合于亲和作用筛选的目的多肽或目的抗体的文库。非强制性地,该方法包括从杂合池中筛选文库成员的附加步骤,以便鉴别具有与预定的大分子,例如一种蛋白质受体,肽,寡糖,病毒颗粒,或其它预定的化合物或结构相结合或相互作用(例如催化抗体)的能力的单个杂合文库成员。目的多肽,抗体,模拟肽抗体,和从这样的文库中鉴别出的可变区序列可用于治疗,诊断,研究,和有关目的(例如催化剂,用于提高水溶液渗透性的溶质等等),和/或可用于一个或多个混合和/或亲和选择的其它的循环。对该方法进行修改,以便使选择步骤除具有与预定的分子亲和结合外还具有表型特性(例如催化活性,稳定性,抗氧化性,抗药性,或授予宿主细胞的可检测表型)。
在一个实施方案中,通过体外PCR将第一批大量选定的文库成员分裂成片段并且同源重组。
在一个实施方案中,体外将第一批大量选定的文库成员分裂成片段,将得到的片段转移到宿主细胞或生物体并且同源重组,体内形成杂合的文库成员。
在一个实施方案中,不将第一批大量选定的文库成员分裂成片段,但是将它克隆在一个脂质体的可复制的载体中或在该载体中扩增为直系重复片段,其中每个重复片段含有一个远缘品种的选定的文库成员序列,将所说载体转移到一个细胞中并且通过内-载体重组方法进行同源重组以便体内形成杂合的文库成员。
在一个实施方案中,提供了体外和体内杂合的组合方法以加强组合多样性。
本发明提供了用于生产适于亲和作用筛选的目的抗体文库的方法。该方法包括(1)获得第一批大量的选定的文库成员,含有目的抗体和编码所说和目的抗体的相关多核苷酸,以及获得所说相关多核苷酸或其复制本,其中所说的相关多核苷酸含有实际上相同的可变区域骨架序列的一个区域,和(2)在适合于PCR扩增的条件下通常随机地将所说相关多核苷酸或复制本合并和分裂以形成其片段,进行PCR扩增和非强制性地诱变,从而使所说片段同源重组以形成一个包含新的CDR组合的重组多核苷酸杂合池,从而在第一批大量选定的文库成员中不存在含有CDR组合的所说杂合池的重组多核苷酸的基本片段(例如,大于10%),所说杂合池组成了适合于亲和作用筛选的含有CDR预突变的目的抗体的文库。非强制性地,将杂合池用于亲和筛选以选出与预定的表位抗原决定基(抗原)结合的杂合文库成员以及从而选出了大量的选定的杂合文库成员。非强制性地,将选定的杂合文库成员进行杂合并且重复地筛选1-1000个循环或者按照需要直到获得具有所需结合亲和力的文库成员。
因此,本发明的一个方面提供了一种方法,包括将一个或多个突变导入到模板双链多核苷酸中,其中通过将一个或多个单链或双链寡核苷酸加到得到的双链片段群体上,已经将模板双链多核苷酸裂解为所需大小的随机片段,其中所说的寡核苷酸含有一个等同于模板多核苷酸的区域和异源于模板多核苷酸的区域;使得到的双链随机片段和寡核苷酸的混合物变性为单链片段;将得到的单链片段群体与一种聚合酶一起保温,保温条件是使所说的单链片段退火在相当于该单链片段的区域上并且形成诱变的双链多核苷酸;并且按照需要重复上述步骤。
另一方面,本发明涉及生产具有生物学活性的重组蛋白质的方法,包括通过在使所说模板多核苷酸裂解为具有所需大小的随机双链片段的条件下处理含有编码野生型蛋白质的双链模板多核苷酸的样本;将一个或多个单链或双链寡核苷酸加到得到的随机片段群体上,其中所说的寡核苷酸含有一个等同于模板多核苷酸的区域和异源于模板多核苷酸的区域;使得到的双链随机片段和寡核苷酸的混合物变性为单链片段;将得到的单链片段群体与一种聚合酶一起保温,保温条件是使所说的单链片段退火在等同区域上并且形成诱变的双链多核苷酸;按照需要重复上述步骤,以及然后从诱变的双链多核苷酸表达该重组蛋白质。
本发明的第三个方面涉及获得嵌合多核苷酸的方法,包括在使所说模板多核苷酸裂解为具有所需大小的随机双链片段的条件下处理含有不同双链模板多核苷酸的样本,其中所说的不同模板多核苷酸含有一个等同区域和异源区域;使得到的含有被处理样本的双链随机片段变性为单链片段;将得到的单链片段与一种聚合酶一起保温,保温条件是使所说的单链片段退火在等同区域上并且形成一种嵌合的双链多核苷酸序列,该序列含有模板多核苷酸序列;并且按照需要重复上述步骤。
本发明的第四个方面涉及复制模板多核苷酸的方法,包括通过体外将单链模板多核苷酸与由模板多核苷酸的裂解和变性产生的随机单链小片段结合,以及在核酸多聚酶存在下保温所说的核酸片段混合物,保温条件是形成双链模板多核苷酸群体。
本发明还提供了将体外和/或体内多核苷酸杂合方法用于使编码多肽的多核苷酸和/或含有转录调节序列的多核苷酸进行杂合。
本发明还提供了将多核苷酸杂合方法用于使病毒基因(例如衣壳蛋白,针尖糖蛋白,聚合酶,蛋白酶等等)或病毒基因组(例如副粘病毒科,正粘病毒科,疱疹病毒,反录病毒,呼肠病毒,鼻病毒等等)群体进行杂合。在一个实施方案中,本发明提供了使编码整个或部分免疫病毒蛋白的序列进行杂合以产生新组合的表位决定基以及由重组产生的新的表位决定基的方法;这种杂合的病毒蛋白可以含有表位决定基或表位决定基的组合,它们可能在病毒演变(例如流感病毒菌株的重组)的天然环境中产生。
本发明还提供了适于使多核苷酸序列杂合的方法,用于产生基因治疗载体以及复制缺陷型基因治疗构件体,例如可用于人的基因治疗,包括但不限于基于DNA的免疫接种的免疫接种载体,以及抗瘤形成的基因治疗和其它基因治疗方法。
附图简述
附图1图解比较由易于产生错误的PCR进行的诱变杂合;(a)起始文库;(b)在亲和选择的第一个周期中选定序列的集合体;(d)选定序列的体外重组(‘杂合’);(f)在杂合之后亲和选择的第二个周期中选定序列的集合体;(c)易于产生错误的PCR;(e)在易于产生错误的PCR之后亲和选择的第二个周期中选定序列的集合体。
附图2描述了1.0kb LacZα基因片段与10-50bp随机片段的重组。(a)具有LacZα基因的DNA片段经PCR扩增后凝胶电泳的照片。(b)在用DNA酶I(DNAseI)消化之后的DNA片段凝胶电泳下照片。(c)从被消化的LacZα基因DNA片段纯化的10-50bpDNA片段的凝胶电泳的照片;(d)在DNA重组进行指定数目的周期之后10-50bpDNA片段的凝胶电泳的照片;(e)在用引物进行PCR扩增之后重组混合物凝胶电泳的照片。
附图3图解描述了LacZα基因终止密码子突变体和其DNA序列。加方框的区域是异源区,作为标记。该终止密码子定位于较小的框中或者底下划线。“+”表示野生型基因,“-”表示该基因的突变区。
附图4图解描述一个合成的寡核苷酸导入或插入的LacZα基因的重组过程中。
附图6图解显示用scFv的抗兔IgG抗体(A10B)的抗体CDR杂合模型系统。
附图7描述在scFv的抗兔IgG抗体(A10B)的杂合DNA中观察到的CDRs的特定组合出现的频率。
附图8描述了在DNA杂合和每个选择周期之后scFv的抗兔IgG抗体的改善的亲和力。
附图9图解描绘了pBR322-Sfi-BL-LA-Sfi和通过直系重复区进行的体内质粒内重组,以及由重新构成一个功能性β-内酰胺酶质粒内重组产生氨苄青霉素抗性菌落的速率。
附图10图解描绘了pBR322-Sfi-2Bla-Sfi和通过直系重复区进行的体内质粒内重组,以及由重新构成一个功能性β-内酰胺酶质粒内重组产生氨苄青霉素抗性菌落的速率。
附图11描述了用于检测将多核苷酸片段导入到产生重组蛋白的细胞之后多个周期同源重组的效率的方法。
附图12图解描绘了通过基因盒在下列位点杂合而产生的载体文库:启动子,前导肽,终止子,可选择的抗药性基因,和复制原点。在每个位点的多条平行线表示对于那个盒具有盒多样性。
附图13图解显示在各个位点适合于通过杂合方法构建原核载体文库的盒的一些例子。
优选实施例的描述
本发明涉及用于在随机片段化之后核酸分子发生重组的方法以及将该方法用于DNA序列的诱变。还描述了用于生产编码具有增强的生物活性的突变蛋白的核酸片段的方法。尤其是,本发明还涉及重复循环的诱变,核酸杂合和可以制备具有增强的生物活性的突变蛋白的选择的方法。
本发明涉及产生DNA,RNA或蛋白质突变体的极大文库的方法。该方法在产生可选出所需核酸片段的有关DNA片段方面有特别的优点。特别是本发明还涉及重复循环的诱变,同源重组和可以制备具有增强的生物活性的突变蛋白的选择的方法。
但是在详细讨论本发明之前,首先定义下列术语。
定义
如本文所用,下列术语具有下列含义:
术语“DNA重组”用于指两个相同序列之间出现重组。
相反,术语“DNA杂合”用于指基本上同源但不相同的序列之间的重组,在一些实施方案中,DNA杂合是指非同源重组出现的交叉,例如借助于cre/lox和/或flp/frt系统等等。
术语“扩增”是指增加一个核酸片段的拷贝数。
术语“相同”或“等同”是指两个核酸序列具有相同序列或一个互补序列。因此“等同区域”是指一个核酸片段或多核苷酸的区域相同或互补于另一个多核苷酸或核酸片段。
术语“相应于”是指一个多核苷酸序列与整个或部分参照多核苷酸序列同源(即相同,演化上不严格相关),或者是指一个多肽序列等同于参照多肽序列。与之相区别,本文中使用的术语“互补于”是指该互补序列与整个或部分参照多核苷酸序列同源。为了描述,核苷酸序列“TATAC”对应于参照序列“TATAC”并且互补于参照序列“GTATA”。
下列术语用于描述两个或多个多核苷酸之间的序列关系:“参照序列”,“比较窗口”,“序列等同性”,“序列等同百分数”和“基本等同”。“参照序列”是指用作为序列比较的基础的一个选定的序列;参照序列可以是较大序列一个子集,例如在序列表给出的全长cDNA或基因序列的片段,例如图1或图2(b)的多核苷酸序列,或者可以包括完整的cDNA或基因序列。通常,参照序列是长度为至少20个核苷酸,通常长度为至少25个核苷酸,以及经常长度为至少50个核苷酸。由于两个多核苷酸可以各(1)含有两个多核苷酸之间相类似的一个序列(即,整个多核苷酸序列的一部分),(2)进一步可含有两个多核苷酸之间差异较大的一个序列,通常通过借助于“比较窗口”对两个多核苷酸序列进行比较以鉴别和比较定位区序列相似性通常可完成对两个(或多个)多核苷酸序列的比较。
本文中使用的“比较窗口”是指至少20个连接位点片段,其中多核苷酸序列相当于至少20个连接核苷酸的参照序列以及其中将两个序列最佳排列之后与参照序列(不含有叠加或缺失)相比比较窗口中多核苷酸序列的一部分可以含有20%或者更少的叠加或者缺失(即缺口)。采用Smith and Waterman(1981)Adv.App1.Math.2:482的位点同源规则,采用Needleman and Wunsch(1970)J.Mol.Biol.48:443的同源排列规则,根据Pearson and Lipman(1988)Proc.Natl.Acad.Sci.(U.S.A.)85:2444对相似方法的研究,这些规则的计算机应用(GAP,BESTFIT,FASTA,and TFASTA in the Wisconsin Genetic Software Package Release 7.0,GeneticsComputer Group,575 Science Dr.,Madison,WI),或者通过检查可以完成对比较窗口进行排列而使序列排列最佳,并且选出有各种方法产生的最佳排列(即产生比较窗口的最高同源百分数)。
术语“序列等同性”是指两个多核苷酸序列的比较窗口是相同的(即,以一个核苷酸接一个核苷酸为基础)。术语“序列等同百分数”是通过下列方法计数的:将两个最佳排列的序列的比较窗口进行比较,测定两个序列上出现等同核酸碱基(例如,A,T,C,G,U,或I)的位置的数目以得出错配位置的数目,将错配位置的数目除于比较窗口中总位置数目(即窗口大小),以及将得到的结果乘于100以产生序列等同百分数。本文中使用的术语“基本等同”是指多核苷酸序列的特性,其中该多核苷酸含有一个序列,在至少20个核苷酸位置,最常见的是至少25-50个核苷酸的比较窗口内,该序列与参照序列至少有80%的序列等同性,优选地至少85%等同以及通常为90-95%序列等同,最通常为99%序列等同,其中通过将参照序列与多核苷酸序列进行比较而计算出序列等同百分数,所说多核苷酸可以含有参照序列比较窗口内总共20%或更少序列的缺失或叠加。
保守的氨基酸组成是指可内部转化的具有相似侧链的残基。例如,具有脂族侧链的一组氨基酸是甘氨酸,丙氨酸,缬氨酸,亮氨酸,和异亮氨酸;具有脂族-羟基侧链的一组氨基酸是丝氨酸,和苏氨酸;具有含酰胺侧链的一组氨基酸是天冬氨酸和谷氨酰胺;具有芳香族侧链的一组氨基酸是苯丙氨酸,酪氨酸和色氨酸;具有碱性侧链的一组氨基酸是赖氨酸,精氨酸和组氨酸;具有含硫侧链第一组氨基酸是半胱氨酸和甲硫氨酸。优选的保守氨基酸组成基团是:缬氨酸-亮氨酸-异亮氨酸,苯丙氨酸-酪氨酸,赖氨酸-精氨酸,丙氨酸-缬氨酸,和天冬氨酸-谷氨酰胺。
术语“同源”是指一个单链核酸序列与一个互补单链核酸序列杂交。杂交程度取决于多个因素,包括序列之间等同数目和杂交条件例如温度和下文中讨论的盐浓度。优选地等同区域是大于约5bp,更优选地等同区域是大于约10bp。
术语“异源”是指一个单链核酸序列不能与另一个单链核酸序列后其互补酸序列杂交。因此,异源区域是指具有不能与另一个核酸或多核苷酸杂交的序列的区域的核酸片段或多核苷酸。例如这样的区域是突变区。
本文中使用的术语“关连”是指品种之间演化和功能上相关的一个基因序列。例如但不限于,在人基因组中,人CD4基因与鼠CD4基因是一个关连基因,因为这两个基因的序列和结构显示它们是高度同源的并且两个基因编码一个蛋白质,该蛋白质通过MHCII型限定的抗原识别而在作为标记的T细胞活化中起作用。
术语“野生型”是指不含有任何突变的核酸片段。一种“野生型”蛋白质是指在天然存在的活性水平上时该蛋白质是有活性的并且含有天然存在的氨基酸序列。
术语“相关的多核苷酸”是指该多核苷酸区域是相同的并且该多核苷酸区域是异源的。
术语“嵌合多核苷酸”是指该多核苷酸含有野生型区域以及被突变的区域。也是指该多核苷酸含有来自一个多核苷酸的野生型区域以及来自另一个相关多核苷酸的野生型区域。
术语“切割”是指用酶消化一个多核苷酸或裂解该多核苷酸。
本文中使用的术语“群体”是指成分例如多核苷酸,核酸片段或蛋白质的集合。一种“混合的群体”是指属于相同核酸或蛋白质族(即相关)但是其序列不同(即不相同)因此其活性不相同的成分的集合。
术语“特定的核酸片段”是指具有一定的端点并且具有一定的核酸序列的核酸片段。两个核酸片段具有两个不同的特定的核酸片段,这两个核酸片段中一个核酸片段具有相同于第二个核酸片段的一部分但是末端不同的序列。
术语“突变”是指野生型核酸序列内发生变化或肽序列内发生变化。这样的突变可以是点突变例如碱基转换或者转变。突变可以是缺失,插入或者复制。
在本文中使用的肽标记中,按照标准用法和规律左手方向是氨基末端方向,右手方向是羧基末端的方向。类似地,除非有特定的说明,单链多核苷酸序列的左手末端是5′末端;双链多核苷酸序列所左手末端是5′末端。5′3′新生RNA转录物的叠加方向是指转录方向;位于具有类似于RNA的序列的DNA链上并且是5′至RNA转录物的5′末端的序列区域称为“上游区域”;位于具有类似于RNA的序列的DNA链上并且是3′至编码RNA转录物的3′末端的序列区域称为“下游区域”。
本文中使用的术语“天然存在”用作为指物体时是指该物体可以在自然界中发现指定事实。例如,存在于可从天然来源分离的生物体(包括病毒)中并且人类并不想在实验室中将它修饰的多肽或多核苷酸序列是天然存在的。通常,术语天然存在是指存在于非病原(未发病)个体中的物体,例如典型物种。
本文中使用的术语“试剂”是指化合物,化合物的混合物,一系列空间定位的化合物(例如,VLSIPS肽列阵,多核苷酸列阵,和/或小分子组合列阵),生物学大分子,噬菌体肽陈列文库,噬菌体抗体(例如,scFv)陈列文库,多核糖体肽陈列文库,或从生物材料例如细菌,植物,真菌或动物(特别是哺乳动物)细胞或者组织。通过参与下文中描述的筛选方法,评价这些试剂作为抗瘤形成,抗炎性或者apoptosis调节子的活性。通过参与下文中描述的筛选方法,评价这些试剂作为特定蛋白质相互作用抑制剂的活性(即,选择性地抑制两种预定多肽之间的相互作用但是基本上不干扰细胞存活性的一种试剂)。
如本文中使用的,“基本上纯化”是指一个物种以优势种存在(即以摩尔为基础,它在该组合物中比其它单个大分子品种的含量更丰富),优选地,一种基本纯化组分是指其中该物种的含量至少为存在的所有大分子的50%(以摩尔计)的组合物。通常,一种基本上纯化的组合物含有该组合物中所有大分子的80-90%以上。更优选地,将该物种纯化至基本上匀质(采用常规方法不能检测出该组合物中的污染物),其中该组合物基本上由单一大分子组成。溶剂,小分子(<500道尔顿),基本离子不认为是大分子。
如本文中使用的,术语“生理条件”是指温度,pH,离子强度,粘度,和类似的生化参数,这些参数与活生物体相对应,和/或通常存在于培养的酵母活细胞或哺乳动物细胞内的条件。例如,在常规实验室培养条件下生长的酵母细胞的胞内条件是生理条件。通常用于体外转录的合适的体外反应条件是生理条件。一般地说,体外生理条件包括50-200mMNaCl或KCl,pH 6.5-8.5,20-45℃和0.001-10mM二价阳离子(例如,Mg++,Ca++);优选地,约150mMNaCl或KCl,pH7.2-7.6,5mM二价离子,通常包括0.01-1.0%非特异蛋白(例如,BSA)。通常存在约0.001-2%的非离子型去污剂(吐温,NP-40,Triton X-100),典型的是0.05-0.2%(v/v)。由常规方法的实践者选定特定的含水条件。对于常规应用,可以应用下列缓冲含水条件:10-250mMNaCl,5-50mM Tris HCl,pH 5-8,非强制性地加入二价阳离子,和/或金属螯合剂和/或非离子型去污剂和/或膜组分和/或消沫剂和/或闪烁材料。
本文中特定的杂交定义为在第一多核苷酸和第二多核苷酸(例如,具有独特的但是与第一多核苷酸基本相同的序列的多核苷酸)之间形成杂合体,其中在严谨杂交条件下第一多核苷酸优选与第二多核苷酸杂交,其中基本上不相关的多核苷酸序列在混合物中不形成杂合体。
如本文中使用的,术语“单链抗体”是指含有以多肽键连接的VH区和VL区,通常通过间隔肽(例如,[Gly-Gly-Gly-Gly-Ser]x)连接并且在氨基末端和/或羧基末端含有其它的氨基酸序列的一个多肽。例如,单链抗体含有用于连接到编码多核苷酸上的一个限制片段。作为举例,scFv是一个单链抗体。单链抗体通常是由一个或多个多肽片段组成的蛋白质,所说多肽片段至少含基本由免疫球蛋白超家族的基因编码的(例如,参见The Immunoglobulin Gene Superfamily,A.F.Woilliams and A.N.Barclay,in Immunoglogulin Genes,T.Honjo,F.W.Alt,and T.H.Rabbitts,eds.,(1989)Academic Press:San Diego,CA,pp.361-387,引入本文作为参考),最常见是由啮齿动物,非人灵长类,鸟类,猪,牛,绵羊,山羊,或者人重链或者轻链基因序列编码的10个相邻氨基酸。通常一个单链抗体含有大部分的免疫球蛋白超家族产物以致于保留了与特定的靶分子,通常一种受体或者抗原(表位决定基)结合的特性。
如本文中使用的,术语“互补决定区”和“CDR”是指本领域内认可的术语如由Kabat和Chothia例举的CDR定义,通常也称为极度可变区或极度可变环(Chothia and Lesk(1987)J.Mol.Biol.196:901;Chothia et al.(1989)Nature 342:877;E.A.Kabat et al.,Sequence of Proteins of Immunological Interest(National Institutesof Health,Bethesda,MD)(1987);and Tramontano et al.(1990)J.Mol.Biol.215:175)。通常可变区域含有天然存在的免疫球蛋白(例如1-110位氨基酸)的约105-115氨基酸氨基末端,尽管更短或更长的可变区域也适合于形成单链抗体。
免疫球蛋白轻链或重链可变区由“主链”区组成,该主链区被三个极度可变区,也称为CDR’s打断。该主链区和CDR’s的长度已被精确地定义(参见“Sequencesof Proteins of Immunological Interest,”E.Kabat et al.,4th Ed.,U.S.Department ofHealth and Human Services Bethesda,MD(1987))。在一个品种内不同轻链或重链的主链区序列是非常保守的。如在本文中使用的,“人骨架区”是一个主链区,它基本上等同(约85%或更多,通常90%-95%或更多)于天然存在的人免疫球蛋白的主链区。作为组成型轻链和重链的组合主链区的一种抗体的主链区可用作为定位和排列CDR’s。该CDR’s主要具有结合到抗原的表位决定基上的作用。
如本文中使用的,术语“可变片段”是指新生肽的一部分,该肽含有一个随机的,假随机的,或限定的核心序列。可变片段可以含有变异的和非变异的残基位置,可以限制一个变异残基位置上残基变异的程度;两种选择由实践者的意见来决定。通常,可变片段的长度是约5-20个氨基酸残基(例如8-10),但是可变片段也可以更长并且可含有抗体部分或受体蛋白,例如抗体片段,核酸结合蛋白,受体蛋白等等。
如本文中使用的,“随机肽序列”是指由两个或多个氨基酸单体组成并且由随机过程构建的氨基酸序列。一种随机肽可包括主链或支架基元,它可以含有非变异序列。
如本文中使用的,“随机肽文库”是指编码一组随机肽的一组多核苷酸序列,并且指由这些多核苷酸序列编码的该组随机肽,以及含有这些随机肽的融合蛋白。
如本文中使用的,术语“假随机”是指具有有限的可变性的一组序列,以至于例如一个位置上的残基变异程度不同于另一个位置上的残基变异程度,但是任何假随机位置都被允许有一定的残基变异程度,但变异程度是有限的。
如本文中使用的,术语“限定的序列骨架”是指以非随机方法,通常以试验数据和结构资料为基础选出的一组限定的序列;例如限定的序列骨架含有被预测为可形成β-片层结构的一组氨基酸序列或者含有一个亮氨酸拉链型七个一套的重复基元,一个锌--指状物区域,其它为变异区。“限定的序列核心”是变异性有限的一套序列。(1)一个20个常规氨基酸的序列的完全随机的十聚体可以是(20)10序列,(2)一个20个常规氨基酸的序列的假随机的十聚体可以是(20)10序列,但是在特定位置和/或整个序列显示偏向于特定残基,(3)限定的序列核心是一组序列,如果每个残基位置允许是所说20个常规氨基酸(和/或允许的非常规氨基/亚氨基酸)的任一种则该组序列数低于可能序列数的最大数目。通常限定的序列核心在选定单个文库成员序列的片段上或整个长度内含有变异和非变异残基位点和/或含有变异残基位点,这些位点可含有选自于限定的氨基酸残基亚组的一个残基等等。选定的序列核心可以指氨基酸序列或多核苷酸序列。为了说明而不是为了限制,对序列(NNK)10和(NNM)10选定了序列核心,其中N代表A,T,G,或C;K代表G或T,和M代表A或C。
如本文中使用的,“表位决定基”是指一个抗原或其它大分子上能够形成结合作用的组分,它与一种抗体的可变区结合位置发生相互作用。通常这样的结合作用显示为与CDR的一个或多个氨基酸残基发生分子内接触。
如本文中使用的,“受体”是指与一个给定的配体有亲和力的分子。受体可以是天然存在或合成的分子。可以使用非变化状态的受体或者与其它种的结合体形式的受体。可以直接或借助于一个特定的结合物质将受体共价或非共价吸附到结合成员上。受体的例子包括但不限于与特定的抗原决定基(例如病毒上的,细胞,或其它材料)发生反应的抗体,包括单克隆抗体和抗血清,细胞膜受体,碳水复合物和糖蛋白,酶和激素受体。
如本文中使用的,“配体”是指由特定的受体识别的一种分子,例如随机肽或变异片段序列。如本领域内任一熟练技术人员将认识到,一个分子(分子大分子复合物)即可以是受体又可以是配体。通常具有较小分子量的结合配对体被称为配体,具有较大分子量的结合配对体被称为受体。
如本文中使用的,“连接头”或“间隔区”是指分子或连接两个分子的分子团,例如DNA结合蛋白和一种随机肽,并且将两个分子以优选的构型放置,(例如使该随机肽结合到与DNA结合蛋白有基本空间障碍的一个受体上)的一个分子或一组分子。
如本文中使用的,术语“可操作连接”是指多核苷酸元素以一定的功能关系进行连接。当置于功能关系中时一种核酸与另一种核酸序列可操作连接。例如如果实现了该编码序列的转录则一种启动子或增强子可操作连接到一编码序列上。可操作连接是指通常被连接的DNA序列是相邻的,并且如果必须要连接二个蛋白质编码区,它们是相邻的并且在阅读框架内。
方法论
核酸杂合方法是用于核酸片段或多核苷酸集合体的体外或体内同源重组的方法。将相关核酸序列或多核苷酸序列的混合物随机地裂解成片段,并且重新装配以产生重组核酸分子或多核苷酸的文库或混合群体。
与盒诱变相反,单独的杂合和易于产生错误的PCR可以将序列集合体盲目地突变(除引物外没有序列信息)。
最好是用抗体遗传工程的实例来解释在重复选择时使用本发明的诱变杂合比仅用易于产生错误的PCR具有优点。在附图1中显示了下文中描述的DNA杂合方法。起始文库由各种来源的相关序列(即来自天然mRNA的抗体)组成或者由任何类型的单抗体基因诱变(包括杂合)产生。在第一轮亲和选择之后得到了选定的互补决定区的集合(“CDRs”)(图1)。在该图中浓的CDRs使抗体分子与抗体的亲和力增强。杂合方法使所有的CDR1s和所有的CDR2s和所有的CDR3s等等自由组合(图1)。
该方法不同于PCR,不同之处在于它是一个逆转链反应。在PCR中,聚合酶起始位点的数目和分子数目呈指数增长。但是聚合酶起始位点的序列和该分子的序列基本保持相同。相反在随机片段的核酸重组或杂合方法中,起始位点的数目和随机片段的数目(但不是大小)同时降低。对于从整个质粒衍生的片段理论上的关键点是一种单链,大多联体分子。
由于在同源区域出现了交叉,因此首先在相同序列族成员之间出现重组。这阻碍了严重不相容的(例如抗相同抗原的不同表位决定基)的CDRs的组合。观察到在相同反应中多个序列族可以杂合。此外杂合保存了相对位置序列,以至于例如在CDR2位置上未发现CDR1。
稀有的杂合体含有大量的最好的(例如最高亲和力)CDRs并且基于其优异的亲和力可以选出这些稀少的杂合体(图1)。
以高达1006不同方法可以将来自100个不同的选定的抗体序列的集合体的CDRs排列。在DNA序列单个文库中不能体现这大量的排列。因此,根据序列长度和所需序列的多样性决定需要进行的DNA杂合和选择的多次循环。
相反易于产生错误的PCR在同样的相关序列内保留了所有选定的CDRs(图1),产生了更小的突变云。
在本发明方法中使用的模板多核苷酸可以是DNA或RNA。根据重组或重装配的基因或DNA片段的大小模板具有不同的长度。优选地模板多核苷酸大小从50bp--50kb。在本发明的方法中可以使用含有编码所需蛋白质的所需核酸的完整载体,事实上已经成功地使用。
通过利用PCR反应进行扩增(美国专利№4683201和4683195)或其它扩增或克隆方法可以获得模板多核苷酸。但是,在分裂成片段之前从PCR产物中除去游离引物可以获得更有效的结果。不能合适地除去引物可以导致产生低频率的交叉克隆。
通常模板多核苷酸应该是双链的。要求双链核酸分子可以确保得到的单链核酸片段的区域互相互补,由此可以杂交以形成双链分子。
在该步骤中将具有等同于模板多核苷酸的区域和异源于模板多核苷酸的区域的单链或双链核酸片段加到模板多核苷酸上。还涉及在该步骤中将两个不同但相关的多核苷酸模板混合。
将双链多核苷酸模板和任何增加的双链或单链片段随机地消化为约5bp--5kb或更大的片段。优选地随机片段的大小为约10bp--1000bp,更优选地随机片段的大小为约20bp--500bp。
另一种可选的方法,还涉及在本发明的方法中使用具有多个缺口的双链核酸。一个缺口是在双链核酸的一条链上有一断裂。所说缺口之间的距离优选的是5bp--5kp,更优选的是10bp--1000bp。
可用许多不同的方法消化核酸片段。可用核酸酶,例如DNA酶I或RNA酶消化核酸片段。采用超声处理方法或通过一个有小洞的管可以随机的剪切核酸。
还涉及用一种或多种限制性酶部分消化核酸,以至于从统计学上保留了交叉点。
任何一种特定核酸片段的浓度不会大于总核酸重量的百分之一,更优选的任何一种特定核酸片段的浓度不会大于总核酸重量的0.1%。
在该混合物中不同的特定核酸片段的数目至少为约100,优选的至少约500,更优选至少约1000。
在该步骤中将合成的或天然的单链或双链核酸片段加到随机双链片段上以便提高该核酸片段混合物的不均匀性。
在该步骤还涉及将随机断裂的双链核酸片段群体混合或组合。
如果需要在模板多核苷酸中插入突变,则以相当于总核酸重量20倍的过量加入具有等同于模板多核苷酸的区域和具有异源于模板多核苷酸的区域的单链或双链核酸片段,更优选地,加入相当于总核酸重量10倍的过量的单链核酸片段。
如果需要不同但相关的模板多核苷酸的混合物,以低于1∶100的比例,更优选地以低于1∶40的比例将来自每个模板的核酸片段群体组合。例如,按照需要将野生型多核苷酸与突变多核苷酸群体回交以去除中性突变(例如,产生所选定的表型特性发生非本质变化的突变)。在一个实施例中,加到随机消化的突变多核苷酸上的随机消化的野生型多核苷酸片段的比例是约1∶1-约100∶1,并且更优选的是从1∶1-40∶1。
将随机发生片段的混合群体变性以形成单链核酸片段并且随后重退火。只有具有与其它单链核酸片段同源的区域的那些单链核酸片段将会退火。
通过加热,随机核酸片段可以变性。本领域内技术人员可以确定使双链核酸完全变性所必须的条件。优选地温度是80℃-100℃,更优选地温度是90℃-96℃。可用于使核酸片段变性的其它方法包括压力(36)和pH。
通过冷却可将核酸片段重退火。优选地温度是20℃-75℃,更优选地温度是40℃-65℃。如果基于仅四个基本碱基同源性的平均值需要高频率的交叉,通过使用低退火温度可以加强重组,尽管该方法变为更复杂。出现变性的程度将依赖于单链核酸片段群体之间同源性的程度。
通过加入聚乙二醇(“PEG”)或盐可以加速变性恢复。优选的盐浓度是从0mM-200mM,更优选的盐浓度是从10mM-100mM。所说盐可以是KCl或NaCl。优选地PEG浓度是0%-20%,更优选地5%-10%。
接着在核酸聚合酶和dNTP′s(即dATP,dCTP,dGTP和dTTP)存在下保温退火的核酸片段。核酸聚合酶可以是Klenow片段,Taq聚合酶或本领域内已知的其它DNA聚合酶。
重组所使用的方法取决于应该产生回交的同源性的基本程度。如果等同区域较大,可将Taq聚合酶与45-65℃的退火温度一起使用。如果等同区域较小,可将Klenow聚合酶与20-30℃的退火温度一起使用。本领域技术人员可以改变退火的温度以增加回交的数目。
可以在退火之前,与退火同时或退火之后将聚合酶加到随机核酸片段上。
在聚合酶存在下变性,变性恢复和保温的循环是指核酸的杂合或重组。将该循环重复预定的时间。优选的将该循环重复2-50次,更优选的重复10-40次。
得到的核酸是约50bp--约100kb的较大的双链多核苷酸,优选的较大多核苷酸是500bp--50kb。
该较大的多核苷酸片段可以含有互相串联的多个拷贝的核酸片段,该核酸片段的大小相同于模板多核苷酸。然后将该多联体片段消化为多拷贝的模板多核苷酸。结果产生大小几乎相同于模板多核苷酸的核酸片段群体。该群体是一个混合群体,其中在杂合之前已经向模板多核苷酸加入了具有等同区和异源区的单链或双链核酸片段。
然后将这些片段克隆到合适的载体中并将该连接混合物用于转化细菌。在克隆之前利用各种各样的方法包括PCR(美国专利№4683195和4683202)扩增单链合适片段而不是通过消化多联体可以从较大的多联体核酸片段获得单链核酸片段。
用于克隆的载体不是关键的,条件是它可以接受所需大小的DNA片段。如果需要该DNA片段进行表达,该克隆载体应该进一步含有与该DNA片段插入位点相连接的转录和转译信号以使该DNA片段在宿主细胞中表达。优选的载体包括pUC质粒系列和pBR质粒系列。
得到的细菌群体包括含有具有随机突变的许多重组DNA片段。对该混合群体进行检测以鉴别所需的重组核酸片段。选择方法取决于所需DNA片段。
例如如果需要为具有与配体的结合效力增强的蛋白质编码的DNA片段,采用本领域内已知的方法(即panning,亲和层析)检测由该群体或文库中每个DNA片段表达的蛋白质结合到配体上的能力。如果需要编码抗药性增加蛋白质的DNA片段,检测由该群体或文库中每个DNA片段表达的蛋白质授予宿主生物体抗药性的能力。本领域内技术人员借助于所需蛋白质的有关知识,很容易检测该群体以鉴别授予该蛋白质所需特性的DNA片段。
本发明涉及本领域内技术人员可以使用有关噬菌体展示系统,在该系统中在噬菌体的表面表达融合蛋白形式的蛋白质片段(Pharmacia,Milwaukee WI)。在导致融合蛋白转录的位点处将重组DNA分子克隆到噬菌体DNA中,该融合蛋白的一部分是由重组DNA分子编码的。含有重组核酸分子的噬菌体在细胞中进行复制或转录。该融合蛋白的前导序列指导该融合蛋白运输到噬菌体颗粒的顶端。因此由重组DNA分子部分编码的融合蛋白陈列于噬菌体颗粒上,采用上面描述的方法可以检测和选择。
本发明进一步涉及用来自第一群体的亚群体的核酸片段进行多个循环的核酸杂合,所说亚群体含有编码所需重组蛋白的DNA。按这种方式,可以获得有较高结合亲和力或酶促活性的蛋白质。
本发明还涉及用野生型核酸片段和来自第一或随后轮次的核酸杂交的核酸亚群体的混合物可以进行多个循环的核酸杂合,以便从亚群体中去除静止突变。
可以利用任何来源的纯化形式的核酸作为起始核酸。因此该方法可以利用DNA或RNA包括信使RNA,其中DNA或RNA可以是单链或双链。另外,可以利用含有各一条链的DNA-RNA杂合体。依据待诱变的核酸序列的大小,所说核酸序列可以是各种长度。优选的特定的核酸序列是50-50000bp。还涉及在本发明的方法中可使用含有编码所需蛋白质的核酸的完整载体。
可以从任何来源例如从质粒如pBR322,从克隆DNA或RNA或从来自细菌,酵母,病毒和高等生物如植物或动物的天然DNA或RNA获得核酸。可以从血液或组织材料中提取DNA或RNA。通过利用多核苷酸链反应(PCR)进行扩增可以获得模板多核苷酸(美国专利№4683202和4683195)。另一种方法,在存在于细胞中的载体中含有该核苷酸,并且通过培养该细胞和采用本领域内已知的方法从该细胞中提取核酸可以获得足够量的核酸。
采用本发明的方法可以利用任何特定的核酸序列生产突变群体。只需要在本发明方法之前存在或制造特定核酸序列的突变序列的小群体。
可采用许多不同的方法制备含有突变的特定核酸序列的起始小群体。采用易于产生错误的PCR可制备突变。易于产生错误的PCR利用低精确性的聚合条件以在整个序列长度内随机导入低水平的点突变。另一种方法,采用寡核苷酸定位诱变方法可将突变导入到模板多核苷酸中。在寡核苷酸定位诱变方法,利用限制性酶消化从该多核苷酸上去除短序列多核苷酸并且用一个合成多核苷酸取代,其中该合成的多核苷酸的各个碱基已经从原始序列发生变化。还可采用化学诱变方法改变该多核苷酸。化学诱变包括例如亚硫酸钠,亚硝酸羟胺,肼或甲酸。作为核酸前体类似物的其它试剂包括亚硝基胍,5-溴代尿嘧啶,2-氨基嘌呤或者吖啶。通常将这些试剂加到PCR反应中替代核酸前体从而使该序列突变。还可以使用插入试剂例如副核黄素,吖啶黄素,喹吖因等等。通过用X射线或紫外光照射也可以获得多核苷酸序列的随机诱变。通常,将如此诱变的质粒DNA或DNA片段导入到大肠杆菌中并且繁殖成突变质粒集合或文库。
另一种可用的方法找到了天然存在的特定核酸的混合小群体,它们由相同基因的不同等位基因或者不同相关种类的相同基因(即同族基因)组成。另一种可选择的方法,它们是一个种类存在的相关DNA序列,例如免疫球蛋白基因。
一旦产生了特定核酸分子的混合群体,可直接使用该多核苷酸或者利用本领域内熟知的技术将它插入到合适克隆载体中。
载体的选择依赖于多核苷酸序列的大小和本发明方法使用的宿主细胞。本发明的模板可以是质粒,噬菌体,粘粒,噬菌粒,病毒(例如反录病毒,副流感病毒,疱疹病毒,呼肠病毒,副粘病毒等等)或其选定的部分(例如包膜蛋白,针尖糖蛋白,衣壳蛋白)。例如,粘粒和噬菌粒是优选的,其中待诱变的特定核酸序列较大,因为这些载体能够稳定地繁殖大核酸片段。
如果将特定的核酸序列的混合群体克隆到一个载体中,通过将该各个载体插入到宿主细胞中并且使该宿主细胞扩增载体可以扩增该群体。这种方法称为克隆扩增,因为当核酸序列的绝对数增加时,突变数没有增加。
实用性
可以在未知序列的集合体中实施本发明的DNA杂合方法。通过在任何特定位点上将任何序列混合物加入到重组混合寡核苷酸(具有与被重组的序列同源的末端),而将该序列混合物掺入到另一序列混合物中,因此本发明还涉及将合成寡核苷酸,PCR片段或者整个基因的混合物在限定的位置上混合到另一序列中。一个序列(混合物)的插入不依赖于一个序列插入到该模板的另一部分中。因此重组程度所需同源性,和文库的多样性可独立地和同时随重组DNA的长度而变化。
将两种基因混合的方法可用于使来自鼠杂交瘤的抗体具有人的特性。将两种基因混合或者将突变序列插入到基因中的方法可用于任何治疗上使用的蛋白质,例如白介素I,抗体,tPA,生长激素等等。该方法也用于任何核酸例如启动子或者内含子或者基因的3′未转移区或5′未转移区以提高表达或改变所表达蛋白质的特异性。该方法也可用于使核酶或aptamers。
杂合要求存在使多种多样的区域分离开的同源区。类似于支架状的蛋白质结构特别适合于杂合。当显示介导特定结合的相对非限制环时,保守的支架状蛋白确定了由自我联系进行的总体折迭。这样的支架状蛋白的例子是免疫球蛋白β管以及4个螺旋线束(24)。这种杂交方法结合各种组合的用于结合的突变序列可以制备类似支架状的蛋白。
体外杂合
用体外杂合也可以完成等量的一些标准遗传接合。例如,通过将突变体的核酸与野生型核酸重复混合,同时筛选所需的突变就可以完成’分子回交’。象在传统育种中一样,可以用这种方法将来自不同来源的表型结合到所选的背景中。例如,将其用于除去影响非选择特征(即免疫原性)的中性突变。因此,可以用来确定蛋白质中的哪个突变与生物活性的提高有关,而哪一个无关,用易出错误的诱变或盒诱变方法不能得到有利的突变。
可以从小随机片段混合物正确组装大的功能性基因。可以用所述反应对来自化石(25)的许多片段化的DNA进行基因组装。此外,可以将来自化石的随机核酸片段与来自相关种的相似基因的核酸片段结合。
还设想将本发明方法用于体外扩增进行各种研究和诊断应用所需的来自单个细胞的整个基因组。用PCR进行的DNA扩增在实践中限于约40kb的长度。用PCR扩增整个基因组,例如大肠杆菌(5,000kb)的,就需要约250个引物产生125个40kb片段。由于无法得到足够的序列资料,因而该方法不可行。另一方面,用DNAseI随机消化,然后用凝胶纯化小片段会得到许多可能的引物。用随机小片段的混合物在PCR反应中作为引物,单独或与整个基因组一起作为模板,会产生反向链反应,理论上结果产生含许多基因组拷贝的单个连环体。
当只使用随机片段时(见实施例2)可以得到拷贝数扩增100倍,平均片段大小大于50kb的结果。认为较大的连环体是由于许多较小片段的重叠而产生的。用合成引物得到的特异性PCR产物的性质无法与从未扩增的DNA得到的产物区别开。预期可以将所述方法用于基因组作图。
按照实践者的意愿,可以将杂合的多核苷酸制成随机的或非随机片段。
体内杂合
在体内杂合的实施方案中,在至少两种不同核酸序列存在于各宿主细胞的条件下,将特定核酸序列混合物导入到细菌或真核细胞中。可以用各种不同的方法,将所述片段导入到宿主细胞中。可以用本领域已知的方法,例如用氯化钙处理,用所述片段转化宿主细胞。如果所述片段被插入到噬菌体基因组中,则可以用含有特定核酸序列的重组噬菌体基因组转染宿主细胞。另外,可以用电穿孔,转染,脂染(lipofection),biolistics,结合和类似的方法将所述核酸序列导入到宿主细胞中。
总之,在本实施方案中,所述特定的核酸序列将存在于能够在宿主细胞中稳定复制序列的载体中。另外,设想所述载体编码有关标记基因,以便可以筛选含有载体的宿主细胞。这样确保在导入到宿主细胞后,可以回收突变的特定核酸序列。然而,特定核酸序列的全部混合物不必均存在于载体序列上。相反,需要将足够数量的序列克隆到载体中以确保在所述片段导入到宿主细胞中后,各宿主细胞均含有一个携带至少一个存在于其上的特定核酸序列的载体。还设想不光是将特定核酸序列群体的子集克隆到载体中,该子集还已被稳定地整合到宿主细胞中。
已经发现,当将有相同区的两个片段插入到宿主细胞中时,在两个片段之间发生同源重组。在两个突变的特定核酸序列之间的所述重组在某些情况下,将会产生双或三突变体。
还发现如果某些突变的特定核酸序列存在于线性核酸分子上,则重组的频率会提高。因此,在优选的实施方案中,一些特定的核酸序列存在于线性核酸片段上。
转化后,将宿主转化体置于选择条件下,以鉴定含有带有所需性质的特定核酸序列的那些宿主细胞转化体。例如,如果需要对特定药物的增强抗性,则可以使转化宿主细胞经受增加浓度的特定药物,筛选那些产生突变蛋白质的转化体,所述蛋白质能够赋予增加的药物抗性。如果需要提高特定蛋白质与受体结合的能力,则从转化体诱导蛋白质的表达,然后用本领域熟知的方法,经配体结合试验检测所得的蛋白质以鉴定与配体结合能力提高的突变群体的子集。另外,可以在另一系统中表达所述蛋白质以确保适当的加工。
一旦鉴定了携带所需特征的第一重组的特定核酸序列的子集(女儿序列),就可以使其进行第二个循环的重组。
在第二个重组循环中,可以将重组的特定核酸序列与源突变的特定核酸序列(亲本序列)混合,然后,重复上述的循环。用这种方法,可以鉴定一组第二重组的特定核酸序列,它们具有增强的特征或编码有增强的特性的蛋白质。可以按需要将所述循环重复数次。
还设想在第二或随后的重组循环中,可以进行回交。将所需的特定核酸序列与大量野生型序列混合,以便在转化后至少一个野生型核酸序列和突变的核酸序列存在于同一宿主细胞中,以完成分子回交。与野生型特定核酸序列的重组将会消除那些中性突变,所述中性突变会影响非选择特征如免疫原性,而不会影响所选择的特征。
在本发明的另一实施方案中,设想在第一轮中,在导入到宿主细胞之前,可以将特定核酸序列的子集制成片段。片段必须足够大以便含有与其他序列相同的一些区域,从而与所述其他序列进行同源重组。片段的大小为0.03kb到100kb,优选0.2kb到10kb。还设想在随后的数轮中,在导入到宿主细胞之前,将所有特定核酸序列而不是来自前一轮所选的序列裂解成片段。
可以用本领域已知的各种方法完成序列的片段化。可以在核酸序列的特定位点将所述序列制成随机片段或制成片段。通过断裂核酸或使其经严格的物理处理(例如剪切或辐射)或严格化学试剂(例如游离基团;金属离子;酸处理至脱嘌呤和裂解)可以得到随机片段。如果是DNA,也可以用DNase或类似的核酸酶得到随机片段。可以利用限制酶在特定的位点裂解而得到成片段的序列。制成片段的序列可以是单链或双链的。如果所述序列原本是单链的,那么在将其导入到宿主细胞之前可以用热、化学物质或酶将其变性。分开核酸链的合适的反应条件是本领域熟知的。
可以无限地重复本方法的步骤,但只受限于可得到的可能的突变体数目。在一定的循环数后,会得到所有可能的突变体,再循环就是多余的。
在一个实施方案中,重复重组相同的突变的模板核酸,然后筛选有所需特征的重组体。
因此,将突变模板核酸的起始池或群体克隆到能够在细菌,如大肠杆菌中复制的载体中。不需要特定的载体,只要它能够在大肠杆菌中能自我复制。在优选的实施方案中,设计所用的载体以便表达并生产由与载体相连的突变特定核酸编码的任何蛋白质。优选还有含有编码选择性标记的基因的载体。
将含有突变核酸序列池的载体群体导入到大肠杆菌宿主细胞中。可以经转化,转染或用噬菌体感染将载体核酸序列导入。用于转化细菌的载体浓度就是导入到各细胞中的载体量。一旦存在于细胞中后,同源重组的效率就是在不同载体之间发生的同源重组。这样会产生突变体(女儿),它含有不同于源初亲本突变序列的突变的组合。
然后克隆复制宿主细胞并根据在载体上存在的标记基因进行筛选。只有含有质粒的那些细胞才能在选择条件下生长。
接着检测含载体的宿主细胞是否存在有利的突变。例如,如果待选的基因是一种改进的药物抗性基因,所述检测可由在选择的压力下涂布细胞组成。如果载体表达由突变的核酸序列编码的蛋白质,那么所述选择可包括表达所编码的蛋白质,分离所述蛋白质并检测所述蛋白质以确定例如它是否以提高的效率与所需的配体结合。
一旦鉴定了赋予所需特征的特定女儿突变核酸序列,就分离已与载体相连的核酸或从所述载体中分离核酸。然后将所述核酸与第一或亲本群体核酸混合,重复所述循环。
已经表明利用本方法可以筛选具有提高的所需特性的核酸序列。
在另一实施方案中,将第一代突变体保持在细胞中,然后将亲本的突变序列再加到所述细胞中。因此,按上述完成了实施方案I的第一循环。但是,在鉴定女儿核酸序列后,保留含有这些序列的宿主细胞。
将亲本突变的特定核酸序列(不论作为片段还是被克隆到相同的载体中)导入已含有女儿核酸的宿主细胞中。使得在细胞中发生重组,用上述方法筛选下一代重组体或孙女代。
可以将该循环重复许多次直到得到具有所需特征的核酸或肽。设想在随后的循环中,被加到优选突变体中的突变序列群体来自亲本突变体或任何后代。
在另一实施方案中,本发明提供了进行所得重组体的特定核酸的“分子”回交的方法,以便消除任何中性突变。中性突变是未赋予核酸或肽以所需特征的突变。但是,所述突变常常赋予核酸或肽以不需要的特征。因此,需要消除这样的中性突变。本发明的方法就提供了完成此项工作的方法。
在本实施方案中,用本实施方案的方法得到有所需特征的突变核酸后,分离所述核酸,含有所述核酸的载体或含所述载体的细胞。
然后将所述核酸或载体导入带有大量野生型核酸的宿主细胞中。使得突变体的核酸和野生型的核酸序列进行重组。将所得的重组体置于与突变体核酸相同的选择条件下,只有保留了所需特征的那些重组体才会被选择。不提供所需特征的任何不活动突变型通过与野生型DNA重组而被丢失。可以重复所述循环直到消除了所有不活动突变型。
因此可在分子回交中使用本发明的方法,以便消除不必的或不活动的突变。
实用性
可以对未知突变体的池或特定核酸片段或序列的等位基因盲目地使用本发明的体内重组方法。然而不必知道特定核酸片段的实际DNA或RNA序列。
在一个混合的基因群体内使用重组的方法可用于产生任何有用的蛋白质,例如白细胞介素I,抗体,tPA,生长激素等。可以用所述方法生产具有改变的特异性或活性的蛋白质。还可以用所述方法生产突变核酸序列,例如,启动子区,内含子,外显子,增强子序列,基因的3’非翻译区或5’非翻译区。因此可以用该方法产生高表达率的基因。还可用该方法研究重复DNA序列。最后,可以用该方法突变核酶或aptamers。
在蛋白质中分开多样性区的支架状(scaffold)样区特别适用于本发明.1的方法。保守的支架状区通过自我相连而确定所有的折叠,同时显示了介导特异性结合的相对不受限制的环。所述支架状区的实例是免疫球蛋白β管(barrel)和四螺旋束(bundle)。可以用本发明的方法生产具有用于结合的突变序列的不同组合的支架状区样蛋白质。
用本发明方法还可以完成一些标准遗传交配方法。例如通过将突变体核酸与野生型核酸重复混合,同时筛选所需的突变就可以完成“分子”回交。象在传统育种中一样,可以用本方法将不同来源的表型结合到所选的背景中。这对于例如除去影响非选择特征(即免疫原性)的中性突变是有用的。因此,可用其确定在蛋白质中哪个突变与增强的生物学活性有关,哪个无关。
肽展示方法
可以用本发明方法通过公开的体外和/或体内重组方法,并以任何组合杂合用肽展示方法筛选的多核苷酸序列,其中,有关的多核苷酸编码用于表型(如与预定受体(配体)的亲和性)筛选的展示的肽。
生物药物的研究和分子生物学的不断增长的重要性在于鉴定肽结构,包括肽的一级氨基酸序列,或于生物大分子相互作用的肽模拟。鉴定具有所需结构或功能特性,例如与预定生物大分子(如受体)的结合,包括筛选具有由所述肽氨基酸序列赋予的所需结构或功能特性的大文库或个体文库成员的肽。
除用直接的化学合成方法来产生肽文库外,还报道了数种重组DNA方法。一种是在噬菌体颗粒或细胞表面展示肽序列,抗体,或其他蛋白质。通常在这些方法中,各噬菌体颗粒或细胞是作为展示除天然噬菌体或细胞蛋白质序列之外的一种展示肽的个体文库成员。各噬菌体或细胞含有编码特定的展示肽序列的核苷酸序列信息;因此,通过确定所分离文库成员的核苷酸序列可以确定展示肽的序列。
熟知的肽显示方法包括在丝状噬菌体的表面上展示肽序列,通常是与噬菌体被膜蛋白融合。可将噬菌体文库与固定的,预先确定的大分子或小分子(如受体)一起保温,以便将呈现与固定大分子结合的肽序列的噬菌体颗粒与不呈现与预定大分子结合的肽序列的颗粒区别开。然后回收并复制与固定大分子结合的噬菌体颗粒(即文库成员)以扩增所选的噬菌体亚群体以便进行随后一轮的亲和富集及噬菌体复制。亲和富集及噬菌体复制数轮后,分离由此所选的噬菌体文库的成员,然后确定编码展示肽序列的核苷酸序列,从而鉴定与预定大分子(如受体)结合的肽的序列。所述方法在PCT专利公开号91/17271,91/18980,及91/19818和93/08278文本中有进一步的描述。
后一份PCT专利公开文本描述了用于展示肽配体的重组DNA方法,包括用各融合蛋白生产融合蛋白文库,所述融合蛋白由用于与预定大分子进行潜在结合的第一多肽部分,通常含有可变序列,以及结合DNA的第二多肽部分,例如编码单个融合蛋白的DNA载体组成。当在允许表达融合蛋白的条件下培养转化的宿主细胞时,融合蛋白就与编码它的DNA载体结合。将宿主细胞溶解后,用与在基于噬菌体的展示系统中筛选噬菌体颗粒极为相似的方法,对预定的大分子筛选融合蛋白/载体DNA复合物,以DNA载体在所选融合蛋白/载体DNA复合物中的复制和测序作为鉴定所选文库肽序列的基础。
生产肽和类似聚合物文库的其他系统有重组和体外化学合成方法双重功能。在这些杂交方法中,用无细胞的酶促机制完成文库成员(即肽或多核苷酸)的体外合成。在其中的一种方法中,利用改变选择和PCR扩增的轮次来选择具有与预定蛋白质或预定染料分子结合的能力的RNA分子(Tuerk and Gold(1990)Science249:505;Ellington and Szostak(1990)Nature 346:818)。相似的技术用于鉴定与预定的人转录因子结合的DNA序列(Thiesen and Bach(1990)Nucleic Acids Res.18:3203;Beaudry and Joyce(1992)Science 257;635;PCT专利92/05258和92/14843公开文本)。以相似的方式,已经用体外翻译技术合成所需的蛋白质并且作为生产大肽文库的方法。通常依赖于体外翻译,一般包括稳定的多核糖体复合物的这些方法在PCT专利公开88/08453,90/05785,90/07003,91/02076,91/05058和92/02536文本中有进一步的描述。申请人描述了其中文库成员含有融合蛋白的方法,所述融合蛋白含有具有DNA结合活性的第一多肽部分和具文库成员独特肽序列的第二多肽部分。所述方法适用于无细胞体外选择方式。
展示的肽序列其长度可以有所不同,通常为3-5000个氨基酸长或更长,一般为5-100个氨基酸长,且经常为8-15个氨基酸长。文库可以含有具有不同长度的展示肽序列的文库成员,或可含有固定长度的展示肽序列的文库成员。部分或所有展示的肽序列可以是随机的,伪随机的,限定的核心的,固定的等。本发明的展示方法包括用于体外和体内展示单链抗体的方法,例如,在多核糖体上的新单链Fv或在噬菌体上展示的单链Fv,所述方法可以大规模筛选含有较大可变区序列和结合特异性多样性的单链Fv文库。
本发明还提供随机,伪随机和限定的序列骨架肽文库以及生产并筛选这些文库以鉴定有用化合物(如肽,包括单链抗体)的方法,所述化合物以所需模式与受体分子或所需抗原决定簇或修饰肽的基因产物或的RNA结合。从肽文库成员的文库生产随机,伪随机和限定的序列骨架肽,包括肽文库成员附着于展示肽所来自的多核苷酸模板的展示肽或展示的单链抗体。附着模式随本发明的具体实施方案而不同,而且可包括包被在噬菌体颗粒中或掺入到细胞中。
利用亲和富集的方法可以筛选很大的肽和单链抗体文库,并筛选编码所需肽或单链抗体的多核苷酸序列。然后分离多核苷酸序列并杂合以便将所选肽(或其预定部分)或单链抗体(或仅其VH,VL或CDR)的氨基酸序列组合性重组。用这些方法,人们可以鉴定的由于具有对分子的所需的结合亲和性,肽或单链抗体并开发杂合方法以迅速地集中于所需的高亲和肽或scFv(单链Fv)。然后用适用于任何用途(例如治疗或诊断)的常规方法大量合成肽或抗体。
本发明的显著优点是事先不需要考虑预期的配体结构以用来分离所需的肽配体或抗体。所鉴定的肽会有生物学活性,这意味着包括对所选受体分子的特异性结合亲和性,在某些情况下,还包括阻断其他化合物结合、刺激或抑制代谢途径、作为信号或信使、刺激或抑制细胞活性等的能力。
本发明还提供杂合通过亲和筛选展示有新肽(包括单链抗体)的多核糖体的文库而选择的多核苷酸池的方法,所述新肽为结合预定受体(如哺乳动物蛋白类受体,例如peptidergic激素受体,细胞表面受体,与其他蛋白质结合以形成细胞内蛋白质复合物,如异二聚物等的细胞内蛋白质等)或抗原决定簇(例如固定的蛋白质,糖蛋白,寡糖等)的文库成员。
收集用这些方法中的任何方法在第一轮筛选(通常用对受体,如配体结合的亲和选择)中筛选的多核苷酸序列,然后在体外和/或体内重组杂合所述池以生产含有重组的所选多核苷酸序列的群体。使重组的所选多核苷酸序列经至少一次下一轮筛选。在后几轮中筛选的多核苷酸序列可被直接地使用,测序,和/或经一或多轮的杂合和选择。也可以将所选的序列与编码中性序列(即对结合无实质性影响)的多核苷酸序列回交,例如通过与野生型或实质上等同于所选序列的天然产生的序列回交来生产类似天然的,免疫原性较低的功能肽。总之,在回交过程中,用随后的选择保留与预定受体(配体)的结合特性。
在杂合所选的序列之前或同时,可以诱变所述序列。在一个实施方案中,将所选的文库成员克隆在原核载体(如质粒,噬菌粒,或噬菌体)中,其中产生代表不同文库成员的个体菌落(或噬菌斑)的集合。然后对单个的所选的文库成员进行操作(例如经定点诱变,盒诱变,化学诱变,PCR诱变等)以产生代表序列多样性的核心文库成员的集合,所述序列多样性以所选的文库成员为基础。可以对单个所选的文库成员或池的序列进行操作以掺入或者在所述单个所选文库成员序列的片段上,或在其全长上掺入。随机突变,伪随机突变,限定的核心突变(即含有变异体和非变异体残基位置和/或含有可含选自限定氨基酸残基子集的变异体残基位置),密码子为基础的突变等,然后用本文所述的体外和/或他内重组杂合来杂合诱变后的所选文库成员。
本发明还提供含有本发明单个文库成员多样性的肽文库,其中(1)所述多样性的各文库成员含有通过杂合所选序列的池而产生的序列,和(2)各单个文库成员含有在所述多样性中不同于其他单个文库成员的可变肽片段序列或单链抗体序列的可变肽片段序列或单链抗体序列(尽管由于不均匀扩增,随机可能性等,某些文库成员可能以多于1个拷贝/文库存在)。
本发明还提供产物的生产方法,其中具有(或编码的肽具有)预定结合特异性的所选的多核苷酸序列经下列过程形成:(1)筛选抗预定受体(如配体)或抗原决定簇(如抗原大分子)的展示肽或展示的单链抗体文库,然后鉴定和/或富集与所述预定受体或抗原决定簇结合的文库成员以产生所选文库成员的池,(2)通过重组与预定的抗原决定簇结合所选的文库成员(或扩增或克隆其拷贝)并且由此从文库中分离和/或富集而进行杂合以产生杂合的文库,和(3)筛选抗预定受体(如配体)或抗原决定簇(如抗原大分子)的杂合的文库并鉴定和/或富集与预定受体或抗原决定簇结合的文库成员以产生所选杂合文库成员的池。
抗体展示和筛选方法
可以用本发明方法通过任何公开的体外和/或体内重组方法并以任何组合杂合用抗体展示方法筛选的多核苷酸序列,其中有关的多核苷酸编码用于表型(例如用于结合预定抗原(配体)的亲和性)筛选的展示的抗体。
已经设计了各种分子遗传学方法以得到由极大量可存在于免疫球蛋白链上的不同可变区所代表的大量免疫学组分。天然产生的种系免疫球蛋白重链基因座位由位于不同(D)片段基因串联排列上游的可变(V)片段基因的分开的串联排列组成,D片段基因自身位于连接(J)区基因串联排列的上游,J区位于恒定(C)区基因的上游。在B淋巴细胞发育的过程中,发生V-D-J重排,其中通过重排形成融合的D-J片段,然后又与V片段重排形成V-D-J相连的产物基因,从而形成重链可变区基因(VH),如果是生产性重排,V-D-J编码重链的功能可变区(VH)。相似地,轻链基因座位上,数个V片段之一与数个J片段之一重排以形成编码轻链可变区的基因。
免疫球蛋白上许多可能的可变区的所有组成成分部分来自在B细胞发育中重排过程中V和J片段(在重链情况下,和D片段)连接的大量组合性可能性。在重链可变区中其他的序列多样性产生于V-D-J连接过程中非均一地重排和N区的增加。此外,特异性B细胞克隆的抗原选择作用选择在重链和轻链可变区之一或两者中有非种系突变的高亲和突变体;这是一种称为“亲和性成熟”或“亲和性加强”的现象。通常,这些“亲和性加强”集结在可变区的特定区域,常常在互补性决定区(CDRs)。
为了克服通过抗原-刺激的B细胞发育(即免疫)生产和鉴定高亲和性免疫球蛋白的许多限制,已经研究了各种可操作的原核表达系统以生产可用于筛选高亲和性的抗特异性抗原的抗体的组成型抗体文库。在大肠杆菌和噬菌体系统中表达抗体的最近进展(见“Altermative Peptide Display Methods”同下文)已经产生了实际上可通过从表征的杂交瘤克隆抗体基因或用抗体基因文库(如从Ig cDNA)重新筛选得到任何特异性的可能性。
在可筛选为噬菌斑或溶原菌落的噬菌体λ表达系统中已经生产了抗体的组成型文库(Huse et al.(1989)Science 246:1275;Caton and Koprowski(1990)Proc.Natl.Acad.Sci.(U.S.A.)87:6450;Mullinax et al(1990)Proc.Natl.Acad.Sci.(U.S.A.)87:8095;Persson et al.(1991)Proc.Natl.Acad.Sci.(U.SA.)88:2432)。已经描述了噬菌体抗体展示文库和λ噬菌体表达文库的各种实施方案(Kang et al.(1991)Proc.Natl.Acad.Sci.(U.S.A.)88:4363;Clackson et al.(1991)Nature 352:624;McCafferty et al.(1990)Nature 348:552;Burton et al.(1991)Proc.Natl.Acad.Sci.(U.S.A.)88:10134;Hoogenboom et al.(1991)Nucleic Acids Res.19:4133;Chang et al.(1991)J.Immunol.147:3610;Breitling et al(1991)Gene 104:147;Marks et al.(1991)J.Mol.Biol.222:581;Barbas et al.(1992)Proc.Natl.Acad.Sci.(U.S.A.)89:4457;Hawkins and Winter(1 992)J.Immunol.22:867;Marks et al.(1 992)Biotechnology 10:779;Marks et al.(1992)J.Biol.Chem.267:16007;Lowman et al.(1991)Biochemistry 30:10832;Lerner et al.(1992)Science 258:1313;均引入本文作为参考)。通常,用固定(如通过与层析树脂共价结合以便用亲和层析富集反应性噬菌体)和/或标记(如以筛选噬菌斑或挑取菌落)的受体(如多肽,碳水化合物,糖蛋白,核酸)筛选噬菌体抗体展示文库。
一种特别有利的方法是利用所谓单链片段可变(scFv)文库(Marks et al.(1992)Biotechnology 10:779;Winter G and Milstein C(1991)Nature 349:293;Clackson et al.(1991),在所引的书中;Marks et al.(1991)J.Mol.Biol.222:581;Chaudhary et al.(1990)Proc.Natl.Acad.Sci.(U.SA.)87:1066;Chiswell et al.(1992)TIBTECH 10:80;McCafferty et al.(1990)在所引的书中;and Huston et al.(1988)Proc.Natl.Acad.Sci.(U.S.A.)85:5879)。已经描述了各种展示在噬菌体被膜蛋白上的scFv文库的实施方案。
从1988年开始,用抗体基因工程方法就很容易生产Fv片段的单链类似物和其融合蛋白。通常第一步包括得到编码具有所需结合特性的VH和VL区的基因;这些V基因可以从特定的杂交瘤细胞系中分离,或从组成型V-基因文库中筛选或通过V基因合成来制备。通过将成分V基因和编码适当设计的接头肽,例如(Gly-Gly-Gly-Gly-Ser)3或接头肽等同物的寡核苷酸连接起来形成单链Fv。接头桥接第一个V区的C-末端和第二个的N-末端,连接成VH-接头-VL或VL-接头-VH。理论上,scFv结合位点可以精确地复制其亲本抗体结合位点的亲和性和特异性。
因此,scFv片段由通过灵活的接头肽连接到一单链多肽中的VH和VL区组成。组装成scFv基因后,将其克隆到噬菌粒中,然后在M13噬菌体(或相似丝状噬菌体)的顶部表达为与噬菌体pIII(基因3)被膜蛋白融合的融合蛋白。通过培养(panning)重组噬菌体来富集表达所需抗体的噬菌体,所述重组噬菌体带有与预定抗原决定簇(例如靶抗原,受体)结合的scFv群体。
连接的文库成员的多核苷酸提供了在筛选或选择方法后复制文库成员的基础,同时还提供了通过核苷酸测序确定展示的肽序列或VH和VL氨基酸序列相同性的基础。抗原在适宜的表达系统中克隆并表达展示的肽或单链抗体(如scFv)和/或其VH和VL区或其CDRs。经常将编码分离的CDRs的VH和VL区与编码恒定区(CH和CL)的多核苷酸相连以形成编码完整抗体,(如嵌合的或完全的人)抗体片段等。经常将编码分离的CDRs的多核苷酸移植到编码适宜可变区骨架(和可选择的恒定区)多核苷酸中以形成编码完整抗体,(如嵌合的或完全的人的)抗体片段等。可以用抗体通过免疫亲和层析分离制备量的抗原。所述抗体的其他用途是诊断和/或确定疾病的阶段(如瘤形成),用于治疗疾病,例如瘤形成,自体免疫疾病,AIDS,心血管病,感染等。
已经报告了各种方法以增加scFv文库组成型的多样性,从而扩大结合种类(个体基因型谱)的所有组成。用PCR可以迅速从特定杂交瘤或作为基因文库从非固定的细胞中克隆可变区,在可以组合的VH和VL盒的分类中提供组成型多样性。此外,例如通过随机,伪随机或定位诱变可将VH和VL盒自身多样化。通常,在或靠近互补性决定区(CDRs),经常在第三个CDR,CDR3将VH和VL盒多样化。由于有易差错的PCR和化学诱变(Deng et al.(1994)J.Biol.Chem.269:9533),已经表明酶促反向PCR诱变是一种简单可行的构建相对大的scFv定点诱变突变体文库的方法(Stemmer et al.(1993)Biotechniques 14:256)。Riechmann等人((1993)Biochemistry 32:8848)使用通过简并寡核苷酸PCR和所得scFv突变体的噬菌体展示的定点随机化列出了半推理设计的抗体scFv片段。Barbas等人((1992),在所引的书中)试图回避限制所有组分大小的问题,而该问题是由于使用偏移的可变区序列通过随机化在人破伤风类毒素-结合Fab的合成CDR区中的序列而造成的。
CDR随机化有可能仅对重链CDR3的约1×1020就产生CDRs,以及大约相似量的重链CDR1和CDR2突变体和轻链CDR1-3突变体。单独或一起考虑,重链和/或轻链CDR随机化的组成要产生抑制量的噬菌体克隆以生产单独代表所有可能组合的一个克隆文库,其中大多数是非结合的。用目前的转化技术和噬菌体展示系统要生产这样大量的一级转化体并不容易。例如Barbas等人(1992,在所引的书中)只产生了5×107个转化体,这只代表了所有随机化CDRs文库潜在多样性的很小的部分。
尽管有这些实质性的限制,但scFv的噬菌体展示还是产生了各种有用的抗体和抗体融合蛋白。已经表明双特异性单链抗体介导有效的肿瘤细胞溶解(Gruber et al;(1994)J.Immunol.152:5368)。已表明抗-Rev scFv的细胞内表达抑制HIV-1的体外复制(Duan et al.(1994),Proc.Natl.Acad.Sci.(USA)91:5075),抗-p21rasscFv的细胞内表达抑制Xenopus卵母细胞的减数分裂成熟(Biocca et al.(1993)Biochem.Biophys.Res.Commun.197:422)。还报告了用于诊断HIV感染的重组scFv,表明了scFv的诊断实用性(Lilley et al.(1994)J.Immunol.Meth.171:211)。也已经报告了scFv与第二多肽,如毒素或血纤维蛋白激活蛋白相连的融合蛋白(Holvost et al.(1992)Eur.J.Biochem.210:945;Nicholls et al.(1993)J.Biol.chem.268:5302)。
如果可能生产具有更多抗体多样性并克服常规CDR诱变和随机化方法的许多限制的scFv文库,就可以使适用于治疗和诊断用途的scFv抗体的数量和质量得到很大的提高,所述的常规CDR诱变和随机化方法只能覆盖潜在序列组合中很小的部分。为了达到这一目的,用本发明的体外和体内杂合方法重组已经从核酸得到(通常经PCR扩增或克隆)的CDRs,所述核酸是从筛选的展示抗体得到的。可以在细胞上,噬菌体颗粒上,多核糖体或其中有抗体与编码它的核酸相连的适宜的抗体展示系统上展示所述的展示抗体。在改变中,CDRs开始是从生产抗体的细胞(例如来自免疫的野生型小鼠,人或能够生产WO92/03918,WO93/12227和WO94/25585中的人抗体的转基因小鼠的浆细胞/脾细胞),包括从其得到的杂交瘤的mRNA(或cDNA)得到的。
收集用任何这些方法在第一轮筛选(通常通过亲和性筛选与抗原(例如,配体)结合的展示的抗体)中筛选的多核苷酸序列,然后经体外和/或体内重组进行杂合,特别是杂合CDRs(通常杂合重链CDRs和其他重链CDRs以及轻链CDRs和其他轻链CDRs)以得到杂合的池,所述池含有重组的筛选过的多核苷酸序列群体。将重组的选择的多核苷酸序列在选择方式中表达随后再经至少一轮筛选。直接使用,测序在随后的选择中筛选的多核苷酸序列,和/或使其经一次或多次的杂合和筛选过程,直到得到具有所需结合亲和性的抗体。也可以将所选的序列与编码中性抗骨架序列的多核苷酸序列(即对结合抗原没有实质性的功能影响)回交,例如通过与人可变区骨架回交以得到类似人的抗体序列。总而言之,在回交过程中,用随后的选择作用来保留与预定抗原结合的特性。
另外,或与注明的改变相结合,可以改变靶抗原决定簇的效价以控制所选scFv文库成员的平均结合亲和性。可以将靶抗原决定簇以不同的密度,通过例如包括竞争抗原决定簇,通过稀释或通过本领域已知的其他方法,与表面或底物结合。可以用高密度(效价)的预定抗原决定簇富集具有相对低亲和性的scFv文库成员,而低密度(效价)可优选地富集较高亲和性的scFv文库成员。
为了产生不同的可变片段,通过连接到预定位点(如CDR)插入编码随机,伪随机,或限定的核心序列组肽序列的合成寡核苷酸插入集合。相似地,用定点诱变,CDR-取代等通过突变CDR来扩展单链抗体盒的一个或多个CDRs的序列多样性。在杂合前,可以在克隆和扩增的宿主中增殖所得的DNA分子,或将其直接使用(即可以避免在宿主细胞中增殖时可能发生的丢失),然后杂合所选的文库成员。
通过亲和富集技术从所述文库中筛选编码所需可变片段肽序列或所需单链抗体的肽/多核苷酸复合物(文库成员)。利用固定的大分子或对所需肽序列特异性的抗原决定簇,例如受体,其他大分子,或其他抗原决定簇达到所述目的。重复亲和筛选方法可以富集编码所需序列的文库成员,然后将其分离以进行收集和杂合,测序和/或进行进一步增殖和亲和富集。
通过洗涤除去没有所需特异性的文库成员。确定对于所需的各肽序列或单链抗体及固定的预定大分子或抗原决定簇所需的洗涤程度和严谨度。通过调节结合温育和随后洗涤的条件,可以在一定程度上控制回收的新肽/DNA复合物的结合特征。在固定的大分子亲和性的特定范围内,将选择用于新肽/DNA复合物的温度,pH,离子强度,二价阳离子浓度以及洗涤体积和持续的时间。以慢解离速率为基础的选择(通常预测到高亲和性)是最常用的实施途径。通过在存在饱和量的游离预定大分子条件下继续保温或通过增加洗涤体积,次数和时间长度来达到所述目的。在各情况下,要预防解离的新肽/DNA或肽/RNA复合物的再结合,而且随着时间的增加,回收亲和性越来越高的新肽/DNA或肽/RNA复合物。
也可以使用对结合和洗涤过程有其他改进的方法以发现具有特殊特征的肽。某些肽的亲和性依赖于离子强度或阳离子浓度。当需要从肽中除去蛋白质的条件柔和时,这对于在各种蛋白质的亲和纯化中使用的肽来说是有用的特征。
一种改变是利用多种结合靶(多种抗原决定簇,多种受体)以便同时筛选scFv文库,筛选具有不同结合特异性的多重性的scFv。由于scFv文库的大小经常限制潜在scFv序列的多样性,因此,一般我们希望scFv文库尽可能地大。出于时间和经济上的考虑,产生许多很大的多核糖体scFv-展示文库会受到限制。为了避免这个实际问题,在单个文库中可以同时筛选多种预定的抗原决定簇(受体),或对大量抗原决定簇进行依次筛选。在一种改变中,可以混合在不同珠(或珠组)上编码的多种靶抗原决定簇,然后在适宜的结合条件下与多核糖体-展示scFv文库保温。然后通过亲和筛选,收集的含有多种抗原决定簇的珠来分离scFv文库成员。通常,随后的亲和筛选过程包括混合相同的小珠,其子集或含有仅一种或两种抗原决定簇的小珠。所述方法提供了有效的筛选,而且与实验室自动化,批量加工,筛选方法的高处理量相协调。
在本发明中可以使用各种技术以便使肽文库或单链抗体文库多样化,或在杂合前或同时,使在较早的panning过程中发现的可变片段肽或VH,VL或CDRs周围多样化使其对预定大分子或抗原决定簇具有足够的结合活性。在一种方法中,将筛选的阳性肽/多核苷酸复合物(在较早的亲和富集过程中鉴定的那些)测序以确定活性肽的一致性。然后在这些活性肽的基础上合成寡核苷酸,在各步骤中通过低水平的所有碱基掺入以得到有轻微改变的一级寡核苷酸序列。将所述(轻微)简并寡核苷酸的混合物在适当的位置克隆到可变片段序列中。这种方法对起始肽序列产生了系统的控制的改变,然后可用于杂合。然而,它要求在诱变前对单个阳性新肽/多核苷酸复合物测序,因此对于扩大少量所回收的复合物的多样性并筛选具有更高结合亲和性和/或更高结合特异性的变异体来说是有用的。在一种改变中,经诱变PCR扩增所选的阳性肽/多核苷酸复合物(特别是可变区序列,在体外和/或体内杂合的扩增产物)并在测序前再进行一轮或多轮的筛选。对于单链抗体可以使用大致相同的方法以便通过在杂合前或同时将CDRs或相邻的骨架区多样化而扩大多样性并提高结合亲和性/特异性。如果需要,用能够与包括所选文库成员进行体外重组的诱变寡核苷酸抑制杂合反应。因此,可以将合成的寡核苷酸和PCR片段(用易于差错或高精确度方法合成的)混合物加到体外杂合混合物中,然后掺入到所得的杂合文库成员(杂合体)中。
本发明的杂合能够产生大的CDR-变异体单链抗体文库。产生所述抗体的一种方法是在杂合前或同时将合成的CDRs插入到单链抗体和/或随机化的CDR中。通过参考已知的人CDR的序列资料来筛选合成的CDR盒序列并且根据下列原则由实施慎重选择:合成的CDRs与已知CDR序列至少有40%的序列一致性,而且优选的与已知序列至少有50-70%的一致性。例如,在Kabat等人(1991,在所引的书中)所列的天然产生的人CDR序列的基础上,通过合成一批寡核苷酸序列来产生一批合成的CDR序列;计算合成CDR序列的池以使其编码与至少一种已知的天然产生的CDR序列有至少40%一致性的CDR肽序列。另外,可以比较一批天然产生的CDR序列以得到一致序列以便将在频率高的残基位置(即占已知CDR序列至少5%)所用的氨基酸掺入到合成CDRs的相应位置。通常比较并观察一些(如3到约50个)一致的CDR序列,将一致CDRs之间的天然序列变异列成表,然后合成一批编码CDR肽序列的寡核苷酸,所述CDR肽序列包括所有或大多数观察到的天然序列变异的置换。例如并不是为了限制,如果一批人VHCDR序列含有以Tyr,Val,Phe,或Asp为C-末端氨基酸,那么就可以设计合成CDR寡核苷酸序列的池以使所述C-末端CDR残基是这些氨基酸中的任何一种。在一些实施方案中,掺入除在CDR序列中的残基位置上的天然残基之外的残基:经常插入保守的氨基酸取代物,而且可以改变高达5个残基位置以掺入与天然CDR序列相比是非保守的氨基酸取代。可以将所述CDR序列用于一级文库成员(在第一轮筛选前)和/或可用其抑制所选文库成员序列的体外杂合反应。本领域专业人员很容易构建限定的和/或简并序列的所述池。
所述合成的CDR序列含有至少一个不是已知天然CDR序列的成员。实施者可任选包括或不包括相对于重链CDR N区的随机或伪随机序列部分;在V-D和D-J的连接中N区序列的范围是1个核苷酸至约4个核苷酸。一批合成的重链CDR序列含有至少约100个特有的CDR序列,通常至少为1,000个特有的CDR序列,优选地为至少约10,000个特有的CDR序列,经常多于50,000个特有的CDR序列;但是在一批中通常不超过1×106个特有的CDR序列,尽管有时存在1×107-1×108个特有CDR序列,特别是如果在天然人CDRs中,在没有保守氨基酸取代物的位置或在该位置保守氨基酸取代物稀少(即少于0.1%)的情况下,允许保守氨基酸取代。总之,在文库中所包括的特有CDR序列的数量不能超过所述文库中一级转化体预期数量的10倍以上。所述单链抗体通常可以以约至少1×107M-1的亲和性,优选有约至少5×107M-1的亲和性,更优选的约至少1×108M-1到约至少1×109M-1的亲和性或更高,有时高达1×1010M-1或更高的亲和性与预定抗原(如免疫原)结合。通常预定抗原是人蛋白质,例如人细胞表面抗原(如CD4,CD8,IL-2受体,EGF受体,PDGF受体),其他人生物大分子(如血栓调节蛋白,蛋白质C,碳水化合物抗原,sialyl Lewis抗原,L-选择素(selectin)),或与人疾病无关的大分子(如细菌LPS,病毒颗粒衣壳蛋白或被膜糖蛋白)等。
抗原在各种系统中加工并表达具有所需特异性的高亲和单链抗体。例如已经在植物中生产了scFv(Firek et al.(1993)Plant Mol.Biol.23:861),而且很容易在原核系统中制备(Owens RJ(1994)J.Immunol.Meth.168:149;Johnson S and Bird RE(1991)Methods Enzymol.203:88)。此外,可以用单链抗体作为构建完全抗体或其各种片段(Kettleborough et al.(1994)Eur.J.Immunol.24:952)。可以分离(如经PCR扩增或亚克隆)可变区编码序列并将其与编码所需人恒定区的序列相拼接以编码人抗体序列,所述抗体更适于免疫原性最小的的人治疗应用。在宿主细胞中表达含有所得的人编码序列的多核苷酸(例如在哺乳动物细胞中从表达载体开始),然后将其纯化用于药物配方。
DNA表达构建体通常包括与编码序列可操作相连的表达控制DNA序列,包括天然相关的或异源的启动子区。优选的,表达控制序列是在能够转化或转染真核宿主细胞的载体中的真核启动子系统。一旦所述载体被插入到适宜的宿主中,就在适于高水平表达核苷酸序列的条件下保持所述宿主,然后收集纯化突变的“工程”抗体。
正如上文所述,在将DNA序列与表达控制序列可操作相连(即定位以确保结构基因的转录和翻译)后,在宿主中表达所述序列。这些载体通常作为附加体或宿主染色体DNA的整合部分在宿主生物体中是可复制的。总之,表达载体将含有选择性标记如,四环素或新霉素以便检测带有所需的DNA序列的那些转化细胞(见,如美国专利4,704,362,该文献引入本文作为参考)。
除象酵母这样的转化微生物外,也可以用哺乳动物组织细胞生产本发明的多肽(见Winnacker,“From Genes to Clones,”VCH Publishers,N.Y.,N.Y.(1987),该文献引入本文作为参考)。实际上真核细胞是优选的,原因在于在本领域中已经研究了许多能够分泌完整免疫球蛋白的适宜的宿主细胞系,而且包括CHO细胞系,各种COS细胞系,Hela细胞系,骨髓瘤细胞系等,但最好是转化的B-细胞或杂交瘤。用于这些细胞的表达载体包括表达控制序列,如复制源点,启动子,增强子(Queen et al.(1986)Immunol.Rev.89:49),和必需的加工信息位点,如核糖体结合位点,RNA拼接位点,多腺苷酸化位点以及转录终止序列。优选的表达控制序列源于免疫球蛋白基因,细胞肥大病毒,SV40,腺病毒,牛乳头状瘤病毒等的的启动子。
通过将增强子序列插入到载体中来提高真核DNA的转录。增强子是10-300bp的提高启动子转录的顺式作用序列。当在转录单位5′或3′时,增强子可以有效地提高转录。如果在内含子内或在其自身编码序列内,它们也是有效的。通常使用的表达增强子包括SV40增强子,细胞肥大病毒增强子,多形瘤增强子和腺病毒增强子。来自哺乳动物系统的增强子序列也是常用的,例如小鼠免疫球蛋白重链增强子。
哺乳动物表达载体系统通常还包括可选择的标记基因。适宜标记基因的实例包括二氢叶酸还原酶(DHFR),胸苷激酶基因(TK)或赋予药物抗性的原核基因。前两种标记倾向于使用在未将胸苷加到生长培养基中就不能生长的突变体细胞系。根据其在非补充培养基中生长的能力来鉴定转化的细胞。作为标记的有用的原核药物抗性基因的实例包括赋予G418,霉酚酸和潮霉素抗性的基因。
根据细胞宿主类型,用熟知的方法,可以将含所需的DNA片段的载体转移到宿主细胞中。例如常用于原核细胞的氯化钙转染,而磷酸钙处理。脂染或电穿孔用于其他细胞宿主。用于转化哺乳动物细胞的其他方法包括使用聚凝胺,原生质体融合,脂质体,电穿孔和微注射(见,Sambrook et al.同上文)。
一旦表达后,可以用本领域的标准方法,包括硫酸铵沉淀,分离柱层析,凝胶电泳等纯化本发明的抗体,个体突变的免疫球蛋白链,突变的抗体片段和其他免疫球蛋白多肽(见Scopes R.,Protein Purification,Springer-Verlag,N.Y.(1982))。纯化后,按照部分或均一性的要求,将多肽用于治疗或研究和完成检测方法,没有荧光染色等(见,Immunological Methods,Vols.I and II,Eds.Lefkovits and Pernis,Academic Press,New York,N.Y.(1979 and 1981))。
用本发明方法生产的抗体可用于诊断和治疗。用以说明而不是限制为目的,可以用它们治疗癌,自体免疫疾病或病毒感染。为了治疗癌,通常抗体将与常在癌细胞上表达的抗原,例如erbB-2,CEA,CD33以及许多其他抗原和本领域专业人员熟知的结合成员结合。
酵母两杂交筛选试验
可以用杂合重组对通过筛选两杂交筛选系统来鉴定结合预定多肽序列的文库成员而得到的所选文库成员池多样化。收集所选的文库成员,然后进行体外和/或体内重组。然后在酵母两杂交系统中筛选杂合的池以筛选结合所述预定多肽序列(如SH2区)或结合其他预定多肽序列(如来自另一蛋白质的SH2区)的文库成员。
鉴定结合预定多肽序列的多肽序列鉴定方法已经使用了所谓“两杂交”系统,其中预定多肽序列存在于融合蛋白中(Chien et al.(1991)Proc.Natl.Acad.Sci.(USA)88:9578)。所述方法通过重建转录活化因子(Fields S and Song O(1989)Nature 340:245),酵母Ga14转录蛋白来鉴定蛋白质-蛋白质之间的相互作用。通常,该方法是以酵母Ga14蛋白质的特性为基础的,所述蛋白质由导致DNA结合和转录活化的可分开的区组成。构建编码两种杂交蛋白质的多核苷酸并将其导入到酵母宿主细胞中,所述两种杂交蛋白,一种由与已知蛋白质的多肽序列融合的酵母Ga14 DNA结合区组成,另一个由与第二蛋白质的多肽序列融合的Ga14活化区组成。两种融合蛋白之间的细胞间结合重建了Ga14 DNA结合区和Ga14活化区,这样导致与Ga14结合位点可操作相连的报告基因(如lacZ,HIS3)的转录活化。通常用两杂交方法鉴定与已知蛋白质相互作用的新多肽(Silver SC and Hunt SW(1993)Mol.Biol.Rep.17:155;Durfee et al.(1993)Genes Devel.7:555;Yang et al.(1992)Science 257:680;Luban et al.(1993)Cell 73:1067;Hardy et al.(1992)GenesDevel.6;801;Bartel et al.(1993)Biotechniques 14:920;and Vojtek et al.(1993)Cell74:205)。但是,已经用改进的两杂交方法鉴定影响其与第二已知蛋白质结合的已知蛋白质的突变体(Li B and Fields S(1993)FASEB J.7:957;Lalo et al.(1993)Proc.Natl.Acad.Sci.(USA)90:5524;Jackson et al.(1993)Mol.Cell.Biol.13:2899;andMadura et al.(1993)J.Biol.Chem.268:12046)。还已经用两杂交系统鉴定了两个已知蛋白质结构区(Bardwell et al.(1 993)med.Microbiol.8:1177;Chakraborty et al.(1992)J.Bio.Chem.267:17498;Staudinger et al.(1993)J.Biol.Chem.268:4608;andMilne GT and Weaver DT(1993)Genes Devel.7:1755)或引起单个蛋白质寡聚的区(Iwabuchi et al.(1993)Oncogene 8:1693;Bogerd et al.(1993)J.Virol.67:5030)之间的相互作用。还用改进的两杂交系统研究蛋白水解酶的体内或(Dasmahapatra etal.(1992)Proc.Natl.Acad Sci.(USA)89:4159)。另外,可以用大肠杆菌/BCCP相互作用筛选系统(Germino et al.(1993)Proc.Natl.Acad Sci.(USA)90:933;GuarenteL(1993)Proc.Natl.Acad Sci.(USA)90:1639)鉴定相互作用的蛋白质序列(即异二聚的或形成更高级异多聚体的蛋白质序列)。收集用两杂交系统选择的序列,将其杂合,然后导入到用于随后一或多轮筛选以鉴定与含预定结合序列结合的多肽序列的两杂交系统中。将由此鉴定的序列进行比较以鉴定一致序列或一致序列核心。
从上述公开内容可以理解,本发明有广泛的应用。因此提供下列实施例是为了说明而不是限制。
在下列实施例中,下列缩写有下列含义。如果在下文未说明,那么所述缩写含有本领域已知的含义。
ml=毫升
μl=微升
μM=微摩尔
nM=毫微摩尔
PBS=磷酸缓冲的盐
ng=毫微克
μg=微克
IPTG=异丙基硫代-β-D-半乳糖苷
bp=碱基对
kb=千碱基对
dNTP=三磷酸脱氧核苷酸
PCR=聚合酶链反应
X-gal=5-溴-4-氯-3-吲哚基-β-D-半乳糖苷
DNAseI=脱氧核糖核酸酶
PBS=磷酸缓冲的盐
CDR=互补性决定区
MIC=最小抑制浓度
scFv=抗体的单链Fv片段
总之,在各种文献中描述了标准的重组DNA技术,例如Sambrook et al.,1989,Molecular Cloning:A Laboratory Manual,Cold Spring Harbor Laboratry;Ausubel et al.1987,Current Protocols in Moleculat Biology,Vols 1 and 2和补充,and Berger andKimmel,Methods in Enzymology,Volume 152,Guide to Molecular ClongingTechniques(1987),Academic Press,Inc.Sam Diego,Ca,以上文献均全部引入本文作为参考。按照制造商的说明使用限制酶和多核苷酸修饰酶。使用ABI混合物,在Applied Biosystems Inc.Model 394 DNA合成仪上合成寡核苷酸。如果需要,根据实践者的需要选择扩增预定DNA序列的PCR引物。
实施例
实施例1.LacZα基因重装配
1)底物制备
重组反应的底物是来自pUC18(图2)(28;Gene BankNo.XO2514)的野生型LacZα基因的dsDNA聚合酶链反应(“PCR”)产物。引物序列是5′AAAGCGTCGATTTTTGTGAT3′(SEQ ID NO:1)和5′ATGGGGTTCCGCGCACATTT3′(SEQ ID NO:2)。根据厂家说明书以Wizard PCR制品(Promega,Madison WI)从PCR产物中去掉游离的引物。发现游离引物的清除是重要的。
2)DNAseI消化:
用溶于100μl[50mM Tris-HCl pH7.4,1mM MgCl2]中的0.15单位的DNAseI(Sigma,St.Louis MO)在室温下消化大约5μg DNA底物10-20分钟。消化的DNA在2%低熔点琼脂糖凝胶上电泳。经过电泳到DE81离子交换纸(Whatman,Hillsborough OR)上从2%低熔点琼脂糖凝胶上纯化10-70碱基对(bp)的片段。用1M NaCl从纸上洗脱出DNA片段并用乙醇沉淀。
3)DNA重装配:
将纯化的片段以10-30ng/μl的浓度重悬于PCR混合物(各0.2mM dNTP,2.2mM MgCl2,50mM KCl,10mM Tris-HCl pH9.0,0.1%Triton X-100,0.3μl Taq DNA聚合酶,总体积50μl)。在此时不加引物。在MJ Research(Watertown MA)PTC-150热循环器中使用的重组程序是94℃ 60秒,30-45个循环的[94℃ 30秒,50-55℃ 30秒,72℃ 30秒]及72℃ 5分钟。小片段重组进较大序列的PCR后在重组25,30,35,40和45个循环后取反应样品(图2)。
由于100-200bp片段的重组可产生正确大小的单个PCR产物,10-50碱基片段典型地产生正确大小的一些产物以及不均一分子量的产物。大多数这种大小不均一性似乎是由于产物末端是单链序列,因为限制性酶消化后获得正确大小的单一带。
4)有引物的PCR
将重组产物稀释进含上述引物(SEQ ID NO:1和2)各0.8μM的PCR混合物中并进行由[94℃ 30秒,50℃ 30秒,72℃ 30秒]组成的循环大约15次PCR循环后,获得正确大小的单一产物(图2)。
5)克隆和分析:
用末端限制性酶BamHI和EcoO109消化上面第4步的PCR产物并按上面第2步所述进行凝胶纯化。将重组的片段连接进用BamHI和EcoO109消化的pUC18上。按厂家建议(Stratagene,San Diego CA)在标准条件下用连接混合物转化大肠杆菌并涂布到含100μg/ml氨苄青霉素,0.004%X-gal和2mM IPTG的琼脂板上。鉴别出所得的鉴定为++重组子的具有HinD III-NheI片段的菌落,因为它们是蓝色的。
本实施例说明了携带LacZα基因的1.0kb序列可消化成10-70bp的片段且这些凝胶纯化的10-70bp片段可重组进正确大小的单一产物中以便84%(N=377)的所得的菌落是LacZ+(相对于无交换的94%;图2)。
编码来自所得LacZ-菌落的LacZ基因的DNA根据厂家说明书用测序试剂盒(美国生化公司,Cleveland OH)进行测序,发现该基因由于重组过程而具有点突变(表1)。发现11/12类型的取代且无阅读框。
表1
经诱变交换导入突变
转变 频率 易位 频率
G-A 6 A-T 1
A-G 4 A-C 2
C-T 7 C-A 1
T-C 3 C-G 0
G-C 3
G-T 2
T-A 1
T-G 2
测序了总共4,437碱基的交换LacZ DNA
从DNA测序测定10-70bp片段的DNA重组期间点诱变率为0.7%(N=4,473),这与PCR误差倾向相似。由于不受任何理论的限制,据信如果较大片段用于重组或如果加入防止阅读聚合酶,点诱变率可能较低。
当组合14个这些点突变的LacZ-菌落的质粒DNA并以上述方法再重组/交换时,34%(N=291)的所得菌落是LacZ+,这些菌落推测由不同菌落的DNA重组产生。
假定诱变率为0.7%(10),PCR误差引起的单一点突变的预期回复率可能是<1%。
因此,可从小片段的随机混合物经过效率惊人且简单的反应重组大DNA序列。本技术的一个应用是基于同源性的相关序列的重组或交换。
实施例2.LacZ基因和完整质粒DNA杂合
1)LacZ基因的杂合
使用2个LacZ基因构建体测量以75个碱基分开两个标记之间的交换。在LacZα基因的两个分隔区插入终止编码子用作阴性标记。各标记是具有4个终止密码子的25bp非同源序列,其中两个在LacZ基因阅读框中。25bp非同源序列在图3中以大盒表示。终止密码子以盒表示或划线。含LacZα基因+-和-+型(图3)的2个1.0kb LacZ模板的1∶1的混合物用DNAseI消化并按实施例1所述纯化出100-200bp的片段。除了加入0.5μl聚合酶且总体积为100μl外在与实施例1的重组中所述相似的条件下进行交换程序。
克隆后,获得的蓝色菌落数是24%(N=386);它与兰色菌落的理论最大数(即,25%)相近,表明在两个标记之间完成了重组。所有10个蓝色菌落含预期的HindIII-NheI限制性片段。
2)完整质粒DNA的杂合
也试验了完整2.7kb质粒(pUC18-+和pUC18+-)。用DNA seI消化含LacZα的+-和-+型(图3)的两个2.9kb质粒的1∶1混合物并按实施例1所述纯化100-200bp的片段。除了进行[94℃ 30秒,55℃ 30秒,72℃ 30秒]的60次循环外在与上面步骤(1)重组所述相似的条件下进行交换程序。凝胶分析表明:经过交换程序后,大多数产物大于20kb。因此,完整2.7kb质粒(pUC18-+和pUC18+-)从不加引物的随机100-200bp片段中高效重组。
用在质粒上具有单一位点的限制性酶(EcoO109)消化后,大多数产物由预期大小的单一带组成。将该带凝胶纯化,再连接并将DNA用于转化大肠杆菌。转化子按实施例1所述涂布在0.004%X-gal板上。所得的质粒11%(N=328)是兰色,因而是++重组子。
3)峰DNA杂合
混合进交换混合物中的寡核苷酸可基于该寡核苷酸侧翼序列与模板DNA的同源性掺入终产物中(图4)。上面描述的LacZ-终止密码突变子(pUC18-+)用作DNAseI消化的模板。将在两端包括与野生型LacZ基因同源的18个碱基的66聚体寡核苷酸以超出原始基因中存在的正确终止密码突变4倍的摩尔数加入到反应中。在与上面步骤2相似的条件下进行交换反应。消化所得的产物,连接后按上面所述插入大肠杆菌中。
表2
兰菌落%
对照 0.0(N>1000)
上链峰 8.0(N=855)
下链峰 9.3(N=620)
上、下链峰 2.1(N=537)
假定由于竞争性杂交,ssDNA似乎比dsDNA更有效。经过调节超出的摩尔数,退火温度,或同源性长度可大范围地改变插入程度。
实施例3.在完全缺乏引物的DNA重装配
用限制性酶EcoRI,EcoO109,XmnI和AlwNI消化质粒pUC18,产生大约370,460,770和1080bp的片段。电泳并从2%低熔点琼脂糖凝胶中分别纯化这些片段(370和460碱基的带不能分离)。产生在3个单独的试管中的大型片段,中型片段和2个小片段的混合物。
按实施例1所述用DNAseI消化各片段,对于各原始片段从2%低熔点琼脂糖凝胶中纯化50-130bp的片段。
自PCR混合物(如上面实施例1所述)中加入纯化的消化片段至片段终浓度为10ng/μl。不加入引物。分别对三个消化的DNA片段混合物进行重组反应75次循环[94℃ 30秒,60℃ 30秒]以琼脂糖电泳分析产物。
结果清楚地显示从纯化片段中有效地重新形成的1080,770和370及460bp的带,证实交换根本不需使用任何引物。
实施例4.IL-1β基因杂合
本实施例描述了可获得基于同源性不超过15个碱基的交换。作为一个例子,交换人和鼠IL-1β基因。
具有大肠杆菌密码子用法的鼠IL1-β基因(BBG49)和人IL1-β基因(BBG2;R&D Systems,Inc.Minneapolis MN)用作交换反应中的模板。人和鼠IL-1β序列的全部同源区平均仅4.1碱基长(图5,同源区用盒表示)。
各基因dsDNA PCR产物的制备,引物的清除,DNAseI消化和10-50bp片段的纯化与上面实施例1所述相似。用于PCR反应的引物序列是:5′TTAGGCACCCCAGGCTT3′(SEQ ID NO:3)和5′ATGTGCTGCAAGGCGATT3′(SEQ ID NO:4)。
用DNA聚合酶I的Klenow片段进行交换反应的前15个循环,在每次循环中加入1单位的新鲜酶。将DNA加入实施例1的PCR混合物中,该混合物没有聚合酶。操作方法是94℃ 1分钟,然后进行15次[95℃ 1分钟,干冰/乙醇上10秒(直到冷冻),25℃保温大约20秒,加入1U的Klenow片段并在25℃保温2分钟]的循环。在每次循环中经变性步骤后,在干冰/乙醇中将试管迅速冷却并预热到退火温度。然后加入热变性聚合酶。在每次循环中都需加入该酶。使用本方法,获得了高水平的变换,其基础仅是未间断的具同源性的少数碱基(图5,交换位置以
表示)。
经过这15次循环操作后,加入Taq聚合酶,进行无引物的另外22次交换反应循环[94℃30秒,35℃30秒]。
然后将反应物稀释20倍。加入下列引物至终浓度为0.8μM:5′AACGCCGCATGCAAGCTTGGATCCTTATT3′(SEQ ID NO:5)和5′AAAGCCCTCTAGATGATTACGAATTCATAT3′(SEQ ID NO:6),按上面实施例1所述进行PCR应。第二引物对与第一对不同,仅仅因为据信限制性位点的改变是必需的。
用XbaI和SphI消化PCR产物后,将片段连接进XbaI-SphI-消化的pUC18。用双脱氧DNA测序试剂盒(美国生化公司,Cleveland OH)根据厂家说明书测定一些菌落的插入序列。
经过对9个菌落的DNA测序发现总共17个交换。一些交换仅以未间断同源的1-2个碱基为基础。
发现为了加强以短同源性为基础的有效交换,需要非常低的有效退火温度。使用任何热稳定性聚合酶,PCR机器的冷却时间(以1-2度/秒从94℃到25℃)引起的有效退火温度比系统的退火温度更高。因此,以Taq聚合酶为基础的方法都不能产生交换,即使所使用的超出IL1-β基因的10倍。相反,热变性聚合酶,如DNA聚合酶I的Klenow片段可用于精确地获得低退火温度。
实施例5.TEM-1β内酰胺酶基因的DNA杂合
在β内酰胺酶模型系统上试验了直接分子进化的诱变DNA变换的实用性。TEM-1β内酰胺酶是一种非常有效的酶,主要以扩散限制其反应速率。本实施例确定了改变其反应特异性和获得对药品头胞噻肟的抗性是否可能,正常情况下它不水解头胞噻肟。
经过在具有不同水平的头胞噻肟(Sigma,St.Louis MO)平板上涂布10μl 10-2稀释的大肠杆菌XL1-blue细胞(Stratagene,San Diego CA)的过夜细菌培养物(大约1000cfu)确定头胞噻肟对缺乏质粒的细菌细胞的最低抑制浓度(MIC),接着在37℃下培养24小时。
在头胞噻肟上生长对稠密的细胞具有敏感性,因此需要将相似的细胞数涂布到各板上(经过在简单LB板上涂布获得)。均匀地进行1000个细胞的涂布。
1)起始质粒构建
使用携带细菌性TEM-1β-内酰胺酶基因的pUC18衍生物(28)。TEM-1β-内酰胺酶基因赋予细菌对大约0.02μg/ml的头胞噻肟产生抗性。用下列两个引物对载体序列进行PCR:Primer A(SEQ ID NO:7):5′TTCTATTGACGGCCTGTCAGGCCTCATATATACTTTAGATTGATTT3′andPrimer B(SEQ ID NO:8):5′TTGACGCACTGGCCATGGTGGCCAAAAATAAACAAATAGGGGTTCCGCGCACATTT3′以及用其它如下两个引物对β内酰胺酶基因序列进行PCR:Primer C(SEQ ID NO:9):5′AACTGACCACGGCCTGACAGGCCGGTCTGACAGTTACCAATGCTT,和Primer D(SEQ ID NO:10):5′AACCTGTCCTGGCCACCATGGCCTAAATACATTCAAATATGTAT。
将Sfi1限制性位点加到启动子5′端和该基因3′端。
两个反应产物用SfiI消化,混合,连接并用于转化细菌。
所得的质粒是pUC182Sfi。该质粒含有携带TEM-1曲因和P-3启动子的Sfi1片段。
37℃培养24小时后头胞噻肟对携带该质粒的大肠杆菌XL1-blue(Stratagene,San Diego CA)最低抑制浓度是0.02μg/ml。
经过逐步在2倍增加的药物水平上再涂布稀释库的细胞(大约107cfu)确定无交换时β内酰胺酶基因对头胞噻肟抗性增加的能力。无交换时可获得高达1.28μG/ml的抗性。这代表抗性增加64倍。
2)DNAseI消化
第一次交换反应的底物是经过用引物C和D(两者都含SfiI位点)对pUC182Sfi进行PCR获得的0.9kb的dsDNA。
以Wizard PCR制品(Promega,Madison WI)在每次循环时去掉PCR产物的游离引物。
用在100μl 50mM Tris-HCl pH7.4,1mM MgCl2中的0.15单位的DNAseI(Sigma,St.Louis MO)在室温下消化大约5μg的DNA底物10分钟,经电泳到DE81离子交换纸(Whatman,Hillsborough OR)上从2%低熔点琼脂凝胶上纯化100-300bp的片段,以实施例1所述的方法用1M NaCl洗脱和乙醇沉淀。
3)基因杂合
将纯化片段以10-30ng/μl的浓度重悬于PCR混合物(各0.2mM的dNTP,2.2mMMgCl2,50mM KCl,10mM Tris-HCl pH9.0,0.1%Triton X-100)。此时不加引物。在MJ Research(Watertown MA)PTC-150热循环器中使用的重组方法是94℃ 60秒,然后进行40次[94℃ 30秒,50-55℃ 30秒,72℃ 30秒]的循环,再72℃ 5分钟。
4)用引物扩增重装配产物:
将重组产物稀释进含引物(C和D)各0.8μM的PCR混合物并进行20次[94℃ 30秒,50℃ 30秒,72℃ 30秒]的PCR循环后,获得900bp大小的单一产物。
5)克隆和分析:
用末端限制性酶SfiI消化900bp的产物并进行琼脂糖凝胶纯化后,用T4 DNA连接酶(BRL,Gaithersburg MD)将900bp产物连接进载体pUC182Sfi的单一SfiI位点。混合物电穿孔进大肠杆菌XL1-蓝细胞并涂布到含0.32-0.64μg/ml头胞噻肟(Sigma,St.Louis MO)的LB板上。将细胞在37℃生长24小时,从板上刮下所得的菌落作为细胞库并用作下一轮交换的PCR模板。
6)随后的重装配步骤
将3中每轮交换后获得的转化子涂布到水平增加的头胞噻肟上。合并含有最高水平头胞噻肟平板上的菌落(>100,保持多样性)并用作下一轮PCR反应的模板。
在步骤(5)中以0.32-0.64μg/ml获得的头胞噻肟菌落的混合物用作下一轮交换的模板。10μl在LB培养基中的细胞用作重组过程的模板,重组方法是99℃ 10分钟,然后进行35次[94℃ 30秒,52℃ 30秒,72℃ 30秒]循环,再按上面所述在72℃进行5分钟。
按上面步骤(5)所述消化重组产物并连接进pUC182Sfi。混合物电穿孔进大肠杆菌XL1-blue细胞并涂布到含5-10μg/ml头胞噻肟的LB平板上。
除了细胞涂布到含80-160μg/ml头胞噻肟的LB板上外以5-10μg/ml获得的菌落用于与第一、和第二轮相似的第三轮。第三轮后,以80-160μg/ml获得菌落,在浓度增加的头胞噻肟上重新涂布后,37℃培养24小时后可获得高达320μg/ml的菌落(MIC=320μg/ml)。
在头胞噻肟上的生长取决于细胞密度,需要所有的MICs标准化(在本例中大约1,000细胞/板)。在更高的细胞密度,获得在高达1280μg/ml时生长。在1,280μg/ml上生长的5个最大菌落涂布2次以产生单个菌落,以菌落PCR产物的限制性图谱分析Sfil插入片段。
获得了-个对头胞噻肟抗性增加16,000倍(MIC=0.02μg/ml到MIC=320μg/ml)的突变子。
选择后,将选定克隆的质粒转移回到野生型大肠杆菌XL1-blue细胞(Stratagene,San Diego CA)中以确保测定药物抗性的菌落不是由染色体突变引起。
三轮交换和选择产物对TEM-1β内酰胺酶扩大的广谱抗菌素头胞噻肟的最小抑制浓度增加1.6×104倍。相反,无交换的重复涂布导致抗性仅增加16倍(PCR误差或序列盒突变)。
7)序列分析
生长于1,280μg/ml的所有5个最大菌落具有与野生型TEM-1酶相同的限制性图谱。从一个这些菌落中获得的质粒的sfiI插入片段以双脱氧DNA测序(美国甘化公司,Cleveland OH)根据厂家说明书测序。所有的碱基数与修改的pBR322序列相对应(29),氨基酸序数与ABL标准编序方法相对应(30)。以Z字母编码代表氨基酸,以一字母码表示核苷酸。术语G4205A指4205核苷酸从鸟嘌呤变成腺嘌呤。
发现9个单一碱基取代。G4205A位于β内酰胺酶P3启动子(31)-35和-10位之间。Chen和Clowes(31)获得的启动子上游突变位于这里所用的Sfil片段外,因而不能检测出来。四个突变是沉默突变(A3689G,G3713A,G3934A和T3959A),四个导致氨基酸改变(C3448T导致Gly238Ser,A3615G产生Met182Thr,C3850T产生Glu104Lys,G4107产生Ala18Val)。
8)分子回交
然后使用与额外的野生型DNA发生的分子回交,以便去掉非义必需突变。
以上面所述的正常交换相同的方法对来自第三轮DNA交换的选定质粒进行分子回交,除了DNAseI消化和交换反应在超出40倍的野生型TEM-1基因片段存在的条件下进行外。为了使回交更有效,在交换反应中使用非常小的DNA片段(30至100bp)。回交突变子再次在含80-160μg/ml头胞噻肟(Sigma,St.Louis MO)的LB板上选择。
在超出40倍的野生型TEM-1 DNA存在的条件下用第一轮回交菌落的DNA重复该回交交换。使用小DNA片段(30-100bp)增加回交的效率。再次在含80-160μg/ml头胞噻肟的LB平板上选择第二轮回交的突变子。
将所得的转化子涂布在160μg/ml头胞噻肟上,将合并的菌落再次涂布到水平增加到1,280μg/ml的头胞噻肟上。重新涂布在1,280μg/ml获得的最大菌落以得到单一菌落。
该回交突变子抗生比野生型高32,000倍(MIC=640μg/ml)。该突变菌株对头胞噻肟抗性比以前报道的临床或工程TEM-1来源的菌株高64倍。因此,似乎DNA交换对直接分子进化的至少一些循环而是快速且有效的工具。
使用双脱氧DNA测序试剂盒(美国生化公司,Cleveland OH)根据厂家说明书测定回交突变子SfiI插入片段的DNA序列(表3)。该突变子有9个单碱基对突变。与预期一样,所有4年以前鉴定的沉默突变丢失,回复到野生型基因的序列。在回交克隆中保留了启动子突变(G4205A)以及四个氨基酸突变中的3个(Glu104Lys,Met182Thr,和Gly238Ser),表明它们对高水平的头胞噻肟抗性是必需的。然而,发现了2个新沉默突变(T3842C和A3767G)以及3个导致氨基酸改变的新突变(C3441T导致Arg241 His,C3886T导致Gly92Ser,G4035C导致Ala42Gly)。尽管这两个沉默突变不影响蛋白质的一级序列,但它们可能影响蛋白质的表达水平(例如以mRNA结构)和甚至可能影响蛋白质的折叠(经过改变密码子应用并从而改变中止位点,它可能涉及蛋白质的折叠)。
表3
β内酰胺酶的突变
突变类型 非回交 回交
氨基酸改变 Ala18Lys -
Glu104Lys Glu104Lys
Met182Thr Met182Thr
Gly238Ser Gly238Ser
- Ala42Gly
- Gly92Ser
沉默 T3959A -
G3934A -
G3713A -
A3689G -
- T3842C
- A3767G
启动子 G4205A G4205A
回交和非回交突变具有一个启动子突变(以其本身或组合导致表达水平增加2-3倍)以及3个普通氨基酸改变(Glu104Lys,Met182Thr和Gly238Ser)。Glu104Lys和Gly238Ser是存在于一些头胞噻肟抗性或其它TEM-1衍生物中的突变(表4)。
9)表达水平比较
经过对根据Witholt,B.(32)的方法以渗压休克制备的外周胞质提取物进行SDS-聚丙烯酰胺凝胶电泳(4-20%;Novex,San Diego CA)比较了β内酰胺酶基因在野生型质粒,非回交突变子和回交突变子中的表达水平。
纯化的TEM-1β内酰胺酶(Sigma,St.Louis MO)用作分子量标记,缺乏质粒的大肠杆菌XL1-blue细胞用作阴性对照。
突变子和回交突变子与野生型基因相比似乎产生的β内酰胺酶蛋白质率高2-3倍。启动子突变似乎导致β-内酰胺酶水平增加2-3倍。
实施例6.TEM-1β内酰胺酶基因的突变组合的构建
为了确定不同突变组合的抗生以及为了比较新突变子和公开的突变子,将一些突变子构建进相同质粒背景中。两个突变Glu104Lys和Gly238Ser称为头胞噻肟突变子。构建的所有突变子组合具有启动子突变,允许比较选定的突变子。结果如表4所示。
经PCR将特定的突变组合导入野生型pUC182Sfi中,每一突变使用2个寡核苷酸。
获得下列突变的寡核苷酸是:Ala42Gly(SEQ ID NO:11)AGTTGGGTGGACGAGTGGGTTACATCGAACT和(SEQ IDNO:12)AACCCACTCGTCCACCCAACTGATCTTCAGCAT;Gln39Lys:(SEQ ID NO:13)AGTAAAAGATGCTGAAGATAAGTTGGGTGCAC GAGTGGGTT和(SEQ ID NO:14)ACTTATCTTCAGCATCTTTTACTT;Gly92Ser:(SEQ ID NO:15)AAGAGCAACTCAGTCGCCGCATACACTATTCT和(SEQ ID NO:16)ATGGCGGCGACTGAGTTGCTCTTGCCCGGCGTCAAT;Glu104Lys:(SEQ ID NO:17)TATTCTCAGAATGACTTGGTTAAGTACTCACCAGT CACAGAA和(SEQ ID NO:18)TTAACCAAGTCATTCTGAGAAT;Met182Thr:(SEQ ID NO:19)AACGACGAGCGTGACACCACGACGCCTGTAGCAATG和(SEQ ID NO:20)TCGTGGTGTCACGCTCGTCGTT;Gly238Ser单独:(SEQ ID NO:21)TTGCTGATAAATCTGGAGCCAGTGAGCGTGGGTCTCGCGGTA和(SEQ ID NO:22)TGGCTCCAGATTTATCAGCAA;Gly238Ser and Arg241His(组合):(SEQ ID NO:23)ATGCTCACTGGCTCCAGATTTATCAGCAAT和(SEQ ID NO:24)TCTGGAGCCAGTGAGCATGGGTCTCGCGGTATCATT;G4205A:(SEQ ID NO:25)AACCTGTCCAGGCCACCATGGCCTAAATACAATCAAATATGTATCCGCTTATGAGACAATAACCCTGATA。
从合成的寡核苷酸中凝胶纯化出这些分离的PCR片段。组合各片段10ng,重组反应在94℃进行1分钟,然后经过25次[94℃ 30秒,50℃ 30秒和72℃ 45秒]循环。在含SifI的外侧引物(来自实施例5的引物C和D)存在的条件下对重组产物进行PCR 25个循环。用SfiI消化DNA并插入野生型pUC182Sfi载体中,获得下列突变子组合(表4)。
表4
名称 | 基因型 | MIC | MIC来源 |
TEM-1 | 野生型 | 0.02 | |
Glu104Lys | 0.08 | 10 | |
Gly238Ser | 016 | 10 | |
TEM-15 | Glu104Lys/Gly238Ser* | 10 | |
TEM-3 | Glu104Lys/Gly238Ser/Gln39Lys | 102-32 | 37,15 |
ST-4 | Glu104Lys/Gly238Ser/Met182Thr* | 10 | |
ST-1 | Glu104Lys/Gly238Ser/Met182Thr/Ala18Val/T3959A/G3713A/G3934A/A3689G* | 320 | |
ST-2 | Glu104Lys/Gly238Ser/Met182Thr/Ala42Gly/Gly92Ser/Arq241His/T3842C/A3767G* | 640 | |
ST-3 | Glu104Lys/Gly238Ser/Met182Thr/Ala42Gly/Gly92Ser/Arq241His* | 640 |
*所有这些突变子另外还含有G4205A启动子突变。
推断保守的突变在MIC的15个倍增体中占9个。
Glu104Lys单独显示出仅导致倍增体的MIC达0.08μg/ml,且Gly238Ser(在一些情况下具有另一个氨基酸改变)仅导致MIC为0.16μg/ml(26)。双突变子Glu104Lys/Gly238Ser具有MIC为10μg/ml。这一突变子与TE-15相对应。
这些相同的Glu104Lys和Gly238Ser突变与Glu39Lys(TEM-3)或Thr263Met(TEM-4)组合导致高水平的抗性(TEM-3为2-32μg/ml,TEM-4为8-32μg/ml)(34,35)。
含有在回交后保守的3个氨基酸改变的突变(Glu104Lys/Met182Thr/Gly238.Ser)也具有MIC为10μg/ml。这意味着各新选择的突变子加上3个已知的突变后产生的突变体导致基因对cefotaxime的抗性进一步增加32到64倍。
天然存在的,衍生自临床TEM-1的酶(TEM-1-19)各含有仅5-7个相同突变(前述)的不同组合。由于这些突变在基因中的位置完全分离,所以经过单个区域的序列盒诱变不能获得具有高cefotaxime抗性的突变子。这可以解释为什么经过标准序列盒诱变研究获得的最大MIC仅为0.64μg/ml(26)。例如,在这一研究中分别发现G104Lys和Gly238Ser突变MIC低于0.16μg/ml。使用DNA交换允许发生组合,从而发现Glu104Lys/Gly238Ser组合的MIC为10μg/ml。
本实施例的重要局限是使用单个基因作为直始点。预期如果大量相关的,天然存在的基因发生交换会发现更好的组合。存在于该混合物中的多样性比经过诱变交换产生的随机突变更有意义。例如,预期可使用来自单一物种相关基因的所有组成成份,例如预先存在的免疫系统的多样性,或从许多不同种类获得的相关基因。
实施例7.经过所有6个突变子CDRs文库的DNA杂合改进抗体A10B
A10B scFv抗体,小鼠抗-兔IgG由Pharmacia(Milwaukee WI)赠送。使用商业上可获得的Pharmacia噬菌体演示系统,它使用pCANTAB5噬菌体演示载体。
原始A10B抗体仅具有能重复的低亲合力,因为获得的克隆仅微弱地结合固相抗原(兔IgG),(以噬菌体ELISA(Pharmacia试验试剂盒)或噬菌体滴定测量)。在竞争试验中对A10B抗体结合产生50%抑制的兔IgG浓度是13微微摩尔。观察到的低亲合力可能是由于A10B克隆的不稳定性。
根据厂家说明书测序A10B scFv DNA(美国生化公司,Cleveland OH)。根据与Kabat(33)的比较,该序列与现存抗体相似。
1)噬菌体DNA的制备:
具有A10B野生型抗体基因(10μl)的噬菌体DNA在99℃保温10分钟;然后在72℃ 2分钟。向噬菌体DNA中加入PCR混合物(50mM KCl,10mM Tris-HClpH9.0,0.1%Triton X-100,各200μm的dNTP,1.9mM MgCl2),各0.6μm的引物和0.5μm Taq DNA聚合酶(Promega,Madison WI)。PCR程序进行了35个[94℃30秒,45℃ 30秒,72℃ 45秒]循环。使用的引物是:5′ATGATTACGCCAAGCTTT3′(SEQ ID NO:26)和5′TTGTCGTCTTTCCAGACGTT3′(SEQ ID NO:27)。
然后电泳850bp PCR产物并从2%低熔点琼脂糖凝胶中纯化。
2)片段化
将300ng凝胶纯化的850bp带用存在于50mM Tris-HCl pH7.5,10mM MgCl2中的0.18单位的DNAseI(Sigma,St.Louis MO)室温消化20分钟。消化的DNA在2%低熔点琼脂凝胶上分离并从凝胶中纯化出50至200bp之间的带。
3)试验文库的构建
本实验的目的是试验CDRs的插入是否有效。
合成下列具有内部限制性酶位点的CDR序列。“CDR H”指重链中的CDR,“CDR L”指抗体中轻链上的CDR。
具有限制性位点的CDR寡聚体:CDR H1(SEQ ID NO:34)5′TTCTGGCTACATCTTCACAGAATTCATCTAGATTTGGGTGAGGCAGACGCCTGAA3′CDR H2(SEQ ID NO:35)5′ACAGGGACTTGAGTGGATTGGAATCACAGTCAAGCTTATCCTTTATCTCAGGTCTCGAGTTCCAAGTACTTAAAGGGCCACACTGAGTGTA3′CDR H3(SEQ ID NO:36)5′TGTCTATTTCTGTGCTAGATCTTGACTGCAGTCTTATACGAGGATCCATTGGGGCCAAGGGACCAGGTCA3′CDR L1(SEQ ID NO:37)5′AGAGGGTCACCATGACCTGCGGACGTCTTTAAGCGATCGGGCTGATGGCCTGGTACCAACAGAAGCCTGGAT3′CDR L2(SEQ ID NO:38)5′TCCCCCAGACTCCTGATTTATTAAGGGAGATCTAAACAGCTGTTGGTCCCTTTTCGCTTCAGT3′CDR L3(SEQ ID NO:39)5′ATGCTGCCACTTATTACTGCTTCTGCGCGCTTAAAGGATATCTTCATTTCGGAGGGGGGACCAAGCT3′
将CDR寡聚体以超出10倍的摩尔数加入上面步骤(2)50至200bp之间的纯化A10B抗体DNA片段中。加入PCR混合物(50mM KCl,10mM Tris-HCl pH9.0,0.1%Triton X-100,1.0mM MgCl2各200μm的dNTP,0.3μl Taq DNA聚合酶(Promega,Madison WI),总体积为50μl),交换程序是在94℃进行1分钟,在72℃进行1分钟,然后进行35次循环:94℃ 30秒,55℃ 30秒,72℃ 30秒。
将1μl交换混合物加入100μl PCR混合物(50mM KCl,10mM Tris-HCl pH9.0,0.1%Triton X-100,各200μm的dNTP,1.9mM MgCl2,各0.6μm的两种外侧引物(SEQ ID NO:26和27,见下面),0.5μl Taq DNA聚合酶)中,PCR程序进行30个[94℃ 30秒,45℃ 30秒,72℃ 45秒]循环。所得的850碱基对大小的DNA片段混合物用酚/氯仿提取并用乙醇沉淀。
外侧引物是:
外侧引物1:SEQ ID NO:27
5′TTGTCGTCTTTCCAGACGTT3′
外侧引物2:SEQ ID NO:26
5′ATGATTACGCCAAGCTTT3′
将850bp PCR产物用限制性酶SfiI和NotI消化,从低熔点琼脂糖凝胶中纯化并连接进从Pharmacia,Milwankee WI获得的pCANTAB5表达载体中。根据Invitrogen(San Diego CA)阐述的方法将连接的载体电穿孔进TG1细胞(Pharmacia,MilwallKee WI)并涂布成单个菌落。
将所得菌落的DNA加入100μl PCR混合物(50mM KCl,10mM Tris-HCl,pH9.0,0.1%Triton X-100,各200μm的dNTP,1.9mM MgCl2,0.6μm的外侧引物1(SEQ ID NO:27;见下面),6个内部引物(SEQ ID NO:40-45;见下面),和0.5μl Taq DNA聚合酶)中,PCR过程进行35次[94℃ 30秒,45℃ 30秒,72℃45秒]循环。以琼脂糖凝胶电泳测定PCR产物的大小并用于确定哪一个具有限制性位点的CDRs被插入。CDR内部引物:H1(SEQ ID NO:40)5′AGAATTCATCTAGATTTG3′H2(SEQ ID NO:41)5′GCTTATCCTTTATCTCAGGTC3′H3(SEQ ID NO:42)5′ACTGCAGTCTTATACGAGGAT3′L1(SEQ ID NO:43)5′GACGTCTTTAAGCGATCG3′,L2(SEQ ID NO:44)5′TAAGGGAGATCTAAACAG3′,L3(SEQ ID NO:45)5′TCTGCGCGCTTAAAGGAT3′
在野生型A10B抗体DNA的预期位置插入6个合成的CDRs(图7)。这些研究表明:尽管特定克隆的6个CDRs中的每一个成为具有限制性位点的CDR的机会较小,但大多数克隆携带至少一个具有限制性位点的CDR,并产生了具有限制性位点的CDR的任意可能的组合。
4)突变的互补决定区(“CDRs”)的构建:
根据我们的序列资料,制备了与6个CDRs相应的6个寡核苷酸。CDR(Kabat定义)在合成时突变的比率为70(现存碱基):10∶10∶10,以大约20碱基的侧翼序列在5′和3′两侧,当以摩尔数超出的量混合进未诱变的抗体基因片段混合物中时它为CDR的插入提供了同源性。所得的突变序列在下面给出:
CDR文库的寡核苷酸:CDR H1(SEQ ID NO:28)5′TTCTGGCTACATCTTCACAACTTATGATATAGACTGGGTGAGGCAGACGCCTGAA3′CDR H2(SEQ ID NO:29)5′ACAGGGACTTGAGTGGATTGGATGGATTTTTCCTGGAGAGGGTGGTACTGAATACAATGAGAAGTTCAAGGGCAGGGCCACACTGAGTGTA3′CDR H3(SEQ ID NO:30)5′TGTCTATTTCTGTGCTAGAGGGGACTACTATAGGCGCTACTTTGACTTGTGGGGCCAAGGGACCACGGTCA3′CDR L1(SEQ ID NO:31)5′AGAGGGTCACCATGACCTGCAGTGCCAGCTCAGGTATACGTTACATATATTGGTACCAACAGAAGCCTGGAT3′CDR L2(SEQ ID NO:32)5′TCCCCCAGACTCCTGATTTATGACACATCCAACGTGGCTCCTGGAGTCCCTTTTCGCTTCAGT3′CDR L3(SEQ ID NO:33)5′ATGCTGCCACTTATTACTTGCC AGGAGTGGAGTGGTTATCCGTACACGTTCGGAGGGGGGACCAAGC T3′
黑体字及划线序列是使用核苷酸70∶10∶10∶10的混合物合成的突变序列,其中70%是野生型核苷。
将摩尔数超出10倍的CDR突变寡核苷酸加入以上面步骤(2)得到的长度在50至200bp之间的纯化A10B抗体DNA片段中。加入PCR混合物(50mM KCl,10mMTris-HCl pH9.0,0.1%Triton X-100,1.9mM MgCl2,各200μm dNTP,0.3μl TaqDNA聚合酶(Promega,Madison WI),总体积为50μl),交换程序在94℃进行1分钟,72℃ 1分钟,然后进行35个[94℃ 30秒,55℃ 30秒,72℃ 30秒]循环。
将1μl交换混合物加入100μl PCR混合物(50mM KCl,10mM Tris-HClpH9.0,0.1%Triton X-100,各200μm的dNTP,1.9mM MgCl2,各0.6μm的两个外侧引物(SEQ ID NO:26和27,见下面),0.5μl Taq DNA聚合酶)中,PCR程序进行30个[94℃ 30秒,45℃ 30秒,72℃ 45秒]循环,所得的850碱基对大小的DNA片段混合物用酚/氯仿提取并用乙醇沉淀。
外侧引物是:外侧引物1:SEQ ID NO:27 5′TTGTCGTCTTTCCAGACGTT3′外侧引物2:SEQ DI NO:26 5′ATGATTACGCCAAGCTTT3′
5)将scFv抗体DNA克隆进pCANTAB5
用限制性酶SfiI和NotI消化850bp PCR产物。从低熔点琼脂糖凝胶中纯化并连接进从Pharmacia,Milwaukee WI获得的pCANTAB5表达载体中。根据Invitrogen(San Diego CA)阐述的方法将连接的载体电穿孔进TG1细胞(Pharmacia,Milwaukee WI),按照厂家建议的说明书使用辅助噬菌体生长噬菌体文库。
使用6轮选择筛选在该方法产生的文库中改进抗体的存在。
6)高亲合力克隆的选择
用兔IgG(Jackson Immunoresearch,Bar Harbor ME)以10μg/孔在37℃覆盖96孔微8滴板的15个孔1小时,然后用2%的溶于PBS的脱脂半乳在37℃封闭1小时。
用100μl 2%乳液在室温下封闭100μl的噬菌体文库(1×1010cfu)30分钟,然后加到15个孔的各孔中并在37℃保温1小时。
然后用含0.5%Tween-20的PBS洗涤各孔3次,每次10分钟。结合的噬菌体用100μl洗脱缓冲液(甘氨酸-HCl,pH2.2)洗脱,接着用2M Tris pH7.4立即中和并转染用于噬菌体生产。重复该选择循环6次。
第6个循环后,挑出单个噬菌体克隆并以噬菌体ELISA比较相对亲合力,用Pharmacia(Milwaukee WI)的试剂盒根据厂家建议的方法试验兔IgG的特异性。
当以Western分析试验时,与野生型A10B比较,最好的克隆表达水平提高大约100倍。与最佳克隆在竞争试验中产生50%抑制的兔IgG浓度是1微微摩尔。最佳克隆对兔抗原具有可重复的特异性。以噬菌体显示的抗体拷贝数似乎增加。
实施例8.经部分基因的直接重复进行体内重组
以两部分灭活的相同基因(β-内酰胺酶)拷贝构建质粒以证实这两个直接重复的共同区之间的重组产生全长的,有活性的重组基因。
使用携带细菌TEM-1β内酰胺酶基因的pUC18衍生物(Yanish-Perron et al.,1985,Gene 33:103-119)。TEM-1β内酰胺酶基因(“Bla”)赋予细菌对大约0.02μg/ml的cefotaxime产生抗性。用2个引物对载体序列进行PCR:Primer A(SEQ ID NO:46)5′TTCTATTGACGGCCTGTCAGGCCTCATATATACTTTAGATTGTTTT3′Primer B (SEQ ID NO:47)5′TTGACGCACTGGCCATGGTGGCCAAAAATAAACAAATAGGGGTTCCGCGCACATTT3′
及用另外两个引物对β-内酰胺酶基因序列进行PCR:Primer C(SEQ ID NO:48)5′AACTGACCACGGCCTGACAGGCCGGTCTGACAGTTACCAATGCTT3′Primer D(SEQ ID NO:49)5′AACCTGTCCTGGCCACCATGGCCTAAATACATTCAAATATGTAT3′
将Sfil限制性位点加到启动子5′端和β内酰胺酶基因3′端。
用Sfil消化两个反应产物,混合,连接并用于以下述程序转化受体大肠杆菌。所得的质粒是pUC182Sfi-Bla-Sfi。该质粒含有携带Bla基因和P-3启动子的Sfil片段。
携带pUC182Sfi-Bla-Sfi的大肠杆菌XL1-blue(Stratagene,San Diego CA)在37℃培养24小时后的cefotaxime最低抑制浓度为0.02μg/ml。
使用同源区域将pBR322的四环素基因克隆区pUC18Sif-Bla-Sfi,产生pBR322TetSfi-Bla-Sfi。然后用SspI和FspI限制性消化pBR322 TetSfi-Bla-Sfi去掉TEM-1基因并连接末端,产生pUC322 TetSfi-Sfi。
使用标准PCR技术和下列引物扩增TEM-1基因的重叠区:Primer 2650(SEQ ID NO:50)5′TTCTTAGACGTCAGGTGGCACTT3′Primer 2493(SEQ ID NO:51)5′TTT TAA ATC AAT CTA AAG TAT3′Primer 2651(SEQ ID NO:52)5′TGCTCATCCACGAGTGTGGAGAAGTGGTCCTGCAACTTTAT3′,以及rimer 2652(SEQ ID NO:53)ACCACTTCTCCACACTCGTGGATGAGCACTTTTAAAGTT
用Sfil和BstX1消化2个所得的DNA片段并连接进pBR322 Tet Sfi-Sfi的Sfi位点。所得的质粒称为pBR322Sfi-BL-LA-Sfi。质粒的图谱以及功能性β-内酰胺酶的质粒内重组和再构建示意图在图9中表示。
将质粒电穿孔进TG-1或JC8679大肠杆菌细胞。大肠杆菌JC8679是RecBC sbcA(Dliner et al.,1993,NAR 21:5192)。将细胞涂布到含四环素的琼脂平板上。然后将生长的那些克隆涂布到含100μg/ml氨苄青霉素的固体琼脂板上并计数活菌落数。将表现出氨苄青霉素抗性的那些转化子中的β内酰胺酶基因插入片段以标准PCR技术扩增,使用的引物是:Primer 2650(SEQ ID NO:50)5′TTCTTAGACGTCAGGTGGCACTT3′和Primer 2493(SEQ ID NO:51)5′TTTTAAATCAATCTAAAGTAT3′
测量插入片段的长度。1kb插入片段的存在表明该基因已成功地重组,如图9和表5所示。
表5
细胞 | 菌落 | 菌落 | 菌落 |
TG-1 | 131 | 21 | 3/3 at 1 kb |
JC8679 | 123 | 31 | 4/4 at 1 kb |
载体对照 | 51 | 0 |
大约17-25%的四环素抗性菌落也是氨苄青霉素抗性,经菌落PCR测定全部氨苄青霉素抗性菌落已正确重组。因此,位于相同质粒的部分基因将成功地重组以产生功能基因。
实施例9.经全长基因的直接重复进行体内重组
构建具有β内酰胺酶基因不同等位基因的两个全长拷贝的质粒。两个基因的同源重组产生该基因的单个重组全长拷贝。
pBR322Tet Sfi-Sfi和pBR322 Tet Sfi-Bla-Sfi的构建描述如上。
按下面构建β内酰胺酶基因的两上等位基因。用pUC18Sfi-Bla-Sfi作模板进行两个PCR反应。一个反应用下列引物进行:Primer 2650(SEQ ID NO:50)5′TTCTTAGACGTCAGGTGGCACTT3′Primer 2649(SEQ ID NO:51)5′ATGGTAGTCCACGAGTGTGGTAGTGACAGGCCGGTCTGACAGTTACCAATGCTT3′
用下列引物进行第二个PCR反应:Primer 2648(SEQ ID NO:54)5′TGTCACTACCACACTCGTGGACTACCATGGCCTAAATACATTCAAATATGTAT3′Primer 2493(SEQ ID NO:51)5′TTT TAA ATC AAT CTA AAG TAT 3′
这样产生两个Bla基因,一个具有5′Sfi1位点和3′BstX1位点,另一个具有5′Bst X1位点和3′Sfi1位点。
用BstX1和Sfi1消化这两个基因后,连接进Sfi1消化的质粒pBR322Tet Sfi-Sfi中,获得具有Bla基因串联重复的质粒(pBR322-Sfi-2BLA-Sfi),(见图10)。将该质粒电穿孔进大肠杆菌细胞中。将细胞涂布到含15μg/ml四环素的固态琼脂板上。然后将那些生长的菌落涂布到含100μg/ml氨苄青霉素的固态琼脂板上并计数活菌落数。将表现出氨苄青霉素抗性的转化子中的Bla插入片段以标准PCR技术使用实施例8描述的方法和引物扩增。1kb插入片段的存在表明:复制基因已重组如表6所示。
表6
细胞 | 菌落 | 菌落 | 菌落 |
TG-1 | 28 | 54 | 7/7 at 1kb |
JC8679 | 149 | 117 | 3/3 at 1kb |
载体对照 | 51 | 0 |
菌落PCR证实串联重复有效重组形成了单个重组基因。
实施例10.多轮直接重复重组-质粒内
为了确定多轮重组是否可用于更快地生产抗性细胞,进行实施例9所述方法的多个循环。
负重组控制由单拷贝的β内酰胺酶基因组成,而正重组实验由插入的两个拷贝的β内酰胺酶直接重复组成。四环素标记用于平衡在每轮中选择cefotaxime抗性的菌落数以补偿连接效率。
在第一轮中,用EcrI消化pBR322TetSfi-Bla-Sfi并用正常和Cadwell PCR混合物(Cadwell and Joyce(1992)PCR Methods and Applications 2:28-33)的1∶1混合物(1ml)进行PCR以获得发生误差的PCR。PCR程序是开始在70℃ 2分钟。然后进行30次循环,每循环在94℃ 30秒;52℃ 30秒和72℃ 3分钟6秒,接着在72℃ 10分钟。
在PCR反应中用于产生一个Bla基因控制质粒的引物是引物2650(SEQ IDNO:5))和引物2719(SEQ ID NO:55)5′TTAAGGGATTTTGGTCATGAGATT3′。这产生扩增DNA片段的混合群体,集中命名为片段#59。这些片段有不同突变数目。
用于两个不同PCR反应以产生两个Bla基因质粒的引物对于第一基因是引物2650(SEQ ID NO:50)和引物2649(SEQ ID NO:51),对于第二基因是引物2719(SEQID NO:55)。这产生两个扩增DNA片段中每一个的混合群体:片段#89(用引物2648和2719扩增)和片段#90(用引物2650和2649扩增)。在每种情况下将不同突变数导入各片段的混合群体中。
经过有误差的PCR后,用Sfil消化扩增DNA片段#59的群体,然后克隆进pBR322TetSfi-Sfi以产生质粒pBR322Sfi-Bla-Sfi1的混合群体。
经过有误差的PCR后,用SfiI和BstXI在50℃消化扩增DNA片段#90和#89的群体并连接进pBR322TetSfi-Sfi以产生质粒pBR322TetSfi-2Bla-Sfi1的混合群体(图10)。
将质粒pBR322Sfi-Bla-Sfi1和pBR322Sfi-2Bla-Sfi1电穿孔进大肠杆菌JC8679并涂布在具有不同cefotaxime浓度的琼脂板上以选择抗性菌株并涂布在四环素板上滴定。
挑出等数目的菌落(根据在四环素上生长的菌落数),在LB-tet上生长并从菌落中提取DNA。这是一轮重组。用EcrI消化该DNA并按上面所述用于第二轮有误差的PCR。
经过5轮后,一个片段质粒对cefotaxime的MIC(最低抑制浓度)是0.32,而两个片段质粒的MIC是1.28。结果表明,经过5次循环后,重组获得的抗性比体内重组存在的抗性高4倍。
实施例11.经片段的电穿孔进行体内重组
按所述制备含pUC18Sfi-Bla-Sfi的感受态大肠杆菌。如上所述质粒pUC18Sfi-Bla-Sfi含标准TEM-1β-内酰胺酶基因。
获得来自pUC18Sfi-cef-Sfi(克隆ST2)(Stemmer WPC(1994))Nature370:389-91,本文引用作为参考)的TE-1衍生的cefotaxime抗性基因,它赋予携带该质粒的大肠杆菌对cefotaxime的MIC为640μg/ml。在一个实验中,将完整的质粒pUC18Sfi-cef-Sfi DNA电穿孔进具有质粒pUC18Sfi-Bla-Sfi的大肠杆菌细胞中。
在另一实验中,将含来自pUC18Sfi-cef-Sfi的cefotaxime基因的DNA片段使用引物2650(SEQ ID NO:50)和2719(SEQ ID NO:55)经PCR扩增。所得的1kb PCR产物以DNase消化成<100bp的DNA片段,将这些片段电穿孔进已含有pUC18Sfi-Bla-Sfi的感受态大肠杆菌细胞中。
然后经过将转化细胞涂布到具有不同cefotaxime浓度的琼脂板上试验来自两个实验中的转化细胞对cefotaxime的抗性。结果在表7中表示。
表7 菌落/cefotaxime浓度
无DNA对照 | 0.16 | 0.32 | 1.28 | 5.0 | 10.0 |
ST-2突变子,整体 | 14 | ||||
ST-2突变子,片段 | 4000 | 2000 | 800 | 400 | |
野生型,整体 | 1000 | 120 | 22 | 7 | |
野生型,片段 | 27 | ||||
18 |
该结果表明电穿孔后完整ST-2 Cef基因插入了细菌基因组成质粒中。由于大多数插入片段是同源的,预期该基因插入质粒中,取代野生型基因。St-2的Cef基因片段也有效地插入质粒的野生型基因中。对导入野生型基因(整体或片段)和无DNA观察不到cefotaxime抗性的急剧增加。因此,St-2片段显示出比野生型片段产生更大的cefotaxime抗性。期望从增加抗性基因库中制备的重复的插入片段会导致抗性增加。
因此,分离具有St-2基因片段,产生增加的cefotaxime抗性的那些菌落并提取质粒DNA。使用上面描述的PCR方法扩增该DNA。用DNase将扩增DNA消化成片段(<100bp),将2-4μg该片段电穿孔进已含有pUC322Sfi-Bla-Sfi的上面所述的感受态大肠杆菌细胞中。将转化的细胞涂布在含有不同cefotaxime浓度的琼脂上。
作为对照,也使用具有质粒pUC18Sfi-Kan-Sfi的感受态大肠杆菌。将pUC18Sfi-cef-Sfi PCR产物消化的DNA片段电穿孔进这些细胞中。在卡那霉素基因和β内酰胺酶基因间无同源性,因此不会发生重组。
本实验重复2轮,结果在表8中显示。
表8
次数 | 浓度 | 对照 | 抗性菌落 |
1重复涂布 | 0.16-0.640.32 | 菌落10小 | 菌落1000 |
2重复涂布 | 10 | 10100sm@2.5 | 40050@10 |
3 | 401280 | 100sm | 100sm |
实施例12.重组形式的确定
设计本实验以确定哪一种重组形式在每个循环中产生最多重组子。
在第一种方法中,用PCR引物扩增载体pUC18Sfi-Bla-Sfi以产生大型和小型片段。大片段具有质粒和部分Bla基因的末端,小片段编码中央Bla基因。使用实施例8的PCR方法产生具有完整Bla基因的第三个片段。以上面描述的方法将大质粒片段和含完整Bla基因的片段同时电穿孔进大肠杆菌JC8679细胞中,将转化子涂布在不同浓度的cefotaxime上。
在第二种方法中,扩增载体pUC18Sfi-Bla-Sfi以产生如上面第一种方法中分离的大质粒片段。经PCR获得各包含部分完整Bla基因的2个片段,使两个片段一起覆盖完整的Bla基因。将大质粒片段和2个Bla基因片段都电穿孔进感受态的大肠杆菌JC8679细胞中,将转化子涂布在不同浓度的cefotaxime上。
在第三种方法中,将载体和质粒都电穿孔进大肠杆菌JC8679细胞中并将转化子涂布在不同浓度的cefotaxime上。
在第四种方法中,将完整Bla基因电穿孔进已含有载体pUCSfi-Sfi的大肠杆菌细胞保并将转化子涂布在不同浓度的cefotaxime上。作为对照用完整Bla基因或仅用载体电穿孔大肠杆菌JC8671细胞。
结果在图11中表示,与使用具有完整Bla基因的一个片段相比,两个片段插入载体的效率低100倍。第3步研究表明:插入效率取决于自由DNA末端的存在,因为在这一步研究中设有获得重组子。然而,方法3中的结果也是由于载体电穿孔的效率低,当表达载体已存在于感受态细胞中时,载体电穿孔的效率不再是因素,甚至用未切割的载体可获得有效的同源重组。
实施例13.优化载体效果的序列盒杂合试剂盒
为了提供能赋予优化表型的载体(例如,载体编码序列的最大表达,如克隆的基因),提供了一套试剂盒,包含各种能被交换的序列盒,并选择优化的交换子。图12是一个实施方案的图示,每个基因座具有许多序列盒。例如,在细菌表达系统中,图13显示了在各自基因座使用的序列盒例子。给字基因座的各序列盒(例如,本实施例中的所有启动子)两侧是能重叠邻近基因座序列盒侧翼序列且优选也能参与同源重组或非同源重组(例如,lox/cre或flp/frt系统)的基本相同的序列,以便实现在一个基因座内而基本上不是基因座之间的序列盒的交换。
在试剂盒中以PCR片段的形式提供序列盒,其中各序列盒类型或单个序列盒种类包装在分离的试管中,经过合并试管的内容物以装配完整质粒或其主要部分构建载体文库,其中经过使每个基因座序列盒重叠的侧翼序列与邻近基因座的序列盒杂交来实现。装配的载体连接到预定的目的基因上以形成载体文库,其中各文库成员包含预定的目的基因和序列盒的组合,这经过序列盒的联接来确定。将载体转移进合适的宿主细胞中,在适合于表达的条件下培养细胞并选择所需的表型。
尽管使用认为是优选的实施例对本发明进行了描述,但应清楚本发明不受所公开实施例的限制。相反,本发明试图覆盖包括在所附权利要求的实质和范围内的各种修改和等价方法。
参考文献
本申请在说明书的相关部分引用了下列参考文献:
1.J·H·霍兰德,《美国科学》,1992,7,66-72。
2.J·H·霍兰德,《天然和人工系统的适应》,1992,第二版,MIT出版,剑桥。
3.G·F·乔易斯,《科学美国人》,1992,12,90-97。
4.S·A·考夫曼,《秩序起源》,1993,牛津大学出版,纽约。
5.G·D·斯多莫,《酶学方法》,1991,208:458-468。
6.T·D·施奈德等,《分子生物学杂志》,1988,188:415-431。
7.J·F·瑞德哈尔奥森和R.T.绍尔,《科学》,1988,241:53-57。
8.W·P·C·斯提莫等,《生物技术》,1992,14:256-265。
9.H·P·约克等,《理论生物学杂志》,1977,67:345-376。
10.H·P·约克等,《理论生物学杂志》,1974,46:369-380。
11.D·W·利昂等,《技术》,1989,1:11-15。
12.R·C·卡尔德威尔和G·F乔易斯,《PCR方法和应用》,1992,2:28-33。
13.D·P·巴特尔和J·W·佐斯泰克,《科学》,1993,261:1411-1418。
14.L·C·博克等,《自然》,1992,355:564-566。
15.J·K·斯各特和G.P.史密斯,《科学》,1990,249:386-390。
16.S·E·克威尔拉等,《美国自然科学院进展》,1990,87:6378-6382。
17.S·E·麦克卡佛蒂等,《自然》,1990,348:552-554。
18.M·G·卡尔等,《美国自然科学院进展》,1992,89:1865~1869。
19.H·格拉姆等,《美国自然科学院进展》,1992,89:3576-3580。
20.A·阿金和D·C·尤文,《美国自然科学院进展》,1992,89:7811-7815。
21.A·R·奥利芬特等,《基因》,1986,44:177-183。
22.J·D·赫米斯等,《美国自然科学院进展》,1990,87:696-700。
23.A·迈尔汉斯等,《核酸研究》,1990,18:1687-1691。
24.J·J·奥斯特霍特等,《美国化学社会杂志》,1992,114:331-337。
25.R·J·卡农等,《自然》,1993,363:536-538。
26.帕尔兹基尔和博特斯蒂思,《细菌学杂志》,1992,174:5237-5243。
27.马腾等,《核酸研究》,19:2423。
28.杨尼斯-佩龙等,《基因》,1985,33:103-119。
29.瓦特森,《基因》,1988,70:399-403。
30.安布勒等,《生物化学杂志》,1991,276:269-272。
31.切恩和克洛斯,《核酸研究》,1984,12:3219-3234。
32.B·威特赫特,《分析生物化学》,1987,164(2):320-330。
33.卡巴特等,“免疫学蛋白质的序列”美国健康与人类服务部,NIH发表,19-3242。
34.菲利蓬等,《抗微生物试剂化学》,1989,33:1131-1136。
35.雅各比和梅代罗斯,《抗微生物试剂化学》,1991,35:167~1704。
36.科埃略萨姆陪奥,《生物化学》,1993,32:10929-10935。
37.C·图尔克等,《美国自然科学院进展》,1992,89:6988-6992。
38.第4,683,195号美国专利。
39.第4,683,202号美国专利。
40.德拉哥瑞伍等,《蛋白质工程》,1993,6:327-331。
41.德拉哥瑞伍等,《生物/技术》,1993,11:1548-1552。
42.ER.戈德曼和DC.优文,《生物/技术》,1992,10:1557-1561。
43.尼斯姆等,《EMBO杂志》,1994,13:692-698。
44.温特等,《免疫学年志》,1994,12:433-55。
45.凯伦等,《生物/技术》,1994,12:517-520。
46.卡洛盖洛等,《FEMS微生物学通信》,1992,97:41-44。
47.盖利兹等,WO91/01087。
48.海雅西等,《生物技术》,1994,17:310-315。
49.拉达姆等,WO90/07576。(1. Holland,J.H.(1992)Sci.Am.July,66-72.2. Holland,J.H.(1992)″Adaptation in natural and artificial
systems″Second edition,MIT Press,Cambridge.3. Joyce,G.F.(1992)Scientific American,December,90-97.4. Kauffman,S.A.(1993)″The origins of order″.Oxford
University Press,New York.5. Stormo,G.D.(1991)Methods Enzymol.208:458-468.6. Schneider,T.D.et al.,(1986)J.Mol.Biol.188:415-431.7. Reidhaar-Olson,J.F and Sauer,R.T.(1988)Science 241:53-
57.8. Stemmer,W.P.C.et al.,(1992)Biotechniques 14:256-265.9. Yockey,H.P.(1977)J.Theor.Biol.67:345-376.10.Yockey,H.P.(1974)J.Theor.Biol.46:369-380.11.Leung,D.W.et al.,(1989)Tachnique 1:11-15.12.Caldwell,R.C.and Joyce,G.F.(1992)PCR Methods and
Applications 2:28-33.13.Bartel,D.P.,and Szostak,J.W.(1993)Science 261:1411-1418.14.Bock,L.C.et al.,(1992)Nature 355:564-566.15.Scott,J.K.and Smith,G.P.(1990) Science 249:386-390.16.Cwirla,S.E.et al.(1990)Proc.Natl.Acad.Sci.USA87:6378-6382.17.McCafferty,J.et al.(1990)Nature 348:552-554.18.Cull,M.G.et al.,(1992)Proc.Natl.Acad.Sci.USA89:1865-1869.19.Gramm,H.et al.,(1992)Proc. Natl.Acad.Sci.USA 89:3576-3580.20.Arkin,A.and Youvan,D.C.(1992)Proc.Natl.Acad.Sci.USA 89:7811-7815.21.Oliphant,A.R.et al.,(1986)Gene 44:177-183.22.Hermes,J.D.et al.,(1990)Proc.Natl.Acad.Sci.USA87:696-700.23.Meyerhans,A.et al.,(1990)Nucleic Acids Res.18:1687-1691.24.Osterhout,J.J.et al.,(1992)J.Am.Chem.Soc.114:331-337.25.Cano,R.J.et al.,(1993)Nature 363:536-538.26.Palzkill and Botstein,(1992)J.Bacteriol.174:5237-5243.27.Marton et al.,Nucleic Acids Res.19:2423.28.Yanish-Perron et al.,[1985] Gene 33:103-119.29.Watson(1988)Gene 70:399-403.30.Ambler et al.(1991)Biochem J.276:269-272.31.Chen and Clowes,(1984)Nucleic Acid Res.12:3219-3234.32.Witholt,B.([1987] Anal.Biochem.164(2):320-33033.Kabat et al.,(1991)″Sequences of Proteins of ImmunologicalInterest″U.S.Department of Health and Human Services,NIHPublication 91-3242.34.Philippon et al.,(1989)Antimicrob Agents Chemother33:1131-1136.35.Jacoby and Medeiros(1991)Antimicrob.Agents Chemother.35:167-1704.36.Coelhosampaio(1993)Biochem.32:10929-1093537.Tuerk,C.et al.,(1992)Proc.Natl.Acad.Sci.USA 89:6988-6992.38.United States Patent No.4,683,19539.United States Patent No.4,683,20240.Delagrave et al.(1993)Protein Engineering 6:327-33141.Delgrave et al.(1993)Bio/Technology 11:1548-155242.Goldman,ER and Youvan DC(1992)Bio/Technology 10:1557-156143.Nissim et al.(1994)EMBO J.13:692-69844.Winter et al.(1994)Ann.Rev.Immunol.12:433-5545.Caren et al.(1994)Bio/Technology 12:517-52046.Calogero et al.(1992)FEMS Microbiology Lett.97:41-4447.Galizzi et al. WO91/0108748.Hayashi et al.(1994)Biotechniques 17:310-31549.Radman et al.WO90/07576)
此处引用的所有文献,专利和专利申请以其整体所为参考,其程度与以其全文作为参考引用时具体和单独说明的各文献、专利或专利申请一样。
Claims (32)
1.用于将一个或多个突变导入模板双链多核苷酸的方法,其中模板双链多核苷酸已裂解成所需大小的双链随机片段,该方法包括:
a)将一种或多种单链或双链寡核苷酸加入所得的双链片段群体中,其中所说的寡核苷酸包含与模板多核苷酸相同的区域和异源区域;
b)将所得的双链随机片段与寡核苷酸的混合物变性成单链片段;
c)在导致所说单链片段在单链片段之间相同区域上退火的条件下将所得的单链片段群体与聚合酶保温并形成诱变的双链多核苷酸;以及
d)重复步骤(b)和(c)。
2.权利要求1的方法,其中在双链片段混合物中特定双链片段的浓度不超过总DNA重量的1%。
3.权利要求1的方法,其中不同特定双链片段的数目包括至少大约100个。
4.权利要求1的方法,其中双链片段的大小从56bp到5kb。
5.权利要求1的方法,其中诱变的双链多核苷酸的大小包含50bp到100kb。
6.生产具有生物活性重组蛋白质的方法,包括:
a)在提供将所说模板多核苷酸裂解成具有所需大小的随机双链片段的条件下处理包含编码野生型蛋白质的双链模板多核苷酸的样品;
b)向所得的随机片段的群体中加入一种或多种单链或双链寡核苷酸,其中所说的寡核苷酸包含模板多核苷酸的相同区和异源区;
c)将所得的双链随机片段和寡核苷酸的混合物变性成单链片段;
d)在导致所说的单链片段在相同区域退火的条件下将所得的单链片段群体与聚合酶保温并形成诱变的双链多核苷酸;
e)重复步骤(c)和(d);
f)从诱变的双链多核苷酸表达重组蛋白质。
7.权利要求6的方法,其中在步骤(a)中双链片段混合物中的特定双链片段的浓度不到总DNA重量的1%。
8.权利要求6的方法,其中步骤(a)中不同的特定双链片段的数目包含至少大约100个。
9.权利要求6的方法,其中双链片段的大小是从大约5bp到5kb。
10.权利要求6的方法,其中诱变的双链多核苷酸大小包括从50bp到100kb。
11.权利要求6的方法,进一步包含从重组蛋白质群体中选择所需的重组蛋白质。
12.获得嵌合多核苷酸的方法,包含:
a)在提供将所说的模板多核苷酸裂解成所需大小的随机双链片段的条件下处理包含不同双链模板多核苷酸的样品,其中所说的不同模板多核苷酸含有相同区和异源区;
b)将包含在步骤(a)产生的处理样品中的所得随机双链模板片段变性成单链片段;
c)在提供靶单链片段在相同区域退火的条件下将所得的单链片段与聚合酶保温并形成包含模板多核苷酸序列的嵌合双链多核苷酸序列;
d)按需要重复步骤(b)和(c)。
13.权利要求12的方法,其中在步骤(a)中双链片段混合物中的特定双链片段浓度不超过总DNA重量的1%。
14.权利要求12的方法,其中步骤(a)不同的特定双链片段的数目包含至少大约100个。
15.权利要求12的方法,其中双链片段的大小是从大约5bp到5kb。
16.权利要求12的方法,其中诱变的双链多核苷酸的大小包含从50bp到100kb。
17.复制模板多核苷酸的方法,该方法包括:体外结合单链模板多核苷酸与来自模板多核苷酸裂解和变性的小随机单链片段,在形成双链模板多核苷酸群体的条件下,在核酸聚合酶存在的条件下保温所说的核酸片段混合物。
18.一种产生适于亲和作用筛选或表型筛选的演示肽或演示抗体文库的方法,该方法包括:
(1)获得包含演示肽或演示抗体和编码所说演示肽或演示抗体的相关多核苷酸的第一群选定的文库成员,并获得所说相关多核苷酸或其拷贝,其中所说的相关多核苷酸包含基本相同序列的区域,以及
(2)在适于PCR扩增的条件下合并且片段化所说的相关多核苷酸或拷贝,进行PCR扩增,且由此同源重组所说的片段使形成重组多核苷酸的杂合库,其中所说的杂合库的重组多核苷酸的主要部分不存在于第一群选定的文库成员中。
19.权利要求18的方法,进一步包含将突变导入所说的多核苷酸或拷贝中。
20.权利要求19的方法,其中经过进行PCR扩增导入突变。
21.权利要求20的方法,其中PCR扩增是有误差的PCR。
22.权利要求18的方法,包含另一步筛选杂合库的文库成员以鉴定具有结合预定大分子之能力的单个杂合文库成员。
23.权利要求18的方法,其中经过选择不同于对预定分子的结合亲和力的表型特征来获得第一群选定的文库成员。
24.权利要求18的方法,其中合并第一群选定的文库成员并片段化,经体外PCR同源重组。
25.权利要求18的方法,其中合并第一群选定的文库成员并体外片段化,所得的片段转移进宿主细胞或有机体并同源重组形成体内杂合文库成员。
26.权利要求18的方法,其中第一群选定的文库成员在游离的可复制载体上克隆或扩增,所说的多重性载体转移进细胞和同源重组以形成体内杂合文库成员。
27.产生适于亲和作用筛选或表型筛选的演示肽或演示抗体的文库的方法,该方法包括:
(1)获得包含演示肽或演示抗体和编码所说演示肽或演示抗体的相关多核苷酸的第一群选定的文库成员,获得所说相关多核苷酸或其拷贝,其中所说的相关多核苷酸包含基本相同序列的区域;且
(2)在游离可复制载体上克隆或扩增所说相关多核苷酸或拷贝并将所说的多重性载体转移进细胞和同源重组以形成体内杂合文库成员。
28.权利要求27的方法,进一步包含将突变导入所说的多核苷酸或其拷贝中。
29.权利要求27的方法,其中所说的游离可复制载体包含许多相关多核苷酸或其拷贝的直接重复。
30.一种产生适于亲和作用筛选的演示抗体的文库的方法,该方法包含:
(1)获得包含演示抗体和编码所说的演示抗体的相关多核苷酸的第一群选定的文库成员,获得所说的相关多核苷酸或其拷贝,其中所说的相关多核苷酸包含基本相同的可变区框架序列的区域;以及
(2)在适于PCR扩增的条件下合并和片段化所说的相关多核苷酸或拷贝以形成其片段,进行PCR扩增,并由此同源重组所说的片段以形成包含新CDR组合的重组多核苷酸的杂合库,其中包含CDR组合的所说杂合库的重组多核苷酸主要部分不存在于第一群选定的文库成员中。
31.权利要求30的方法,包含另一个步骤,其中对杂合库进行亲和筛选以选择结合预定抗原决定基的杂合文库成员,并由此选择许多选定的杂合文库成员。
32.权利要求31的方法,包含另一步杂合许多选定的杂合文库成员并从1到大约1000次循环进行筛选。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/198,431 US5605793A (en) | 1994-02-17 | 1994-02-17 | Methods for in vitro recombination |
US08/198,431 | 1994-02-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1145641A true CN1145641A (zh) | 1997-03-19 |
Family
ID=22733354
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN95191679A Pending CN1145641A (zh) | 1994-02-17 | 1995-02-17 | 通过随机片段化和重装配进行的dna诱变 |
Country Status (12)
Country | Link |
---|---|
US (14) | US5605793A (zh) |
EP (4) | EP0934999B1 (zh) |
JP (6) | JPH10500561A (zh) |
CN (1) | CN1145641A (zh) |
AT (2) | ATE216722T1 (zh) |
AU (3) | AU703264C (zh) |
CA (1) | CA2182393C (zh) |
DE (5) | DE934999T1 (zh) |
DK (2) | DK0934999T3 (zh) |
ES (2) | ES2165652T3 (zh) |
RU (1) | RU2157851C2 (zh) |
WO (1) | WO1995022625A1 (zh) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101258244B (zh) * | 2005-08-08 | 2012-02-15 | 基因技术股份公司 | 用于在体内进行蛋白质的选择性进化的方法 |
CN104805508A (zh) * | 2015-04-29 | 2015-07-29 | 江南大学 | 一种基于合成单链dna文库进化代谢途径的方法 |
CN104837994A (zh) * | 2012-12-06 | 2015-08-12 | 安捷伦科技有限公司 | 分子制造 |
WO2016058127A1 (zh) * | 2014-10-14 | 2016-04-21 | 深圳华大基因科技有限公司 | 一种转座酶打断核酸并加接头的方法和试剂 |
CN105934541A (zh) * | 2013-11-27 | 2016-09-07 | Gen9股份有限公司 | 核酸文库及其制造方法 |
US10081807B2 (en) | 2012-04-24 | 2018-09-25 | Gen9, Inc. | Methods for sorting nucleic acids and multiplexed preparative in vitro cloning |
US10202608B2 (en) | 2006-08-31 | 2019-02-12 | Gen9, Inc. | Iterative nucleic acid assembly using activation of vector-encoded traits |
US10308931B2 (en) | 2012-03-21 | 2019-06-04 | Gen9, Inc. | Methods for screening proteins using DNA encoded chemical libraries as templates for enzyme catalysis |
CN110366593A (zh) * | 2017-02-21 | 2019-10-22 | 苏黎世联邦理工学院 | Dna零件,途径和基因组的进化指导的多重dna装配 |
US10457935B2 (en) | 2010-11-12 | 2019-10-29 | Gen9, Inc. | Protein arrays and methods of using and making the same |
US11072789B2 (en) | 2012-06-25 | 2021-07-27 | Gen9, Inc. | Methods for nucleic acid assembly and high throughput sequencing |
US11084014B2 (en) | 2010-11-12 | 2021-08-10 | Gen9, Inc. | Methods and devices for nucleic acids synthesis |
US11702662B2 (en) | 2011-08-26 | 2023-07-18 | Gen9, Inc. | Compositions and methods for high fidelity assembly of nucleic acids |
Families Citing this family (2261)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0834576T3 (da) * | 1990-12-06 | 2002-04-22 | Affymetrix Inc A Delaware Corp | Påvisning af nukleinsyresekvenser |
US6150141A (en) * | 1993-09-10 | 2000-11-21 | Trustees Of Boston University | Intron-mediated recombinant techniques and reagents |
US20060257890A1 (en) * | 1996-05-20 | 2006-11-16 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
US6117679A (en) * | 1994-02-17 | 2000-09-12 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
US6995017B1 (en) | 1994-02-17 | 2006-02-07 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
US5837458A (en) * | 1994-02-17 | 1998-11-17 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
US6335160B1 (en) | 1995-02-17 | 2002-01-01 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
US5605793A (en) * | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
US6165793A (en) * | 1996-03-25 | 2000-12-26 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
US6395547B1 (en) | 1994-02-17 | 2002-05-28 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
US6406855B1 (en) * | 1994-02-17 | 2002-06-18 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
US6309883B1 (en) * | 1994-02-17 | 2001-10-30 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
US6808904B2 (en) * | 1994-06-16 | 2004-10-26 | Syngenta Participations Ag | Herbicide-tolerant protox genes produced by DNA shuffling |
US7262055B2 (en) | 1998-08-25 | 2007-08-28 | Gendaq Limited | Regulated gene expression in plants |
JP4118327B2 (ja) | 1994-08-20 | 2008-07-16 | ゲンダック・リミテッド | Dna認識のための結合タンパク質におけるまたはそれに関連する改良 |
US7285416B2 (en) * | 2000-01-24 | 2007-10-23 | Gendaq Limited | Regulated gene expression in plants |
GB9824544D0 (en) | 1998-11-09 | 1999-01-06 | Medical Res Council | Screening system |
US6063562A (en) * | 1994-09-16 | 2000-05-16 | Sepracor, Inc. | In vitro method for predicting the evolutionary response of HIV protease to a drug targeted thereagainst |
US7597886B2 (en) * | 1994-11-07 | 2009-10-06 | Human Genome Sciences, Inc. | Tumor necrosis factor-gamma |
US7820798B2 (en) * | 1994-11-07 | 2010-10-26 | Human Genome Sciences, Inc. | Tumor necrosis factor-gamma |
EP0799888B1 (en) * | 1994-12-09 | 2005-05-18 | Wakunaga Seiyaku Kabushiki Kaisha | Method of inhibiting non specific hybridization in primer extension |
US20010053523A1 (en) * | 1995-06-02 | 2001-12-20 | M&E Biotech A/S. | Method for identification of biologically active peptides and nucleic acids |
US7670823B1 (en) | 1999-03-02 | 2010-03-02 | Life Technologies Corp. | Compositions for use in recombinational cloning of nucleic acids |
US6143557A (en) * | 1995-06-07 | 2000-11-07 | Life Technologies, Inc. | Recombination cloning using engineered recombination sites |
US6936289B2 (en) | 1995-06-07 | 2005-08-30 | Danisco A/S | Method of improving the properties of a flour dough, a flour dough improving composition and improved food products |
US6964861B1 (en) | 1998-11-13 | 2005-11-15 | Invitrogen Corporation | Enhanced in vitro recombinational cloning of using ribosomal proteins |
US6720140B1 (en) | 1995-06-07 | 2004-04-13 | Invitrogen Corporation | Recombinational cloning using engineered recombination sites |
US6495357B1 (en) * | 1995-07-14 | 2002-12-17 | Novozyme A/S | Lipolytic enzymes |
US6004788A (en) | 1995-07-18 | 1999-12-21 | Diversa Corporation | Enzyme kits and libraries |
US6057103A (en) * | 1995-07-18 | 2000-05-02 | Diversa Corporation | Screening for novel bioactivities |
US5958672A (en) | 1995-07-18 | 1999-09-28 | Diversa Corporation | Protein activity screening of clones having DNA from uncultivated microorganisms |
US6455254B1 (en) | 1995-07-18 | 2002-09-24 | Diversa Corporation | Sequence based screening |
WO1997007205A1 (en) * | 1995-08-11 | 1997-02-27 | Novo Nordisk A/S | Method for preparing polypeptide variants |
ATE219517T1 (de) | 1995-08-18 | 2002-07-15 | Morphosys Ag | Protein-/(poly)peptidbibliotheken |
US6713279B1 (en) | 1995-12-07 | 2004-03-30 | Diversa Corporation | Non-stochastic generation of genetic vaccines and enzymes |
US6537776B1 (en) | 1999-06-14 | 2003-03-25 | Diversa Corporation | Synthetic ligation reassembly in directed evolution |
US5939250A (en) * | 1995-12-07 | 1999-08-17 | Diversa Corporation | Production of enzymes having desired activities by mutagenesis |
US20020031771A1 (en) * | 1995-12-07 | 2002-03-14 | Short Jay M. | Sequence based screening |
US20030219752A1 (en) * | 1995-12-07 | 2003-11-27 | Diversa Corporation | Novel antigen binding molecules for therapeutic, diagnostic, prophylactic, enzymatic, industrial, and agricultural applications, and methods for generating and screening thereof |
US6790605B1 (en) * | 1995-12-07 | 2004-09-14 | Diversa Corporation | Methods for obtaining a desired bioactivity or biomolecule using DNA libraries from an environmental source |
US6489145B1 (en) | 1996-07-09 | 2002-12-03 | Diversa Corporation | Method of DNA shuffling |
US20020028443A1 (en) * | 1999-09-27 | 2002-03-07 | Jay M. Short | Method of dna shuffling with polynucleotides produced by blocking or interrupting a synthesis or amplification process |
US6344328B1 (en) | 1995-12-07 | 2002-02-05 | Diversa Corporation | Method for screening for enzyme activity |
US6361974B1 (en) | 1995-12-07 | 2002-03-26 | Diversa Corporation | Exonuclease-mediated nucleic acid reassembly in directed evolution |
GB9621295D0 (en) * | 1995-12-07 | 1996-11-27 | Cambridge Antibody Tech | Specific binding members,materials and methods |
US6358709B1 (en) | 1995-12-07 | 2002-03-19 | Diversa Corporation | End selection in directed evolution |
US6764835B2 (en) * | 1995-12-07 | 2004-07-20 | Diversa Corporation | Saturation mutageneis in directed evolution |
US20020164580A1 (en) * | 1995-12-07 | 2002-11-07 | Diversa Corporation | Combinatorial screening of mixed populations of organisms |
US6352842B1 (en) | 1995-12-07 | 2002-03-05 | Diversa Corporation | Exonucease-mediated gene assembly in directed evolution |
US7018793B1 (en) * | 1995-12-07 | 2006-03-28 | Diversa Corporation | Combinatorial screening of mixed populations of organisms |
US6740506B2 (en) | 1995-12-07 | 2004-05-25 | Diversa Corporation | End selection in directed evolution |
US6939689B2 (en) | 1995-12-07 | 2005-09-06 | Diversa Corporation | Exonuclease-mediated nucleic acid reassembly in directed evolution |
US6238884B1 (en) | 1995-12-07 | 2001-05-29 | Diversa Corporation | End selection in directed evolution |
US5965408A (en) | 1996-07-09 | 1999-10-12 | Diversa Corporation | Method of DNA reassembly by interrupting synthesis |
US5830696A (en) | 1996-12-05 | 1998-11-03 | Diversa Corporation | Directed evolution of thermophilic enzymes |
US7888466B2 (en) | 1996-01-11 | 2011-02-15 | Human Genome Sciences, Inc. | Human G-protein chemokine receptor HSATU68 |
US5976846A (en) * | 1996-01-13 | 1999-11-02 | Passmore; Steven E. | Method for multifragment in vivo cloning and mutation mapping |
AU1874997A (en) * | 1996-02-15 | 1997-09-02 | Pangenetics B.V. | Molecules for the induction of immunological tolerance |
US6506602B1 (en) | 1996-03-25 | 2003-01-14 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
US6096548A (en) | 1996-03-25 | 2000-08-01 | Maxygen, Inc. | Method for directing evolution of a virus |
US6372480B1 (en) | 1996-04-19 | 2002-04-16 | Mycogen Corporation | Pesticidal proteins |
US6242211B1 (en) | 1996-04-24 | 2001-06-05 | Terragen Discovery, Inc. | Methods for generating and screening novel metabolic pathways |
US7465571B1 (en) | 1996-05-22 | 2008-12-16 | Verenium Corporation | Endoglucanases |
US20020120118A1 (en) * | 1996-05-22 | 2002-08-29 | Short Jay M. | Enzymes having endoglucanase activity and methods of use thereof |
US6617434B1 (en) * | 1996-05-31 | 2003-09-09 | North Shore Long Island Jewish Research Institute | Identificiaton of differentially methylated and mutated nucleic acids |
US5871917A (en) | 1996-05-31 | 1999-02-16 | North Shore University Hospital Research Corp. | Identification of differentially methylated and mutated nucleic acids |
PT938584E (pt) | 1996-07-10 | 2008-08-29 | Lonza Ag | Processo para o fabrico do ácido (s)-3,3,3-trifluoro-2-hidroxi-2-metilpropiónico ou (r)-3,3,3-trifluoro-2-hidroxi-2-metilpropiónico |
JPH1066577A (ja) * | 1996-08-07 | 1998-03-10 | Novo Nordisk As | 核酸プールおよびその製造方法 |
JPH1066576A (ja) * | 1996-08-07 | 1998-03-10 | Novo Nordisk As | 突出末端を有する2本鎖dna及びこれを用いたdnaのシャフリング方法 |
GB9618960D0 (en) | 1996-09-11 | 1996-10-23 | Medical Science Sys Inc | Proteases |
WO1998013485A1 (en) * | 1996-09-27 | 1998-04-02 | Maxygen, Inc. | Methods for optimization of gene therapy by recursive sequence shuffling and selection |
US5811381A (en) * | 1996-10-10 | 1998-09-22 | Mark A. Emalfarb | Cellulase compositions and methods of use |
US7883872B2 (en) * | 1996-10-10 | 2011-02-08 | Dyadic International (Usa), Inc. | Construction of highly efficient cellulase compositions for enzymatic hydrolysis of cellulose |
US6838238B1 (en) * | 1996-10-17 | 2005-01-04 | Invitrogen Corporation | Morphatides: novel shape and structure libraries |
US6242669B1 (en) | 1996-10-30 | 2001-06-05 | Mycogen Corporation | Pesticidal toxins and nucleotide sequences which encode these toxins |
IL119586A (en) * | 1996-11-07 | 2001-09-13 | Univ Ramot | Discontinuous library of a single biological unit and a method for its preparation |
US20070009930A1 (en) * | 1996-12-18 | 2007-01-11 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
US7148054B2 (en) * | 1997-01-17 | 2006-12-12 | Maxygen, Inc. | Evolution of whole cells and organisms by recursive sequence recombination |
AU6029998A (en) | 1997-01-17 | 1998-08-07 | Regents Of The University Of Minnesota | Dna molecules and protein displaying improved triazine compound degrading ability |
IL130635A0 (en) | 1997-01-17 | 2000-06-01 | Maxygen Inc | Evolution of whole cells and organisms by recursive sequence recombination |
US6326204B1 (en) | 1997-01-17 | 2001-12-04 | Maxygen, Inc. | Evolution of whole cells and organisms by recursive sequence recombination |
AU1022402A (en) * | 1997-01-17 | 2002-03-14 | Maxygen, Inc. | Evolution of whole cells and organisms by recursive sequence recombination |
US6261804B1 (en) * | 1997-01-21 | 2001-07-17 | The General Hospital Corporation | Selection of proteins using RNA-protein fusions |
US8207093B2 (en) * | 1997-01-21 | 2012-06-26 | The General Hospital Corporation | Selection of proteins using RNA-protein fusions |
AU738328B2 (en) | 1997-01-21 | 2001-09-13 | General Hospital Corporation, The | Selection of proteins using RNA-protein fusions |
GB9701425D0 (en) | 1997-01-24 | 1997-03-12 | Bioinvent Int Ab | A method for in vitro molecular evolution of protein function |
CN1246150A (zh) * | 1997-01-31 | 2000-03-01 | 科斯米克斯分子生物有限公司 | 组合文库的多样性的产生 |
IL131332A (en) | 1997-02-12 | 2003-07-31 | Eugene Y Chan | Methods and products for analyzing polymers |
US5851808A (en) | 1997-02-28 | 1998-12-22 | Baylor College Of Medicine | Rapid subcloning using site-specific recombination |
US6410220B1 (en) | 1997-02-28 | 2002-06-25 | Nature Technology Corp | Self-assembling genes, vectors and uses thereof |
EP1015575B1 (en) * | 1997-03-18 | 2010-05-19 | Novozymes A/S | Shuffling of heterologous dna sequences |
US6159687A (en) * | 1997-03-18 | 2000-12-12 | Novo Nordisk A/S | Methods for generating recombined polynucleotides |
US6159688A (en) | 1997-03-18 | 2000-12-12 | Novo Nordisk A/S | Methods of producing polynucleotide variants |
US6291165B1 (en) * | 1997-03-18 | 2001-09-18 | Novo Nordisk A/S | Shuffling of heterologous DNA sequences |
JP4263248B2 (ja) * | 1997-03-18 | 2009-05-13 | ノボザイムス アクティーゼルスカブ | Dnaのシャッフリングによるライブラリーの作成方法 |
US5948653A (en) * | 1997-03-21 | 1999-09-07 | Pati; Sushma | Sequence alterations using homologous recombination |
US6153410A (en) * | 1997-03-25 | 2000-11-28 | California Institute Of Technology | Recombination of polynucleotide sequences using random or defined primers |
JP2002514919A (ja) * | 1997-04-04 | 2002-05-21 | バイオサイト ダイアグノスティックス,インコーポレイテッド | 多価ライブラリーおよびポリクローナルライブラリー |
CA2286262A1 (en) | 1997-04-11 | 1998-10-22 | California Institute Of Technology | Apparatus and method for automated protein design |
IL124275A (en) * | 1997-05-02 | 2002-03-10 | Bio Merieux Vitek Inc | A method to produce sequences of nucleic acids |
US6558901B1 (en) * | 1997-05-02 | 2003-05-06 | Biomerieux Vitek | Nucleic acid assays |
GB9712512D0 (en) * | 1997-06-16 | 1997-08-20 | Bioinvent Int Ab | A method for in vitro molecular evolution of protein function |
US6391547B1 (en) * | 1997-09-09 | 2002-05-21 | Center For The Application Of Molecular Biology To International Agriculture | Microbial β-glucuronidase genes, gene products and uses thereof |
US7087420B1 (en) | 1997-07-17 | 2006-08-08 | Cambia | Microbial β-glucuronidase genes, gene products and uses thereof |
DE19731990A1 (de) * | 1997-07-25 | 1999-01-28 | Studiengesellschaft Kohle Mbh | Verfahren zur Herstellung und Identifizierung von neuen Hydrolasen mit verbesserten Eigenschaften |
WO1999011818A1 (fr) * | 1997-08-28 | 1999-03-11 | Isao Karube | Procede de detection d'acides nucleiques ou de polypeptides hautement fonctionnels |
EP1015601B1 (en) * | 1997-09-19 | 2015-01-07 | Promega Corporation | Thermostable luciferases and methods of production |
US6602677B1 (en) * | 1997-09-19 | 2003-08-05 | Promega Corporation | Thermostable luciferases and methods of production |
US6187576B1 (en) | 1997-10-13 | 2001-02-13 | Novo Nordisk A/S | α-amylase mutants |
GB9722131D0 (en) | 1997-10-20 | 1997-12-17 | Medical Res Council | Method |
CN101125873A (zh) * | 1997-10-24 | 2008-02-20 | 茵维特罗根公司 | 利用具重组位点的核酸进行重组克隆 |
NZ504214A (en) | 1997-10-24 | 2003-06-30 | Invitrogen Corp | Recombination cloning using nucleic acids having recombination sites |
US7351578B2 (en) * | 1999-12-10 | 2008-04-01 | Invitrogen Corp. | Use of multiple recombination sites with unique specificity in recombinational cloning |
WO1999021979A1 (en) | 1997-10-28 | 1999-05-06 | Maxygen, Inc. | Human papillomavirus vectors |
US6423299B1 (en) | 1997-10-31 | 2002-07-23 | Vincent Fischetti | Composition for treatment of a bacterial infection of an upper respiratory tract |
US6428784B1 (en) | 1997-10-31 | 2002-08-06 | New Horizons Diagnostics Corp | Vaginal suppository for treating group B Streptococcus infection |
US20030129147A1 (en) * | 1997-10-31 | 2003-07-10 | Vincent Fischetti | Use of bacterial phage associated lysing proteins for treating bacterial dental caries |
US6277399B1 (en) | 1997-10-31 | 2001-08-21 | New Horizon Diagnostics Corporation | Composition incorporating bacterial phage associated lysing enzymes for treating dermatological infections |
US6399098B1 (en) | 1997-10-31 | 2002-06-04 | New Horizons Diagnostics Corp | Composition for treating dental caries caused by streptococcus mutans |
US6752988B1 (en) * | 2000-04-28 | 2004-06-22 | New Horizons Diagnostic Corp | Method of treating upper resiratory illnesses |
US20030129146A1 (en) * | 1997-10-31 | 2003-07-10 | Vincent Fischetti | The use of bacterial phage associated lysing proteins for treating bacterial dental caries |
US7232576B2 (en) | 1997-10-31 | 2007-06-19 | New Horizons Diagnostics Corp | Throat lozenge for the treatment of Streptococcus Group A |
US20030082110A1 (en) * | 1997-10-31 | 2003-05-01 | Vincent Fischetti | Use of bacterial phage associated lysing proteins for treating bacterial dental caries |
US6399097B1 (en) | 1997-10-31 | 2002-06-04 | New Horizons Diagnostics Corporation | Composition for treatment of a bacterial infection of the digestive tract |
EP1690868A1 (en) * | 1997-10-31 | 2006-08-16 | Maxygen, Inc. | Modification of virus tropism and host range by viral genome shuffling |
US20020136712A1 (en) * | 1997-10-31 | 2002-09-26 | Fischetti Vincent | Bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of colonization and infections caused by streptococcus pneumoniae |
US6056954A (en) | 1997-10-31 | 2000-05-02 | New Horizons Diagnostics Corp | Use of bacterial phage associated lysing enzymers for the prophylactic and therapeutic treatment of various illnesses |
US6406692B1 (en) | 1997-10-31 | 2002-06-18 | New Horizons Diagnostics Corp | Composition for treatment of an ocular bacterial infection |
US6432444B1 (en) | 1997-10-31 | 2002-08-13 | New Horizons Diagnostics Corp | Use of bacterial phage associated lysing enzymes for treating dermatological infections |
US7321023B2 (en) * | 1997-11-07 | 2008-01-22 | Incyte Corporation | SP16 protein |
AU752105B2 (en) * | 1997-12-05 | 2002-09-05 | Europaisches Laboratorium Fur Molekularbiologie (Embl) | Novel dna cloning method |
CA2313380C (en) | 1997-12-08 | 2008-12-30 | California Institute Of Technology | Method for creating polynucleotide and polypeptide sequences |
AR017831A1 (es) | 1997-12-10 | 2001-10-24 | Pioneer Hi Bred Int | Metodo para alterar la composicion de aminoacidos de una proteina nativa de interes, proteina elaborada, y polinucleotido |
US20030027173A1 (en) * | 1998-01-16 | 2003-02-06 | Della-Cioppa Guy | Method of determining the function of nucleotide sequences and the proteins they encode by transfecting the same into a host |
US20020164585A1 (en) * | 1998-01-16 | 2002-11-07 | Sean Chapman | Method for enhancing RNA or protein production using non-native 5' untranslated sequences in recombinant viral nucleic acids |
US6468745B1 (en) | 1998-01-16 | 2002-10-22 | Large Scale Biology Corporation | Method for expressing a library of nucleic acid sequence variants and selecting desired traits |
US6426185B1 (en) * | 1998-01-16 | 2002-07-30 | Large Scale Biology Corporation | Method of compiling a functional gene profile in a plant by transfecting a nucleic acid sequence of a donor plant into a different host plant in an anti-sense orientation |
US6303848B1 (en) | 1998-01-16 | 2001-10-16 | Large Scale Biology Corporation | Method for conferring herbicide, pest, or disease resistance in plant hosts |
US20030166169A1 (en) * | 1998-01-16 | 2003-09-04 | Padgett Hal S. | Method for constructing viral nucleic acids in a cell-free manner |
US7390619B1 (en) * | 1998-02-11 | 2008-06-24 | Maxygen, Inc. | Optimization of immunomodulatory properties of genetic vaccines |
US6541011B2 (en) * | 1998-02-11 | 2003-04-01 | Maxygen, Inc. | Antigen library immunization |
KR20010041943A (ko) * | 1998-03-17 | 2001-05-25 | 한스 루돌프 하우스, 헨리테 브룬너, 베아트리체 귄터 | Mlo 단백질을 암호화하며 식물에 진균 내성을 부여하는유전자 |
BR9910174A (pt) | 1998-05-01 | 2001-03-06 | Maxygen Inc | Processo para se obter um gene recombinante otimizado de resistência à praga, biblioteca, e, processo para se obter um organismo que seja patogênico a uma praga de vegetal |
US6287765B1 (en) * | 1998-05-20 | 2001-09-11 | Molecular Machines, Inc. | Methods for detecting and identifying single molecules |
US20030207345A1 (en) * | 1998-05-21 | 2003-11-06 | California Institute Of Technology | Oxygenase enzymes and screening method |
US6902918B1 (en) | 1998-05-21 | 2005-06-07 | California Institute Of Technology | Oxygenase enzymes and screening method |
AU755850B2 (en) | 1998-06-10 | 2002-12-19 | Novozymes A/S | Novel mannanases |
US7153655B2 (en) * | 1998-06-16 | 2006-12-26 | Alligator Bioscience Ab | Method for in vitro molecular evolution of protein function involving the use of exonuclease enzyme and two populations of parent polynucleotide sequence |
AU4441699A (en) | 1998-06-17 | 2000-01-05 | Maxygen, Inc. | Method for producing polynucleotides with desired properties |
US6365408B1 (en) | 1998-06-19 | 2002-04-02 | Maxygen, Inc. | Methods of evolving a polynucleotides by mutagenesis and recombination |
US6846655B1 (en) | 1998-06-29 | 2005-01-25 | Phylos, Inc. | Methods for generating highly diverse libraries |
WO2000005396A1 (en) | 1998-07-21 | 2000-02-03 | Danisco A/S | Foodstuff |
US20030153042A1 (en) * | 1998-07-28 | 2003-08-14 | California Institute Of Technology | Expression of functional eukaryotic proteins |
US6991922B2 (en) * | 1998-08-12 | 2006-01-31 | Proteus S.A. | Process for in vitro creation of recombinant polynucleotide sequences by oriented ligation |
US20030104417A1 (en) * | 1998-08-12 | 2003-06-05 | Proteus S.A. | Template-mediated, ligation-oriented method of nonrandomly shuffling polynucleotides |
WO2000009727A2 (en) * | 1998-08-12 | 2000-02-24 | Maxygen, Inc. | Dna shuffling to produce herbicide selective crops |
US20040191772A1 (en) * | 1998-08-12 | 2004-09-30 | Dupret Daniel Marc | Method of shuffling polynucleotides using templates |
US6951719B1 (en) * | 1999-08-11 | 2005-10-04 | Proteus S.A. | Process for obtaining recombined nucleotide sequences in vitro, libraries of sequences and sequences thus obtained |
AU5347999A (en) | 1998-08-12 | 2000-03-06 | Maxygen, Inc. | Dna shuffling of monooxygenase genes for production of industrial chemicals |
US20030092023A1 (en) * | 1998-08-12 | 2003-05-15 | Daniel Dupret | Method of shuffling polynucleotides using templates |
US20060242731A1 (en) * | 1998-08-12 | 2006-10-26 | Venkiteswaran Subramanian | DNA shuffling to produce herbicide selective crops |
DE69941193D1 (de) | 1998-08-17 | 2009-09-10 | Bristol Myers Squibb Co | Identifizierung von verbindung-protein wechselwirkungen mit bibliotheken von gekoppelten protein-nukleinsäure-molekülen |
CN1160470C (zh) * | 1998-09-03 | 2004-08-04 | 洛马林达大学 | 研究体内蛋白质相互作用的方法 |
US20070178475A1 (en) * | 1998-09-17 | 2007-08-02 | Nehls Michael C | Novel human polynucleotides and polypeptides encoded thereby |
US7897843B2 (en) | 1999-03-23 | 2011-03-01 | Mendel Biotechnology, Inc. | Transcriptional regulation of plant biomass and abiotic stress tolerance |
US20050086718A1 (en) | 1999-03-23 | 2005-04-21 | Mendel Biotechnology, Inc. | Plant transcriptional regulators of abiotic stress |
DK1117808T3 (da) * | 1998-10-06 | 2005-04-25 | Mark Aaron Emalfarb | Transformaationssystem inden jfjor området filamentöse svampeværter: I chrysosporium |
US6500639B2 (en) | 1998-10-07 | 2002-12-31 | Maxygen, Inc. | DNA shuffling to produce nucleic acids for mycotoxin detoxification |
US7315786B2 (en) | 1998-10-16 | 2008-01-01 | Xencor | Protein design automation for protein libraries |
US6403312B1 (en) | 1998-10-16 | 2002-06-11 | Xencor | Protein design automatic for protein libraries |
US20020048772A1 (en) | 2000-02-10 | 2002-04-25 | Dahiyat Bassil I. | Protein design automation for protein libraries |
WO2000023564A2 (en) * | 1998-10-16 | 2000-04-27 | Xencor, Inc. | Protein design automation for protein libraries |
CA2346989A1 (en) | 1998-10-19 | 2000-04-27 | The Board Of Trustees Of The Leland Stanford Junior University | Dna-templated combinatorial library chemistry |
JP5043254B2 (ja) | 1998-10-26 | 2012-10-10 | ノボザイムス アクティーゼルスカブ | 糸状面細胞内の問題のdnaライブラリーの作製及びスクリーニング |
GB9823468D0 (en) * | 1998-10-28 | 1998-12-23 | Secr Defence | Novel enzyme |
JP3267576B2 (ja) * | 1998-11-09 | 2002-03-18 | 三光純薬株式会社 | プローブ高分子の形成方法 |
WO2000028018A1 (en) | 1998-11-10 | 2000-05-18 | Maxygen, Inc. | Modified adp-glucose pyrophosphorylase for improvement and optimization of plant phenotypes |
US6438561B1 (en) * | 1998-11-19 | 2002-08-20 | Navigation Technologies Corp. | Method and system for using real-time traffic broadcasts with navigation systems |
US6303342B1 (en) | 1998-11-20 | 2001-10-16 | Kason Biosciences, Inc. | Recombinant methods and materials for producing epothilones C and D |
US6410301B1 (en) | 1998-11-20 | 2002-06-25 | Kosan Biosciences, Inc. | Myxococcus host cells for the production of epothilones |
DE69942782D1 (de) * | 1998-11-27 | 2010-10-28 | Ucb Sa | Zusammensetzungen und Verfahren zur Erhöhung der Knochenmineralisierung |
US20040009535A1 (en) | 1998-11-27 | 2004-01-15 | Celltech R&D, Inc. | Compositions and methods for increasing bone mineralization |
ATE504651T1 (de) | 1998-12-18 | 2011-04-15 | Novozymes As | Subtilase enzyme der i-s1- und i-s2-untergruppen mit einem zusätzlichen aminosäurerest in einer aktiven schleifenregion |
US20020031802A1 (en) * | 2000-05-12 | 2002-03-14 | Yi Hu | Novel seven transmembrane proteins and polynucleotides encoding the same |
US6570003B1 (en) * | 2001-01-09 | 2003-05-27 | Lexion Genetics Incorporated | Human 7TM proteins and polynucleotides encoding the same |
US6358712B1 (en) | 1999-01-05 | 2002-03-19 | Trustee Of Boston University | Ordered gene assembly |
US20040005673A1 (en) * | 2001-06-29 | 2004-01-08 | Kevin Jarrell | System for manipulating nucleic acids |
EP1141275B1 (en) * | 1999-01-05 | 2009-08-12 | Trustees Of Boston University | Improved nucleic acid cloning |
US7070934B2 (en) | 1999-01-12 | 2006-07-04 | Sangamo Biosciences, Inc. | Ligand-controlled regulation of endogenous gene expression |
US7013219B2 (en) | 1999-01-12 | 2006-03-14 | Sangamo Biosciences, Inc. | Regulation of endogenous gene expression in cells using zinc finger proteins |
US6534261B1 (en) * | 1999-01-12 | 2003-03-18 | Sangamo Biosciences, Inc. | Regulation of endogenous gene expression in cells using zinc finger proteins |
US20030054390A1 (en) * | 1999-01-19 | 2003-03-20 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
US6376246B1 (en) | 1999-02-05 | 2002-04-23 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
US6368861B1 (en) * | 1999-01-19 | 2002-04-09 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
US6917882B2 (en) * | 1999-01-19 | 2005-07-12 | Maxygen, Inc. | Methods for making character strings, polynucleotides and polypeptides having desired characteristics |
EP1151409A1 (en) * | 1999-01-18 | 2001-11-07 | Maxygen, Inc. | Methods of populating data stuctures for use in evolutionary simulations |
US6436675B1 (en) | 1999-09-28 | 2002-08-20 | Maxygen, Inc. | Use of codon-varied oligonucleotide synthesis for synthetic shuffling |
US7702464B1 (en) | 2001-08-21 | 2010-04-20 | Maxygen, Inc. | Method and apparatus for codon determining |
EP1108781A3 (en) | 1999-01-19 | 2001-09-12 | Maxygen, Inc. | Method for making character strings, polynucleotides and polypeptides |
US6961664B2 (en) | 1999-01-19 | 2005-11-01 | Maxygen | Methods of populating data structures for use in evolutionary simulations |
US7024312B1 (en) * | 1999-01-19 | 2006-04-04 | Maxygen, Inc. | Methods for making character strings, polynucleotides and polypeptides having desired characteristics |
US20070065838A1 (en) * | 1999-01-19 | 2007-03-22 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
US8457903B1 (en) | 1999-01-19 | 2013-06-04 | Codexis Mayflower Holdings, Llc | Method and/or apparatus for determining codons |
US7873477B1 (en) * | 2001-08-21 | 2011-01-18 | Codexis Mayflower Holdings, Llc | Method and system using systematically varied data libraries |
US20090130718A1 (en) * | 1999-02-04 | 2009-05-21 | Diversa Corporation | Gene site saturation mutagenesis |
KR20010102069A (ko) | 1999-02-11 | 2001-11-15 | 추후제출 | 고효율 질량 분석 |
EP1161451A4 (en) | 1999-02-26 | 2006-05-17 | Human Genome Sciences Inc | HUMAN ALPHA ENDOKIN AND METHOD FOR ITS USE |
JP3399518B2 (ja) * | 1999-03-03 | 2003-04-21 | インターナショナル・ビジネス・マシーンズ・コーポレーション | 半導体構造およびその製造方法 |
US6531316B1 (en) | 1999-03-05 | 2003-03-11 | Maxyag, Inc. | Encryption of traits using split gene sequences and engineered genetic elements |
EP1165775A2 (en) * | 1999-03-05 | 2002-01-02 | Maxygen, Inc. | Recombination of insertion modified nucleic acids |
AU3623800A (en) * | 1999-03-08 | 2000-09-28 | Protogene Laboratories, Inc. | Methods and compositions for economically synthesizing and assembling long dna sequences |
AU3879300A (en) * | 1999-03-09 | 2000-09-28 | Diversa Corporation | End selection in directed evolution |
US8148110B2 (en) * | 1999-03-15 | 2012-04-03 | The Board Of Trustees Of The Leland Stanford Junior University | Detection of molecular interactions by β-lactamase reporter fragment complementation |
KR100312070B1 (ko) * | 1999-03-15 | 2001-11-03 | 박호군 | 고속 선별법을 포함하는 개선된 형질을 갖는 효소 변이체의 제조방법 |
US7105315B2 (en) * | 1999-06-16 | 2006-09-12 | Incyte Genomics, Inc. | Transmembrane protein differentially expressed in cancer |
US7030215B2 (en) * | 1999-03-24 | 2006-04-18 | Sangamo Biosciences, Inc. | Position dependent recognition of GNN nucleotide triplets by zinc fingers |
US20030104526A1 (en) * | 1999-03-24 | 2003-06-05 | Qiang Liu | Position dependent recognition of GNN nucleotide triplets by zinc fingers |
BRPI0009362B8 (pt) | 1999-03-30 | 2019-08-20 | Novozymes As | variante de uma alfa-amilase precursora, e, uso de uma variante de alfa-amilase |
JP4745503B2 (ja) | 1999-03-31 | 2011-08-10 | ノボザイムス アクティーゼルスカブ | アルカリα−アミラーゼ活性を有するポリペプチド及びそれらをコードする核酸 |
AU3419200A (en) | 1999-03-31 | 2000-10-23 | Novozymes A/S | Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
US6703240B1 (en) | 1999-04-13 | 2004-03-09 | Maxygar, Inc. | Modified starch metabolism enzymes and encoding genes for improvement and optimization of plant phenotypes |
US20020110809A1 (en) * | 1999-04-30 | 2002-08-15 | Nehls Michael C. | Novel human polynucleotides and polypeptides encoded thereby |
US20020095031A1 (en) * | 1999-05-04 | 2002-07-18 | Nehls Michael C. | Novel human polynucleotides and polypeptides encoded thereby |
ATE408676T1 (de) | 1999-05-20 | 2008-10-15 | Novozymes As | Subtilase enzyme der i-s1 und i-s2 untergruppen mit mindestens einer zusätzlichen aminosäure zwischen position 132 und 133 |
WO2000071691A1 (en) | 1999-05-20 | 2000-11-30 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additional amino acid residue between positions 125 and 126 |
EP1183340B1 (en) | 1999-05-20 | 2008-09-03 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additional amino acid residue between positions 126 and 127 |
DE60040287D1 (de) | 1999-05-20 | 2008-10-30 | Novozymes As | Subtilase enzyme der i-s1 und i-s2 untergruppen mit mindestens einer zusätzlichen aminosäure zwischen position 128 und 129 |
DE60040284D1 (de) | 1999-05-20 | 2008-10-30 | Novozymes As | Subtilase enzyme der i-s1 und i-s2 untergruppen mit mindestens einer zusätzlichen aminosäure zwischen position 129 und 130 |
WO2000071689A1 (en) | 1999-05-20 | 2000-11-30 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additional amino acid residue between positions 127 and 128 |
US7332308B1 (en) | 1999-05-21 | 2008-02-19 | The Penn State Research Foundation | Incrementally truncated nucleic acids and methods of making same |
IL146743A0 (en) * | 1999-05-31 | 2002-07-25 | Novozymes As | Screening method for peptides |
EP1067181A1 (en) * | 1999-06-10 | 2001-01-10 | Rijksuniversiteit te Groningen | Enzyme selection |
CA2378687A1 (en) | 1999-06-18 | 2000-12-28 | Elitra Pharmaceuticals, Inc. | Nucleotide sequences of moraxella catarrhalis genome |
WO2001004287A1 (en) * | 1999-07-07 | 2001-01-18 | Maxygen Aps | A method for preparing modified polypeptides |
US6421613B1 (en) * | 1999-07-09 | 2002-07-16 | Pioneer Hi-Bred International, Inc. | Data processing of the maize prolifera genetic sequence |
CN100510067C (zh) | 1999-07-09 | 2009-07-08 | 诺维信公司 | 葡糖淀粉酶变体 |
US6387620B1 (en) * | 1999-07-28 | 2002-05-14 | Gilead Sciences, Inc. | Transcription-free selex |
US7179638B2 (en) | 1999-07-30 | 2007-02-20 | Large Scale Biology Corporation | Microarrays and their manufacture by slicing |
US6713309B1 (en) | 1999-07-30 | 2004-03-30 | Large Scale Proteomics Corporation | Microarrays and their manufacture |
US6653151B2 (en) | 1999-07-30 | 2003-11-25 | Large Scale Proteomics Corporation | Dry deposition of materials for microarrays using matrix displacement |
GB9918154D0 (en) * | 1999-08-02 | 1999-10-06 | Zeneca Ltd | Expression system |
CN1186446C (zh) | 1999-08-12 | 2005-01-26 | 辉瑞产品公司 | 介导除虫菌素b2:b1比例的除虫链霉茵基因 |
US6251604B1 (en) * | 1999-08-13 | 2001-06-26 | Genopsys, Inc. | Random mutagenesis and amplification of nucleic acid |
US6720142B1 (en) * | 1999-08-19 | 2004-04-13 | University Of Rochester | Method of determining evolutionary potential of mutant resistance genes and use thereof to screen for drug efficacy |
US20020115838A1 (en) * | 2000-08-22 | 2002-08-22 | Friddle Carl Johan | Novel human proteases and polynucleotides encoding the same |
US20050153323A1 (en) * | 2000-07-28 | 2005-07-14 | Yi Hu | Novel human proteases and polynucleotides encoding the same |
US20080003673A1 (en) * | 1999-09-02 | 2008-01-03 | Alejandro Abuin | Novel human proteases and polynucleotides encoding the same |
US6448388B1 (en) | 2000-08-16 | 2002-09-10 | Lexicon Genetics Incorporated | Human proteases and polynucleotides encoding the same |
US6716614B1 (en) * | 1999-09-02 | 2004-04-06 | Lexicon Genetics Incorporated | Human calcium dependent proteases, polynucleotides encoding the same, and uses thereof |
US20030050464A1 (en) * | 2000-07-28 | 2003-03-13 | Yi Hu | Novel human proteases and polynucleotides encoding the same |
US6472588B1 (en) * | 1999-09-10 | 2002-10-29 | Texas Tech University | Transgenic cotton plants with altered fiber characteristics transformed with a sucrose phosphate synthase nucleic acid |
US7063837B2 (en) * | 1999-09-14 | 2006-06-20 | New Horizons Diagnostics Corp | Syrup composition containing phage associated lytic enzymes |
US20020127215A1 (en) * | 1999-09-14 | 2002-09-12 | Lawrence Loomis | Parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections |
US20020107382A1 (en) * | 2000-09-27 | 2002-08-08 | Friddle Carl Johan | Novel human protease inhibitor proteins and polynucleotides encoding the same |
US6790660B1 (en) * | 2001-09-18 | 2004-09-14 | Lexicon Genetics Incorporated | Human kielin-like proteins and polynucleotides encoding the same |
US6867291B1 (en) * | 2000-09-15 | 2005-03-15 | Lexicon Genetics Incorporated | Human hemicentin proteins and polynucleotides encoding the same |
US6511840B1 (en) | 2000-06-15 | 2003-01-28 | Lexicon Genetics Incorporated | Human kinase proteins and polynucleotides encoding the same |
US20080050809A1 (en) * | 1999-09-28 | 2008-02-28 | Alejandro Abuin | Novel human kinases and polynucleotides encoding the same |
US6716616B1 (en) | 1999-09-28 | 2004-04-06 | Lexicon Genetics Incorporated | Human kinase proteins and polynucleotides encoding the same |
US6586230B1 (en) | 2000-10-27 | 2003-07-01 | Lexicon Genetics Incorporated | Human kinase and polynucleotides encoding the same |
US6841377B1 (en) | 2001-06-13 | 2005-01-11 | Lexicon Genetics Incorporated | Human kinase and polynucleotides encoding the same |
US6734009B2 (en) * | 2000-12-27 | 2004-05-11 | Lexicon Genetics Incorporated | Human kinases and polynucleotides encoding the same |
US6541252B1 (en) | 2000-05-19 | 2003-04-01 | Lexicon Genetics Incorporated | Human kinases and polynucleotides encoding the same |
US6797510B1 (en) * | 2001-05-24 | 2004-09-28 | Lexicon Genetics Incorporated | Human kinases and polynucleotides encoding the same |
US6900045B2 (en) * | 2000-08-31 | 2005-05-31 | Lexicon Genetics Incorporated | Human kinase proteins and polynucleotides encoding the same |
US20040002474A1 (en) * | 1999-10-07 | 2004-01-01 | Maxygen Inc. | IFN-alpha homologues |
CA2387479A1 (en) | 1999-10-11 | 2001-04-19 | Lexicon Genetics Incorporated | Human ldl receptor family proteins and polynucleotides encoding the same |
US7430477B2 (en) * | 1999-10-12 | 2008-09-30 | Maxygen, Inc. | Methods of populating data structures for use in evolutionary simulations |
WO2001027275A1 (en) * | 1999-10-13 | 2001-04-19 | Lexicon Genetics Incorporated | Novel human membrane proteins |
ES2335385T3 (es) | 1999-10-13 | 2010-03-26 | The Board Of Trustees Of The Leland Stanford Junior University | Biosintesis de sustratos de policetido sintasa. |
US20080213878A1 (en) * | 1999-10-19 | 2008-09-04 | Gregory Donoho | Novel human membrane proteins and polynucleotides encoding the same |
US6346249B1 (en) * | 1999-10-22 | 2002-02-12 | Ludwig Institute For Cancer Research | Methods for reducing the effects of cancers that express A33 antigen using A33 antigen specific immunoglobulin products |
GB9925161D0 (en) | 1999-10-26 | 1999-12-22 | Secr Defence | Novel enzyme |
US6635438B2 (en) * | 1999-11-02 | 2003-10-21 | Catch, Inc. | Enzymatic cycling assays for homocysteine and cystathionine |
AU1456101A (en) | 1999-11-03 | 2001-05-14 | Maxygen, Inc. | Antibody diversity generation |
DE19953854C2 (de) | 1999-11-09 | 2002-01-17 | Max Planck Gesellschaft | Verfahren zur Herstellung von Biopolymeren mit veränderten Eigenschaften |
CN1654641A (zh) | 1999-11-10 | 2005-08-17 | 诺维信公司 | Fungamyl样α-淀粉酶变体 |
US6686515B1 (en) | 1999-11-23 | 2004-02-03 | Maxygen, Inc. | Homologous recombination in plants |
JP2003517823A (ja) * | 1999-11-26 | 2003-06-03 | ビーエーエスエフ プランド サイエンス ゲーエムベーハー | 植物、藻類または真菌類のヌクレオチド配列の突然変異誘発のための方法 |
US7115712B1 (en) | 1999-12-02 | 2006-10-03 | Maxygen, Inc. | Cytokine polypeptides |
CA2393447A1 (en) * | 1999-12-07 | 2001-06-14 | Lexicon Genetics Incorporated | Novel human membrane proteins and polynucleotides encoding the same |
WO2001042435A2 (en) * | 1999-12-07 | 2001-06-14 | Lexicon Genetics Incorporated | Novel human kinase proteins and polynucleotides encoding the same |
JP2004500060A (ja) | 1999-12-09 | 2004-01-08 | レキシコン・ジェネティクス・インコーポレーテッド | ヒトadam−tsプロテアーゼおよびそれをコードするポリヌクレオチド |
NZ530816A (en) | 1999-12-10 | 2005-10-28 | Invitrogen Corp | Use of multiple recombination sites with unique specificity in recombinational cloning |
WO2001046476A1 (en) * | 1999-12-23 | 2001-06-28 | Maxygen, Inc. | Alteration of hydrolase genes and screening of the resulting libraries for the ability to catalyze specific reactions |
ATE366419T1 (de) * | 1999-12-27 | 2007-07-15 | Crucell Holland Bv | Auswahl von epitop-bindungsfähigen verbindungen aus bibliotheken |
US6927046B1 (en) * | 1999-12-30 | 2005-08-09 | Archer-Daniels-Midland Company | Increased lysine production by gene amplification using coryneform bacteria |
US6395485B1 (en) * | 2000-01-11 | 2002-05-28 | Aventis Cropscience N.V. | Methods and kits for identifying elite event GAT-ZM1 in biological samples |
AU2788101A (en) * | 2000-01-11 | 2001-07-24 | Maxygen, Inc. | Integrated systems and methods for diversity generation and screening |
EP1248846A2 (en) | 2000-01-18 | 2002-10-16 | Lexicon Genetics Incorporated | Human kinase protein and polynucleotides encoding the same |
DE60118527D1 (de) | 2000-01-24 | 2006-05-18 | Compound Therapeutics Inc | Sensible und multiplexe diagnostische tests zur proteinanalyse |
US7022479B2 (en) * | 2000-01-24 | 2006-04-04 | Compound Therapeutics, Inc. | Sensitive, multiplexed diagnostic assays for protein analysis |
EP1257579B1 (en) * | 2000-02-04 | 2009-08-05 | Lexicon Pharmaceuticals, Inc. | Novel human g protein coupled receptor proteins and polynucleotides encoding the same |
EP1621617A1 (en) * | 2000-02-10 | 2006-02-01 | Xencor, Inc. | Protein design automation for protein libraries |
DK1255826T3 (da) * | 2000-02-10 | 2006-01-30 | Xencor Inc | Automatisering af proteindesign for proteinbiblioteker |
WO2001064864A2 (en) * | 2000-02-28 | 2001-09-07 | Maxygen, Inc. | Single-stranded nucleic acid template-mediated recombination and nucleic acid fragment isolation |
WO2001064912A2 (en) * | 2000-02-29 | 2001-09-07 | Maxygen, Inc. | Triazine degrading enzymes |
US6436677B1 (en) * | 2000-03-02 | 2002-08-20 | Promega Corporation | Method of reverse transcription |
CA2402227A1 (en) * | 2000-03-10 | 2001-09-20 | Lexicon Genetics Incorporated | Human g-coupled protein receptor kinases and polynucleotides encoding the same |
WO2001073000A2 (en) * | 2000-03-24 | 2001-10-04 | Maxygen, Inc. | Methods for modulating cellular and organismal phenotypes |
JP2004505610A (ja) * | 2000-04-03 | 2004-02-26 | レキシコン・ジェネティクス・インコーポレーテッド | 新規ヒトイオンチャンネルタンパク質およびそれをコードするポリヌクレオチド |
EP1272644A1 (en) * | 2000-04-12 | 2003-01-08 | Lexicon Genetics Incorporated | Human metalloprotease and polynucleotides encoding the same |
CA2747325A1 (en) | 2000-04-12 | 2001-10-25 | Human Genome Sciences, Inc. | Albumin fusion proteins |
CA2405715C (en) * | 2000-04-14 | 2011-11-15 | Genencor International, Inc. | Methods for selective targeting |
US7129326B2 (en) * | 2000-04-14 | 2006-10-31 | Genencor International, Inc. | Methods for selective targeting |
WO2001081411A2 (en) * | 2000-04-27 | 2001-11-01 | Lexicon Genetics Incorporated | Human 7-transmembrane g-protein coupled receptors and polynucleotides encoding the same |
WO2001082945A2 (en) * | 2000-04-28 | 2001-11-08 | New Horizons Diagnostic Corporation | The use of bacterial phage associated lysing enzymes for treating various illnesses |
US6534292B1 (en) | 2000-05-08 | 2003-03-18 | Genencor International, Inc. | Methods for forming recombined nucleic acids |
EP1280909A2 (en) * | 2000-05-12 | 2003-02-05 | Lexicon Genetics Incorporated | Human lipocalin homologs and polynucleotides encoding the same |
US7115403B1 (en) * | 2000-05-16 | 2006-10-03 | The California Institute Of Technology | Directed evolution of galactose oxidase enzymes |
WO2001088133A2 (en) * | 2000-05-18 | 2001-11-22 | Lexicon Genetics Incorporated | Human semaphorin homologs and polynucleotides encoding the same |
US7244560B2 (en) * | 2000-05-21 | 2007-07-17 | Invitrogen Corporation | Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites |
WO2001090179A2 (en) * | 2000-05-23 | 2001-11-29 | Lexicon Genetics Incorporated | Novel human thrombospondin-like proteins and polynucleotides encoding the same |
US20030032059A1 (en) * | 2000-05-23 | 2003-02-13 | Zhen-Gang Wang | Gene recombination and hybrid protein development |
US6790667B1 (en) | 2000-05-30 | 2004-09-14 | Lexicon Genetics Incorporated | Human mitochondrial proteins and polynucleotides encoding the same |
US20030031675A1 (en) | 2000-06-06 | 2003-02-13 | Mikesell Glen E. | B7-related nucleic acids and polypeptides useful for immunomodulation |
AU2001275337A1 (en) * | 2000-06-07 | 2001-12-17 | Lexicon Genetics Incorporated | Novel human transporter proteins and polynucleotides encoding the same |
US6465632B1 (en) | 2000-06-09 | 2002-10-15 | Lexicon Genetics Incorporated | Human phosphatases and polynucleotides encoding the same |
WO2001094417A2 (en) * | 2000-06-09 | 2001-12-13 | Lexicon Genetics Incorporated | Novel human seven transmembrane proteins and polynucleotides encoding the same |
FR2810339B1 (fr) * | 2000-06-14 | 2004-12-10 | Hoechst Marion Roussel Inc | Banques combinatoires ameliorees par recombinaison dans la levure et procede d'analyse |
CA2413160A1 (en) | 2000-06-15 | 2001-12-20 | Human Genome Sciences, Inc. | Human tumor necrosis factor delta and epsilon |
US7468475B2 (en) | 2000-06-16 | 2008-12-23 | Schmuelling Thomas | Method for modifying plant morphology, biochemistry and physiology |
CA2407910C (en) | 2000-06-16 | 2013-03-12 | Steven M. Ruben | Antibodies that immunospecifically bind to blys |
WO2002000717A2 (en) * | 2000-06-23 | 2002-01-03 | Maxygen, Inc. | Novel co-stimulatory molecules |
US6406863B1 (en) * | 2000-06-23 | 2002-06-18 | Genetastix Corporation | High throughput generation and screening of fully human antibody repertoire in yeast |
EP1297146A2 (en) * | 2000-06-23 | 2003-04-02 | Maxygen, Inc. | Novel chimeric promoters |
US6410271B1 (en) | 2000-06-23 | 2002-06-25 | Genetastix Corporation | Generation of highly diverse library of expression vectors via homologous recombination in yeast |
US6410246B1 (en) | 2000-06-23 | 2002-06-25 | Genetastix Corporation | Highly diverse library of yeast expression vectors |
US7846733B2 (en) | 2000-06-26 | 2010-12-07 | Nugen Technologies, Inc. | Methods and compositions for transcription-based nucleic acid amplification |
AU2001267333A1 (en) | 2000-06-26 | 2002-01-08 | Novozymes A/S | Lipolytic enzyme |
AU7151601A (en) * | 2000-06-27 | 2002-01-08 | Lexicon Genetics Inc | Novel human gaba receptors and polynucleotides encoding the same |
WO2002004629A2 (en) * | 2000-07-07 | 2002-01-17 | Maxygen, Inc. | Molecular breeding of transposable elements |
US6994963B1 (en) | 2000-07-10 | 2006-02-07 | Ambion, Inc. | Methods for recombinatorial nucleic acid synthesis |
US6858422B2 (en) * | 2000-07-13 | 2005-02-22 | Codexis, Inc. | Lipase genes |
WO2002006469A2 (en) * | 2000-07-18 | 2002-01-24 | Enchira Biotechnology Corporation | Methods of ligation mediated chimeragenesis utilizing populations of scaffold and donor nucleic acids |
US6878861B2 (en) * | 2000-07-21 | 2005-04-12 | Washington State University Research Foundation | Acyl coenzyme A thioesterases |
EP1315800A2 (en) * | 2000-07-21 | 2003-06-04 | Incyte Genomics, Inc. | Human proteases |
US7435562B2 (en) | 2000-07-21 | 2008-10-14 | Modular Genetics, Inc. | Modular vector systems |
US6887685B1 (en) | 2000-07-25 | 2005-05-03 | Lexicon Genetics Incorporated | Human thymosin protein and polynucleotides encoding the same |
US20020127623A1 (en) * | 2000-07-31 | 2002-09-12 | Maxygen, Inc. | Biosensors, reagents and diagnostic applications of directed evolution |
WO2002010183A1 (en) * | 2000-07-31 | 2002-02-07 | Menzel, Rolf | Compositions and methods for directed gene assembly |
AU2001278415A1 (en) | 2000-08-01 | 2002-02-13 | Novozymes A/S | Alpha-amylase mutants with altered stability |
JP3859947B2 (ja) * | 2000-08-04 | 2006-12-20 | 独立行政法人理化学研究所 | 突然変異導入方法 |
CA2419322C (en) | 2000-08-14 | 2012-10-23 | Donald L. Court | Enhanced homologous recombination mediated by lambda recombination proteins |
CA2419896C (en) | 2000-08-21 | 2014-12-09 | Novozymes A/S | Subtilase enzymes |
US7198924B2 (en) * | 2000-12-11 | 2007-04-03 | Invitrogen Corporation | Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites |
WO2002015675A1 (en) | 2000-08-22 | 2002-02-28 | Mendel Biotechnology, Inc. | Genes for modifying plant traits iv |
JP2004506447A (ja) * | 2000-08-22 | 2004-03-04 | レキシコン・ジェネティクス・インコーポレーテッド | 新規ヒト7tmタンパクおよびそれをコードするポリヌクレオチド |
US20030157643A1 (en) * | 2000-08-24 | 2003-08-21 | Almond Brian D | Synthetic nucleic acids from aquatic species |
US7879540B1 (en) * | 2000-08-24 | 2011-02-01 | Promega Corporation | Synthetic nucleic acid molecule compositions and methods of preparation |
JP2004527215A (ja) * | 2000-08-24 | 2004-09-09 | マキシジェン, インコーポレイテッド | 構築物、および代謝経路操作におけるそれらの使用 |
FR2813314B1 (fr) * | 2000-08-25 | 2004-05-07 | Biomethodes | Procede de mutagenese dirigee massive |
CN1564869A (zh) | 2000-08-25 | 2005-01-12 | 巴斯福种植科学有限公司 | 编码新型异戊二烯基蛋白酶的植物多核苷酸 |
US6395504B1 (en) | 2000-09-01 | 2002-05-28 | New Horizons Diagnostics Corp. | Use of phage associated lytic enzymes for the rapid detection of bacterial contaminants |
WO2002020753A2 (en) * | 2000-09-01 | 2002-03-14 | Lexicon Genetics Incorporated | Human gaba transporter protein and polynucleotides encoding the same |
EP1322786A4 (en) * | 2000-09-11 | 2005-11-16 | Univ Rochester | METHOD FOR IDENTIFYING PUTATIVE ANTIBIOTIC RESISTANCE GENES |
WO2002024953A1 (en) * | 2000-09-21 | 2002-03-28 | Merck & Co., Inc. | Method for generating recombinant polynucleotides |
US20020142324A1 (en) * | 2000-09-22 | 2002-10-03 | Xun Wang | Fungal target genes and methods to identify those genes |
EP2336339A3 (en) | 2000-09-25 | 2011-09-14 | The Regents of the University of Michigan | Production of viral vectors |
AU2001293019B2 (en) | 2000-09-27 | 2007-01-18 | Lexicon Pharmaceuticals, Inc. | Human ion-exchanger proteins and polynucleotides encoding the same |
US20040091920A1 (en) * | 2000-09-27 | 2004-05-13 | Mitsubishi Chemical Corporation | Method of constructing a mutant DNA library and use thereof |
WO2002026964A1 (fr) * | 2000-09-27 | 2002-04-04 | Mitsubishi Chemical Corporation | Procede de construction d'une banque d'adn mutants et utilisation de celle-ci |
US6777232B1 (en) * | 2000-10-02 | 2004-08-17 | Lexicon Genetics Incorporated | Human membrane proteins and polynucleotides encoding the same |
WO2002033089A2 (en) * | 2000-10-05 | 2002-04-25 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Ixodes scapularis tissue factor pathway inhibitor |
AU2002211624A1 (en) * | 2000-10-10 | 2002-04-22 | Genencor International, Inc. | Information rich libraries |
AU2001294199A1 (en) * | 2000-10-11 | 2002-04-22 | Sanko Junyaku Co., Ltd. | Method of constructing self-assembly of probes and method of detecting the same |
AU2002213183A1 (en) | 2000-10-12 | 2002-04-22 | Lexicon Genetics Incorporated | Human kinases and polynucleotides encoding the same |
CN100497617C (zh) | 2000-10-13 | 2009-06-10 | 诺维信公司 | 枯草杆菌酶变体 |
EP1975229A3 (en) | 2000-10-13 | 2009-03-18 | Novozymes A/S | Alpha-amylase variant with altered properties |
US7001763B1 (en) | 2000-10-17 | 2006-02-21 | Lexicon Genetics Incorporated | Human semaphorin proteins and polynucleotides encoding the same |
US7045283B2 (en) | 2000-10-18 | 2006-05-16 | The Regents Of The University Of California | Methods of high-throughput screening for internalizing antibodies |
WO2002070705A2 (en) * | 2000-10-27 | 2002-09-12 | Lexicon Genetics Incorporated | Human 7tm proteins and polynucleotides encoding them |
US7060442B2 (en) * | 2000-10-30 | 2006-06-13 | Regents Of The University Of Michigan | Modulators on Nod2 signaling |
JP2004531209A (ja) * | 2000-10-30 | 2004-10-14 | レキシコン・ジェネティクス・インコーポレーテッド | 新規ヒト7tmタンパクおよびそれをコードするポリヌクレオチド |
US7241742B2 (en) | 2000-10-31 | 2007-07-10 | Mgi Pharma Biologics, Inc. | CYP1B1 nucleic acids and methods of use |
US7202070B2 (en) * | 2000-10-31 | 2007-04-10 | Biocatalytics, Inc. | Method for reductive amination of a ketone using a mutated enzyme |
CA2427828A1 (en) * | 2000-11-01 | 2002-05-10 | Lexicon Genetics Incorporated | Novel human proteases and polynucleotides encoding the same |
WO2002102405A1 (en) * | 2000-11-02 | 2002-12-27 | New Horizons Diagnostics Corporation | The use of bacterial phage associated lytic enzymes to prevent food poisoning |
JP3777158B2 (ja) * | 2000-11-10 | 2006-05-24 | アミコージェン・インコーポレイテッド | 一方向性の一本鎖dna切片を用いた組換えdnaライブラリーの製造方法 |
WO2002050278A2 (en) * | 2000-11-15 | 2002-06-27 | Lexicon Genetics Incorporated | Novel human secreted proteins and polynucleotides encoding the same |
US7858559B2 (en) * | 2000-11-17 | 2010-12-28 | University Of Rochester | In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells |
EP1830190A3 (en) * | 2000-11-17 | 2008-07-09 | University Of Rochester | In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells |
WO2002042438A2 (en) | 2000-11-20 | 2002-05-30 | Lexicon Genetics Incorporated | Human kinases and polynucleotides encoding the same |
EP2412384A1 (en) | 2000-11-28 | 2012-02-01 | MedImmune, LLC | Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
EP1354064A2 (en) | 2000-12-01 | 2003-10-22 | Visigen Biotechnologies, Inc. | Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity |
CA2431007A1 (en) * | 2000-12-11 | 2002-07-18 | Lexicon Genetics Incorporated | Novel human kinase and polynucleotides encoding the same |
US6958213B2 (en) | 2000-12-12 | 2005-10-25 | Alligator Bioscience Ab | Method for in vitro molecular evolution of protein function |
AU3264202A (en) * | 2000-12-12 | 2002-06-24 | Lexicon Genetics Inc | Novel human kinases and polynucleotides encoding the same |
ATE475720T1 (de) | 2000-12-13 | 2010-08-15 | Nugen Technologies Inc | Methoden und zusammensetzungen zur generierung einer vielzahl von kopien von nukleinsäuresequenzen und methoden zur detektion derselben |
DE10062086A1 (de) * | 2000-12-13 | 2002-07-04 | Wella Ag | Mittel und Verfahren zum Färben von Keratinfasern |
US6583269B1 (en) * | 2000-12-18 | 2003-06-24 | Lexicon Genetics Incorporated | Human protease inhibitor and polynucleotides encoding the same |
WO2002050271A2 (en) * | 2000-12-20 | 2002-06-27 | Lexicon Genetics Incorporated | Human ion channel protein and polynucleotides encoding the same |
US6852844B1 (en) * | 2000-12-20 | 2005-02-08 | Lexicon Genetics Incorporated | Human protocadherin proteins and polynucleotides encoding the same |
US20020150895A1 (en) * | 2000-12-22 | 2002-10-17 | Raymond Wheeler | Method and apparatus for filtering and extending RNA alignment coverage |
US20020086292A1 (en) | 2000-12-22 | 2002-07-04 | Shigeaki Harayama | Synthesis of hybrid polynucleotide molecules using single-stranded polynucleotide molecules |
US7070973B2 (en) | 2000-12-26 | 2006-07-04 | Board Of Regents Of The University Of Nebraska | Butyrylcholinesterase variants and methods of use |
AU2001297533A1 (en) * | 2000-12-28 | 2002-09-12 | Lexicon Genetics Incorporated | Novel human ion channel-related proteins and polynucleotides encoding the same |
WO2002053753A2 (en) * | 2001-01-05 | 2002-07-11 | Lexicon Genetics Incorporated | Novel human lipase and polynucleotides encoding the same |
EP1353941B1 (en) * | 2001-01-22 | 2013-03-13 | Sangamo BioSciences, Inc. | Modified zinc finger binding proteins |
CA2434896A1 (en) * | 2001-01-23 | 2002-08-01 | Lexicon Genetics Incorporated | Novel human kinases and polynucleotides encoding the same |
AU2002338446A1 (en) * | 2001-01-23 | 2002-11-05 | University Of Rochester Medical Center | Methods of producing or identifying intrabodies in eukaryotic cells |
CA2434897A1 (en) * | 2001-01-24 | 2002-08-01 | Lexicon Genetics Incorporated | Human lipase and polynucleotides encoding the same |
US20020127674A1 (en) * | 2001-02-02 | 2002-09-12 | Xuanchuan Yu | Novel human transporter protein and polynucleotides encoding the same |
EP1683865A3 (en) | 2001-02-02 | 2006-10-25 | Eli Lilly & Company | Mammalian proteins and in particular CD200 |
US20020192675A1 (en) * | 2001-02-02 | 2002-12-19 | The University Of Rochester | Methods of identifying regulator molecules |
CN1564826A (zh) | 2001-02-09 | 2005-01-12 | 人类基因组科学公司 | 人类g蛋白趋化因子受体(ccr5)hdgnr10 |
CA2473197A1 (en) * | 2001-02-20 | 2002-08-29 | Lexicon Genetics Incorporated | Novel human protease and polynucleotides encoding the same |
US6849449B2 (en) * | 2001-03-01 | 2005-02-01 | Regents Of The University Of Michigan | Orphanin FQ receptor nucleic acids |
ZA200210369B (en) | 2001-03-09 | 2004-07-08 | Nugen Technologies Inc | Methods and compositions for amplification or RNA sequences. |
WO2002072603A2 (en) * | 2001-03-12 | 2002-09-19 | Lexicon Genetics Incorporated | Novel human dectin proteins and polynucleotides encoding the same |
WO2002072611A2 (en) * | 2001-03-12 | 2002-09-19 | Lexicon Genetics Incorporated | Novel human egf-family proteins and polynucleotides encoding the same |
US20020164627A1 (en) * | 2001-03-12 | 2002-11-07 | Wilganowski Nathaniel L. | Novel human transporter proteins and polynucleotides encoding the same |
US6994995B1 (en) | 2001-03-16 | 2006-02-07 | Lexicon Genetics Incorporated | Human synaptotagmin and polynucleotides encoding the same |
IL158000A0 (en) * | 2001-03-19 | 2004-03-28 | Harvard College | Evolving new molecular function |
WO2002074978A2 (en) * | 2001-03-19 | 2002-09-26 | President And Fellows Of Harvard College | Nucleic acid shuffling |
US7807408B2 (en) * | 2001-03-19 | 2010-10-05 | President & Fellows Of Harvard College | Directed evolution of proteins |
WO2002074932A2 (en) | 2001-03-20 | 2002-09-26 | Lexicon Genetics Incorporated | Novel human kinase and polynucleotides encoding the same |
US20030049619A1 (en) * | 2001-03-21 | 2003-03-13 | Simon Delagrave | Methods for the synthesis of polynucleotides and combinatorial libraries of polynucleotides |
AR035799A1 (es) | 2001-03-30 | 2004-07-14 | Syngenta Participations Ag | Toxinas insecticidas aisladas de bacillus thuringiensis y sus usos. |
EP1383880A1 (en) | 2001-04-06 | 2004-01-28 | Lexicon Genetics Incorporated | Novel human kinase and polynucleotides encoding the same |
CA2443516A1 (en) | 2001-04-06 | 2002-10-17 | Lexicon Genetics Incorporated | Novel human kinases and polynucleotides encoding the same |
FR2823219B1 (fr) * | 2001-04-10 | 2003-07-04 | Pasteur Institut | Mutants de la desoxycytidine kinase possedant une activite enzymatique elargie |
US6644173B2 (en) * | 2001-04-11 | 2003-11-11 | Keuring, Incorporated | Beverage filter cartridge holder |
JP2004536579A (ja) | 2001-04-13 | 2004-12-09 | ヒューマン ジノーム サイエンシーズ, インコーポレイテッド | 血管内皮増殖因子2 |
AU2002307340A1 (en) * | 2001-04-16 | 2002-10-28 | California Institute Of Technology | Peroxide-driven cytochrome p450 oxygenase variants |
WO2002083706A1 (en) * | 2001-04-16 | 2002-10-24 | Lexicon Genetics Incorporated | Nucleic acid encoding a human adenylosuccinate synthetase |
EP1390394A4 (en) * | 2001-04-19 | 2004-05-26 | Invitrogen Corp | COMPOSITIONS AND METHODS FOR RECOMBINANT CLONING OF NUCLEIC ACID MOLECULES |
AU2002338443B2 (en) * | 2001-04-25 | 2007-07-19 | Proteus | Template-mediated, ligation-oriented method of nonrandomly shuffling polynucleotides |
FR2824073B1 (fr) * | 2001-04-25 | 2003-12-19 | Proteus | Procede de creation in vitro de sequences polynucleotidiques recombinees par ligation orientee |
AU2002259011A1 (en) * | 2001-04-30 | 2002-11-11 | Lexicon Genetics Incorporated | Novel human nuclear transporters and polynucleotides encoding the same |
EP1383887A4 (en) * | 2001-05-03 | 2004-07-07 | Rensselaer Polytech Inst | NEW DIRECTED EVOLUTION METHODS |
EP1950305A1 (en) | 2001-05-09 | 2008-07-30 | Monsanto Technology, LLC | Tyr a genes and uses thereof |
CA2446967A1 (en) * | 2001-05-09 | 2002-11-14 | Lexicon Genetics Incorporated | Novel human kinases and polynucleotides encoding the same |
EP3000881A3 (en) | 2001-05-15 | 2016-07-20 | Novozymes A/S | Alpha-amylase variant with altered properties |
AU2002342955A1 (en) * | 2001-05-17 | 2002-11-25 | Proteus | Method of preparing polynucleotide fragments for use in shuffling, and shuffling of same |
BR0209154A (pt) | 2001-05-18 | 2004-07-20 | Danisco | Processo de preparação de uma massa com uma enzima |
AU2002309989A1 (en) * | 2001-05-18 | 2002-12-03 | Rigel Pharmaceuticals, Incorporated | Directed evolution of protein in mammalian cells |
WO2002095055A2 (en) * | 2001-05-21 | 2002-11-28 | Invitrogen Corporation | Compositions and methods for use in isolation of nucleic acid molecules |
WO2002097095A1 (en) * | 2001-05-25 | 2002-12-05 | Lexicon Genetics Incorporated | Novel human transporter proteins and polynucleotides encoding the same |
US7064189B2 (en) | 2001-05-25 | 2006-06-20 | Human Genome Sciences, Inc. | Antibodies that immunospecifically bind to trail receptors |
US6867025B2 (en) | 2001-05-29 | 2005-03-15 | Lexicon Genetics Incorporated | Human hydroxylases and polynucleotides encoding the same |
US20030044980A1 (en) * | 2001-06-05 | 2003-03-06 | Gorilla Genomics, Inc. | Methods for low background cloning of DNA using long oligonucleotides |
JP4242761B2 (ja) | 2001-06-06 | 2009-03-25 | ノボザイムス アクティーゼルスカブ | エンド−β−1,4−グルカナーゼ |
JP2004531268A (ja) * | 2001-06-14 | 2004-10-14 | レキシコン・ジェネティクス・インコーポレーテッド | 新規ヒトトランスポータータンパクおよびそれをコードするポリヌクレオチド |
WO2002102820A1 (en) | 2001-06-20 | 2002-12-27 | Nuevolution A/S | Nucleoside derivatives for library preparation |
MXPA03011890A (es) | 2001-06-22 | 2004-06-03 | Du Pont | Polinucleotidos de defensina y metodos de uso. |
EP1925672A1 (en) | 2001-06-22 | 2008-05-28 | Syngeta Participations AG | Abiotic stress responsive polynucleotides and polypeptides |
DK2298868T3 (en) | 2001-06-26 | 2015-04-20 | Novozymes As | Polypeptides with cellobiohydrolase I activity and the same coding polynucleotides |
EP1404825A2 (en) * | 2001-06-27 | 2004-04-07 | Roche Diagnostics GmbH | A WALK-THROUGH TECHNIQUE FOR i IN VITRO /i RECOMBINATION OF POLYNUCLEOTIDE SEQUENCES |
GB0115841D0 (en) | 2001-06-28 | 2001-08-22 | Medical Res Council | Ligand |
WO2003004609A2 (en) * | 2001-07-03 | 2003-01-16 | Lexicon Genetics Incorporated | Novel human kielin-like proteins and polynucleotides encoding the same |
DK200101090A (da) | 2001-07-12 | 2001-08-16 | Novozymes As | Subtilase variants |
US20040213765A1 (en) * | 2001-07-13 | 2004-10-28 | Vincent Fischetti | Use of bacterial phage associated lytic enzymes to prevent food poisoning |
US7112423B2 (en) * | 2001-07-15 | 2006-09-26 | Keck Graduate Institute | Nucleic acid amplification using nicking agents |
EP1277835A1 (en) * | 2001-07-19 | 2003-01-22 | Libragen | Methods of creating genetic diversity |
US7226768B2 (en) | 2001-07-20 | 2007-06-05 | The California Institute Of Technology | Cytochrome P450 oxygenases |
AU2002333269A1 (en) | 2001-07-23 | 2003-02-17 | Dsm Ip Assets B.V. | Process for preparing variant polynucleotides |
US6867189B2 (en) * | 2001-07-26 | 2005-03-15 | Genset S.A. | Use of adipsin/complement factor D in the treatment of metabolic related disorders |
DE60232523D1 (de) * | 2001-07-26 | 2009-07-16 | Stratagene California | Multi-stellen-mutagenese |
US6833441B2 (en) * | 2001-08-01 | 2004-12-21 | Abmaxis, Inc. | Compositions and methods for generating chimeric heteromultimers |
WO2003012126A2 (en) * | 2001-08-03 | 2003-02-13 | Diversa Corporation | Epoxide hydrolases, nucleic acids encoding them and methods for making and using them |
US6943001B2 (en) * | 2001-08-03 | 2005-09-13 | Diversa Corporation | Epoxide hydrolases, nucleic acids encoding them and methods for making and using them |
US6987079B2 (en) * | 2001-08-14 | 2006-01-17 | W.R. Grace & Co.-Conn. | Supported catalyst systems |
JP2005500060A (ja) * | 2001-08-14 | 2005-01-06 | レキシコン・ジェネティクス・インコーポレーテッド | 新規ヒトコラーゲンタンパクおよびそれをコードするポリヌクレオチド |
US20030096275A1 (en) * | 2001-08-20 | 2003-05-22 | Laing Lance G. | Biosensor for small molecule analytes |
US7647184B2 (en) * | 2001-08-27 | 2010-01-12 | Hanall Pharmaceuticals, Co. Ltd | High throughput directed evolution by rational mutagenesis |
HU230373B1 (hu) | 2001-08-29 | 2016-03-29 | Genentech Inc | Mitogén aktivitású Bv8-nukleinsavak és polipeptidek |
WO2003020936A1 (en) * | 2001-08-31 | 2003-03-13 | The Dow Chemical Company | Nucleic acid compositions conferring altered metabolic characteristics |
KR100428998B1 (ko) * | 2001-09-10 | 2004-04-28 | 한국과학기술원 | 모체 단백질과는 크기와 서열이 다른 단백질의 변이집단을생산하는 방법 |
EP1436385A4 (en) * | 2001-09-14 | 2005-12-14 | Invitrogen Corp | DNA POLYMERASES AND MUTANTS CORRESPONDING |
WO2003025215A1 (en) * | 2001-09-14 | 2003-03-27 | The University Of Queensland | Detection of dna methylation |
US7582425B2 (en) * | 2001-09-21 | 2009-09-01 | The Regents Of The University Of Michigan | Atlastin |
US7108975B2 (en) * | 2001-09-21 | 2006-09-19 | Regents Of The University Of Michigan | Atlastin |
DE10147074A1 (de) * | 2001-09-25 | 2003-05-08 | Beru Ag | Verfahren zum Betreiben einer aus mehreren Heizelementen bestehenden mehrstufigen elektrischen Heizung |
US20030104445A1 (en) * | 2001-09-25 | 2003-06-05 | Hayes Robert J. | RNA dependent RNA polymerase mediated protein evolution |
ES2327905T3 (es) * | 2001-10-01 | 2009-11-05 | Dyax Corp. | Vectores de presentacion eucariotas multi-cadena y usos de los mismos. |
US7214660B2 (en) | 2001-10-10 | 2007-05-08 | Neose Technologies, Inc. | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
US7173003B2 (en) * | 2001-10-10 | 2007-02-06 | Neose Technologies, Inc. | Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF |
DK2279755T3 (da) | 2001-10-10 | 2014-05-26 | Ratiopharm Gmbh | Remodellering og glycokonjugering af fibroblastvækstfaktor (FGF) |
ES2606840T3 (es) | 2001-10-10 | 2017-03-28 | Ratiopharm Gmbh | Remodelación y glicoconjugación de factor estimulante de colonias de granulocitos (G-CSF) |
US7157277B2 (en) | 2001-11-28 | 2007-01-02 | Neose Technologies, Inc. | Factor VIII remodeling and glycoconjugation of Factor VIII |
US8008252B2 (en) | 2001-10-10 | 2011-08-30 | Novo Nordisk A/S | Factor VII: remodeling and glycoconjugation of Factor VII |
US20040005709A1 (en) * | 2001-10-24 | 2004-01-08 | Hoogenboom Henricus Renerus Jacobus Mattheus | Hybridization control of sequence variation |
JP2005522988A (ja) | 2001-10-25 | 2005-08-04 | メディカル リサーチ カウンシル | 分子 |
EP1840211A1 (en) | 2001-10-31 | 2007-10-03 | Danisco A/S | Pyranosone dehydratase from phanerochaete chrysosporium |
US7175983B2 (en) * | 2001-11-02 | 2007-02-13 | Abmaxis, Inc. | Adapter-directed display systems |
US6768476B2 (en) * | 2001-12-05 | 2004-07-27 | Etenna Corporation | Capacitively-loaded bent-wire monopole on an artificial magnetic conductor |
US7049121B2 (en) * | 2001-12-20 | 2006-05-23 | Applied Molecular Evolution | Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use |
US6989261B2 (en) * | 2001-12-20 | 2006-01-24 | Eli Lilly And Company | Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use |
MY139056A (en) * | 2001-12-28 | 2009-08-28 | Ab Enzymes Gmbh | Microbially-expressed thermotolerant phytase for animal feed |
KR100475305B1 (ko) * | 2002-01-08 | 2005-03-10 | 주식회사 마이크로아이디 | 단일가닥 특이적인 dna 절단효소 엑소뉴클리아제ⅶ을 이용하여 키메라 dna 라이브러리를 만드는 방법 |
US20040009498A1 (en) * | 2002-01-14 | 2004-01-15 | Diversa Corporation | Chimeric antigen binding molecules and methods for making and using them |
WO2003062395A2 (en) * | 2002-01-18 | 2003-07-31 | Bristol-Myers Squibb Company | Predictor sets for tyrosine kinase pathways |
US7262054B2 (en) * | 2002-01-22 | 2007-08-28 | Sangamo Biosciences, Inc. | Zinc finger proteins for DNA binding and gene regulation in plants |
DE20200926U1 (de) * | 2002-01-23 | 2002-04-18 | Hegenscheidt Mfd Gmbh & Co Kg | Festwalzgerät einer Festwalzmaschine für Kurbelwellen |
US20040096826A1 (en) * | 2002-01-30 | 2004-05-20 | Evans Glen A. | Methods for creating recombination products between nucleotide sequences |
US7255986B2 (en) * | 2002-01-31 | 2007-08-14 | The Board Of Trustees Operating Michigan State University | Compositions for the diagnosis and treatment of epizootic catarrhal enteritis in ferrets |
EP2295553A1 (en) | 2002-02-08 | 2011-03-16 | Novozymes A/S | Phytase variants |
KR100718378B1 (ko) * | 2002-02-12 | 2007-05-14 | 화이자 프로덕츠 인코포레이티드 | B2:b1 아베르멕틴의 비를 제어하는 스트렙토마이세스아베르미틸리스 유전자 |
MXPA04007886A (es) | 2002-02-13 | 2004-10-15 | Dow Global Technologies Inc | Sobre-expresion de genes de extremozimo en pseudomonadas y bacterias estrechamente relacionadas. |
US20030166010A1 (en) * | 2002-02-25 | 2003-09-04 | Affholter Joseph A. | Custom ligand design for biomolecular filtration and purification for bioseperation |
US20030224404A1 (en) * | 2002-02-25 | 2003-12-04 | Manuel Vega | High throughput directed evolution of nucleic acids by rational mutagenesis |
AU2003216403A1 (en) * | 2002-02-26 | 2003-09-09 | E.I. Du Pont De Nemours And Company | Method for the recombination of genetic elements |
AU2003230568A1 (en) * | 2002-02-27 | 2003-09-09 | California Institute Of Technology | Novel glucose 6-oxidases |
US6977162B2 (en) * | 2002-03-01 | 2005-12-20 | Ravgen, Inc. | Rapid analysis of variations in a genome |
DK2315145T3 (en) | 2002-03-01 | 2016-01-25 | Codexis Mayflower Holdings Llc | Methods, systems, and software for identifying the functional biomolecules |
US20040132101A1 (en) | 2002-09-27 | 2004-07-08 | Xencor | Optimized Fc variants and methods for their generation |
JP2006523082A (ja) * | 2002-03-01 | 2006-10-12 | ラブジェン, インコーポレイテッド | ゲノム内の変異の迅速分析 |
US7244592B2 (en) * | 2002-03-07 | 2007-07-17 | Dyax Corp. | Ligand screening and discovery |
US7620500B2 (en) | 2002-03-09 | 2009-11-17 | Maxygen, Inc. | Optimization of crossover points for directed evolution |
WO2003078645A2 (en) * | 2002-03-11 | 2003-09-25 | Nugen Technologies, Inc. | Methods for generating double stranded dna comprising a 3’ single stranded portion and uses of these complexes for recombination |
WO2003078446A2 (en) * | 2002-03-15 | 2003-09-25 | Nuevolution A/S | A building block forming a c-c or a c-hetero atom bond upon reaction |
US20050221318A1 (en) * | 2002-03-15 | 2005-10-06 | Gouliaev Alex H | Building block forming a c-c bond upon reaction |
EP1487849A2 (en) * | 2002-03-15 | 2004-12-22 | Nuevolution A/S | A building block capable of transferring a functional entity |
DE60324778D1 (de) | 2002-03-15 | 2009-01-02 | Nuevolution As | Eine verbesserte methode zur synthese von matritzenabhängigen molekülen |
ATE509111T1 (de) * | 2002-03-20 | 2011-05-15 | Simplot Co J R | Verfeinerte pflanzentransformation |
US20050034188A1 (en) * | 2002-03-20 | 2005-02-10 | J. R. Simplot Company | Refined plant transformation |
EP2360179A1 (en) | 2002-03-22 | 2011-08-24 | Bayer BioScience N.V. | Novel bacillus thuringiensis insecticidal proteins |
US20030228598A1 (en) * | 2002-03-25 | 2003-12-11 | The Regents Of The University Of California | DNA/RNA as a write/read medium |
US20030180781A1 (en) * | 2002-03-25 | 2003-09-25 | The Regents Of The University Of California | Constructing very long DNA sequences from synthetic DNA molecules |
US20030186301A1 (en) * | 2002-03-25 | 2003-10-02 | The Regents Of The University Of California | Constructing user-defined, long DNA sequences |
US7452666B2 (en) * | 2002-03-25 | 2008-11-18 | Lawrence Livermore National Security, Llc | Synthesis of DNA |
EP1497445A2 (en) * | 2002-04-01 | 2005-01-19 | Human Genome Sciences, Inc. | Antibodies that specifically bind to gmad |
WO2003087763A2 (en) | 2002-04-03 | 2003-10-23 | Celltech R & D, Inc. | Association of polymorphisms in the sost gene region with bone mineral density |
EP1499352A4 (en) | 2002-04-12 | 2006-10-11 | Medimmune Inc | ANTI-INTERLEUKIN-9 RECOMBINANT ANTIBODIES |
BR0309391A (pt) | 2002-04-19 | 2005-10-25 | Diversa Corp | Fosfolipases, ácidos nucléicos codificando-as e métodos para preparar e usá-las |
US7226771B2 (en) | 2002-04-19 | 2007-06-05 | Diversa Corporation | Phospholipases, nucleic acids encoding them and methods for making and using them |
US6776751B2 (en) * | 2002-04-22 | 2004-08-17 | Kendor Laboratory Products, Lp | Rotor cover attachment apparatus |
US7442506B2 (en) | 2002-05-08 | 2008-10-28 | Ravgen, Inc. | Methods for detection of genetic disorders |
US20070178478A1 (en) * | 2002-05-08 | 2007-08-02 | Dhallan Ravinder S | Methods for detection of genetic disorders |
US7727720B2 (en) | 2002-05-08 | 2010-06-01 | Ravgen, Inc. | Methods for detection of genetic disorders |
US7202067B2 (en) | 2002-05-14 | 2007-04-10 | Martek Biosciences Corporation | Carotene synthase gene and uses therefor |
ES2285118T5 (es) * | 2002-05-17 | 2012-09-21 | Alligator Bioscience Ab | Un método para el desarrollo molecular in vitro de una función proteica. |
DE10222858A1 (de) | 2002-05-23 | 2003-12-04 | Basf Ag | Verfahren zur fermentativen Herstellung schwefelhaltiger Feinchemikalien |
US7425618B2 (en) | 2002-06-14 | 2008-09-16 | Medimmune, Inc. | Stabilized anti-respiratory syncytial virus (RSV) antibody formulations |
DE60319259T2 (de) * | 2002-06-14 | 2009-03-05 | Dyax Corp., Cambridge | Rekombination von nukleinsäurebibliotheksmitgliedern |
US7132100B2 (en) | 2002-06-14 | 2006-11-07 | Medimmune, Inc. | Stabilized liquid anti-RSV antibody formulations |
US7667099B2 (en) * | 2002-06-20 | 2010-02-23 | Board Of Trustees Of Michigan State University | Plastid division and related genes and proteins, and methods of use |
MXPA04012496A (es) * | 2002-06-21 | 2005-09-12 | Novo Nordisk Healthcare Ag | Glicoformos del factor vii pegilados. |
SI1517921T1 (sl) * | 2002-06-28 | 2006-10-31 | Domantis Ltd | Dvojno-specificni ligandi z zvisano serumsko razpolovno dobo |
US9321832B2 (en) | 2002-06-28 | 2016-04-26 | Domantis Limited | Ligand |
ES2311731T3 (es) | 2002-06-28 | 2009-02-16 | Dow Agrosciences Llc | Proteinas de accion pesticida y polinucleotidos que se pueden obtener a partir de especies de paenibacillus. |
US20060002935A1 (en) | 2002-06-28 | 2006-01-05 | Domantis Limited | Tumor Necrosis Factor Receptor 1 antagonists and methods of use therefor |
WO2004009768A2 (en) * | 2002-07-18 | 2004-01-29 | Invitrogen Corporation | Viral vectors containing recombination sites |
CA2851035C (en) | 2002-07-18 | 2018-05-29 | Stanislaw Flasinski | Methods for using artificial polynucleotides and compositions thereof to reduce transgene silencing |
JP4575160B2 (ja) * | 2002-07-25 | 2010-11-04 | バイオ−ラッド ラボラトリーズ インコーポレーティッド | ハイブリッドタンパク質方法および組成物 |
US7560260B2 (en) * | 2002-07-25 | 2009-07-14 | Bio-Rad Laboratories, Inc. | Compositions with polymerase activity |
US10730906B2 (en) | 2002-08-01 | 2020-08-04 | Nuevolutions A/S | Multi-step synthesis of templated molecules |
BR0313281A (pt) | 2002-08-06 | 2007-07-24 | Verdia Inc | variantes de ap1 amina oxidase |
US20040067532A1 (en) | 2002-08-12 | 2004-04-08 | Genetastix Corporation | High throughput generation and affinity maturation of humanized antibody |
US7425620B2 (en) | 2002-08-14 | 2008-09-16 | Scott Koenig | FcγRIIB-specific antibodies and methods of use thereof |
JP4657919B2 (ja) * | 2002-08-19 | 2011-03-23 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 進化する新しい分子機能 |
US7361635B2 (en) | 2002-08-29 | 2008-04-22 | Sangamo Biosciences, Inc. | Simultaneous modulation of multiple genes |
US20050202438A1 (en) * | 2002-09-09 | 2005-09-15 | Rene Gantier | Rational directed protein evolution using two-dimensional rational mutagenesis scanning |
ATE466085T1 (de) * | 2002-09-09 | 2010-05-15 | Hanall Pharmaceutical Co Ltd | Protease-resistente modifizierte interferon alpha polypeptide |
US20060020396A1 (en) * | 2002-09-09 | 2006-01-26 | Rene Gantier | Rational directed protein evolution using two-dimensional rational mutagenesis scanning |
US7563600B2 (en) | 2002-09-12 | 2009-07-21 | Combimatrix Corporation | Microarray synthesis and assembly of gene-length polynucleotides |
EP2270166A3 (en) | 2002-09-18 | 2011-08-10 | Mendel Biotechnology, Inc. | Polynucleotides and polypeptides in plants |
CN1705491B (zh) | 2002-09-27 | 2013-05-29 | 赞科股份有限公司 | 优化的Fc变体及其产生方法 |
GB0222846D0 (en) | 2002-10-03 | 2002-11-06 | Choo Yen | Cell culture |
AU2002951899A0 (en) * | 2002-10-04 | 2002-10-24 | Macquarie University | Random drift mutagenesis |
US6863731B2 (en) * | 2002-10-18 | 2005-03-08 | Controls Corporation Of America | System for deposition of inert barrier coating to increase corrosion resistance |
JP3447009B1 (ja) * | 2002-10-29 | 2003-09-16 | 實 平垣 | 構築物用構成体およびその製造方法 |
ATE513055T1 (de) | 2002-10-30 | 2011-07-15 | Nuevolution As | Enzymatisches codieren |
WO2004039995A1 (en) * | 2002-11-01 | 2004-05-13 | Evogenix Pty Ltd | Mutagenesis methods using ribavirin and/or rna replicases |
TWI319007B (en) | 2002-11-06 | 2010-01-01 | Novozymes As | Subtilase variants |
US7365186B2 (en) * | 2002-11-22 | 2008-04-29 | Arborgen, Llc | Vascular-preferred promoter sequences and uses thereof |
CN102584951A (zh) * | 2002-11-25 | 2012-07-18 | 金克克国际有限公司 | 皮肤或毛发结合肽 |
EP1581253A4 (en) * | 2002-12-04 | 2007-02-14 | Applied Molecular Evolution | BUTYRYLCHOLINESTERASE VARIANTS MODIFYING THE ACTIVITY OF CHEMOTHERAPEUTIC AGENTS |
US9121110B2 (en) | 2002-12-19 | 2015-09-01 | Nuevolution A/S | Quasirandom structure and function guided synthesis methods |
WO2004056981A2 (en) | 2002-12-20 | 2004-07-08 | Novozymes A/S | Polypeptides having cellobiohydrolase ii activity and polynucleotides encoding same |
WO2004056988A2 (en) | 2002-12-20 | 2004-07-08 | Novozymes A/S | Galactanase variants |
US20050221443A1 (en) * | 2003-01-06 | 2005-10-06 | Xencor, Inc. | Tumor necrosis factor super family agonists |
US7553930B2 (en) * | 2003-01-06 | 2009-06-30 | Xencor, Inc. | BAFF variants and methods thereof |
US20060014248A1 (en) * | 2003-01-06 | 2006-01-19 | Xencor, Inc. | TNF super family members with altered immunogenicity |
US20050130892A1 (en) * | 2003-03-07 | 2005-06-16 | Xencor, Inc. | BAFF variants and methods thereof |
EP2368578A1 (en) | 2003-01-09 | 2011-09-28 | Macrogenics, Inc. | Identification and engineering of antibodies with variant Fc regions and methods of using same |
ES2375492T3 (es) | 2003-01-17 | 2012-03-01 | Danisco A/S | Procedimiento para la producción in situ de un emulsionante en un alimento. |
US7955814B2 (en) | 2003-01-17 | 2011-06-07 | Danisco A/S | Method |
US20050196766A1 (en) | 2003-12-24 | 2005-09-08 | Soe Jorn B. | Proteins |
DE602004030000D1 (de) | 2003-01-17 | 2010-12-23 | Danisco | Verfahren zur in-situ-herstellung eines emulgators in einem nahrungsmittel |
JP2006518997A (ja) * | 2003-01-21 | 2006-08-24 | ブリストル−マイヤーズ スクイブ カンパニー | 新規アシルコエンザイムa:モノアシルグリセロールアシルトランスフェラーゼ−3(mgat3)をコードするポリヌクレオチドおよびその用途 |
US8709435B2 (en) | 2003-01-21 | 2014-04-29 | Biomay Ag | Hypallergenic mosaic antigens and methods of making same |
ES2316963T3 (es) | 2003-02-20 | 2009-04-16 | Athenix Corporation | Genes delta-entotoxino y los metodos para su uso. |
EP1597395A2 (en) * | 2003-02-21 | 2005-11-23 | Nuevolution A/S | Method for producing second-generation library |
US20060269920A1 (en) * | 2003-02-21 | 2006-11-30 | Nuevolution A/S | Method for obtaining structural information about an encoded molecule |
ES2713024T3 (es) | 2003-03-06 | 2019-05-17 | Basf Enzymes Llc | Amilasas, ácidos nucleicos que las codifican y métodos para su fabricación y uso |
US8298799B2 (en) | 2003-03-07 | 2012-10-30 | Dsm Ip Assets B. V. | Hydrolases, nucleic acids encoding them and methods for making and using them |
KR101118340B1 (ko) | 2003-03-12 | 2012-04-12 | 제넨테크, 인크. | 조혈을 촉진하기 위한 bv8 및(또는) eg-vegf의용도 |
CA2519092C (en) * | 2003-03-14 | 2014-08-05 | Neose Technologies, Inc. | Branched water-soluble polymers and their conjugates |
WO2004083427A2 (en) * | 2003-03-20 | 2004-09-30 | Nuevolution A/S | Ligational encoding of small molecules |
WO2004087882A2 (en) * | 2003-03-26 | 2004-10-14 | Washington University | Neuregulin protein regulation of synaptic proteins |
WO2004087735A2 (en) * | 2003-03-26 | 2004-10-14 | The University Of Texas | Proteolytic and covalent antibodies |
WO2004087059A2 (en) | 2003-03-26 | 2004-10-14 | The University Of Texas | Covalent attachment of ligands to nucleophilic proteins guided by non-covalent binding |
US8017323B2 (en) * | 2003-03-26 | 2011-09-13 | President And Fellows Of Harvard College | Free reactant use in nucleic acid-templated synthesis |
JP2007524603A (ja) * | 2003-03-27 | 2007-08-30 | ザ ユニバーシティー オブ テキサス | Hiv/エイズの受動免疫治療用ループス抗体 |
CA2521402C (en) | 2003-04-04 | 2015-01-13 | Diversa Corporation | Pectate lyases, nucleic acids encoding them and methods for making and using them |
US20070026485A1 (en) * | 2003-04-09 | 2007-02-01 | Neose Technologies, Inc. | Glycopegylation methods and proteins/peptides produced by the methods |
US8791070B2 (en) | 2003-04-09 | 2014-07-29 | Novo Nordisk A/S | Glycopegylated factor IX |
WO2006127896A2 (en) | 2005-05-25 | 2006-11-30 | Neose Technologies, Inc. | Glycopegylated factor ix |
KR20110094361A (ko) | 2003-04-11 | 2011-08-23 | 메디뮨 엘엘씨 | 재조합 il9 항체 및 그의 용도 |
WO2004092418A2 (en) | 2003-04-14 | 2004-10-28 | Nugen Technologies, Inc. | Global amplification using a randomly primed composite primer |
US20040214194A1 (en) * | 2003-04-17 | 2004-10-28 | Mj Bioworks, Inc. | Methods of making hybrid proteins |
US7348420B2 (en) | 2003-04-25 | 2008-03-25 | North Carolina State University | Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore |
US7834147B2 (en) | 2003-04-28 | 2010-11-16 | Childrens Hospital Medical Center | Saposin C-DOPS: a novel anti-tumor agent |
EP2322629A3 (en) | 2003-04-29 | 2011-11-02 | Pioneer Hi-Bred International Inc. | Novel glyphosate-n-acetyltransferase (GAT) genes |
US7413888B2 (en) | 2003-05-02 | 2008-08-19 | Novozymes, Inc. | Variants of beta-glucosidases |
US20050009772A1 (en) * | 2003-05-06 | 2005-01-13 | The Regents Of The University Of California | Methods and compositions for the treatment of glaucoma and other retinal diseases |
CA2526341C (en) | 2003-05-07 | 2013-02-19 | Novozymes A/S | Variant subtilisin enzymes (subtilases) |
US7521242B2 (en) | 2003-05-09 | 2009-04-21 | The United States Of America As Represented By The Department Of Health And Human Services | Host cells deficient for mismatch repair and their use in methods for inducing homologous recombination using single-stranded nucleic acids |
BRPI0410164A (pt) * | 2003-05-09 | 2006-05-16 | Neose Technologies Inc | composições e métodos para preparação de mutantes de glicosilação de hormÈnio do crescimento humano |
WO2005007808A2 (en) | 2003-05-15 | 2005-01-27 | Chiron Corporation | Hiv polynucleotides and polypeptides derived from botswana mj4 |
US7173010B2 (en) * | 2003-05-19 | 2007-02-06 | Regents Of The University Of Michigan | Orphanin FQ receptor |
US7655833B2 (en) * | 2003-05-29 | 2010-02-02 | Brookhaven Science Associates, Llc | ADS genes for reducing saturated fatty acid levels in seed oils |
CA2528536A1 (en) | 2003-06-06 | 2005-01-06 | Arborgen, Llc. | Transcription factors |
WO2005001051A2 (en) * | 2003-06-06 | 2005-01-06 | Arborgen Llc. | Compositions and methods for regulating polysaccharides of a plant cell |
EA015166B1 (ru) * | 2003-06-16 | 2011-06-30 | Ю-Си-Би Мэньюфэкчуринг, Инк. | Иммуногенные пептиды склеростина (sost), индуцирующие образование специфических антител |
WO2005017106A2 (en) * | 2003-06-17 | 2005-02-24 | California Institute Of Technology | Libraries of optimized cytochrome p450 enzymes and the optimized p450 enzymes |
WO2005017105A2 (en) | 2003-06-17 | 2005-02-24 | California University Of Technology | Regio- and enantioselective alkane hydroxylation with modified cytochrome p450 |
JP2006527590A (ja) | 2003-06-18 | 2006-12-07 | ディレボ・ビオテク・アーゲー | 新規生物学的実体およびその使用 |
ES2346654T3 (es) | 2003-06-19 | 2010-10-19 | Novozymes A/S | Proteasas. |
AU2004252528B8 (en) | 2003-06-23 | 2010-08-05 | North Carolina State University | Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof |
WO2005028615A2 (en) * | 2003-06-26 | 2005-03-31 | Invitrogen Corporation | Methods and compositions for detecting promoter activity and expressing fusion proteins |
AU2004254640B2 (en) | 2003-07-02 | 2010-08-26 | Bp Corporation North America Inc. | Glucanases, nucleic acids encoding them and methods for making and using them |
WO2005012484A2 (en) | 2003-07-25 | 2005-02-10 | Neose Technologies, Inc. | Antibody-toxin conjugates |
US7741089B2 (en) | 2003-08-11 | 2010-06-22 | Verenium Corporation | Laccases, nucleic acids encoding them and methods for making and using them |
DK1660646T3 (en) * | 2003-08-11 | 2015-03-09 | California Inst Of Techn | Thermostable peroxide-driven cytochrome P450 oxygenase variants and methods of use |
US20060228350A1 (en) * | 2003-08-18 | 2006-10-12 | Medimmune, Inc. | Framework-shuffling of antibodies |
EP2272566A3 (en) | 2003-08-18 | 2013-01-02 | MedImmune, LLC | Humanisation of antibodies |
WO2005021586A2 (en) * | 2003-08-21 | 2005-03-10 | Wisconsin Alumni Research Foundation | Metabolic engineering of viomycin biosynthesis |
ATE510011T1 (de) | 2003-08-25 | 2011-06-15 | Funzyme Biotechnologies Sa | Neue pilzproteine und diese codierende nukleinsäuren |
EP1660637A4 (en) | 2003-08-25 | 2009-10-21 | Novozymes Inc | VARIANTS OF GLYCOSIDE HYDROLASES |
DK1664343T3 (da) | 2003-09-09 | 2014-08-11 | Integrigen Inc | Fremgangsmåder og sammensætninger til generering af kimcelle humane antistofgener |
EP1670939B1 (en) | 2003-09-18 | 2009-11-04 | Nuevolution A/S | A method for obtaining structural information concerning an encoded molecule and method for selecting compounds |
DE602004022323D1 (de) * | 2003-10-07 | 2009-09-10 | United Therapeutics Corp | Tyrosinasemutante und verfahren zur verwendung davon |
CN1867668A (zh) | 2003-10-10 | 2006-11-22 | 诺维信公司 | 蛋白酶变体 |
WO2005035564A2 (en) | 2003-10-10 | 2005-04-21 | Xencor, Inc. | Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
US20050084868A1 (en) * | 2003-10-16 | 2005-04-21 | Wolfgang Aehle | Generation of stabilized proteins by combinatorial consensus mutagenesis |
JP4880469B2 (ja) | 2003-10-23 | 2012-02-22 | ノボザイムス アクティーゼルスカブ | 洗剤中で改良された安定性を有するプロテアーゼ |
CN1902310B (zh) | 2003-10-28 | 2011-09-21 | 诺维信股份有限公司 | 具有β-葡糖苷酶活性的多肽和编码所述多肽的多核苷酸 |
AU2004290052B2 (en) | 2003-11-12 | 2008-12-04 | Corteva Agriscience Llc | Delta-15 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous plants and yeast |
US7985569B2 (en) | 2003-11-19 | 2011-07-26 | Danisco Us Inc. | Cellulomonas 69B4 serine protease variants |
US8535927B1 (en) | 2003-11-19 | 2013-09-17 | Danisco Us Inc. | Micrococcineae serine protease polypeptides and compositions thereof |
EP1694837A4 (en) * | 2003-11-20 | 2008-07-23 | Agency Science Tech & Res | METHOD |
ES2445948T3 (es) * | 2003-11-24 | 2014-03-06 | Ratiopharm Gmbh | Eritropoyetina glicopegilada |
US20080305992A1 (en) | 2003-11-24 | 2008-12-11 | Neose Technologies, Inc. | Glycopegylated erythropoietin |
US8633157B2 (en) * | 2003-11-24 | 2014-01-21 | Novo Nordisk A/S | Glycopegylated erythropoietin |
EP1697534B1 (en) | 2003-12-01 | 2010-06-02 | Life Technologies Corporation | Nucleic acid molecules containing recombination sites and methods of using the same |
US20060040856A1 (en) * | 2003-12-03 | 2006-02-23 | Neose Technologies, Inc. | Glycopegylated factor IX |
MXPA06006029A (es) * | 2003-12-03 | 2006-08-23 | Neose Technologies Inc | Factor de estimulacion de colonias de granulocitos modificado por glicopolietilenglicol. |
US7956032B2 (en) | 2003-12-03 | 2011-06-07 | Novo Nordisk A/S | Glycopegylated granulocyte colony stimulating factor |
ATE352616T1 (de) * | 2003-12-04 | 2007-02-15 | Hoffmann La Roche | Verfahren zur herstellung von zirkulären mutierten und/oder chimären polynukleotiden |
US20070169227A1 (en) | 2003-12-16 | 2007-07-19 | Pioneer Hi-Bred International Inc. | Dominant Gene Suppression Transgenes and Methods of Using Same |
US7718408B2 (en) | 2003-12-24 | 2010-05-18 | Danisco A/S | Method |
WO2008090395A1 (en) | 2007-01-25 | 2008-07-31 | Danisco A/S | Production of a lipid acyltransferase from transformed bacillus licheniformis cells |
EP2119771B1 (en) | 2003-12-24 | 2018-08-22 | DuPont Nutrition Biosciences ApS | Proteins |
GB0716126D0 (en) | 2007-08-17 | 2007-09-26 | Danisco | Process |
ES2560657T3 (es) * | 2004-01-08 | 2016-02-22 | Ratiopharm Gmbh | Glicosilación con unión en O de péptidos G-CSF |
CN104726431B (zh) | 2004-01-30 | 2018-06-01 | 诺维信股份有限公司 | 具有分解纤维增强活性的多肽及其编码多核苷酸 |
US7432057B2 (en) * | 2004-01-30 | 2008-10-07 | Michigan State University | Genetic test for PSE-susceptible turkeys |
EP1715736A4 (en) | 2004-02-12 | 2008-09-03 | Novozymes Inc | POLYPEPTIDES HAVING XYLANASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME |
ES2531753T3 (es) | 2004-02-25 | 2015-03-18 | Novozymes A/S | Enzima de degradación de la pared celular fúngica |
PT2184360E (pt) | 2004-02-25 | 2015-12-02 | Pioneer Hi Bred Int | Novos polipéptidos cristalinos de bacillus thuringiensis, polinucleótidos e composições destes |
US20060127920A1 (en) * | 2004-02-27 | 2006-06-15 | President And Fellows Of Harvard College | Polynucleotide synthesis |
US7459289B2 (en) | 2004-03-08 | 2008-12-02 | North Carolina State University | Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor |
GB0405637D0 (en) | 2004-03-12 | 2004-04-21 | Danisco | Protein |
CN1933850B (zh) | 2004-03-22 | 2011-01-12 | 索尔瓦药物有限公司 | 含表面活性剂的、含脂肪酶产品尤其是胰酶的口服药物组合物 |
EP1730277B1 (en) * | 2004-03-22 | 2009-10-28 | Nuevolution A/S | Ligational encoding using building block oligonucleotides |
US7569223B2 (en) * | 2004-03-22 | 2009-08-04 | The Rockefeller University | Phage-associated lytic enzymes for treatment of Streptococcus pneumoniae and related conditions |
US7973139B2 (en) * | 2004-03-26 | 2011-07-05 | Human Genome Sciences, Inc. | Antibodies against nogo receptor |
JP2007530679A (ja) * | 2004-03-27 | 2007-11-01 | ジ・アリゾナ・ボード・オブ・リージェンツ・オン・ビハーフ・オブ・ザ・ユニバーシティー・オブ・アリゾナ | 癌治療のための組成物および方法 |
CA2561450A1 (en) | 2004-04-02 | 2005-10-13 | Cropdesign N.V. | Plants having improved growth characteristics and method for making the same |
US8470315B2 (en) * | 2004-04-13 | 2013-06-25 | Quintessence Biosciences, Inc. | Non-natural ribonuclease conjugates as cytotoxic agents |
ES2407857T5 (es) | 2004-04-30 | 2017-07-31 | Dow Agrosciences Llc | Nuevo gen de resistencia a los herbicidas |
US7622125B2 (en) | 2004-05-05 | 2009-11-24 | Novartis Vaccines And Diagnostics, Inc. | Polycistronic HIV vector constructs |
KR101083595B1 (ko) * | 2004-05-14 | 2011-11-16 | 가톨릭대학교 산학협력단 | 단백질 형질도입 도메인 유전자를 함유하는 재조합베큘로바이러스 발현벡터 |
US7674621B2 (en) | 2004-05-21 | 2010-03-09 | The United States Of America As Represented By The Department Of Health And Human Services | Plasmids and phages for homologous recombination and methods of use |
WO2005121351A2 (en) | 2004-05-27 | 2005-12-22 | Novozymes, Inc. | Methods for transforming and expression screening of filamentous fungal cells with a dna library |
US7825293B2 (en) | 2004-05-28 | 2010-11-02 | Cropdesign N.V. | Plants having improved growth characteristics and a method for making the same |
AU2005254993B2 (en) | 2004-06-09 | 2009-08-06 | Pioneer Hi-Bred International, Inc. | Plastid transit peptides |
AU2005264938B2 (en) | 2004-06-16 | 2011-11-24 | Verenium Corporation | Compositions and methods for enzymatic decolorization of chlorophyll |
US20060008844A1 (en) | 2004-06-17 | 2006-01-12 | Avidia Research Institute | c-Met kinase binding proteins |
BRPI0512341A (pt) | 2004-06-21 | 2008-03-04 | Novozymes As | polipeptìdeo isolado tendo atividade de protease, seqüência de ácido nucleico isolada, construto de ácido nucleico, vetor de expressão, célula hospedeira recombinante, planta ou parte vegetal transgênica, animal não humano transgênico, uso de pelo menos uma protease, métodos para produzir um polipeptìdeo, para melhorar o valor nutricional de uma ração animal e para tratar proteìnas, ração animal, e, aditivo de ração animal |
US7985892B1 (en) | 2004-06-29 | 2011-07-26 | Dow Agrosciences Llc | Truncated Cry35 proteins |
WO2006005032A2 (en) | 2004-06-29 | 2006-01-12 | Novozymes, Inc. | Polypeptides having alpha-glucosidase activity and polynucleotides encoding same |
DE602005026021D1 (de) | 2004-06-30 | 2011-03-03 | Pioneer Hi Bred Int | Verfahren zum schutz von pflanzen vor pathogenen pilzen |
BRPI0512920B1 (pt) | 2004-07-02 | 2017-05-16 | Du Pont | cassete de expressão, microorganismo transformado, método para indução de resistência a patógeno de planta em uma planta, composição anti-patogênica e método para proteção de uma planta contra um patógeno de planta |
BRPI0512776A (pt) | 2004-07-05 | 2008-04-08 | Novozymes As | variante de uma alfa-amilase tipo termamil originária, construto de dna, vetor de expressão recombinante, célula, composição, aditivo de detergente, composição detergente, composição de lavagem de roupa manual ou automática, uso de uma variante de alfa-amilase ou composição, e, método de produzir uma variante |
AU2005261646B2 (en) | 2004-07-12 | 2012-02-02 | Cropdesign N.V. | Plants having improved growth characteristics and method for making the same |
WO2006010143A2 (en) | 2004-07-13 | 2006-01-26 | Neose Technologies, Inc. | Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1] |
EP2275522A3 (en) | 2004-07-16 | 2011-09-21 | Danisco A/S | Enzymatic oil-degumming method |
CA2574802A1 (en) | 2004-07-20 | 2006-02-02 | Isogenis, Inc. | Specific inhibition of autoimmunity and diseases associated with autoantigens |
US20090292110A1 (en) * | 2004-07-23 | 2009-11-26 | Defrees Shawn | Enzymatic modification of glycopeptides |
EP1781779A2 (en) | 2004-08-02 | 2007-05-09 | Novozymes A/S | Creation of diversity in polypeptides |
EP1791975A4 (en) * | 2004-08-05 | 2007-11-07 | Biosite Inc | COMPOSITIONS AND METHODS FOR EXPRESSION AT THE SURFACE OF POLYPEPTIDE PHAGES |
US7597884B2 (en) | 2004-08-09 | 2009-10-06 | Alios Biopharma, Inc. | Hyperglycosylated polypeptide variants and methods of use |
US7148051B2 (en) * | 2004-08-16 | 2006-12-12 | E. I. Du Pont De Nemours And Company | Production of 3-hydroxycarboxylic acid using nitrilase |
FI20050753A (fi) | 2004-09-03 | 2006-03-04 | Licentia Oy | Uudet peptidit |
EP1799249A2 (en) * | 2004-09-10 | 2007-06-27 | Neose Technologies, Inc. | Glycopegylated interferon alpha |
US7563443B2 (en) * | 2004-09-17 | 2009-07-21 | Domantis Limited | Monovalent anti-CD40L antibody polypeptides and compositions thereof |
US7728118B2 (en) | 2004-09-17 | 2010-06-01 | Promega Corporation | Synthetic nucleic acid molecule compositions and methods of preparation |
WO2006034292A2 (en) | 2004-09-21 | 2006-03-30 | Medimmune, Inc. | Antibodies against and methods for producing vaccines for respiratory syncytial virus |
US7799906B1 (en) | 2004-09-22 | 2010-09-21 | Arborgen, Llc | Compositions and methods for modulating lignin of a plant |
US7453025B2 (en) | 2004-09-22 | 2008-11-18 | Arborgen, Llc | Reproductive ablation constructs |
GB0421598D0 (en) | 2004-09-29 | 2004-10-27 | Cambridge Advanced Tech | Modification of plant development and morphology |
US7666630B2 (en) | 2004-09-30 | 2010-02-23 | Novozymes, Inc. | Polypeptides having lipase activity and polynucleotides encoding same |
WO2006049777A2 (en) * | 2004-09-30 | 2006-05-11 | Trustees Of Dartmouth College | Nucleic acid sequences encoding luciferase for expression in filamentous fungi |
JP5221137B2 (ja) | 2004-10-04 | 2013-06-26 | ノボザイムス アクティーゼルスカブ | フィターゼ活性を有するポリペプチド及びそれをコードするポリヌクレオチド |
AR050895A1 (es) | 2004-10-04 | 2006-11-29 | Novozymes As | Polipeptidos que tienen actividad de fitasa y polinucleotidos que los codifican |
GB0422052D0 (en) | 2004-10-04 | 2004-11-03 | Dansico As | Enzymes |
EP1645633B1 (en) | 2004-10-05 | 2011-09-21 | SunGene GmbH | Constitutive expression cassettes for regulation of plant expression |
DK1799027T3 (da) | 2004-10-08 | 2012-07-23 | Dow Agrosciences Llc | Planter med intet eller reduceret mætningsniveau af fedtsyrer i frø og olie udvundet af frøene |
RU2401842C2 (ru) | 2004-10-08 | 2010-10-20 | Домантис Лимитед | Антагонисты и способы их применения |
GB0423139D0 (en) * | 2004-10-18 | 2004-11-17 | Danisco | Enzymes |
WO2006047791A2 (en) * | 2004-10-27 | 2006-05-04 | The Board Of Trustees Of The Leland Stanford Junior University | Dna-templated combinatorial library device and method for use |
US20060121042A1 (en) | 2004-10-27 | 2006-06-08 | Medimmune, Inc. | Modulation of antibody specificity by tailoring the affinity to cognate antigens |
US20060141626A1 (en) * | 2004-10-27 | 2006-06-29 | Monsanto Technology Llc | Non-random method of gene shuffling |
DK2586456T3 (en) | 2004-10-29 | 2016-03-21 | Ratiopharm Gmbh | Conversion and glycopegylation of fibroblast growth factor (FGF) |
CA2588281A1 (en) | 2004-10-29 | 2006-05-04 | Cropdesign N.V. | Plants having improved growth characteristics and method for making the same |
EP1655364A3 (en) | 2004-11-05 | 2006-08-02 | BASF Plant Science GmbH | Expression cassettes for seed-preferential expression in plants |
EP1817413B1 (en) | 2004-11-11 | 2012-01-04 | Modular Genetics, Inc. | Oligonucleotide ladder assembly and system for generating molecular diversity |
EP1814996A2 (en) | 2004-11-19 | 2007-08-08 | Novozymes A/S | Polypeptides having antimicrobial activity and polynucleotides encoding same |
EP1662000B1 (en) | 2004-11-25 | 2011-03-30 | SunGene GmbH | Expression cassettes for guard cell-preferential expression in plants |
EP1666599A3 (en) | 2004-12-04 | 2006-07-12 | SunGene GmbH | Expression cassettes for mesophyll- and/or epidermis-preferential expression in plants |
EP2163634A1 (en) | 2004-12-08 | 2010-03-17 | SunGene GmbH | Expression cassettes for vascular tissue-preferential expression in plants |
EP1669456A3 (en) | 2004-12-11 | 2006-07-12 | SunGene GmbH | Expression cassettes for meristem-preferential expression in plants |
CA2592104C (en) | 2004-12-22 | 2016-05-10 | Novozymes A/S | Enzymes for starch processing |
US7198927B2 (en) * | 2004-12-22 | 2007-04-03 | E. I. Du Pont De Nemours And Company | Enzymatic production of glycolic acid |
EP2003205B1 (en) | 2004-12-28 | 2013-05-01 | Pioneer Hi-Bred International, Inc. | Improved grain quality through altered expression of seed proteins |
JP2008526864A (ja) * | 2005-01-06 | 2008-07-24 | ネオス テクノロジーズ インコーポレイテッド | 糖断片を用いる糖結合 |
JP4951527B2 (ja) | 2005-01-10 | 2012-06-13 | バイオジェネリックス アーゲー | 糖peg化顆粒球コロニー刺激因子 |
US20060160138A1 (en) * | 2005-01-13 | 2006-07-20 | George Church | Compositions and methods for protein design |
MX2007008486A (es) | 2005-01-13 | 2008-02-15 | Pioneer Hi Bred Int | Gen y promotor cyclo1 de maiz. |
US8426683B2 (en) | 2005-01-27 | 2013-04-23 | Cropdesign N.V. | Plants having increased yield and a method for making the same |
AU2006214121B9 (en) | 2005-02-15 | 2013-02-14 | Duke University | Anti-CD19 antibodies and uses in oncology |
WO2006094084A2 (en) | 2005-03-02 | 2006-09-08 | Instituto Nacional De Tecnologia Agropecuaria | Herbicide-resistant rice plants, polynucleotides encoding herbicide-resistant acetohydroxyacid synthase large subunit proteins, and methods of use |
CA2614769A1 (en) | 2005-03-10 | 2006-09-21 | Verenium Corporation | Lyase enzymes, nucleic acids encoding them and methods for making and using them |
EP1861506B1 (en) | 2005-03-15 | 2015-04-15 | BP Corporation North America Inc. | Cellulases, nucleic acids encoding them and methods for making and using them |
CN100577805C (zh) * | 2005-03-16 | 2010-01-06 | 中国科学院沈阳应用生态研究所 | 一种基因改组的方法及所获得的重组基因和编码蛋白 |
JP5080440B2 (ja) | 2005-03-18 | 2012-11-21 | ノボザイムス アデニウム バイオテック アクティーゼルスカブ | 抗菌活性を有するポリペプチド及びそれをコードするポリヌクレオチド |
JP5153613B2 (ja) | 2005-03-18 | 2013-02-27 | メディミューン,エルエルシー | 抗体のフレームワーク・シャッフル |
WO2006100449A1 (en) | 2005-03-19 | 2006-09-28 | Medical Research Council | Improvements in or relating to treatment and prevention of viral infections |
US8715988B2 (en) | 2005-03-28 | 2014-05-06 | California Institute Of Technology | Alkane oxidation by modified hydroxylases |
US11214817B2 (en) | 2005-03-28 | 2022-01-04 | California Institute Of Technology | Alkane oxidation by modified hydroxylases |
WO2006107761A2 (en) | 2005-04-01 | 2006-10-12 | Athenix Corporation | Axmi-027, axmi-036 and axmi-038, a family of delta-endotoxin genes and methods for their use |
US20070154992A1 (en) * | 2005-04-08 | 2007-07-05 | Neose Technologies, Inc. | Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants |
JP2008537885A (ja) | 2005-04-15 | 2008-10-02 | ノース・キャロライナ・ステイト・ユニヴァーシティ | 細菌の付着およびストレス耐性を修飾する方法および組成物 |
ES2707152T3 (es) | 2005-04-15 | 2019-04-02 | Macrogenics Inc | Diacuerpos covalentes y usos de los mismos |
ATE552343T1 (de) | 2005-04-19 | 2012-04-15 | Basf Plant Science Gmbh | Endosperm-spezifische expression und/oder expression in keimenden embryos monokotyledoner pflanzen |
DK1877551T4 (da) | 2005-04-27 | 2014-03-31 | Novozymes Inc | Polypeptider, der har endoglucanaseaktivitet, og polynukleotider, der koder for samme |
US8003108B2 (en) * | 2005-05-03 | 2011-08-23 | Amgen Inc. | Sclerostin epitopes |
US7592429B2 (en) * | 2005-05-03 | 2009-09-22 | Ucb Sa | Sclerostin-binding antibody |
CA2607281C (en) | 2005-05-05 | 2023-10-03 | Duke University | Anti-cd19 antibody therapy for autoimmune disease |
CN1861789B (zh) * | 2005-05-13 | 2010-04-28 | 中国科学院沈阳应用生态研究所 | 一种综合的基因改组方法及所获得的重组基因和编码蛋白 |
AR053269A1 (es) | 2005-05-16 | 2007-04-25 | Monsanto Technology Llc | Plantas y semillas de maiz con mejoramiento de asparagina y proteina |
US20060263974A1 (en) * | 2005-05-18 | 2006-11-23 | Micron Technology, Inc. | Methods of electrically interconnecting different elevation conductive structures, methods of forming capacitors, methods of forming an interconnect between a substrate bit line contact and a bit line in DRAM, and methods of forming DRAM memory cell |
US20060281113A1 (en) * | 2005-05-18 | 2006-12-14 | George Church | Accessible polynucleotide libraries and methods of use thereof |
US20060271262A1 (en) * | 2005-05-24 | 2006-11-30 | Mclain Harry P Iii | Wireless agricultural network |
US20110003744A1 (en) * | 2005-05-25 | 2011-01-06 | Novo Nordisk A/S | Glycopegylated Erythropoietin Formulations |
EP1888098A2 (en) * | 2005-05-25 | 2008-02-20 | Neose Technologies, Inc. | Glycopegylated erythropoietin formulations |
US7888095B2 (en) * | 2005-06-03 | 2011-02-15 | The Regents Of The University Of California | Methods of generating protein variants with altered function |
JP4931919B2 (ja) | 2005-06-21 | 2012-05-16 | ゾーマ テクノロジー リミテッド | IL−1β結合抗体およびその断片 |
WO2007002543A2 (en) | 2005-06-23 | 2007-01-04 | Medimmune, Inc. | Antibody formulations having optimized aggregation and fragmentation profiles |
US7582291B2 (en) * | 2005-06-30 | 2009-09-01 | The Rockefeller University | Bacteriophage lysins for Enterococcus faecalis, Enterococcus faecium and other bacteria |
EA020462B1 (ru) | 2005-07-01 | 2014-11-28 | Басф Се | Резистентные к гербицидам растения подсолнечника, полинуклеотиды, кодирующие резистентные к гербицидам большие субъединицы белков ацетогидроксикислотной синтазы, и применение растений и полинуклеотидов |
EP1902135A1 (en) | 2005-07-06 | 2008-03-26 | CropDesign N.V. | Plant yield improvement by ste20-like gene expression |
EP2385111B1 (en) | 2005-07-08 | 2016-09-07 | Novozymes A/S | Subtilase variants |
JP2009501522A (ja) * | 2005-07-12 | 2009-01-22 | コドン デバイシズ インコーポレイテッド | 生体触媒工学のための組成物及び方法 |
WO2007008951A1 (en) * | 2005-07-12 | 2007-01-18 | Codon Devices, Inc. | Compositions and methods for design of non-immunogenic proteins |
WO2007011722A2 (en) | 2005-07-15 | 2007-01-25 | President And Fellows Of Harvard College | Reaction discovery system |
BRPI0612862A2 (pt) | 2005-07-18 | 2010-11-30 | Pioneer Hi Bred Int | polinucleotìdeo isolado, método para obtenção de uma célula transformada, método para obtenção de uma planta transformada, método de produção de recombinação de dna de sìtio especìfico, biblioteca isolada, método de geração de biblioteca de moléculas e método para selecionar sìtio de recombinação frt modificado |
EP1913138B1 (en) | 2005-07-29 | 2016-08-24 | Abbott Laboratories GmbH | Processes for the manufacture of pancreatin powder with low virus content |
EP1924136A4 (en) | 2005-07-29 | 2009-05-13 | Targeted Growth Inc | PROTECTION OF DOMINANT NEGATIVE MUTANT KRP PROTEINS ACTIVE INHIBITION OF CYCLINE / CDK COMPLEX BY WILD TYPE KRP |
CA2618783A1 (en) * | 2005-08-10 | 2007-02-22 | Acambis Inc. | Vaccination against dengue virus infection |
CA2618681C (en) | 2005-08-10 | 2015-10-27 | Macrogenics, Inc. | Identification and engineering of antibodies with variant fc regions and methods of using same |
US11266607B2 (en) | 2005-08-15 | 2022-03-08 | AbbVie Pharmaceuticals GmbH | Process for the manufacture and use of pancreatin micropellet cores |
US9198871B2 (en) | 2005-08-15 | 2015-12-01 | Abbott Products Gmbh | Delayed release pancreatin compositions |
US20070105755A1 (en) | 2005-10-26 | 2007-05-10 | Neose Technologies, Inc. | One pot desialylation and glycopegylation of therapeutic peptides |
CN101297034A (zh) | 2005-08-24 | 2008-10-29 | 洛克菲勒大学 | Ply-gbs突变溶素 |
RS51325B (sr) | 2005-08-26 | 2010-12-31 | Novozymes Adenium Biotech A/S | Polipeptidi koji imaju antimikrobno dejstvo i polinukleotidi koji ih kodiraju |
CA2621267A1 (en) | 2005-09-07 | 2007-03-15 | Nugen Technologies, Inc. | Improved nucleic acid amplification procedure |
US7541431B2 (en) * | 2005-09-07 | 2009-06-02 | Maine Medical Center | Cristin/R-spondin ligands active in the Wnt signaling pathway and methods, compositions and kits relating thereto |
MX2008003389A (es) | 2005-09-15 | 2008-03-27 | Cropdesign Nv | Plantas que tienen rendimiento incrementado y un metodo para efectuar las mismas. |
US8173613B2 (en) * | 2005-09-22 | 2012-05-08 | Maine Medical Center | Modulation of mesenchymal and metastatic cell growth |
NZ589570A (en) | 2005-09-30 | 2012-06-29 | Novozymes Inc | Methods for enhancing the degradation or conversion of cellulosic material |
US7312079B1 (en) | 2005-10-06 | 2007-12-25 | Lexicon Pharmaceuticals, Inc. | Variants of FAM3C |
US7470532B2 (en) | 2005-10-19 | 2008-12-30 | E.I. Du Pont De Nemours And Company | Mortierella alpina C16/18 fatty acid elongase |
DK2484202T3 (en) | 2005-10-28 | 2017-09-11 | Dow Agrosciences Llc | NEW HERBICID RESISTANCE GENES |
US20090048440A1 (en) * | 2005-11-03 | 2009-02-19 | Neose Technologies, Inc. | Nucleotide Sugar Purification Using Membranes |
EP1948807B1 (en) | 2005-11-07 | 2015-09-30 | CropDesign N.V. | Plants having improved growth characteristics and a method for making the same |
US8853492B2 (en) | 2005-11-07 | 2014-10-07 | Cropdesign N.V. | Plants having improved growth characteristics and a method for making the same |
BRPI0618378A2 (pt) | 2005-11-08 | 2011-08-30 | Cropdesign Nv | métodos para aumentar o rendimento de planta e/ou resistência ao estresse em relação às plantas de controle e para produzir uma planta transgênica tendo rendimento aumentado e/ou resistência ao estresse aumentada, construção, usos de uma construção e de um ácido nucléico del1 ou variante do mesmo, ou de um polipeptìdeo del1 ou homólogo do mesmo, polipeptìdeo del1 isolado, e, seqüência de ácido nucleico isolada |
US20070118920A1 (en) | 2005-11-09 | 2007-05-24 | Basf Agrochemical Products B.V. | Herbicide-resistant sunflower plants, polynucleotides encoding herbicide-resistant acetohydroxyacid synthase large subunit proteins, and methods of use |
AR056778A1 (es) | 2005-11-10 | 2007-10-24 | Pioneer Hi Bred Int | Secuencias dof ( que se unen a adn con un dedo ) y metodos para usarlas |
US20070199096A1 (en) | 2005-11-14 | 2007-08-23 | E.I. Du Pont De Nemours And Company | Compositions and Methods for Altering Alpha- and Beta-Tocotrienol Content |
EP1965824A4 (en) * | 2005-11-18 | 2011-10-19 | Gloucester Pharmaceuticals Inc | METABOLITENE DERIVATIVES OF HDAC INHIBITOR FK228 |
GB2432366B (en) * | 2005-11-19 | 2007-11-21 | Alligator Bioscience Ab | A method for in vitro molecular evolution of protein function |
GB0526664D0 (en) * | 2005-11-30 | 2006-02-08 | Plasticell Ltd | Method |
ES2901551T3 (es) | 2005-12-01 | 2022-03-22 | Nuevolution As | Métodos de codificación enzimática para la síntesis eficiente de bibliotecas grandes |
US7674958B2 (en) | 2005-12-01 | 2010-03-09 | Athenix Corporation | GRG23 and GRG51 genes conferring herbicide resistance |
AU2006320596B2 (en) | 2005-12-01 | 2013-02-07 | Cropdesign N.V. | Plants having improved growth characteristics and methods for making the same |
EP1963525B2 (en) * | 2005-12-02 | 2017-10-11 | Synthetic Genomics, Inc. | Synthesis of error-minimized nucleic acid molecules |
KR100784478B1 (ko) * | 2005-12-05 | 2007-12-11 | 한국과학기술원 | 기능요소의 동시 삽입에 의한 신기능을 갖는 단백질을제조하는 방법 |
US20080313769A9 (en) | 2006-01-12 | 2008-12-18 | Athenix Corporation | EPSP synthase domains conferring glyphosate resistance |
EP1987142A4 (en) | 2006-02-02 | 2009-07-15 | Verenium Corp | ESTERASES AND ASSOCIATED NUCLEIC ACIDS AND METHODS |
NZ595499A (en) | 2006-02-10 | 2013-05-31 | Verenium Corp | Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them |
US8043839B2 (en) | 2006-02-14 | 2011-10-25 | Verenium Corporation | Xylanases, nucleic acids encoding them and methods for making and using them |
WO2007103768A2 (en) | 2006-03-02 | 2007-09-13 | Athenix Corporation | Methods and compositions for improved enzyme activity in transgenic plant |
US8389688B2 (en) | 2006-03-06 | 2013-03-05 | Aeres Biomedical, Ltd. | Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease |
EA029538B1 (ru) | 2006-03-07 | 2018-04-30 | Басф Энзаймс Ллк | Полипептид, обладающий активностью альдолазы, полинуклеотид, кодирующий этот полипептид, и способы получения и применения полинуклеотида и полипептида |
CN101437954B (zh) | 2006-03-07 | 2015-09-09 | 嘉吉公司 | 醛缩酶和编码醛缩酶的核酸以及它们的制备和使用方法 |
US20070214515A1 (en) | 2006-03-09 | 2007-09-13 | E.I.Du Pont De Nemours And Company | Polynucleotide encoding a maize herbicide resistance gene and methods for use |
ES2368608T3 (es) | 2006-03-20 | 2011-11-18 | Novozymes, Inc. | Polipéptidos con actividad endoglucanasa y polinucleótidos codifcando los polipéptidos. |
US8703278B2 (en) * | 2006-03-28 | 2014-04-22 | Honeywell International Inc. | Light weight printed wiring board |
BRPI0710217A2 (pt) | 2006-03-30 | 2011-08-02 | Novozymes Inc | polipeptìdeo, polinucleotìdeo, construção de ácido nucleico, vetor de expressão recombinante, célula hospedeira recombinante, métodos para produzir o polipeptìdeo, para produzir um mutante a partir de uma célula precursora, para produzir uma proteìna, para produzir um polinucleotìdeo, para degradar ou converter um material celulósico, para produzir uma substáncia e para inibir a expressão de um polinucleotìdeo em uma célula, célula mutante, planta transgênica, parte de planta ou célula de planta, e, molécula de rna de filamento duplo |
ES2553384T3 (es) | 2006-03-31 | 2015-12-09 | Basf Plant Science Gmbh | Plantas que tienen rasgos potenciados relacionados con el rendimiento y un procedimiento de producción de las mismas |
AU2007234177B2 (en) | 2006-04-04 | 2012-11-08 | Novozymes A/S | Phytase variants |
EP1842915A1 (en) | 2006-04-04 | 2007-10-10 | Libragen | Method of in vitro polynucleotide sequences shuffling by recursive circular DNA molecules fragmentation and ligation |
BRPI0710455A2 (pt) | 2006-04-19 | 2011-08-16 | Pioneer Hi Bred Int | polipeptìdeo isolado, polinucleotìdeo isolado e métodos para aumentar o nìvel de um polipeptìdeo em uma planta, para modular o nìvel de um polipeptìdeo em uma planta e para modificar o crescimento de uma planta |
CA2650520A1 (en) * | 2006-04-24 | 2008-01-31 | Gloucester Pharmaceuticals | Treatment of ras-expressing tumors |
CA2652461C (en) | 2006-05-16 | 2015-12-01 | Pioneer Hi-Bred International, Inc. | Antifungal polypeptides and uses thereof in inducing fungal resistance in plants |
CN103215304A (zh) | 2006-05-17 | 2013-07-24 | 先锋高级育种国际公司 | 人工植物微染色体 |
WO2007136834A2 (en) * | 2006-05-19 | 2007-11-29 | Codon Devices, Inc. | Combined extension and ligation for nucleic acid assembly |
US10072256B2 (en) | 2006-05-22 | 2018-09-11 | Abbott Products Gmbh | Process for separating and determining the viral load in a pancreatin sample |
EP2035562A2 (en) | 2006-05-30 | 2009-03-18 | CropDesign N.V. | Plants with modulated expression of extensin receptor-like kinase having enhanced yield-related traits and a method for making the same |
MX2008014097A (es) | 2006-06-08 | 2008-11-14 | Basf Plant Science Gmbh | Plantas que tienen caracteristicas de crecimiento mejoradas y metodo para producir las mismas. |
US8957027B2 (en) | 2006-06-08 | 2015-02-17 | Celgene Corporation | Deacetylase inhibitor therapy |
EP2455392A3 (en) | 2006-06-15 | 2012-08-22 | Athenix Corporation | A family of pesticidal proteins and methods for their use |
EP2599870A3 (en) | 2006-06-15 | 2013-09-11 | CropDesign N.V. | Plants having enhanced yield-related traits and a method for making the same |
AR069996A1 (es) | 2006-06-15 | 2010-03-10 | Cropdesign Nv | Plantas con caracteristicas aumentadas relacionadas con el rendimiento y un metodo para desarrollar las mismas |
WO2008020333A2 (en) | 2006-06-19 | 2008-02-21 | National Research Council Of Canada | Nucleic acid encoding n-methylputrescine oxidase and uses thereof |
EP2044097A4 (en) * | 2006-06-23 | 2010-10-06 | Quintessence Biosciences Inc | MODIFIED RIBONUCLEASES |
SI2029173T1 (sl) | 2006-06-26 | 2016-12-30 | Macrogenics, Inc. | Protitelesa, specifična za Fc RIIB, in postopki za njihovo uporabo |
US7572618B2 (en) | 2006-06-30 | 2009-08-11 | Bristol-Myers Squibb Company | Polynucleotides encoding novel PCSK9 variants |
US20080004410A1 (en) * | 2006-06-30 | 2008-01-03 | Yu-Chin Lai | Hydrophilic macromonomers having alpha,beta-conjugated carboxylic terminal group and medical devices incorporating same |
US7977535B2 (en) | 2006-07-12 | 2011-07-12 | Board Of Trustees Of Michigan State University | DNA encoding ring zinc-finger protein and the use of the DNA in vectors and bacteria and in plants |
US9668501B2 (en) | 2006-07-13 | 2017-06-06 | Dsm Ip Assets B.V. | Use of bacterial amylases in feed for bovine animals |
WO2008010991A2 (en) | 2006-07-17 | 2008-01-24 | Quintessence Biosciences, Inc. | Methods and compositions for the treatment of cancer |
WO2008011633A2 (en) * | 2006-07-21 | 2008-01-24 | Neose Technologies, Inc. | Glycosylation of peptides via o-linked glycosylation sequences |
WO2008012058A1 (en) * | 2006-07-25 | 2008-01-31 | Commonwealth Scientific And Industrial Research Organisation | Identification of a novel type of sucrose synthase and use thereof in fiber modification |
EP2199395A1 (en) | 2006-08-02 | 2010-06-23 | CropDesign N.V. | Plants transformed with SYT-polypeptide having increased yield under abiotic stress and a method for making the same |
EP2546262A1 (en) | 2006-08-02 | 2013-01-16 | CropDesign N.V. | Modifying the content of storage compounds in seeds by expression of a Class II HD-Zip transcription factor |
BRPI0714876B1 (pt) | 2006-08-04 | 2022-04-19 | Verenium Corporation | Ácido nucleico isolado, sintético ou recombinante, cassete de expressão, vetor ou veículo de clonagem, célula bacteriana, fúngica ou de levedura transformada, polipeptídeo isolado, sintético ou recombinante, composição, bem como métodos de produção e de usos dos mesmos |
WO2008016709A2 (en) * | 2006-08-04 | 2008-02-07 | California Institute Of Technology | Methods and systems for selective fluorination of organic molecules |
US8252559B2 (en) * | 2006-08-04 | 2012-08-28 | The California Institute Of Technology | Methods and systems for selective fluorination of organic molecules |
US7968691B2 (en) | 2006-08-23 | 2011-06-28 | Danisco Us Inc. | Pullulanase variants with increased productivity |
MY162024A (en) | 2006-08-28 | 2017-05-31 | La Jolla Inst Allergy & Immunology | Antagonistic human light-specific human monoclonal antibodies |
PL2064325T3 (pl) | 2006-09-01 | 2012-05-31 | Therapeutic Human Polyclonals Inc | Zwiększona ekspresja ludzkiej lub humanizowanej immunoglobuliny u zwierząt transgenicznych innych niż człowiek |
EP2354254A1 (en) | 2006-09-06 | 2011-08-10 | Ortho-McNeil Pharmaceutical, Inc. | Biomarkers for assessing response to C-met treatment |
US8323653B2 (en) | 2006-09-08 | 2012-12-04 | Medimmune, Llc | Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease |
WO2008036863A2 (en) | 2006-09-21 | 2008-03-27 | Verenium Corporation | Phospholipases, nucleic acids encoding them and methods for making and using them |
EP2617814B1 (en) | 2006-09-21 | 2015-11-18 | BASF Enzymes LLC | Phytases, nucleic acids encoding them and methods for making and using them |
BRPI0716960B1 (pt) | 2006-09-29 | 2021-02-02 | Novozymes A/S | uso de uma xilanase, composição, e, método para melhorar o valor nutricional de uma ração animal |
US8969532B2 (en) | 2006-10-03 | 2015-03-03 | Novo Nordisk A/S | Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography |
SI2068907T1 (en) | 2006-10-04 | 2018-01-31 | Novo Nordisk A/S | Pegylated sugars and glycopeptides are associated with glycerol |
GB0620715D0 (en) | 2006-10-18 | 2006-11-29 | Univ Durham | Ethanol production |
US20100162433A1 (en) | 2006-10-27 | 2010-06-24 | Mclaren James | Plants with improved nitrogen utilization and stress tolerance |
EP2423226A3 (en) * | 2006-11-10 | 2012-05-30 | Amgen Inc. | Antibody-based diagnostics and therapeutics |
EP2460828A3 (en) * | 2006-11-10 | 2012-08-08 | UCB Pharma, S.A. | Antibodies and diagnostics |
WO2008063933A2 (en) | 2006-11-10 | 2008-05-29 | Massachusetts Institute Of Technology | Pak modulators |
EP2082049A1 (en) | 2006-11-16 | 2009-07-29 | BASF Plant Science GmbH | Plants having enhanced yield-related traits and a method for making the same using consensus sequences from the yabby protein family |
CA2664987A1 (en) | 2006-11-24 | 2008-05-29 | Cropdesign N.V. | Transgenic plants comprising as transgene a class i tcp or clavata 1 (clv1) or cah3 polypeptide having increased seed yield and a method for making the same |
ATE533838T1 (de) | 2006-11-29 | 2011-12-15 | Novozymes Inc | Verfahren zur verbesserten einführung von dna in bakterienzellen |
EP2210898A1 (en) | 2006-11-29 | 2010-07-28 | Novozymes Inc. | Bacillus Licheniformis chromosome |
ES2553331T3 (es) | 2006-12-07 | 2015-12-07 | Dow Agrosciences Llc | Nuevos genes marcadores seleccionables |
US9862956B2 (en) | 2006-12-10 | 2018-01-09 | Danisco Us Inc. | Expression and high-throughput screening of complex expressed DNA libraries in filamentous fungi |
WO2008073914A2 (en) | 2006-12-10 | 2008-06-19 | Dyadic International Inc. | Expression and high-throughput screening of complex expressed dna libraries in filamentous fungi |
US20100024067A1 (en) | 2006-12-15 | 2010-01-28 | Cropdesign N.V. | Plants having enhanced seed yield-related traits and a method for making the same |
CA2672773C (en) | 2006-12-20 | 2015-11-24 | Alellyx S.A. | Nucleic acid molecules encoding plant proteins in the c3hc4 family and methods for the alteration of plant cellulose and lignin content |
BRPI0720468A2 (pt) | 2006-12-20 | 2014-01-14 | Alellyx Sa | Construtos de ácido nucleico e métodos para alterar o comprimento da fibra da planta e/ou a altura da planta |
EP2395091A3 (en) | 2006-12-21 | 2012-08-01 | BASF Plant Science GmbH | Plants having enhanced yield-related traits and a method for making the same |
EP2479266B1 (en) | 2006-12-21 | 2016-03-09 | BASF Enzymes LLC | Amylases and glucoamylases, nucleic acids encoding them and methods for making and using them |
BRPI0720734A2 (pt) * | 2006-12-29 | 2014-01-07 | Gloucester Pharmaceuticals Inc | Preparação da romidepsina |
CN107090482A (zh) * | 2006-12-29 | 2017-08-25 | 细胞基因公司 | 制备Romidepsin |
DE102007003143A1 (de) | 2007-01-16 | 2008-07-17 | Henkel Kgaa | Neue Alkalische Protease aus Bacillus gibsonii und Wasch- und Reinigungsmittel enthaltend diese neue Alkalische Protease |
NZ598285A (en) | 2007-01-30 | 2013-10-25 | Syngenta Participations Ag | Enzymes for the treatment of lignocellulosics, nucleic acids encoding them and methods for making and using them |
EP2548963A1 (en) | 2007-01-30 | 2013-01-23 | CropDesign N.V. | Plants having enhanced yield-related traits and a method for making the same |
EP2275560A3 (en) | 2007-01-31 | 2012-01-25 | BASF Plant Science GmbH | Trangenic plants wherein the transgene is a memeber of the REMORIN gene family or a consensus sequence thereof having enhanced yield-related traits and a method for making the same |
WO2008121435A2 (en) * | 2007-02-02 | 2008-10-09 | The California Institute Of Technology | Methods for generating novel stabilized proteins |
US8143046B2 (en) | 2007-02-07 | 2012-03-27 | Danisco Us Inc., Genencor Division | Variant Buttiauxella sp. phytases having altered properties |
US20080268517A1 (en) * | 2007-02-08 | 2008-10-30 | The California Institute Of Technology | Stable, functional chimeric cytochrome p450 holoenzymes |
WO2008103248A1 (en) | 2007-02-08 | 2008-08-28 | Codexis, Inc. | Ketoreductases and uses thereof |
EP2118281A2 (en) | 2007-02-12 | 2009-11-18 | Codexis, Inc. | Structure-activity relationships |
CA2675926A1 (en) | 2007-02-16 | 2008-08-21 | Basf Plant Science Gmbh | Nucleic acid sequences for regulation of embryo-specific expression in monocotyledonous plants |
ES2574981T3 (es) | 2007-02-28 | 2016-06-23 | Cropdesign N.V. | Plantas que tienen rasgos potenciados relacionados con el rendimiento y procedimiento de producción de las mismas |
WO2008116878A1 (en) | 2007-03-26 | 2008-10-02 | Novozymes A/S | Hafnia phytase |
WO2008118445A1 (en) * | 2007-03-26 | 2008-10-02 | Promega Corporation | Methods to quench light from optical reactions |
DE102007016139A1 (de) | 2007-03-30 | 2008-10-02 | Jenabios Gmbh | Verfahren zur regioselektiven Oxygenierung von N-Heterozyklen |
JP5456658B2 (ja) | 2007-03-30 | 2014-04-02 | メディミューン,エルエルシー | 抗体製剤 |
CA2682897C (en) * | 2007-04-03 | 2016-11-22 | Biogenerix Ag | Methods of treatment using glycopegylated g-csf |
WO2009031031A2 (en) | 2007-04-04 | 2009-03-12 | Basf Se | Herbicide-resistant brassica plants and methods of use |
EP2132292B1 (en) | 2007-04-09 | 2014-10-08 | Novozymes A/S | An enzymatic treatment of skin and hide degreasing |
BRPI0810703A2 (pt) | 2007-05-03 | 2012-12-25 | Basf Plant Science Gmbh | mÉtodo para intensificar traÇos relacionados com rendimento em plantas com relaÇço Ás plantas de controle, molÉcula de Ácido nucleico isolada, polipeptÍdeo isolado, mÉtodo para a produÇço de uma planta transgÊnica, planta ou parte da mesma, construÇço, e, uso de um polipeptÍdeo ou de um Ácido nucleico |
EP2164868B1 (en) | 2007-05-04 | 2015-03-25 | Technophage, Investigação E Desenvolvimento Em Biotecnologia, SA | Engineered rabbit antibody variable domains and uses thereof |
EP2068925A4 (en) | 2007-05-07 | 2011-08-31 | Medimmune Llc | ANTI-ICOS ANTIBODIES AND THEIR USE FOR THE TREATMENT OF CANCER, TRANSPLANTATIONS AND AUTOIMMUNE DISEASES |
EP2155910A4 (en) * | 2007-05-08 | 2010-06-02 | Univ Duke | COMPOSITIONS AND METHODS FOR CHARACTERIZING AND REGULATING AN OLFACTORY SENSATION |
MX2009012120A (es) | 2007-05-09 | 2010-02-12 | Dow Agrosciences Llc | Genes novedosos con resistencia a herbicidas. |
WO2008141190A1 (en) * | 2007-05-11 | 2008-11-20 | Wisconsin Alumni Research Foundation | Heterologous production of capreomycin and generation of new capreomycin derivatives through metabolic engineering |
ES2558689T3 (es) | 2007-05-14 | 2016-02-08 | Medimmune, Llc | Métodos para reducir los niveles de eosinófilos |
EP2069508A2 (en) | 2007-05-23 | 2009-06-17 | Cropdesign N.V. | Plants having enhanced yield-related traits and a method for making the same |
CN105925586B (zh) | 2007-05-25 | 2020-09-01 | 22世纪有限责任公司 | 编码调节生物碱合成之转录因子的核酸序列及其在改良植物代谢中的应用 |
WO2008145629A2 (en) | 2007-05-25 | 2008-12-04 | Cropdesign N.V. | Yield enhancement in plants by modulation of maize alfins |
CN101778937A (zh) * | 2007-06-04 | 2010-07-14 | 诺和诺德公司 | 使用n-乙酰葡糖胺转移酶的o-联糖基化 |
MX2009013259A (es) | 2007-06-12 | 2010-01-25 | Novo Nordisk As | Proceso mejorado para la produccion de azucares de nucleotidos. |
US7625555B2 (en) | 2007-06-18 | 2009-12-01 | Novagen Holding Corporation | Recombinant human interferon-like proteins |
CN107226864A (zh) | 2007-06-21 | 2017-10-03 | 宏观基因有限公司 | 共价双抗体及其用途 |
US7968811B2 (en) * | 2007-06-29 | 2011-06-28 | Harley-Davidson Motor Company Group, Inc. | Integrated ignition and key switch |
DE112008001730T5 (de) | 2007-06-29 | 2010-06-02 | Basf Plant Science Gmbh | Pflanzen mit verbesserten Ertragsmerkmalen und Verfahren zu ihrer Herstellung |
EP2676678A1 (en) | 2007-07-17 | 2013-12-25 | The General Hospital Corporation | Methods to identify and enrich populations of ovarian cancer stem cells and somatic stem cells and uses thereof |
DE112008001879T5 (de) | 2007-07-20 | 2010-07-29 | Basf Plant Science Gmbh | Pflanzen mit verbesserten Ertragsmerkmalen und Verfahren zu irer Herstellung |
AU2008281698B2 (en) | 2007-07-31 | 2014-02-20 | Basf Plant Science Gmbh | Plants having enhanced yield-related traits and a method for making the same |
AR067748A1 (es) | 2007-07-31 | 2009-10-21 | Basf Plant Science Gmbh | Plantas que tienen rasgos mejorados relacionados con el rendimiento y un metodo para obtenerlas |
US7923236B2 (en) | 2007-08-02 | 2011-04-12 | Dyadic International (Usa), Inc. | Fungal enzymes |
WO2009021215A1 (en) * | 2007-08-09 | 2009-02-12 | Celula, Inc. | Methods and devices for correlated, multi-parameter single cell measurements and recovery of remnant biological material |
CN101784669B (zh) | 2007-08-24 | 2015-02-18 | 科德克希思公司 | 用于(r)-3-羟基四氢噻吩的立体选择性制备的改善的酮还原酶多肽 |
US8207112B2 (en) * | 2007-08-29 | 2012-06-26 | Biogenerix Ag | Liquid formulation of G-CSF conjugate |
EP2197893B1 (en) | 2007-09-07 | 2013-07-24 | Dyadic International, Inc. | Novel fungal enzymes |
US7579155B2 (en) * | 2007-09-12 | 2009-08-25 | Transgenomic, Inc. | Method for identifying the sequence of one or more variant nucleotides in a nucleic acid molecule |
US7749708B2 (en) * | 2007-09-12 | 2010-07-06 | Transgenomic, Inc. | Method for identifying the sequence of one or more variant nucleotides in a nucleic acid molecule |
RU2503721C2 (ru) | 2007-09-14 | 2014-01-10 | Басф Плант Сайенс Гмбх | Растения, имеющие усиленные признаки, связанные с урожайностью, и способ их получения |
EP3753947A1 (en) | 2007-09-14 | 2020-12-23 | Adimab, LLC | Rationally designed, synthetic antibody libraries and uses therefor |
US8877688B2 (en) | 2007-09-14 | 2014-11-04 | Adimab, Llc | Rationally designed, synthetic antibody libraries and uses therefor |
CL2008002775A1 (es) | 2007-09-17 | 2008-11-07 | Amgen Inc | Uso de un agente de unión a esclerostina para inhibir la resorción ósea. |
WO2009037253A2 (en) | 2007-09-18 | 2009-03-26 | Novozymes A/S | Polypeptides having tyrosinase activity and polynucleotides encoding same |
EP2193203B1 (en) | 2007-09-21 | 2012-07-25 | BASF Plant Science GmbH | Plants having increased yield-related traits and a method for making the same |
EP2205744B1 (en) | 2007-10-03 | 2015-01-14 | BP Corporation North America Inc. | Xylanases, nucleic acids encoding them and methods for making and using them |
WO2009048909A1 (en) * | 2007-10-08 | 2009-04-16 | Quintessence Biosciences, Inc. | Compositions and methods for ribonuclease-based therapies |
US20090126044A1 (en) | 2007-10-10 | 2009-05-14 | Athenix Corporation | Synthetic genes encoding cry1ac |
US20090144852A1 (en) | 2007-10-16 | 2009-06-04 | Athenix Corporation | Axmi-066 and axmi-076: delta-endotoxin proteins and methods for their use |
DE102007051092A1 (de) | 2007-10-24 | 2009-04-30 | Henkel Ag & Co. Kgaa | Subtilisin aus Becillus pumilus und Wasch- und Reinigungsmittel enthaltend dieses neue Subtilisin |
DE112008002848T5 (de) | 2007-10-29 | 2010-11-25 | Basf Plant Science Gmbh | Pflanzen mit verbesserten Ertragsmerkmalen und Verfahren zu ihrer Herstellung |
US7618801B2 (en) * | 2007-10-30 | 2009-11-17 | Danison US Inc. | Streptomyces protease |
US7871802B2 (en) * | 2007-10-31 | 2011-01-18 | E.I. Du Pont De Nemours And Company | Process for enzymatically converting glycolonitrile to glycolic acid |
US7741088B2 (en) * | 2007-10-31 | 2010-06-22 | E.I. Dupont De Nemours And Company | Immobilized microbial nitrilase for production of glycolic acid |
AR069168A1 (es) | 2007-11-05 | 2010-01-06 | Danisco Us Inc Genencor Div | Variantes de alfa -amilasas con propiedades alteradas |
KR20100088675A (ko) | 2007-11-05 | 2010-08-10 | 다니스코 유에스 인크. | 변경된 특성을 지닌 바실러스 종 ts-23 알파-아밀라아제의 변이체 |
BRPI0819286A2 (pt) | 2007-11-22 | 2014-10-07 | Cropdesign Nv | Métodos para aumentar características relacionadas a rendimento em plantas em relação a plantas de controle e para a produção de plantas transgênicas, plantas, partes destas (incluindo sementes), ou células vegetais, construção, uso de uma construção, planta transgênica, partes aptas à colheita, produtos, e, uso de uma seqüência de ácidos nucléicos codificando um polipeptídeo amt. |
MX2010005697A (es) | 2007-11-26 | 2010-06-11 | Basf Plant Science Gmbh | Plantas que tienen rasgos mejorados relacionados con el rendimiento y un metodo para obtenerlas. |
BRPI0820552A2 (pt) | 2007-11-27 | 2014-10-14 | Novozymes As | Polipetídeo isolado, polinucleotídeo isolado, construção de ácido nucléico, vetor de expressão recombinante, célula hospedeira recombinante, métodos para produzir o polipeptídeo, para produzir uma proteína, e para degradar ou converter um material de biomassa, planta, parte vegetal ou célula vegetal transgêncica, método, composição, e. uso do polipeptídio. |
EP2222868A1 (en) | 2007-11-29 | 2010-09-01 | Novozymes A/S | Synthase inhibitor screening method |
EP2615115A3 (en) | 2007-11-30 | 2014-01-08 | Glaxo Group Limited | Antigen-binding constructs |
DK2224822T3 (da) | 2007-12-06 | 2014-08-25 | Novozymes As | Polypeptider med acetylxylanesterase-aktivitet og polynukleotider, der koder for disse |
WO2009076196A1 (en) * | 2007-12-07 | 2009-06-18 | Dow Global Technologies Inc. | High copy number self-replicating plasmids in pseudomonas |
EP2227256A1 (en) * | 2007-12-14 | 2010-09-15 | Amgen Inc. | Method for treating bone fracture with anti-sclerostin antibodies |
JP2011507525A (ja) | 2007-12-19 | 2011-03-10 | ノボザイムス アクティーゼルスカブ | セルロース分解増強活性を有するポリペプチドとこれをコードするポリヌクレオチド |
DE112008003316T5 (de) | 2007-12-20 | 2011-05-05 | Basf Plant Science Gmbh | Pflanzen mit gesteigerten ertragsbezogenen Eigenschaften und Verfahren zur Herstellung derselben |
US9228211B2 (en) | 2007-12-21 | 2016-01-05 | Dupont Nutrition Biosciences Aps | Process of water degumming an edible oil |
CA2710922A1 (en) | 2008-01-03 | 2009-07-16 | Verenium Corporation | Isomerases, nucleic acids encoding them and methods for making and using them |
JP5563990B2 (ja) | 2008-01-03 | 2014-07-30 | ヴェレニウム コーポレイション | トランスフェラーゼおよびオキシドレダクターゼ、それらをコードする核酸並びにそれらを製造および使用する方法 |
US20100286067A1 (en) * | 2008-01-08 | 2010-11-11 | Biogenerix Ag | Glycoconjugation of polypeptides using oligosaccharyltransferases |
KR20100107501A (ko) | 2008-01-18 | 2010-10-05 | 메디뮨 엘엘씨 | 부위 특이적 접합을 위한 시스테인 조작 항체 |
CN101965405B (zh) | 2008-01-25 | 2014-03-05 | 巴斯夫植物科学有限公司 | 具有增强的产量相关性状的植物和用于制备该植物的方法 |
CN101978064A (zh) | 2008-01-31 | 2011-02-16 | 北京生命科学研究所 | 具有改变的生长和/或发育的植物及其生产方法 |
CA2713582C (en) | 2008-02-04 | 2017-02-21 | Danisco Us Inc. | Ts23 alpha-amylase variants with altered properties |
US20100049602A1 (en) * | 2008-02-07 | 2010-02-25 | Softky William R | Systems and Methods for Measuring the Effectiveness of Advertising |
BR122020023189B1 (pt) | 2008-02-08 | 2022-02-01 | Astrazeneca Ab | Uso de uma composição farmacêutica compreendendo um anticorpo específico para ifnar1 |
EP2088432A1 (en) * | 2008-02-11 | 2009-08-12 | MorphoSys AG | Methods for identification of an antibody or a target |
DK2250595T3 (en) | 2008-02-12 | 2017-09-04 | Codexis Inc | PROCEDURE FOR SELECTING AN OPTIMIZED VARIETY OF VARIETIES |
US8768871B2 (en) * | 2008-02-12 | 2014-07-01 | Codexis, Inc. | Method of generating an optimized, diverse population of variants |
US20090203531A1 (en) | 2008-02-12 | 2009-08-13 | Nurith Kurn | Method for Archiving and Clonal Expansion |
PL2257311T3 (pl) | 2008-02-27 | 2014-09-30 | Novo Nordisk As | Koniugaty cząsteczek czynnika VIII |
GB2470672B (en) | 2008-03-21 | 2012-09-12 | Nugen Technologies Inc | Methods of RNA amplification in the presence of DNA |
US20110020368A1 (en) | 2008-03-25 | 2011-01-27 | Nancy Hynes | Treating cancer by down-regulating frizzled-4 and/or frizzled-1 |
US20110020830A1 (en) * | 2008-03-31 | 2011-01-27 | Schneider Jane C | Design for rapidly cloning one or more polypeptide chains into an expression system |
AR073534A1 (es) | 2008-04-16 | 2010-11-17 | Basf Plant Science Gmbh | Plantas que tienen rasgos aumentados relacionados con el rendimiento y un metodo para obtenerlas |
CN102083996A (zh) | 2008-04-30 | 2011-06-01 | 丹尼斯科公司 | 氧化方法 |
EP2383292A1 (en) | 2008-05-02 | 2011-11-02 | Novartis AG | Improved fibronectin-based binding molecules and uses thereof |
JP2011521626A (ja) | 2008-05-02 | 2011-07-28 | エピセンター テクノロジーズ コーポレーション | Rnaポリホスファターゼの組成物、キットおよびそれらの使用 |
BRPI0912244A2 (pt) | 2008-05-05 | 2016-10-11 | Basf Plant Science Gmbh | método para intensificar as características relacionadas com o rendimento em plantas em relação às plantas de controle, constructo, uso do mesmo, planta, parte de planta ou célula de planta, método para a produção de uma planta transgênica, planta transgênica, partes colhíveis de uma planta, produtos, e, uso de um ácido nucleico. |
SI2283034T1 (sl) | 2008-05-08 | 2015-07-31 | Monsanto Do Brasil Ltda. | Geni in postopki za povečanje bolezenske odpornosti pri rastlinah |
EP2116618A1 (en) | 2008-05-09 | 2009-11-11 | Agency for Science, Technology And Research | Diagnosis and treatment of Kawasaki disease |
EP2297310A2 (en) | 2008-05-23 | 2011-03-23 | E. I. du Pont de Nemours and Company | Novel dgat genes for increased seed storage lipid production and altered fatty acid profiles in oilseed plants |
KR101752499B1 (ko) | 2008-06-04 | 2017-06-29 | 모디퀘스트 비.브이. | 소염제 |
JP5492879B2 (ja) | 2008-06-06 | 2014-05-14 | ダニスコ・ユーエス・インク | 改善された性質を有するゲオバチルスステアロセレモフィリス(Geobacillusstearothermophilus)アルファアミラーゼ(AmyS)変異体 |
RU2545721C2 (ru) | 2008-06-06 | 2015-04-10 | Новозимс А/С | Варианты семейства, состоящего из 44 ксилоглюканаз |
EP2300588B1 (en) | 2008-06-06 | 2019-02-06 | The Procter and Gamble Company | Detergent composition comprising a variant of a family 44 xyloglucanase |
US8383346B2 (en) | 2008-06-13 | 2013-02-26 | Codexis, Inc. | Combined automated parallel synthesis of polynucleotide variants |
US20090312196A1 (en) | 2008-06-13 | 2009-12-17 | Codexis, Inc. | Method of synthesizing polynucleotide variants |
ES2705694T3 (es) | 2008-06-13 | 2019-03-26 | Codexis Inc | Método de síntesis de variantes de polinucleótidos |
DE112009001459T5 (de) | 2008-06-20 | 2011-09-29 | Basf Plant Science Gmbh | Pflanzen mit gesteigerten ertragsbezogenen Eigenschaften und Verfahren zur Herstellung derselben |
AU2009271325A1 (en) | 2008-06-24 | 2010-01-21 | Merck Sharp & Dohme Corp. | Biocatalytic processes for the preparation of substantially stereomerically pure fused bicyclic proline compounds |
MX351227B (es) | 2008-06-25 | 2017-09-14 | Athenix Corp | Genes de toxinas y métodos para su uso. |
BRPI0914689A2 (pt) | 2008-06-26 | 2016-08-09 | Basf Plant Science Gmbh | métodos para intensificar as características relacionadas com o rendimento em plantas em relação às plantas de controle, e para a produção de uma planta transgênica, construto, uso de um construto, uso de um ácido nucleico, planta, parte da planta ou célula de planta, partes colhíveis de uma planta, e, produtos |
MX357562B (es) | 2008-07-02 | 2018-07-13 | Athenix Corp | Axmi-115, axmi-113, axmi-005, axmi-163 y axmi-184: proteinas insecticidas vip3a de bacillus thuringiensis y metodos para su uso. |
WO2010000794A1 (en) | 2008-07-04 | 2010-01-07 | Basf Plant Science Gmbh | Plants having enhanced yield-related traits and a method for making the same by overexpressing a polynucleotide encoding a tfl1-like protein |
DE112009001667T5 (de) | 2008-07-17 | 2011-09-29 | Basf Plant Science Gmbh | Pflanzen mit gesteigerten ertragsbezogenen Eigenschaften und Verfahren zur Herstellung derselben |
JP2011528333A (ja) | 2008-07-18 | 2011-11-17 | ノボザイムス アデニウム バイオテック アクティーゼルスカブ | 哺乳動物のベータ・ディフェンシンを用いた、炎症性腸疾患の治療 |
DK2321352T3 (en) | 2008-07-18 | 2016-04-04 | Bristol Myers Squibb Co | Monovalent compositions for CD28 binding, and methods for their use |
US20100034897A1 (en) * | 2008-07-22 | 2010-02-11 | Northwestern University | Method for Removal or Inactivation of Heparin |
EP2669379A3 (en) | 2008-07-31 | 2014-03-19 | BASF Plant Science GmbH | Plants having modified growth characteristics and a method for making the same |
DK2328616T3 (en) | 2008-08-05 | 2015-07-20 | Novartis Ag | Compositions and Methods for Antibodies to Complement Protein C5 |
CN102186877A (zh) | 2008-08-20 | 2011-09-14 | 巴斯夫植物科学有限公司 | 具有增强的产量相关性状的植物和用于产生该植物的方法 |
WO2010025287A2 (en) | 2008-08-27 | 2010-03-04 | Codexis, Inc. | Ketoreductase polypeptides for the production of 3-aryl-3-hydroxypropanamine from a 3-aryl-3-ketopropanamine |
WO2010027710A2 (en) | 2008-08-27 | 2010-03-11 | Codexis, Inc. | Ketoreductase polypeptides and uses thereof |
SI2329013T1 (sl) | 2008-08-27 | 2016-03-31 | Codexis, Inc. | Polipeptidi ketoreduktaze za proizvodnjo 3-aril-3-hidroksipropanamina iz 3-aril-3-ketopropanamina |
US8153391B2 (en) | 2008-08-29 | 2012-04-10 | Bunge Oils, Inc. | Hydrolases, nucleic acids encoding them and methods for making and using them |
US8198062B2 (en) | 2008-08-29 | 2012-06-12 | Dsm Ip Assets B.V. | Hydrolases, nucleic acids encoding them and methods for making and using them |
SI2329014T1 (sl) | 2008-08-29 | 2015-01-30 | Codexis, Inc. | Polipeptidi ketoreduktaze za stereoselektivno produkcijo (4s)-3(5s)-5(4-fluorofenil)-5-hidroksipentanoil)-4-fenil-1,3-oksazolidin -2-ona |
US8357503B2 (en) | 2008-08-29 | 2013-01-22 | Bunge Oils, Inc. | Hydrolases, nucleic acids encoding them and methods for making and using them |
US20100093563A1 (en) * | 2008-09-22 | 2010-04-15 | Robert Anthony Williamson | Methods and vectors for display of molecules and displayed molecules and collections |
WO2010033237A2 (en) * | 2008-09-22 | 2010-03-25 | Calmune Corporation | Methods for creating diversity in libraries and libraries, display vectors and methods, and displayed molecules |
MX2011002675A (es) | 2008-09-24 | 2011-04-21 | Basf Plant Science Gmbh | Plantas que tienen rasgos mejorados relacionados con el rendimiento y un metodo para obtenerlas. |
BRPI0920891B1 (pt) | 2008-09-25 | 2023-01-10 | Danisco Us Inc | Mistura de alfa-amilase e método para produção de um açúcar fermentável |
EP2346995B1 (en) | 2008-09-26 | 2018-11-07 | Tocagen Inc. | Gene therapy vectors and cytosine deaminases |
ES2426717T3 (es) | 2008-09-26 | 2013-10-24 | Novozymes A/S | Variantes de fitasa de Hafnia |
AP2011005671A0 (en) | 2008-09-26 | 2011-04-30 | Basf Agrochemical Products Bv | Herbicide-resistant AHAS-mutants and methods of use. |
JP2012504423A (ja) | 2008-10-01 | 2012-02-23 | クインテッセンス バイオサイエンシズ,インコーポレーテッド | 治療用リボヌクレアーゼ |
WO2010039953A1 (en) * | 2008-10-03 | 2010-04-08 | E.I. Dupont De Nemours And Company | Multi-component peracid generation system |
US9267952B2 (en) * | 2008-11-05 | 2016-02-23 | Morphosys Ag | Deconvolution method |
EP2356146A1 (en) | 2008-11-07 | 2011-08-17 | Fabrus Llc | Anti-dll4 antibodies and uses thereof |
CA2741973A1 (en) | 2008-11-12 | 2010-05-20 | Basf Plant Science Gmbh | Plants having enhanced abiotic stress tolerance and/or enhanced yield-related traits and a method for making the same |
JP5933975B2 (ja) | 2008-11-12 | 2016-06-15 | メディミューン,エルエルシー | 抗体製剤 |
EP2358878B1 (en) | 2008-11-20 | 2014-10-15 | Novozymes Inc. | Polypeptides having amylolytic enhancing activity and polynucleotides encoding same |
EP2960335A1 (en) | 2008-12-03 | 2015-12-30 | BASF Plant Science GmbH | Plants having enhanced abiotic stress tolerance and/or enhanced yield-related traits and a method for making the same |
US8431775B2 (en) | 2008-12-04 | 2013-04-30 | Pioneer Hi Bred International Inc | Methods and compositions for enhanced yield by targeted expression of knotted1 |
US7771983B2 (en) | 2008-12-04 | 2010-08-10 | Novozymos, Inc. | Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
EP2376527A1 (en) | 2008-12-12 | 2011-10-19 | Novozymes Inc. | Polypeptides having lipase activity and polynucleotides encoding same |
WO2010068800A1 (en) | 2008-12-12 | 2010-06-17 | Novozymes, Inc. | Polypeptides having aspartic endopeptidase activity and polynucleotides encoding same |
AR074672A1 (es) | 2008-12-15 | 2011-02-02 | Athenix Corp | Genes que codifican toxinas contra nematodos |
WO2010074972A1 (en) | 2008-12-15 | 2010-07-01 | Novozymes, Inc. | Polypeptides having catalase activity and polynucleotides encoding same |
EP2379716A1 (en) | 2008-12-16 | 2011-10-26 | Novozymes Inc. | Polypeptides having alpha-mannosidase activity and polynucleotides encoding same |
WO2010074955A1 (en) | 2008-12-16 | 2010-07-01 | Novozymes, Inc. | Polypeptides having carboxypeptidase activity and polynucleotides encoding same |
WO2010069847A1 (en) | 2008-12-17 | 2010-06-24 | Basf Plant Science Gmbh | Plants having enhanced yield-related traits and/or abiotic stress tolerance and a method for making the same |
AU2009335798B2 (en) | 2008-12-19 | 2014-11-27 | Macrogenics, Inc. | Covalent diabodies and uses thereof |
EP2379729A2 (en) | 2008-12-19 | 2011-10-26 | Novozymes A/S | Use of enzymes having silicase activity |
BRPI0922431A2 (pt) | 2008-12-22 | 2015-08-04 | Athenix Corp | Genes pesticidas de brevibacillus e métodos para sua utilização |
ES2534581T3 (es) | 2008-12-23 | 2015-04-24 | Athenix Corporation | Gen AXMI-150 de la delta-endotoxina y métodos para su uso |
EP2382308B1 (en) | 2008-12-25 | 2015-03-04 | Codexis, Inc. | Enone reductases |
WO2010081053A2 (en) | 2009-01-08 | 2010-07-15 | Codexis, Inc. | Transaminase polypeptides |
US20110239315A1 (en) | 2009-01-12 | 2011-09-29 | Ulla Bonas | Modular dna-binding domains and methods of use |
EP2206723A1 (en) | 2009-01-12 | 2010-07-14 | Bonas, Ulla | Modular DNA-binding domains |
WO2010084488A1 (en) | 2009-01-20 | 2010-07-29 | Ramot At Tel-Aviv University Ltd. | Mir-21 promoter driven targeted cancer therapy |
CN102361973B (zh) | 2009-01-21 | 2015-09-02 | 诺维信公司 | 具有酯酶活性的多肽和编码该多肽的核酸 |
CN104232679A (zh) | 2009-01-28 | 2014-12-24 | 巴斯夫植物科学有限公司 | 具有增强的产量相关性状的植物及其制备方法 |
CN102388134A (zh) | 2009-01-28 | 2012-03-21 | 诺维信股份有限公司 | 具有β-葡糖苷酶活性的多肽和编码该多肽的多核苷酸 |
WO2010088463A2 (en) | 2009-01-30 | 2010-08-05 | Novozymes, Inc. | Polypeptides having expansin activity and polynucleotides encoding same |
WO2010088447A1 (en) | 2009-01-30 | 2010-08-05 | Novozymes A/S | Polypeptides having alpha-amylase activity and polynucleotides encoding same |
WO2010087927A2 (en) | 2009-02-02 | 2010-08-05 | Medimmune, Llc | Antibodies against and methods for producing vaccines for respiratory syncytial virus |
WO2010091230A1 (en) | 2009-02-05 | 2010-08-12 | Athenix Corporation | Variant axmi-r1 delta-endotoxin genes and methods for their use |
WO2010091221A1 (en) | 2009-02-06 | 2010-08-12 | Novozymes A/S | Polypeptides having alpha-amylase activity and polynucleotides encoding same |
EP2393925B1 (en) | 2009-02-06 | 2014-10-08 | University of Chile | Protein and DNA sequence encoding a cold adapted xylanase |
SG2014012918A (en) | 2009-02-11 | 2014-04-28 | Novozymes Biopharma Dk As | Albumin variants and conjugates |
CN102325876A (zh) | 2009-02-19 | 2012-01-18 | 诺维信公司 | 酿造方法 |
MY189620A (en) * | 2009-02-20 | 2022-02-21 | Malaysian Palm Oil Board | A constitutive promoter from oil palm |
US20110305693A1 (en) | 2009-02-24 | 2011-12-15 | Glaxo Group Limited | Anitigen-binding constructs |
EP2401298A1 (en) | 2009-02-24 | 2012-01-04 | Glaxo Group Limited | Antigen-binding constructs |
US20110305694A1 (en) | 2009-02-24 | 2011-12-15 | Paul Andrew Hamblin | Multivalent and/or multispecific rankl-binding constructs |
US9260490B2 (en) | 2009-02-25 | 2016-02-16 | Basf Plant Science Company Gmbh | Plants having enhanced yield-related traits and a method for making the same |
CA2752818A1 (en) | 2009-02-26 | 2010-09-02 | Codexis, Inc. | Beta-glucosidase variant enzymes and related polynucleotides |
BRPI1008740A8 (pt) | 2009-02-27 | 2022-07-05 | Athenix Corp | Proteínas pesticidas e métodos para seu uso. |
EP2401371A1 (en) | 2009-02-27 | 2012-01-04 | Novozymes A/S | Mutant cells having reduced expression of metallopeptidase, suitable for recombinant polypeptide production |
BRPI1013362A2 (pt) | 2009-03-06 | 2015-09-01 | Athenix Corp | Métodos e composições para controle de pestes de planta. |
EP2405920A1 (en) | 2009-03-06 | 2012-01-18 | Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research | Novel therapy for anxiety |
WO2010141141A2 (en) | 2009-03-11 | 2010-12-09 | Athenix Corporation | Axmi-001, axmi-002, axmi-030, axmi-035, and axmi-045: toxin genes and methods for their use |
EP2408908B1 (en) | 2009-03-17 | 2015-05-27 | Codexis, Inc. | Variant endoglucanases and related polynucleotides |
EP2408314A1 (en) | 2009-03-17 | 2012-01-25 | Novozymes A/S | Polypeptides having tyrosinase activity and polynucleotides encoding same |
CN102365360A (zh) | 2009-03-24 | 2012-02-29 | 诺维信公司 | 具有乙酰木聚糖酯酶活性的多肽和编码该多肽的多核苷酸 |
WO2010111674A2 (en) | 2009-03-27 | 2010-09-30 | Life Technologies Corporation | Methods and apparatus for single molecule sequencing using energy transfer detection |
US20120093775A1 (en) | 2009-03-27 | 2012-04-19 | Proyecto De Biomedicina Cima, S.L. | Methods and compositions for the treatment of cirrhosis and liver fibrosis |
BRPI1010239A2 (pt) | 2009-03-31 | 2016-10-11 | Codexis Inc | endoglucanases aprimoradas, derivados e seus usos |
MX2011010041A (es) | 2009-04-01 | 2011-11-18 | Danisco Us Inc | Composiciones y metodos que comprenden variantes de alfa-amilasa con propiedades alteradas. |
EP2241323A1 (en) | 2009-04-14 | 2010-10-20 | Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research | Tenascin-W and brain cancers |
GB0908770D0 (en) | 2009-04-24 | 2009-07-01 | Danisco | Method |
DE112010001805T5 (de) | 2009-04-29 | 2012-09-06 | Basf Plant Science Company Gmbh | Pflanzen mit gesteigerten Ertragsmerkmalen und Verfahren zu deren Herstellung |
KR20150046788A (ko) | 2009-04-29 | 2015-04-30 | 바스프 플랜트 사이언스 게엠베하 | 향상된 수확량 관련 형질을 갖는 식물 및 이의 제조 방법 |
US8779239B2 (en) | 2009-05-04 | 2014-07-15 | Pioneeri Hi-Bred International, Inc. | Yield enhancement in plants by modulation of AP2 transcription factor |
CN102803291B (zh) | 2009-05-06 | 2015-11-25 | 巴斯夫植物科学有限公司 | 具有增强的产量相关性状和/或增强的非生物胁迫耐受性的植物和制备其的方法 |
EP2248893A1 (en) | 2009-05-06 | 2010-11-10 | Novozymes A/S | DFPase Enzymes from Octopus Vulgaris |
MY186558A (en) * | 2009-05-13 | 2021-07-27 | Malaysian Palm Oil Board | A constitutive promoter from oil palm type 2 |
US20120058222A1 (en) | 2009-05-19 | 2012-03-08 | Danisco A/S | Use |
US9695403B2 (en) | 2009-05-21 | 2017-07-04 | Syngenta Participations Ag | Phytases, nucleic acids encoding them and methods for making and using them |
US8895527B2 (en) | 2009-05-22 | 2014-11-25 | Curna, Inc. | Treatment of transcription factor E3 (TFE3) and insulin receptor substrate 2(IRS2) related diseases by inhibition of natural antisense transcript to TFE3 |
US9989533B2 (en) | 2009-05-28 | 2018-06-05 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Anti-TNF induced apoptosis (ATIA) diagnostic markers and therapies |
RU2569187C2 (ru) | 2009-05-29 | 2015-11-20 | МорфоСис АГ | Коллекция и способы ее применения |
WO2010138754A1 (en) | 2009-05-29 | 2010-12-02 | Novozymes, Inc. | Methods for enhancing the degradation or conversion of cellulosic material |
DK2438163T3 (en) | 2009-06-02 | 2015-04-20 | Novozymes Inc | Polypeptides having cellobiohydrolase activity and polynucleotides encoding them |
MX2011013224A (es) | 2009-06-09 | 2012-06-01 | Pioneer Hi Bred Int | Promotor de endospermo temprano y metodos de uso. |
AR077042A1 (es) | 2009-06-12 | 2011-07-27 | Danisco | Metodo para tratar una composicion que contiene pirofiofitina |
US20100317539A1 (en) * | 2009-06-12 | 2010-12-16 | Guo-Liang Yu | Library of Engineered-Antibody Producing Cells |
EP2443139B1 (en) | 2009-06-16 | 2016-08-10 | Codexis, Inc. | Beta-glucosidase variant enzymes and related polynucleotides |
EP2443240A2 (en) | 2009-06-19 | 2012-04-25 | BASF Plant Science Company GmbH | Plants having enhanced yield-related traits and a method for making the same |
CN102802661B (zh) | 2009-06-22 | 2016-01-13 | 米迪缪尼有限公司 | 用于位点特异性偶联的工程改造的Fc区 |
WO2011005527A2 (en) | 2009-06-22 | 2011-01-13 | Codexis, Inc. | Ketoreductase-mediated stereoselective route to alpha chloroalcohols |
CN102712919B (zh) | 2009-06-26 | 2017-06-23 | 诺维信北美公司 | 热稳定性碳酸酐酶及其用途 |
US8575425B2 (en) | 2009-07-02 | 2013-11-05 | Athenix Corporation | AXMI-205 pesticidal gene and methods for its use |
WO2011000924A1 (en) | 2009-07-03 | 2011-01-06 | Abbott Products Gmbh | Spray-dried amylase, pharmaceutical preparations comprising the same and use |
US20120288914A1 (en) | 2009-07-07 | 2012-11-15 | Pioneer Hi Bred International Inc. | Crystal structure of glyphosate acetyltransferase (glyat) and methods of use |
CA2767169A1 (en) | 2009-07-07 | 2011-01-13 | Novozymes, Inc. | Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
WO2011011630A2 (en) | 2009-07-23 | 2011-01-27 | Codexis, Inc. | Nitrilase biocatalysts |
CN102625833A (zh) | 2009-07-24 | 2012-08-01 | 诺维信公司 | 糖氧化酶 |
WO2011009182A2 (pt) | 2009-07-24 | 2011-01-27 | Embrapa - Empresa Brasileira De Pesquisa Agropecuária | Molécula de ácido nucléico isolada, construção gênica, vetor, célula transgênica, método para obtenção de uma célula e de uma planta transgênica, polipeptídeo isolado e purificado, composição pesticida biodegradável, método para o controle de uma praga, método de obtenção de linhagens transgênicas resistentes a um inseto praga |
WO2011014458A1 (en) | 2009-07-28 | 2011-02-03 | Novozymes, Inc. | Polypeptides having phytase activity and polynucleotides encoding same |
CA2769643C (en) | 2009-07-31 | 2020-01-07 | Athenix Corp. | Axmi-192 family of pesticidal genes and methods for their use |
WO2011018421A1 (en) | 2009-08-10 | 2011-02-17 | Morphosys Ag | Novel screening strategies for the identification of binders |
PL2464664T3 (pl) | 2009-08-13 | 2016-02-29 | Crucell Holland Bv | Przeciwciała przeciwko ludzkiemu syncytialnemu wirusowi oddechowemu (RSV) i sposoby zastosowania |
EP2464661B1 (en) | 2009-08-13 | 2018-01-17 | The Johns Hopkins University | Methods of modulating immune function with anti-b7-h7cr antibodies |
ES2575560T3 (es) | 2009-08-19 | 2016-06-29 | Codexis, Inc. | Polipéptidos cetorreductasa para preparar fenilefrina |
MX2012002045A (es) | 2009-08-19 | 2012-04-11 | Basf Plant Science Co Gmbh | Plantas que tienen mejores rasgos relacionados con el rendimiento y un metodo para producirlas. |
CN102549009A (zh) | 2009-08-20 | 2012-07-04 | 先锋国际良种公司 | 在玉蜀黍中功能性表达改组酵母硝酸盐转运蛋白(ynt1)以改善低硝酸盐环境下的硝酸盐吸收 |
WO2011020910A1 (en) | 2009-08-21 | 2011-02-24 | Novozymes A/S | Polypeptides having isoamylase activity and polynucleotides encoding same |
EP2292266A1 (en) | 2009-08-27 | 2011-03-09 | Novartis Forschungsstiftung, Zweigniederlassung | Treating cancer by modulating copine III |
JP5833553B2 (ja) | 2009-09-01 | 2015-12-16 | ノボザイムス,インコーポレイティド | 糸状菌におけるリンゴ酸生成の改良方法 |
US8785170B2 (en) | 2009-09-04 | 2014-07-22 | Codexis, Inc. | Variant CBH2 cellulases and related polynucleotides |
KR20120083391A (ko) | 2009-09-09 | 2012-07-25 | 유니베르시다데 에스타듀알 데 캄피나스-유니캄프 | 조작된 미생물 및 n-프로판올, 프로필렌 및 폴리프로필렌의 통합 제조방법 |
US8293483B2 (en) | 2009-09-11 | 2012-10-23 | Epitomics, Inc. | Method for identifying lineage-related antibodies |
EP2478096B1 (en) | 2009-09-17 | 2017-05-24 | Novozymes, Inc. | Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
DK2478137T3 (da) | 2009-09-18 | 2017-11-27 | Codexis Inc | Reduceret kodonmutagenese |
US20110189183A1 (en) | 2009-09-18 | 2011-08-04 | Robert Anthony Williamson | Antibodies against candida, collections thereof and methods of use |
WO2011035029A1 (en) | 2009-09-18 | 2011-03-24 | Novozymes, Inc. | Polypeptides having beta-glucosidase activity and polynucleotides encoding same |
WO2011036118A1 (en) | 2009-09-22 | 2011-03-31 | Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research | Treating cancer by modulating mex-3 |
MX2012003387A (es) | 2009-09-25 | 2012-04-10 | Novozymes As | Uso de variantes de proteasa. |
AU2010299799B2 (en) | 2009-09-25 | 2015-10-29 | Novozymes A/S | Subtilase variants |
EA201270440A1 (ru) | 2009-09-25 | 2012-10-30 | Басф Плант Сайенс Компани Гмбх | Растения с улучшенными характеристиками урожайности и способ их получения |
EP3118320A1 (en) | 2009-09-25 | 2017-01-18 | BASF Plant Science Company GmbH | Plants having enhanced yield-related traits and a method for making the same |
CN102648276A (zh) | 2009-09-29 | 2012-08-22 | 诺维信股份有限公司 | 具有木聚糖酶活性的多肽和编码该多肽的多核苷酸 |
MX2012003473A (es) | 2009-09-29 | 2012-05-22 | Novozymes Inc | Polipeptidos que tienen actividad celulitica mejorada y polinucleotidos que codifican para los mismos. |
DK2483296T3 (en) | 2009-09-30 | 2015-11-02 | Novozymes Inc | Polypeptides having cellulolytic enhancing activity and polynucleotides encoding them |
BR112012007390A2 (pt) | 2009-09-30 | 2015-09-15 | Novozymes As | polipeptídeo isolado tendo atividade intensificadora celulolítica, polinucleotídeo isolado, métodos para produzir o polipeptídeo, para produzir um mutante de uma célula precursora, para inibir a expressão de um polipeptídeo, para produzir uma proteína, para degragar ou converter um material celulósico, para produzir um produto de fermentação, e para fermentar um material celulósico, planta transgênica, parte de planta ou célula de planta transformada com um polinucleotídeo, molécula inibidora de filamento duplo, e, composição detergente |
US8222012B2 (en) * | 2009-10-01 | 2012-07-17 | E. I. Du Pont De Nemours And Company | Perhydrolase for enzymatic peracid production |
BR112012009381A2 (pt) | 2009-10-02 | 2017-03-01 | Syngenta Participations Ag | "proteínas inseticidas" |
US9096877B2 (en) | 2009-10-07 | 2015-08-04 | Macrogenics, Inc. | Fc region-containing polypeptides that exhibit improved effector function due to alterations of the extent of fucosylation, and methods for their use |
WO2011045352A2 (en) | 2009-10-15 | 2011-04-21 | Novartis Forschungsstiftung | Spleen tyrosine kinase and brain cancers |
UA109884C2 (uk) | 2009-10-16 | 2015-10-26 | Поліпептид, що має активність ферменту фосфатидилінозитол-специфічної фосфоліпази с, нуклеїнова кислота, що його кодує, та спосіб його виробництва і застосування | |
UA111708C2 (uk) | 2009-10-16 | 2016-06-10 | Бандж Ойлз, Інк. | Спосіб рафінування олії |
CA2777802A1 (en) | 2009-10-22 | 2011-04-28 | Basf Plant Science Company Gmbh | Plants having enhanced yield-related traits and a method for making the same |
BR112012006873A2 (pt) | 2009-10-23 | 2015-09-08 | Novozymes Inc | variante isolada, polinucleotideo isolado, metodo para produzir uma variante, planta transgenica, parte de planta ou celula d eplanta, e, metodos para degradar ou converter um materialcelulósico, para produzir um produto de fermentação, e, para fermentar um material celulósico. |
US8778672B2 (en) | 2009-10-26 | 2014-07-15 | Pioneer Hi Bred International Inc | Somatic ovule specific promoter and methods of use |
CN102666847B (zh) | 2009-10-29 | 2015-12-09 | 诺维信股份有限公司 | 具有纤维二糖水解酶活性的多肽和编码该多肽的多核苷酸 |
WO2011051327A2 (en) | 2009-10-30 | 2011-05-05 | Novartis Ag | Small antibody-like single chain proteins |
GB2488077A (en) | 2009-10-30 | 2012-08-15 | Novozymes Biopharma Dk As | Albumin variants |
US20120213801A1 (en) | 2009-10-30 | 2012-08-23 | Ekaterina Gresko | Phosphorylated Twist1 and cancer |
US9267148B2 (en) | 2009-11-02 | 2016-02-23 | Plant Sensory Systems, Llc | Methods for the biosynthesis of taurine or hypotaurine in cells |
WO2011051466A1 (en) | 2009-11-02 | 2011-05-05 | Novartis Ag | Anti-idiotypic fibronectin-based binding molecules and uses thereof |
WO2011056872A2 (en) | 2009-11-03 | 2011-05-12 | Gen9, Inc. | Methods and microfluidic devices for the manipulation of droplets in high fidelity polynucleotide assembly |
DK2496692T3 (en) | 2009-11-06 | 2016-06-27 | Novozymes Inc | POLYPEPTIDES WITH xylanase AND POLYNUCLEOTIDES ENCODING THEM |
DK2496693T3 (en) | 2009-11-06 | 2018-01-22 | Novozymes Inc | Polypeptides with cellobiohydrolase activity and polynucleotides encoding them |
US20120227133A1 (en) | 2009-11-13 | 2012-09-06 | Basf Plant Science Company Gmbh | Plants Having Enhanced Yield-Related Traits and a Method for Making the Same |
GB0920089D0 (en) | 2009-11-17 | 2009-12-30 | Danisco | Method |
WO2011063198A2 (en) | 2009-11-20 | 2011-05-26 | St. Jude Children's Research Hospital | Methods and compositions for modulating the activity of the interleukin-35 receptor complex |
EP2504441B1 (en) | 2009-11-23 | 2020-07-22 | E. I. du Pont de Nemours and Company | Sucrose transporter genes for increasing plant seed lipids |
WO2011066457A2 (en) | 2009-11-25 | 2011-06-03 | Codexis, Inc. | Recombinant beta-glucosidase variants for production of soluble sugars from cellulosic biomass |
US9216414B2 (en) | 2009-11-25 | 2015-12-22 | Gen9, Inc. | Microfluidic devices and methods for gene synthesis |
ES2574055T3 (es) | 2009-11-25 | 2016-06-14 | Gen9, Inc. | Métodos y aparatos para la reducción de errores en el ADN basada en un chip |
BR112012012192A2 (pt) | 2009-11-25 | 2017-07-04 | Codexis Inc | b-glicosidades variantes recombinantes thermoascus aurantiacus para produção de açúcares fermentáveis a partir da biomassa celulósica |
DE112010004583T5 (de) | 2009-11-27 | 2012-10-18 | Basf Plant Science Company Gmbh | Chimäre Endonukleasen und Anwendungen davon |
BR112012012444A2 (pt) | 2009-11-27 | 2015-09-22 | Basf Plant Science Co Gmbh | "endonuclease quimérica, polinucleotídeo isolado, cassete de expressão, vetor, organismo não humano, método para fornecer uma endonuclease quimérica, método para recombinação homóloga de polinucleotídeos, método para mutação alvejada de polinucleotídeosa e método para recombinação homóloga ou mutação alvejada" |
EP2504439B1 (en) | 2009-11-27 | 2016-03-02 | BASF Plant Science Company GmbH | Optimized endonucleases and uses thereof |
AU2010276468B2 (en) | 2009-11-30 | 2015-05-14 | Novozymes A/S | Polypeptides having glucoamylase activity and polynucleotides encoding same |
MX2012006095A (es) | 2009-11-30 | 2012-07-03 | Novozymes North America Inc | Polipeptidos que tienen actividad glucoamilasa y polinucleotidos que codifican para los mismos. |
ES2534067T3 (es) | 2009-12-01 | 2015-04-17 | Novozymes A/S | Polipéptidos que tienen actividad de glucoamilasa y polinucleótidos que codifican los mismos |
TW201125577A (en) | 2009-12-02 | 2011-08-01 | Novozymes As | Use of defensins for treatment of infective endocarditis |
EP2506861A1 (en) | 2009-12-02 | 2012-10-10 | Amgen Inc. | Binding proteins that bind to human fgfr1c, human b-klotho and both human fgfr1c and human b-klotho |
US20130023028A1 (en) | 2009-12-03 | 2013-01-24 | Novozymes South Asia Pvt. Ltd. | Variants Of A Polypeptide With Lipolytic Activity and Improved Stability |
CN102884178B (zh) | 2009-12-08 | 2014-12-03 | 科德克希思公司 | 拉唑化合物的合成 |
US8951770B2 (en) | 2009-12-09 | 2015-02-10 | Novozymes A/S | GH8 xylanase variants |
MX2012006548A (es) | 2009-12-11 | 2012-07-10 | Novozymes North America Inc | Variantes de proteasa. |
US8653024B2 (en) | 2009-12-11 | 2014-02-18 | Adenium Biotech Aps | Use of AMPs for treatment of UTI/cystitis |
US20120220513A1 (en) | 2009-12-29 | 2012-08-30 | Novozymes A/S | Polypeptides Having Detergency Enhancing Effect |
US20110191903A1 (en) | 2009-12-31 | 2011-08-04 | Pioneer Hi-Bred International, Inc. | Engineering plant resistance to diseases caused by pathogens |
EP2521772A1 (en) | 2010-01-04 | 2012-11-14 | Novozymes A/S | Alpha-amylases |
US9217144B2 (en) | 2010-01-07 | 2015-12-22 | Gen9, Inc. | Assembly of high fidelity polynucleotides |
WO2011089574A2 (en) | 2010-01-22 | 2011-07-28 | Proteus | Methods of generating modified polynucleotide libraries and methods of using the same for directed protein evolution |
EP2529019B1 (en) | 2010-01-25 | 2014-10-01 | Bayer CropScience NV | Methods for manufacturing plant cell walls comprising chitin |
WO2011092233A1 (en) | 2010-01-29 | 2011-08-04 | Novartis Ag | Yeast mating to produce high-affinity combinations of fibronectin-based binders |
RU2573994C2 (ru) | 2010-02-10 | 2016-01-27 | Иммьюноджен, Инк | Антитела против cd20 и их применение |
EP3404087A1 (en) | 2010-02-10 | 2018-11-21 | Novozymes A/S | Alpha-amylase variants with high stability in presence of a chelating agent |
US9080192B2 (en) | 2010-02-10 | 2015-07-14 | Codexis, Inc. | Processes using amino acid dehydrogenases and ketoreductase-based cofactor regenerating system |
EP2357220A1 (en) | 2010-02-10 | 2011-08-17 | The Procter & Gamble Company | Cleaning composition comprising amylase variants with high stability in the presence of a chelating agent |
AU2011218131B2 (en) | 2010-02-18 | 2016-03-17 | BASF Agricultural Solutions Seed US LLC | AXMI221z, AXMI222z, AXMI223z, AXMI224z, and AXMI225z delta-endotoxin genes and methods for their use |
CA2790023A1 (en) | 2010-02-18 | 2011-08-25 | Athenix Corp. | Axmi218, axmi219, axmi220, axmi226, axmi227, axmi228, axmi229, axmi230, and axmi231 delta-endotoxin genes and methods for their use |
WO2011104128A2 (en) | 2010-02-24 | 2011-09-01 | Basf Plant Science Company Gmbh | Plants having enhanced yield-related traits and a method for making the same |
BR112012021232A2 (pt) | 2010-02-24 | 2015-09-08 | Basf Plant Science Co Gmbh | método para acentuar traços relacionados a rendimento em plantas, plantas, construções, usos de uma construção. métodos de produção de uma planta transgênica, planta transgênicas, partes colhíveis de uma planta, produtos derivados de uma planta, uso de um a´cido nuclleíco |
CN102858968B (zh) | 2010-02-25 | 2015-07-01 | 诺维信公司 | 溶菌酶的变体及编码该变体的多核苷酸 |
WO2011104284A1 (en) | 2010-02-25 | 2011-09-01 | Novozymes A/S | Polypeptides having antimicrobial activity |
EP2361927A1 (en) | 2010-02-26 | 2011-08-31 | BASF Plant Science Company GmbH | Plants having enhanced yield-related traits and a method for making the same |
EP2361985A1 (en) | 2010-02-26 | 2011-08-31 | BASF Plant Science Company GmbH | Plants having enhanced yield-related traits and a method for making the same |
CA2791353A1 (en) | 2010-03-03 | 2011-09-09 | Novozymes, Inc. | Xylanase variants and polynucleotides encoding same |
EP2542578A1 (en) | 2010-03-05 | 2013-01-09 | Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research | Smoc1, tenascin-c and brain cancers |
CN102844418B (zh) | 2010-03-12 | 2015-11-25 | 杜邦营养生物科学有限公司 | 方法 |
CN102892890A (zh) | 2010-03-18 | 2013-01-23 | 巴斯夫植物科学有限公司 | 具有增强的产量相关性状的植物和用于制备该植物的方法 |
WO2011114251A1 (en) | 2010-03-18 | 2011-09-22 | Danisco A/S | Foodstuff |
AU2011228707A1 (en) | 2010-03-18 | 2012-09-27 | Basf Plant Science Company Gmbh | Plants having enhanced yield-related traits and method for making the same |
CA2793394A1 (en) | 2010-03-19 | 2011-09-22 | Basf Plant Science Company Gmbh | Plants having enhanced yield-related traits and a method for making the same |
US9556248B2 (en) | 2010-03-19 | 2017-01-31 | The Board Of Trustees Of The Leland Stanford Junior University | Hepatocyte growth factor fragments that function as potent met receptor agonists and antagonists |
US20130025002A1 (en) | 2010-03-19 | 2013-01-24 | Basf Plant Science Company Gmbh | Plants having enhanced yield-related traits and a method for making the same |
EP2371845A1 (en) | 2010-03-22 | 2011-10-05 | BASF Plant Science Company GmbH | Plants having enhanced yield-related traits and a method for making the same |
AU2011231563B2 (en) | 2010-03-26 | 2015-01-29 | Novozymes A/S | Thermostable phytase variants |
CA2794387C (en) | 2010-03-28 | 2019-02-19 | Novozymes A/S | Enzymatic hydroxylation of aliphatic hydrocarbon |
US8883456B2 (en) | 2010-03-30 | 2014-11-11 | Novozymes North America, Inc. | Processes of producing a fermentation product |
WO2011123576A2 (en) | 2010-03-31 | 2011-10-06 | Codexis, Inc. | Production of monoterpenes |
BR112012020503A2 (pt) | 2010-03-31 | 2015-09-15 | Novozymes Inc | variante isolado de celobioidrolase precursor, polipeptídeo isolado, construção de ácido nucleico, vetor de expressão, célula hospedeira, método de produzir um variante de celobioidrolas precursor, métodos para obter o variante, para degradar variante de celobioidrolase precursor, métodos para obter o variante, para degradar ou converter um material celulósico, poara produzir um produto de fermentação e de fermentar um material celulósico, e, composição de enzima. |
KR20130070576A (ko) | 2010-04-09 | 2013-06-27 | 노보자임스 바이오파마 디케이 에이/에스 | 알부민 유도체 및 변이체 |
EP2558484B1 (en) | 2010-04-14 | 2016-01-13 | Novozymes A/S | Polypeptides having glucoamylase activity and polynucleotides encoding same |
US8383793B2 (en) | 2010-04-15 | 2013-02-26 | St. Jude Children's Research Hospital | Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (ALK) kinase inhibitors |
WO2011127933A1 (en) | 2010-04-16 | 2011-10-20 | Nuevolution A/S | Bi-functional complexes and methods for making and using such complexes |
US20130034543A1 (en) | 2010-04-19 | 2013-02-07 | Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Resear | Modulating xrn1 |
WO2011140219A1 (en) | 2010-05-04 | 2011-11-10 | Codexis, Inc. | Biocatalysts for ezetimibe synthesis |
US20110277182A1 (en) | 2010-05-06 | 2011-11-10 | E.I. Dupont De Nemours And Company | Maize acc synthase 3 gene and protein and uses thereof |
EP4234698A3 (en) | 2010-05-06 | 2023-11-08 | Novartis AG | Compositions and methods of use for therapeutic low density lipoprotein-related protein 6 (lrp6) antibodies |
KR20130066631A (ko) | 2010-05-06 | 2013-06-20 | 노파르티스 아게 | 치료적 저밀도 지단백질-관련 단백질 6 (lrp6) 다가 항체에 대한 조성물 및 사용 방법 |
US20120135912A1 (en) | 2010-05-10 | 2012-05-31 | Perseid Therapeutics Llc | Polypeptide inhibitors of vla4 |
HUE033315T2 (en) | 2010-05-14 | 2017-11-28 | Amgen Inc | High concentration antibody preparations |
CA2800734A1 (en) | 2010-05-25 | 2011-12-01 | Universite De Strasbourg | Combination of anti-envelope antibodies and anti-receptor antibodies for the treatment and prevention of hcv infection |
US20110294170A1 (en) | 2010-05-28 | 2011-12-01 | Codexis, Inc. | Pentose Fermentation By a Recombinant Microorganism |
CN103003298B (zh) | 2010-06-04 | 2016-02-10 | 诺维信股份有限公司 | 在丝状真菌中产生c4二羧酸 |
EP2580239A1 (en) | 2010-06-10 | 2013-04-17 | Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research | Treating cancer by modulating mammalian sterile 20-like kinase 3 |
WO2011154286A1 (en) | 2010-06-11 | 2011-12-15 | Novozymes A/S | A method to reduce biogenic amine content in food |
US8835604B2 (en) | 2010-06-12 | 2014-09-16 | Adenium Biotech Aos | Antimicrobial peptide variants and polynucleotides encoding same |
EP2582799B1 (en) | 2010-06-17 | 2017-12-20 | Codexis, Inc. | Biocatalysts and methods for the synthesis of (s)-3-(1-aminoethyl)-phenol |
AR081950A1 (es) | 2010-06-17 | 2012-10-31 | Danisco | Proceso de tratamiento de semillas que contienen aceite |
EP2582829B1 (en) | 2010-06-21 | 2016-11-30 | Novozymes, Inc. | Methods for improved c4-dicarboxylic acid production in filamentous fungi |
EP2769985B1 (en) | 2010-06-21 | 2017-12-06 | Novozymes, Inc. | Aspergillus aculeatus derived polypeptides having C4-dicarboxylic acid transporter activity and polynucleotides encoding same |
EP2585604A4 (en) | 2010-06-24 | 2014-01-01 | Basf Plant Science Co Gmbh | PLANTS HAVING ENHANCED YIELD LINKS AND METHOD FOR OBTAINING SAME |
EP3366117A1 (en) | 2010-06-25 | 2018-08-29 | E. I. du Pont de Nemours and Company | Compositions and methods for enhancing resistance to northern leaf blight in maize |
AU2011268562A1 (en) | 2010-06-25 | 2013-01-10 | Basf Plant Science Company Gmbh | Plants with enhanced yield-related traits and producing method thereof |
CA2804019A1 (en) | 2010-06-28 | 2012-01-12 | Codexis, Inc. | Fatty alcohol forming acyl reductases (fars) and methods of use thereof |
US8581042B2 (en) | 2010-06-30 | 2013-11-12 | Novozymes A/S | Polypeptides having beta-glucosidase activity and polynucleotides encoding same |
EP2590991B1 (en) | 2010-06-30 | 2016-01-20 | Codexis, Inc. | Highly stable beta-class carbonic anhydrases useful in carbon capture systems |
GB201011513D0 (en) | 2010-07-08 | 2010-08-25 | Danisco | Method |
NZ718973A (en) | 2010-07-09 | 2019-01-25 | Janssen Vaccines & Prevention Bv | Anti-human respiratory syncytial virus (rsv) antibodies and methods of use |
RU2016149485A (ru) | 2010-07-12 | 2018-10-31 | Селджин Корпорейшн | Твердые формы ромидепсина и их применение |
US9354228B2 (en) | 2010-07-16 | 2016-05-31 | Adimab, Llc | Antibody libraries |
CN103119170A (zh) | 2010-07-16 | 2013-05-22 | 巴斯夫植物科学有限公司 | 具有增强的产量相关性状的植物及其制备方法 |
WO2012013197A2 (en) | 2010-07-30 | 2012-02-02 | Aalborg Universitet | Aspergillus encoding beta-glucosidases and nucleic acids encoding same |
CN107903321A (zh) | 2010-07-30 | 2018-04-13 | 诺华有限公司 | 纤连蛋白摇篮分子和其库 |
ES2667100T3 (es) | 2010-08-02 | 2018-05-09 | Macrogenics, Inc. | Diacuerpos covalentes y sus usos |
WO2012021410A1 (en) | 2010-08-12 | 2012-02-16 | Novozymes, Inc. | Compositions comprising a polypeptide having cellulolytic enhancing activity and a liquor and uses thereof |
CA2805803A1 (en) | 2010-08-13 | 2012-02-16 | Pioneer Hi-Bred International, Inc. | Compositions and methods comprising sequences having hydroxyphenylpyruvate dioxygenase (hppd) activity |
CA2808098C (en) | 2010-08-16 | 2020-03-10 | Merck Sharp & Dohme Corp. | Process for preparing aminocyclohexyl ether compounds |
WO2012022734A2 (en) | 2010-08-16 | 2012-02-23 | Medimmune Limited | Anti-icam-1 antibodies and methods of use |
WO2012024662A2 (en) | 2010-08-20 | 2012-02-23 | Codexis, Inc. | Expression constructs comprising fungal promoters |
US9493802B2 (en) | 2010-08-20 | 2016-11-15 | Codexis, Inc. | Use of glycohydrolase 61 protein variants with improved thermostability for processing cellulose |
BR112013004012B1 (pt) | 2010-08-20 | 2021-03-23 | Novartis Ag | Anticorpo monoclonal isolado ou fragmento de ligação ao antígeno do mesmo ao receptor her3, seu uso e composição farmacêutica |
CN103154252B (zh) | 2010-08-23 | 2017-05-24 | 先锋国际良种公司 | 防御素变体及其使用方法 |
CN107299095B (zh) | 2010-08-24 | 2021-05-11 | 诺维信公司 | 热稳定性Persephonella碳酸酐酶及其用途 |
MX2013002137A (es) | 2010-08-24 | 2013-05-17 | Basf Plant Science Co Gmbh | Plantas que tienen mejores rasgos relacionados con el rendimiento y un metodo para prepararlas. |
WO2012027698A1 (en) | 2010-08-26 | 2012-03-01 | E.I. Du Pont De Nemours And Company | Mutant hpgg motif and hdash motif delta-5 desaturases and their use in making polyunsaturated fatty acids |
BR112013004356A2 (pt) | 2010-08-26 | 2017-06-27 | Du Pont | polinucleotídeo isolado, polipeptídeo mutante, constructo recombinante, célula transformada, método para produção de um ácido graxo poli-insaturado, óleo microbiano e célula hospedeira microbiana recombinante. |
WO2012030849A1 (en) | 2010-08-30 | 2012-03-08 | Novozymes A/S | Polypeptides having xylanase activity and polynucleotides encoding same |
WO2012030844A1 (en) | 2010-08-30 | 2012-03-08 | Novozymes A/S | Polypeptides having endoglucanase activity and polynucleotides encoding same |
US8629325B2 (en) | 2010-08-30 | 2014-01-14 | Novozymes A/S | Polypeptides having beta-glucosidase activity and polynucleotides encoding same |
EP3470514A1 (en) | 2010-08-30 | 2019-04-17 | Novozymes A/S | Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
WO2012030811A1 (en) | 2010-08-30 | 2012-03-08 | Novozymes A/S | Polypeptides having cellobiohydrolase activity and polynucleotides encoding same |
US20130212746A1 (en) | 2010-08-30 | 2013-08-15 | Novoyzmes A/S | Polypeptides Having Hemicellulolytic Activity And Polynucleotides Encoding Same |
EP2614080A1 (en) | 2010-09-10 | 2013-07-17 | Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research | Phosphorylated twist1 and metastasis |
US8859502B2 (en) | 2010-09-13 | 2014-10-14 | Celgene Corporation | Therapy for MLL-rearranged leukemia |
US20130266554A1 (en) | 2010-09-16 | 2013-10-10 | Novozymes A/S | Lysozymes |
RU2610088C2 (ru) | 2010-09-22 | 2017-02-07 | Байер Интеллектуэль Проперти Гмбх | Применение активных ингредиентов для борьбы с нематодами у сельскохозяйственных культур, резистентных к нематодам |
EP2622070B1 (en) | 2010-09-30 | 2016-08-03 | Novozymes, Inc. | Variants of polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
MX2013003236A (es) | 2010-09-30 | 2013-05-30 | Novozymes Inc | Variantes de polipeptidos que tienen actividad potenciadora celulolitica y polinucleotidos que codifican a los mismos. |
EP2622071B1 (en) | 2010-10-01 | 2015-12-09 | Novozymes A/S | Polypeptides having endopeptidase activity and polynucleotides encoding same |
CN105886485B (zh) | 2010-10-01 | 2019-09-24 | 诺维信股份有限公司 | β-葡糖苷酶变体及其编码多核苷酸 |
AR083354A1 (es) | 2010-10-06 | 2013-02-21 | Bp Corp North America Inc | Polipeptidos variantes cbh i (celobiohidrolasas i) con reducida inhibicion de producto |
WO2012058293A1 (en) | 2010-10-26 | 2012-05-03 | Novozymes North America, Inc. | Methods of saccharifying sugarcane trash |
EP2632943A1 (en) | 2010-10-29 | 2013-09-04 | Novozymes A/S | Polypeptides having succinyl-coa:aceto acetate transferase activity and polynucleotides encoding same |
WO2012058603A1 (en) | 2010-10-29 | 2012-05-03 | Novozymes A/S | Recombinant n-propanol and isopropanol production |
CN103282504A (zh) | 2010-11-02 | 2013-09-04 | 诺维信股份有限公司 | 用家族61多肽预处理纤维素材料的方法 |
EP2635594B1 (en) | 2010-11-04 | 2017-01-11 | Novozymes Inc. | Polypeptides having cellobiohydrolase activity and polynucleotides encoding same |
DK2635607T3 (da) | 2010-11-05 | 2019-11-18 | Zymeworks Inc | Stabilt heterodimert antistofdesign med mutationer i fc-domænet |
CN103298359B (zh) | 2010-11-08 | 2016-01-06 | 诺维信公司 | 具有葡糖淀粉酶活性的多肽和编码该多肽的多核苷酸 |
ES2605235T3 (es) | 2010-11-08 | 2017-03-13 | Novozymes A/S | Polipéptidos que tienen actividad de glucoamilasa y polinucleótidos que codifican los mismos |
DE112011103723T5 (de) | 2010-11-10 | 2013-08-08 | Basf Plant Science Company Gmbh | Pflanzen mit gesteigerten Ertragsmerkmalen und Verfahren zu deren Herstellung |
DK2638153T3 (en) | 2010-11-12 | 2017-10-16 | Novozymes Inc | POLYPEPTIDES WITH ENDOGLUCANASE ACTIVITY AND POLYNUCLEOTIDES CODING THEM |
MX356647B (es) | 2010-11-12 | 2018-06-07 | Novozymes As | Polipeptidos que tienen actividad de fosfolipasa c y polinucleotidos que codifican los mismos. |
EP2640738A1 (en) | 2010-11-15 | 2013-09-25 | Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research | Anti-fungal agents |
DK2640833T3 (en) | 2010-11-18 | 2016-11-28 | Novozymes Inc | Chimeric polypeptides having cellulolytic enhancing ACTIVITY AND POLYNUCLEOTIDES ENCODING THEM |
RU2603080C2 (ru) | 2010-11-19 | 2016-11-20 | МорфоСис АГ | Коллекция и способы ее применения |
WO2012069466A1 (en) | 2010-11-24 | 2012-05-31 | Novartis Ag | Multispecific molecules |
EP2643351A1 (en) | 2010-11-24 | 2013-10-02 | Glaxo Group Limited | Multispecific antigen binding proteins targeting hgf |
EP2649188A1 (en) | 2010-12-06 | 2013-10-16 | Novozymes North America, Inc. | Methods of hydrolyzing oligomers in hemicellulosic liquor |
EP2649187B1 (en) | 2010-12-08 | 2017-11-22 | Codexis, Inc. | Biocatalysts and methods for the synthesis of armodafinil |
EP2655632A1 (en) | 2010-12-22 | 2013-10-30 | Pioneer Hi-Bred International Inc. | Viral promoter, truncations thereof, and methods of use |
CA2821154A1 (en) | 2010-12-22 | 2012-06-28 | Pioneer Hi-Bred International, Inc. | Viral promoter, truncations thereof, and methods of use |
CA2821169A1 (en) | 2010-12-28 | 2012-07-05 | Pioneer Hi-Bred International, Inc. | Novel bacillus thuringiensis gene with lepidopteran activity |
MX2013007852A (es) | 2011-01-14 | 2013-09-26 | Univ Florida | Arboles de frutas citricas con resistencia al chancro de los citricos. |
AU2012208257A1 (en) | 2011-01-20 | 2013-08-01 | Basf Plant Science Company Gmbh | Plants having enhanced yield-related traits and method for making the same |
DK2668210T3 (da) | 2011-01-26 | 2020-08-24 | Celldex Therapeutics Inc | Anti-kit antistoffer og anvendelser deraf |
US9080161B2 (en) | 2011-01-26 | 2015-07-14 | Novozymes, Inc. | Polypeptides having cellobiohydrolase activity and polynucleotides encoding same |
MX337942B (es) | 2011-01-26 | 2016-03-29 | Novozymes As | Polipeptidos que tienen actividad de endoglucanasa y polinucleotidos que codifican los mismos. |
CN108277213B (zh) | 2011-01-26 | 2021-02-02 | 诺维信公司 | 具有纤维二糖水解酶活性的多肽和编码该多肽的多核苷酸 |
MX2013007720A (es) | 2011-01-26 | 2013-08-09 | Novozymes As | Polipeptidos que tienen actividad celobiohidrolasa y polinucleotidos que codifican para los mismos. |
CN110628803A (zh) | 2011-01-26 | 2019-12-31 | 诺维信公司 | 具有纤维二糖水解酶活性的多肽及编码该多肽的多核苷酸 |
BR112013019324B1 (pt) | 2011-01-31 | 2021-06-08 | Novozymes North America, Inc | processos para refinamento enzimático de um material celulósico pré-tratado |
WO2012106579A1 (en) | 2011-02-03 | 2012-08-09 | Bristol-Myers Squibb Company | Amino acid dehydrogenase and its use in preparing amino acids from keto acids |
EP2675900B1 (en) | 2011-02-15 | 2017-09-06 | Pioneer Hi-Bred International, Inc. | Root-preferred promoter and methods of use |
WO2012110562A2 (en) | 2011-02-16 | 2012-08-23 | Novozymes A/S | Detergent compositions comprising metalloproteases |
WO2012110563A1 (en) | 2011-02-16 | 2012-08-23 | Novozymes A/S | Detergent compositions comprising metalloproteases |
US20140038876A1 (en) | 2011-02-16 | 2014-02-06 | Novozymes A/S | Detergent Compositions Comprising Mettaloproteases |
US20140051146A1 (en) | 2011-02-23 | 2014-02-20 | Dupont Nutrition Biosciences Aps | Method |
AR085251A1 (es) | 2011-02-23 | 2013-09-18 | Danisco | Proceso para tratar aceite vegetal |
ES2649912T3 (es) | 2011-02-23 | 2018-01-16 | Dupont Nutrition Biosciences Aps | Tratamiento enzimático de la clorofila en los aceites vegetales |
BR112013016830A2 (pt) | 2011-02-23 | 2017-03-01 | Novozymes Inc | polipeptídeo isolado, polinucleotídeo isolado, método de produzir o polipeptídeo, de produzir um mutante de uma célula parental, de inibir a expressão de um polipeptídeo, de produzir uma proteína, de degradar ou converter um material celulósico, de produzir um produto de fermentação e de fermentar um material celulósico, planta transgênica, parte da planta ou célula de planta transformada com um polinucleotídeo, molécula de rna de fita dupla, composição, e, formulação de caldo completo ou composição de cultura de células |
EA201391243A1 (ru) | 2011-02-28 | 2014-07-30 | Басф Плант Сайенс Компани Гмбх | Растения, обладающие повышенными связанными с урожайностью свойствами, и способ их получения |
US8722387B2 (en) | 2011-02-28 | 2014-05-13 | Novozymes, Inc. | Microorganisms for C4-dicarboxylic acid production |
AU2012222999A1 (en) | 2011-02-28 | 2013-09-19 | Basf Plant Science Company Gmbh | Plants having enhanced yield-related traits and producing methods thereof |
BR112013022227A2 (pt) | 2011-03-01 | 2017-09-19 | Basf Plant Science Co Gmbh | plantas possuindo características relacionadas ao rendimento melhoradas e métodos de produção das mesmas |
CN103649118A (zh) | 2011-03-01 | 2014-03-19 | 安进公司 | 双特异性结合剂 |
US9150842B2 (en) | 2011-03-09 | 2015-10-06 | Novozymes A/S | Methods of increasing the cellulolytic enhancing activity of a polypeptide |
WO2012122477A1 (en) | 2011-03-10 | 2012-09-13 | Novozymes A/S | Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
US8878007B2 (en) | 2011-03-10 | 2014-11-04 | Pioneer Hi Bred International Inc | Bacillus thuringiensis gene with lepidopteran activity |
DK2689015T3 (en) | 2011-03-23 | 2015-04-13 | Novozymes As | A process for the production of secreted polypeptides |
WO2012127002A1 (en) | 2011-03-23 | 2012-09-27 | Novozymes A/S | Sweet-tasting polypeptide from gram-positive bacteria |
EP2689011B1 (en) | 2011-03-25 | 2017-10-25 | Novozymes A/S | Method for degrading or converting cellulosic material |
AU2012236962B2 (en) | 2011-03-25 | 2017-05-11 | Amgen Inc. | Anti-sclerostin antibody crystals and formulations thereof |
WO2012135501A2 (en) | 2011-03-30 | 2012-10-04 | Athenix Corp. | Axmi232, axmi233, and axmi249 toxin genes and methods for their use |
EP2691517A4 (en) | 2011-03-30 | 2015-04-22 | Codexis Inc | FERMENTATION OF PENTOSES BY A RECOMBINANT MICROORGANISM |
WO2012135436A1 (en) | 2011-03-30 | 2012-10-04 | Athenix Corp. | Axmi238 toxin gene and methods for its use |
WO2012135719A1 (en) | 2011-03-31 | 2012-10-04 | Novozymes, Inc. | Cellulose binding domain variants and polynucleotides encoding same |
WO2012135659A2 (en) | 2011-03-31 | 2012-10-04 | Novozymes A/S | Methods for enhancing the degradation or conversion of cellulosic material |
EP3971297A1 (en) | 2011-04-05 | 2022-03-23 | BASF Agricultural Solutions Seed US LLC | Axmi115 variant insecticidal gene and methods for its use |
MX2013011617A (es) | 2011-04-08 | 2013-11-21 | Danisco Us Inc | Composiciones. |
HUE038800T2 (hu) | 2011-04-13 | 2018-11-28 | Codexis Inc | Biokatalitikus eljárás eszlikarbazepin és ennek analógjai elõállítására |
US20140157443A1 (en) | 2011-04-14 | 2014-06-05 | St. Jude Children's Research Hospital | Methods and compositions for detecting and modulating a novel mtor complex |
EP3252155A1 (en) | 2011-04-21 | 2017-12-06 | The Rockefeller University | Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria |
CA2834513A1 (en) | 2011-04-28 | 2012-11-01 | Novozymes, Inc. | Polypeptides having endoglucanase activity and polynucleotides encoding same |
DK2702162T3 (da) | 2011-04-29 | 2020-05-18 | Novozymes Inc | Fremgangsmåder til forbedring af nedbrydningen eller omdannelsen af celluloseholdigt materiale |
GB2491006A (en) | 2011-05-05 | 2012-11-21 | Novozymes Biopharma Uk Ltd | Albumin variants |
WO2012159009A1 (en) | 2011-05-19 | 2012-11-22 | Novozymes, Inc. | Methods for enhancing the degradation of cellulosic material with chitin binding proteins |
EP2710132A1 (en) | 2011-05-19 | 2014-03-26 | Novozymes, Inc. | Methods for enhancing the degradation of cellulosic material with chitin binding proteins |
EP2714079B2 (en) | 2011-05-21 | 2019-08-28 | MacroGenics, Inc. | Deimmunized serum-binding domains and their use for extending serum half-life |
US9150625B2 (en) | 2011-05-23 | 2015-10-06 | E I Du Pont De Nemours And Company | Chloroplast transit peptides and methods of their use |
EP2527432A1 (en) | 2011-05-23 | 2012-11-28 | Novozymes A/S | Bi-directional cytosine deaminase-encoding selection marker |
EP2527448A1 (en) | 2011-05-23 | 2012-11-28 | Novozymes A/S | Simultaneous site-specific integrations of multiple gene-copies in filamentous fungi |
WO2012162561A2 (en) | 2011-05-24 | 2012-11-29 | Zyngenia, Inc. | Multivalent and monovalent multispecific complexes and their uses |
WO2012168259A1 (en) | 2011-06-06 | 2012-12-13 | Novartis Forschungsstiftung, Zweigniederlassung | Protein tyrosine phosphatase, non-receptor type 11 (ptpn11) and triple-negative breast cancer |
US9244074B2 (en) | 2011-06-07 | 2016-01-26 | University Of Hawaii | Biomarker of asbestos exposure and mesothelioma |
US9561274B2 (en) | 2011-06-07 | 2017-02-07 | University Of Hawaii | Treatment and prevention of cancer with HMGB1 antagonists |
WO2012172495A1 (en) | 2011-06-14 | 2012-12-20 | Novartis Ag | Compositions and methods for antibodies targeting tem8 |
US20140216118A1 (en) | 2011-06-14 | 2014-08-07 | Synthon Biopharmaceuticals B.V. | Compositions and Methods for Making and Biocontaining Auxotrophic Transgenic Plants |
AR086995A1 (es) | 2011-06-21 | 2014-02-05 | Pioneer Hi Bred Int | Metodos y composiciones para producir plantas con esterilidad masculina |
MX349517B (es) | 2011-06-24 | 2017-08-02 | Novozymes As | Polipeptidos que tienen actividad de proteasa y polinucleotidos que codifican los mismos. |
HUE042817T2 (hu) | 2011-06-28 | 2019-07-29 | Codexis Inc | Fehérjevariánsok elõállítása régiókeveréssel |
EP2540824A1 (en) | 2011-06-30 | 2013-01-02 | The Procter & Gamble Company | Cleaning compositions comprising amylase variants reference to a sequence listing |
CN112662734A (zh) | 2011-06-30 | 2021-04-16 | 诺维信公司 | 用于筛选α-淀粉酶的方法 |
KR20140056237A (ko) | 2011-06-30 | 2014-05-09 | 노보자임스 에이/에스 | 알파-아밀라제 변이체 |
US8778652B2 (en) | 2011-06-30 | 2014-07-15 | Codexis, Inc. | Pentose fermentation by a recombinant microorganism |
ES2729385T3 (es) | 2011-07-06 | 2019-11-04 | Novozymes As | Variantes de alfa-amilasa y polinucleótidos que codifican las mismas |
US20140234917A1 (en) | 2011-07-07 | 2014-08-21 | Novozymes A/S | Enzymatic Preparation of Diols |
JP6219277B2 (ja) | 2011-07-08 | 2017-10-25 | ディフェンシン セラピューティクス アンパルトセルスカブDefensin Therapeutics Aps | 炎症性腸疾患の経口治療 |
WO2013009935A2 (en) | 2011-07-12 | 2013-01-17 | Two Blades Foundation | Late blight resistance genes |
CN103827298A (zh) | 2011-07-15 | 2014-05-28 | 诺维信公司 | 脂肪酶变体及其编码多核苷酸 |
WO2013012643A1 (en) | 2011-07-15 | 2013-01-24 | Syngenta Participations Ag | Polynucleotides encoding trehalose-6-phosphate phosphatase and methods of use thereof |
RU2632569C2 (ru) | 2011-07-15 | 2017-10-05 | Зингента Партисипейшнс Аг | Способы увеличения урожая и стрессоустойчивости у растения |
WO2013016207A2 (en) | 2011-07-22 | 2013-01-31 | California Institute Of Technology | Stable fungal cel6 enzyme variants |
CN109022518A (zh) | 2011-07-22 | 2018-12-18 | 诺维信北美公司 | 用于预处理纤维素材料和改进其水解的方法 |
WO2013015993A1 (en) | 2011-07-28 | 2013-01-31 | Syngenta Participations Ag | Methods and compositions for controlling nematode pests |
WO2013016617A1 (en) | 2011-07-28 | 2013-01-31 | Athenix Corp. | Axmi205 variant proteins and methods for their use |
CA2844357A1 (en) | 2011-07-28 | 2013-01-31 | Athenix Corp. | Axmi270 toxin gene, peptides, compositions, host cells and methods thereof |
CN103975065B (zh) | 2011-07-29 | 2018-08-10 | 阿森尼克斯公司 | Axmi279杀虫基因及其使用方法 |
BR112014002622A2 (pt) | 2011-08-03 | 2019-09-24 | Du Pont | método para introduzir no genoma de uma célula vegetal um sítio alvo para a integração específica de sítio, célula vegetal, parte de planta, planta ou semente, método para integrar um polinucleotídeo de interesse em um sítio alvo no genoma de uma célula vegetal |
EP2739728B1 (en) | 2011-08-04 | 2017-07-12 | Novozymes A/S | Polypeptides having endoglucanase activity and polynucleotides encoding same |
WO2013019954A1 (en) | 2011-08-04 | 2013-02-07 | Amgen Inc. | Method for treating bone gap defects |
CN103958674B (zh) | 2011-08-04 | 2018-07-31 | 诺维信公司 | 具有木聚糖酶活性的多肽及其编码多核苷酸 |
WO2013021065A1 (en) | 2011-08-10 | 2013-02-14 | Novozymes A/S | Polypeptides having peroxygenase activity and polynucleotides encoding same |
US9382559B2 (en) | 2011-08-10 | 2016-07-05 | Novozymes A/S | Polypeptides having peroxygenase activity and polynucleotides encoding same |
WO2013021060A1 (en) | 2011-08-10 | 2013-02-14 | Novozymes A/S | Polypeptides having peroxygenase activity and polynucleotides encoding same |
CN103732740B (zh) | 2011-08-10 | 2018-07-31 | 诺维信公司 | 具有过氧化酶活性的多肽及编码该多肽的多核苷酸 |
WO2013021062A1 (en) | 2011-08-10 | 2013-02-14 | Novozymes A/S | Polypeptides having peroxygenase activity and polynucleotides encoding same |
WO2013021064A1 (en) | 2011-08-10 | 2013-02-14 | Novozymes A/S | Polypeptides having peroxygenase activity and polynucleotides encoding same |
WO2013021059A1 (en) | 2011-08-10 | 2013-02-14 | Novozymes A/S | Polypeptides having peroxygenase activity and polynucleotides encoding same |
EP2744898A1 (en) | 2011-08-15 | 2014-06-25 | Novozymes A/S | Polypeptides having cellulase activity and polynucleotides encoding same |
WO2013024155A1 (en) | 2011-08-17 | 2013-02-21 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Combinations of anti-hcv-entry factor antibodies and direct acting antivirals for the treatment and the prevention of hcv infection |
WO2013024156A2 (en) | 2011-08-17 | 2013-02-21 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Combinations of anti-hcv-entry factor antibodies and interferons for the treatment and the prevention of hcv infection |
WO2013024157A2 (en) | 2011-08-17 | 2013-02-21 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Combinations of host targeting agents for the treatment and the prevention of hcv infection |
US20130052213A1 (en) | 2011-08-19 | 2013-02-28 | Novozymes A/S | Novel immunomodulatory peptide |
ES2641039T3 (es) | 2011-08-19 | 2017-11-07 | Novozymes A/S | Polipéptidos con actividad de proteasa |
CN103917649A (zh) | 2011-08-19 | 2014-07-09 | 诺维信股份有限公司 | 用于生产c4-二羧酸的重组微生物 |
BR112014004171A2 (pt) | 2011-08-22 | 2018-11-06 | Codexis Inc | variantes da proteína glicósideo hidrolase gh61 e cofatores que aumentam a atividade de gh61 |
EP2748188A4 (en) | 2011-08-26 | 2015-03-18 | Novozymes As | POLYPEPTIDES HAVING GLUCOAMYLASE ACTIVITY AND POLYNUCLEOTIDES ENCODING THESE POLYPEPTIDES |
US11377663B1 (en) | 2011-08-30 | 2022-07-05 | Monsanto Technology Llc | Genetic regulatory elements |
JP6228121B2 (ja) | 2011-08-31 | 2017-11-08 | セント ジュード チルドレンズ リサーチ ホスピタル | リソソームエキソサイトーシス活性のレベルを検出する方法及び組成物並びに使用方法 |
CN103930543B (zh) | 2011-09-06 | 2020-11-27 | 诺维信公司 | 葡糖淀粉酶变体和编码它们的多核苷酸 |
CN103998461B (zh) | 2011-09-08 | 2018-02-02 | 科德克希思公司 | 用于合成取代的内酰胺的生物催化剂和方法 |
WO2013034106A1 (en) | 2011-09-09 | 2013-03-14 | Novozymes A/S | Polypeptides having alpha-amylase activity and polynucleotides encoding same |
PL2753749T3 (pl) | 2011-09-09 | 2019-10-31 | Novozymes As | Polepszone właściwości materiałów papierowych |
WO2013039776A1 (en) | 2011-09-13 | 2013-03-21 | Novozymes North America, Inc. | Methods of hydrolyzing and fermenting cellulosic material |
WO2013043910A1 (en) | 2011-09-20 | 2013-03-28 | Novozymes A/S | Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
JP2014530598A (ja) | 2011-09-22 | 2014-11-20 | ノボザイムスアクティーゼルスカブ | プロテアーゼ活性を有するポリペプチドおよびこれをコードするポリヌクレオチド |
TR201909896T4 (tr) | 2011-09-23 | 2019-07-22 | Novozymes As | Tekstilde renk değiştirme. |
JP2014528726A (ja) | 2011-09-30 | 2014-10-30 | ノボザイムス,インコーポレイティド | デヒドロゲナーゼ変異体およびこれをコードするポリヌクレオチド |
CA2850070A1 (en) | 2011-09-30 | 2013-04-04 | Novozymes A/S | Polypeptides having alpha-amylase activity and polynucleotides encoding same |
WO2013048661A1 (en) | 2011-09-30 | 2013-04-04 | Codexis, Inc. | Fungal proteases |
US9279118B2 (en) | 2011-10-05 | 2016-03-08 | The Rockefeller University | Dimeric bacteriophage lysins |
ES2638669T3 (es) | 2011-10-11 | 2017-10-23 | Novozymes A/S | Variantes de glucoamilasa y polinucleótidos que las codifican |
KR102434073B1 (ko) | 2011-10-11 | 2022-08-18 | 비엘라 바이오, 인크. | Cd40l 특이적 tn3 유래 스카폴드 및 이의 사용 방법 |
WO2013057141A2 (en) | 2011-10-17 | 2013-04-25 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
EP4253534A3 (en) | 2011-10-17 | 2024-02-07 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
CA2850390A1 (en) | 2011-10-28 | 2013-05-02 | E. I. Du Pont De Nemours And Company | Methods and compositions for silencing genes using artificial micrornas |
DK2773656T3 (da) | 2011-10-31 | 2019-09-09 | Novozymes Inc | Polypeptider med cellulolyseforbedrende aktivitet og polynukleotider, som koder for dem |
US9220774B2 (en) | 2011-11-01 | 2015-12-29 | Bionomics Inc. | Methods of treating cancer by administering anti-GPR49 antibodies |
US10598653B2 (en) | 2011-11-01 | 2020-03-24 | Bionomics Inc. | Methods of blocking cancer stem cell growth |
CA2853951A1 (en) | 2011-11-01 | 2013-05-10 | Bionomics, Inc. | Antibodies and methods of treating cancer |
EP2773667A1 (en) | 2011-11-01 | 2014-09-10 | Bionomics, Inc. | Anti-gpr49 antibodies |
WO2013064195A1 (en) | 2011-11-04 | 2013-05-10 | Enel Ingegneria E Ricerca S.P.A. | A new heat-stable carbonic anhydrase and uses thereof |
CN109897103A (zh) | 2011-11-04 | 2019-06-18 | 酵活有限公司 | 在Fc结构域中具有突变的稳定异源二聚的抗体设计 |
EP2776838A1 (en) | 2011-11-08 | 2014-09-17 | Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research | Early diagnostic of neurodegenerative diseases |
US20140314787A1 (en) | 2011-11-08 | 2014-10-23 | Novartis Forschungsstiftung, Zweigniederlassung, Friedrich Miescher Institute | Treatment for neurodegenerative diseases |
EP2794873A1 (en) | 2011-11-08 | 2014-10-29 | Novozymes A/S | Methods for production of archeae protease in yeast |
EP3382017A1 (en) | 2011-11-18 | 2018-10-03 | Novozymes A/S | Polypeptides having beta-glucosidase activity, beta-xylosidase activity, or beta-glucosidase and beta-xylosidase activity and polynucleotides encoding same |
IN2014CN04470A (zh) | 2011-11-18 | 2015-09-04 | Codexis Inc | |
WO2013075066A2 (en) | 2011-11-18 | 2013-05-23 | Eleven Biotherapeutics, Inc. | Proteins with improved half-life and other properties |
US10351834B2 (en) | 2011-11-21 | 2019-07-16 | Novozymes, Inc. | GH61 polypeptide variants and polynucleotides encoding same |
EP3342860A1 (en) | 2011-11-22 | 2018-07-04 | Novozymes, Inc. | Polypeptides having beta-xylosidase activity and polynucleotides encoding same |
WO2013076269A1 (en) | 2011-11-25 | 2013-05-30 | Novozymes A/S | Subtilase variants and polynucleotides encoding same |
US9701952B2 (en) | 2011-11-25 | 2017-07-11 | Novozymes A/S | Polypeptides having lysozyme activity and polynucleotides encoding same |
EP2785732B1 (en) | 2011-12-01 | 2017-04-12 | Novozymes, Inc. | Polypeptides having beta-xylosidase activity and polynucleotides encoding same |
US9404093B2 (en) | 2011-12-02 | 2016-08-02 | Novozymes A/S | Polypeptides having peroxygenase activity and polynucleotides encoding same |
US9169469B2 (en) | 2011-12-02 | 2015-10-27 | Novozymes A/S | Polypeptides having peroxygenase activity and polynucleotides encoding same |
JP2015500829A (ja) | 2011-12-05 | 2015-01-08 | ノバルティス アーゲー | 上皮細胞増殖因子受容体3(her3)のドメインiiに対するher3の抗体 |
WO2013084147A2 (en) | 2011-12-05 | 2013-06-13 | Novartis Ag | Antibodies for epidermal growth factor receptor 3 (her3) |
EP3272862A1 (en) | 2011-12-16 | 2018-01-24 | Novozymes, Inc. | Polypeptides having laccase activity and polynucleotides encoding same |
WO2013091547A1 (en) | 2011-12-19 | 2013-06-27 | Novozymes, Inc. | Polypeptides having catalase activity and polynucleotides encoding same |
US9611462B2 (en) | 2011-12-20 | 2017-04-04 | Codexis, Inc. | Endoglucanase 1B (EG1B) variants |
EP2607468A1 (en) | 2011-12-20 | 2013-06-26 | Henkel AG & Co. KGaA | Detergent compositions comprising subtilase variants |
JP2015504660A (ja) | 2011-12-20 | 2015-02-16 | ノボザイムス アクティーゼルスカブ | サブチラーゼ変異体およびそれをコードするポリヌクレオチド |
US10036050B2 (en) | 2011-12-20 | 2018-07-31 | Novozymes, Inc. | Cellobiohydrolase variants and polynucleotides encoding same |
ES2728278T3 (es) | 2011-12-21 | 2019-10-23 | Novartis Ag | Composiciones que comprenden anticuerpos dirigidos al factor P y C5 |
CA2860220C (en) | 2011-12-22 | 2021-07-13 | E. I. Du Pont De Nemours And Company | Use of the soybean or medicago truncatula sucrose synthase promoter to increase plant seed oil content |
CA2859755C (en) | 2011-12-23 | 2021-04-20 | Pfizer Inc. | Engineered antibody constant regions for site-specific conjugation and methods and uses therefor |
CA2858974A1 (en) | 2011-12-28 | 2013-07-04 | Amgen Inc. | Method of treating alveolar bone loss through the use of anti-sclerostin antibodies |
BR112014015705A8 (pt) | 2011-12-28 | 2017-07-04 | Novozymes A / S | polipeptídeo isolado, composição, polinucleotídeo isolado,, construção de ácido nucleico ou vetor de expressão, célula hospedeira, métodos para produzir um polipeptídeo, para melhorar o valor nutritivo de uma ração parar animais e para o tratamento de proteínas, planta transgênica, parte de planta ou célula vegetal, uso de pelo menos um polipeptídeo, aditivo de ração para animal, ração para animais, e, composição detergente |
US20140363448A1 (en) | 2012-01-02 | 2014-12-11 | Novartis Ag | Cdcp1 and breast cancer |
EP2800816A1 (en) | 2012-01-06 | 2014-11-12 | Pioneer Hi-Bred International Inc. | Ovule specific promoter and methods of use |
WO2013103366A1 (en) | 2012-01-06 | 2013-07-11 | Pioneer Hi-Bred International, Inc. | A method to screen plants for genetic elements inducing parthenogenesis in plants |
WO2013103365A1 (en) | 2012-01-06 | 2013-07-11 | Pioneer Hi-Bred International, Inc. | Pollen preferred promoters and methods of use |
CA2860611A1 (en) | 2012-01-06 | 2013-07-11 | Pioneer Hi-Bred International, Inc. | Compositions and methods for the expression of a sequence in a reproductive tissue of a plant |
WO2013104659A2 (en) | 2012-01-13 | 2013-07-18 | Dupont Nutrition Biosciences Aps | Process |
WO2013104660A1 (en) | 2012-01-13 | 2013-07-18 | Dupont Nutrition Biosciences Aps | Process for treating a plant oil comprising hydrolysing chlorophyll or a chlorophyll derivative and involving partial caustic neutralisation |
BR112014018294B1 (pt) | 2012-01-26 | 2022-01-11 | Norfolk Plant Sciences, Ltd | Método para produzir uma planta, cassete de expressão, e, célula bacteriana |
ES2644007T3 (es) | 2012-01-26 | 2017-11-27 | Novozymes A/S | Uso de polipéptidos con actividad de proteasa en piensos para animales y en detergentes |
AR089793A1 (es) | 2012-01-27 | 2014-09-17 | Du Pont | Metodos y composiciones para generar locus de rasgos transgenicos complejos |
NZ628549A (en) | 2012-02-01 | 2016-10-28 | Dow Agrosciences Llc | Novel class of glyphosate resistance genes |
MX353896B (es) | 2012-02-03 | 2018-02-01 | Procter & Gamble | Composiciones y metodos para el tratamiento de superficies con lipasas. |
MX353911B (es) | 2012-02-03 | 2018-02-02 | Novozymes As | Variantes de lipasa y polinucleotidos que las codifican. |
US10093911B2 (en) | 2012-02-17 | 2018-10-09 | Novozymes A/S | Subtilisin variants and polynucleotides encoding same |
ES2582608T3 (es) | 2012-02-17 | 2016-09-14 | Henkel Ag & Co. Kgaa | Composiciones detergentes que comprenden variantes de subtilasa |
BR112014018876A2 (pt) | 2012-02-20 | 2017-07-04 | Novozymes As | polipeptídeo isolado com atividade endoglicanase, composição, polinucleotídeo isolado, construto de ácido nucleico ou vetor de expressão, célula hospedeira recombinante, e, método de produção de um polipeptídeo |
GB201203374D0 (en) | 2012-02-28 | 2012-04-11 | Univ Sheffield | Alkane production |
EP2822962A1 (en) | 2012-03-08 | 2015-01-14 | Athenix Corp. | Axmi345 delta-endotoxin gene and methods for its use |
WO2013134523A1 (en) | 2012-03-08 | 2013-09-12 | Athenix Corp. | Bacillus thuringiensis toxin gene axmi335 and methods for its use |
IN2014DN06908A (zh) | 2012-03-14 | 2015-05-15 | Du Pont | |
CN104519735A (zh) | 2012-03-14 | 2015-04-15 | 纳幕尔杜邦公司 | 编码fasciated ear4(fea4)的核苷酸序列及其使用方法 |
CN104168760B (zh) | 2012-03-14 | 2018-06-22 | 纳幕尔杜邦公司 | 编码fasciated ear3(fea3)的核苷酸序列及其使用方法 |
US9944691B2 (en) | 2012-03-16 | 2018-04-17 | Albumedix A/S | Albumin variants |
HUE036985T2 (hu) | 2012-03-23 | 2018-08-28 | Codexis Inc | Biokatalizátor és eljárások triptamin és triptamin-analógok származékainak szintetizálására |
US20150266961A1 (en) | 2012-03-29 | 2015-09-24 | Novartis Forschungsstiftung, Zweigniederlassung, Fridrich Miescher Institute | Inhibition of interleukin-8 and/or its receptor cxcr1 in the treatment of her2/her3-overexpressing breast cancer |
JP2015516804A (ja) | 2012-03-31 | 2015-06-18 | ノボザイムス アクティーゼルスカブ | ペルオキシゲナーゼを用いたエポキシ化 |
CN104204198B (zh) | 2012-04-02 | 2018-09-25 | 诺维信公司 | 脂肪酶变体以及编码其的多核苷酸 |
CN104245930A (zh) | 2012-04-23 | 2014-12-24 | 诺维信公司 | 具有葡萄糖醛酸酯酶活性的多肽以及编码其的多核苷酸 |
US9446102B2 (en) | 2012-04-23 | 2016-09-20 | Novozymes A/S | Polypeptides having alpha-glucuronidase activity and polynucleotides encoding same |
WO2013160370A1 (en) | 2012-04-25 | 2013-10-31 | Novozymes A/S | Method of baking |
CA2868308A1 (en) | 2012-04-27 | 2013-10-31 | Novozymes, Inc. | Gh61 polypeptide variants and polynucleotides encoding same |
WO2013160374A1 (en) | 2012-04-27 | 2013-10-31 | Dupont Nutrition Biosciences Aps | Process for refining crude plant oil involving enzymatic hydrolysis and gum recycling |
WO2013160372A1 (en) | 2012-04-27 | 2013-10-31 | Dupont Nutrition Biosciences Aps | Process for treating plant oil involving addition of serial doses of chlorophyll or chlorophyll derivative degrading enzyme |
CN104411823A (zh) | 2012-05-04 | 2015-03-11 | 纳幕尔杜邦公司 | 包含具有大范围核酸酶活性的序列的组合物和方法 |
CN104271723B (zh) | 2012-05-07 | 2021-04-06 | 诺维信公司 | 具有黄原胶降解活性的多肽以及编码其的核苷酸 |
DK2847327T3 (en) | 2012-05-08 | 2019-03-11 | Codexis Inc | BIO-CATALYSTS AND METHODS FOR HYDROXYLATION OF CHEMICAL COMPOUNDS |
CA2872540A1 (en) | 2012-05-10 | 2013-11-14 | Zymeworks Inc. | Heteromultimer constructs of immunoglobulin heavy chains with mutations in the fc domain |
HUE036947T2 (hu) | 2012-05-11 | 2018-08-28 | Codexis Inc | Átalakított iminreduktázok és eljárások keton- és aminvegyületek reduktív aminálására |
CN104379734B (zh) | 2012-05-18 | 2018-05-15 | 诺维信公司 | 具有改进的转化效率的细菌突变体 |
WO2013178808A2 (en) | 2012-05-31 | 2013-12-05 | Novozymes A/S | Polypeptides having organophosphorous hydrolase activity |
WO2013178699A1 (en) | 2012-05-31 | 2013-12-05 | Novozymes A/S | Isopropanol production by bacterial hosts |
US20150104468A1 (en) | 2012-06-04 | 2015-04-16 | Irm Llc | Site-specific labeling methods and molecules produced thereby |
BR112014031024A2 (pt) | 2012-06-11 | 2017-06-27 | Codexis Inc | xilanases e xilosidases fúngicas. |
CA2876426A1 (en) | 2012-06-15 | 2013-12-19 | E. I. Du Pont De Nemours And Company | Methods and compositions involving als variants with native substrate preference |
US20130337442A1 (en) | 2012-06-15 | 2013-12-19 | Pioneer Hi-Bred International, Inc. | Genetic loci associated with soybean cyst nematode resistance and methods of use |
EP2861749A1 (en) | 2012-06-19 | 2015-04-22 | Novozymes Bioag A/S | Enzymatic reduction of hydroperoxides |
BR112014031882A2 (pt) | 2012-06-20 | 2017-08-01 | Novozymes As | uso de um polipeptídeo isolado, polipeptídeo, composição, polinucleotídeo isolado, construto de ácido nucleico ou vetor de expressão, célula hospedeira de expressão recombinante, métodos para produção de um polipeptídeo, para melhoria do valor nutricional de uma ração animal, e para o tratamento de proteínas, uso de pelo menos um polipeptídeo, aditivo de ração animal, ração animal, e, composição detergente |
DK2864491T3 (en) | 2012-06-22 | 2018-12-17 | Phytogene Inc | Enzymes and methods for styrene synthesis |
EP2677035A1 (en) | 2012-06-22 | 2013-12-25 | BASF Plant Science Company GmbH | Plants having enhanced yield-related traits and a method for making the same |
EP2866831A1 (en) | 2012-06-29 | 2015-05-06 | Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research | Treating diseases by modulating a specific isoform of mkl1 |
CA2840683C (en) | 2012-06-29 | 2020-03-10 | Athenix Corp. | Axmi277 nematode toxin and methods for its use |
EP3626267A1 (en) | 2012-07-05 | 2020-03-25 | UCB Pharma, S.A. | Treatment for bone diseases |
EP2870242A1 (en) | 2012-07-05 | 2015-05-13 | Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research | New treatment for neurodegenerative diseases |
CN104471048B (zh) | 2012-07-12 | 2018-11-16 | 诺维信公司 | 具有脂肪酶活性的多肽及编码它的多核苷酸 |
PT2875179T (pt) | 2012-07-18 | 2018-04-23 | Novozymes As | Resumo |
CN104781412A (zh) | 2012-07-20 | 2015-07-15 | 诺维信公司 | 5-羟甲基糠醛及其衍生物的酶氧化 |
EP2877493B1 (en) | 2012-07-25 | 2018-03-21 | Celldex Therapeutics, Inc. | Anti-kit antibodies and uses thereof |
EP2880159A1 (en) | 2012-07-30 | 2015-06-10 | Allylix, Inc. | Sclareol and labdenediol diphosphate synthase polypeptides encoding nucleic acid molecules and uses thereof |
CA2881685C (en) | 2012-08-14 | 2023-12-05 | 10X Genomics, Inc. | Microcapsule compositions and methods |
US10752949B2 (en) | 2012-08-14 | 2020-08-25 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US9388465B2 (en) | 2013-02-08 | 2016-07-12 | 10X Genomics, Inc. | Polynucleotide barcode generation |
US10323279B2 (en) | 2012-08-14 | 2019-06-18 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US9701998B2 (en) | 2012-12-14 | 2017-07-11 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10221442B2 (en) | 2012-08-14 | 2019-03-05 | 10X Genomics, Inc. | Compositions and methods for sample processing |
US11591637B2 (en) | 2012-08-14 | 2023-02-28 | 10X Genomics, Inc. | Compositions and methods for sample processing |
US10273541B2 (en) | 2012-08-14 | 2019-04-30 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US9951386B2 (en) | 2014-06-26 | 2018-04-24 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US9567631B2 (en) | 2012-12-14 | 2017-02-14 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10584381B2 (en) | 2012-08-14 | 2020-03-10 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
TR201809053T4 (tr) | 2012-08-16 | 2018-07-23 | Bangladesh Jute Res Institute | Macrophomina phaseolina'dan elde edilen pektin parçalama enzimleri ve bunların kullanımları. |
TR201815368T4 (tr) | 2012-08-16 | 2018-11-21 | Bangladesh Jute Res Institute | Macrophomina Phaseolina'dan elde edilen selüloz ve hemiselüloz parçalama enzimleri ve bunların kullanımları. |
FI3553172T3 (fi) | 2012-08-16 | 2023-03-21 | Novozymes As | Menetelmä tekstiilin käsittelemiseksi endoglukanaasilla |
US9828595B2 (en) | 2012-08-17 | 2017-11-28 | Novozymes A/S | Thermostable asparaginase variants and polynucleotides encoding same |
EP2888360B1 (en) | 2012-08-22 | 2017-10-25 | Novozymes A/S | Metalloproteases from alicyclobacillus sp. |
CN104619838A (zh) | 2012-08-22 | 2015-05-13 | 诺维信公司 | 来自微小杆菌属的金属蛋白酶 |
BR112015003726A2 (pt) | 2012-08-22 | 2019-09-24 | Novozymes As | composição detergente, uso de uma composição e de um polipeptídeo, e, método para remoção de uma nódoa de uma superfície. |
US9758793B2 (en) | 2012-08-30 | 2017-09-12 | Athenix Corp. | AXMI-234 and AXMI-235 delta-endotoxin genes and methods for their use |
WO2014033266A1 (en) | 2012-08-31 | 2014-03-06 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Anti-sr-bi antibodies for the inhibition of hepatitis c virus infection |
CN104884615B (zh) | 2012-09-05 | 2019-07-12 | 诺维信公司 | 具有蛋白酶活性的多肽 |
AU2013202506B2 (en) | 2012-09-07 | 2015-06-18 | Celgene Corporation | Resistance biomarkers for hdac inhibitors |
BR112015005389B1 (pt) | 2012-09-13 | 2022-10-18 | Indiana University Research And Technology Corporation | Molécula de ácido nucleico recombinante, proteína de substrato modificada de uma protease específica de patógeno de planta expressa através do patógeno de planta, vetor, e método para proteger uma planta da infecção por um patógeno de planta que secreta pelo menos uma protease específica |
EP2898068A2 (en) | 2012-09-19 | 2015-07-29 | Novozymes, Inc. | Methods for enhancing the degradation or conversion of cellulosic material |
WO2014047453A2 (en) | 2012-09-20 | 2014-03-27 | Novozymes A/S | Screening polynucleotide libraries for variants that encode functional proteins |
US20150218567A1 (en) | 2012-09-27 | 2015-08-06 | Novozymes A/S | Bacterial Mutants with Improved Transformation Efficiency |
EP3176260A1 (en) | 2012-10-05 | 2017-06-07 | Novozymes A/S | Preventing adhesion of bacteria |
EP2903412B1 (en) | 2012-10-08 | 2019-09-11 | Novozymes A/S | Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
EP2906598A1 (en) | 2012-10-09 | 2015-08-19 | Igenica Biotherapeutics, Inc. | Anti-c16orf54 antibodies and methods of use thereof |
US20140109259A1 (en) | 2012-10-11 | 2014-04-17 | Pioneer Hi Bred International Inc | Guard Cell Promoters and Uses Thereof |
WO2014056920A2 (en) | 2012-10-12 | 2014-04-17 | Novozymes A/S | Polypeptides having peroxygenase activity |
US9404094B2 (en) | 2012-10-12 | 2016-08-02 | Novozymes A/S | Polypeptides having peroxygenase activity |
WO2014056916A2 (en) | 2012-10-12 | 2014-04-17 | Novozymes A/S | Polypeptides having peroxygenase activity |
WO2014056922A2 (en) | 2012-10-12 | 2014-04-17 | Novozymes A/S | Polypeptides having peroxygenase activity |
US9534208B2 (en) | 2012-10-12 | 2017-01-03 | Novozymes A/S | Polypeptides having peroxygenase activity |
EP2906688B1 (en) | 2012-10-12 | 2018-08-29 | Novozymes A/S | Polypeptides having peroxygenase activity |
EP2906689B1 (en) | 2012-10-12 | 2018-12-12 | Novozymes A/S | Polypeptides having peroxygenase activity |
US9783820B2 (en) | 2012-10-15 | 2017-10-10 | Pioneer Hi-Bred International, Inc. | Methods and compositions to enhance activity of Cry endotoxins |
US10226744B2 (en) | 2012-10-19 | 2019-03-12 | Danisco Us Inc | Stabilization of biomimetic membranes |
AR093116A1 (es) | 2012-10-23 | 2015-05-20 | Univ Montana State | Produccion de trigo candeal de alta calidad con mayor contenido de amilosa |
WO2014066141A2 (en) | 2012-10-24 | 2014-05-01 | Novozymes A/S | Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
US9663532B2 (en) | 2012-10-29 | 2017-05-30 | University Of Rochester | Artemisinin derivatives, methods for their preparation and their use as antimalarial agents |
WO2014068010A1 (en) | 2012-10-31 | 2014-05-08 | Novozymes A/S | Isopropanol production by bacterial hosts |
EP2914729B1 (en) | 2012-11-01 | 2022-01-26 | The University of British Columbia | Cytochrome p450 and cytochrome p450 reductase polypeptides, encoding nucleic acid molecules and uses thereof |
BR112015010318A2 (pt) | 2012-11-08 | 2017-08-22 | Albumedix As | Variantes de albumina |
AU2013202507B9 (en) | 2012-11-14 | 2015-08-13 | Celgene Corporation | Inhibition of drug resistant cancer cells |
WO2014076232A2 (en) | 2012-11-19 | 2014-05-22 | Novozymes A/S | Isopropanol production by recombinant hosts using an hmg-coa intermediate |
AU2013348272A1 (en) | 2012-11-20 | 2015-05-14 | Shell Internationale Research Maatschappij B.V. | Pentose fermentation by a recombinant microorganism |
UY35148A (es) | 2012-11-21 | 2014-05-30 | Amgen Inc | Immunoglobulinas heterodiméricas |
CN105209626B (zh) | 2012-11-30 | 2019-09-03 | 诺维信股份有限公司 | 通过重组酵母生产3-羟基丙酸 |
WO2014084859A1 (en) | 2012-11-30 | 2014-06-05 | Novartis Ag | Molecules and methods for modulating tmem16a activities |
EP3851454A1 (en) | 2012-12-05 | 2021-07-21 | Novartis AG | Compositions and methods for antibodies targeting epo |
CN104837993A (zh) | 2012-12-07 | 2015-08-12 | 诺维信公司 | 用于在丝状真菌中产生位点特异性突变的方法 |
BR112015012982A2 (pt) | 2012-12-07 | 2017-09-12 | Novozymes As | composição detergente, método de lavagem para têxtil, têxtil lavado, e, uso de uma desoxirribonuclease |
PT2928865T (pt) | 2012-12-07 | 2018-06-11 | Merck Sharp & Dohme | Processo de transaminação biocatalítica |
EP2740840A1 (en) | 2012-12-07 | 2014-06-11 | Novozymes A/S | Improving drainage of paper pulp |
CN104884464B (zh) | 2012-12-11 | 2021-02-02 | 诺维信公司 | 具有磷脂酶c活性的多肽以及对其进行编码的多核苷酸 |
WO2014090765A1 (en) | 2012-12-12 | 2014-06-19 | Bayer Cropscience Ag | Use of 1-[2-fluoro-4-methyl-5-(2,2,2-trifluoroethylsulfinyl)phenyl]-5-amino-3-trifluoromethyl)-1 h-1,2,4 tfia zole for controlling nematodes in nematode-resistant crops |
WO2014090940A1 (en) | 2012-12-14 | 2014-06-19 | Novozymes A/S | Removal of skin-derived body soils |
AU2013358981A1 (en) | 2012-12-14 | 2015-06-04 | Novozymes A/S | Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
US10533221B2 (en) | 2012-12-14 | 2020-01-14 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
WO2014099653A1 (en) | 2012-12-17 | 2014-06-26 | Novozymes A/S | Alpha-amylases and polynucleotides encoding same |
JP2016502850A (ja) | 2012-12-18 | 2016-02-01 | ノバルティス アーゲー | ヒアルロナンに結合するペプチドタグを使用する組成物及び方法 |
WO2014099798A1 (en) | 2012-12-19 | 2014-06-26 | Novozymes A/S | Polypeptides having cellulolytic enhancinc activity and polynucleotides encoding same |
HUE051359T2 (hu) | 2012-12-21 | 2021-03-01 | Codexis Inc | Génmódosított biokatalizátorok és eljárások királis aminok szintetizálására |
CN104869841A (zh) | 2012-12-21 | 2015-08-26 | 诺维信公司 | 具有蛋白酶活性的多肽和编码它的多核苷酸 |
BR112015014624A2 (pt) | 2012-12-24 | 2017-10-10 | Novozymes As | polipeptídeo isolado, composição, polinucleotídeo isolado, construto de ácido nucleico ou vetor de expressão, célula hospedeira recombinante, e, método para tratamento de têxtil |
CN103060279B (zh) | 2012-12-25 | 2014-08-13 | 北京大北农科技集团股份有限公司 | 除草剂抗性蛋白质、其编码基因及用途 |
CN103013938B (zh) | 2012-12-25 | 2014-12-17 | 北京大北农科技集团股份有限公司 | 除草剂抗性蛋白质、其编码基因及用途 |
WO2014106593A1 (en) | 2013-01-03 | 2014-07-10 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
WO2014113521A1 (en) | 2013-01-18 | 2014-07-24 | Codexis, Inc. | Engineered biocatalysts useful for carbapenem synthesis |
KR102490720B1 (ko) | 2013-01-31 | 2023-01-27 | 코덱시스, 인코포레이티드 | 상호작용 성분을 이용하여 생체분자를 확인하기 위한 방법, 시스템, 및 소프트웨어 |
WO2014120916A1 (en) | 2013-02-01 | 2014-08-07 | Bristol-Myers Squibb Company | Pegylated domain antibodies monovalent for cd28 binding and methods of use |
WO2014122109A1 (en) | 2013-02-05 | 2014-08-14 | Novozymes A/S | Enzymatic preparation of indigo dyes and intermediates |
WO2014122161A2 (en) | 2013-02-06 | 2014-08-14 | Novozymes A/S | Polypeptides having protease activity |
KR102447350B1 (ko) | 2013-02-08 | 2022-09-23 | 노파르티스 아게 | 면역접합체의 제조를 위한 항체의 변형에 사용되는 특정 부위 |
WO2014124258A2 (en) | 2013-02-08 | 2014-08-14 | Irm Llc | Specific sites for modifying antibodies to make immunoconjugates |
HUE039836T2 (hu) | 2013-02-13 | 2019-02-28 | Athenix Corp | AXMI184 alkalmazása gyökérféreg rovarok kontrollálására |
ES2900102T3 (es) * | 2013-02-20 | 2022-03-15 | Univ Emory | Composiciones para la secuenciación de ácidos nucleicos en mezclas |
DK2961844T3 (da) | 2013-02-28 | 2019-01-02 | Codexis Inc | Modificerede transaminasepolypeptider til industriel biokatalyse |
US9487773B2 (en) * | 2013-03-01 | 2016-11-08 | Technophage, Investigacao E Desenvolvimento Em Biotecnologia, Sa | Cell-based methods for coupling protein interactions and binding molecule selection |
MX369500B (es) | 2013-03-07 | 2019-11-11 | Athenix Corp | Genes de toxinas y métodos para su uso. |
CN110628749A (zh) | 2013-03-08 | 2019-12-31 | 诺维信公司 | 纤维二糖水解酶变体和编码它们的多核苷酸 |
CN105473722A (zh) | 2013-03-11 | 2016-04-06 | 先锋国际良种公司 | 用于改善植物中化学信号扩散的方法及组合物 |
CN105473721A (zh) | 2013-03-11 | 2016-04-06 | 先锋国际良种公司 | 采用磺酰脲类依赖型稳定化结构域的方法和组合物 |
US9273322B2 (en) | 2013-03-12 | 2016-03-01 | Pioneer Hi Bred International Inc | Root-preferred promoter and methods of use |
US9243258B2 (en) | 2013-03-12 | 2016-01-26 | Pioneer Hi Bred International Inc | Root-preferred promoter and methods of use |
GB201308828D0 (en) | 2013-03-12 | 2013-07-03 | Verenium Corp | Phytase |
US9803214B2 (en) | 2013-03-12 | 2017-10-31 | Pioneer Hi-Bred International, Inc. | Breeding pair of wheat plants comprising an MS45 promoter inverted repeat that confers male sterility and a construct that restores fertility |
US9498532B2 (en) | 2013-03-13 | 2016-11-22 | Novartis Ag | Antibody drug conjugates |
BR112015023272A2 (pt) | 2013-03-14 | 2017-07-18 | Pioneer Hi Bred Int | célula vegetal, planta, explante vegetal, semente transgênica, método para produzir uma célula vegetal tendo um polinucleotídeo heterólogo que codifica um polipeptídeo tendo atividade de dicamba descarboxilase, método para controlar plantas daninhas em um campo contendo uma cultura e método para controlar plantas daninhas em um campo contendo uma cultura |
PL2970934T3 (pl) | 2013-03-14 | 2018-01-31 | Evolva Inc | Polipeptydy syntazy walencenu, kodujące cząsteczki kwasu nukleinowego oraz ich zastosowania |
EP2970935A1 (en) | 2013-03-14 | 2016-01-20 | Pioneer Hi-Bred International, Inc. | Compositions having dicamba decarboxylase activity and methods of use |
GB201308843D0 (en) | 2013-03-14 | 2013-07-03 | Verenium Corp | Phytase formulation |
EP3611189A1 (en) | 2013-03-14 | 2020-02-19 | Novartis AG | Antibodies against notch 3 |
RU2015143825A (ru) | 2013-03-15 | 2017-04-26 | Пайонир Хай-Бред Интернэшнл, Инк. | Полипептиды phi-4 и способы их применения |
KR20210068606A (ko) | 2013-03-15 | 2021-06-09 | 오프로 테라퓨틱스 인코퍼레이션 | 점액 점도 정상화를 위한 생성물 및 방법 |
CN105451767B (zh) | 2013-03-15 | 2019-10-18 | 泽恩格尼亚股份有限公司 | 多价和单价多特异性复合物及其用途 |
US9789203B2 (en) | 2013-03-15 | 2017-10-17 | Novartis Ag | cKIT antibody drug conjugates |
CA2906556C (en) * | 2013-03-15 | 2022-07-05 | Gen9, Inc. | Compositions and methods for multiplex nucleic acids synthesis |
DK2976423T3 (en) | 2013-03-21 | 2019-03-18 | Novozymes As | Polypeptides with phospholipase A activity and polynucleotides encoding them |
CN105051174B (zh) | 2013-03-21 | 2018-04-03 | 诺维信公司 | 具有脂肪酶活性的多肽和编码它们的多核苷酸 |
CN105378050A (zh) | 2013-04-18 | 2016-03-02 | 诺维信公司 | 具有蛋白酶活性的多肽和编码它们的多核苷酸 |
KR102218930B1 (ko) | 2013-04-18 | 2021-02-23 | 코덱시스, 인코포레이티드 | 조작된 페닐알라닌 암모니아 리아제 폴리펩티드 |
CN111394202B (zh) | 2013-04-23 | 2022-04-26 | 诺维信公司 | 具有稳定的枯草杆菌蛋白酶的液体自动餐具清洗洗涤剂组合物 |
WO2014177541A2 (en) | 2013-04-30 | 2014-11-06 | Novozymes A/S | Glucoamylase variants and polynucleotides encoding same |
BR112015026972B1 (pt) | 2013-04-30 | 2023-05-02 | Novozymes A/S | Variantes de glucoamilase, composição, uso de um polipeptídeo, processo de produção de um produto de fermentação e processo de produção de um produto de xarope a partir de material contendo amido |
US20160075976A1 (en) | 2013-05-03 | 2016-03-17 | Novozymes A/S | Microencapsulation of Detergent Enzymes |
EP2994529B1 (en) | 2013-05-10 | 2018-11-21 | Novozymes A/S | Polypeptides having xylanase activity and polynucleotides encoding same |
US10351833B2 (en) | 2013-05-14 | 2019-07-16 | Novozymes A/S | Detergent compositions |
WO2014183921A1 (en) | 2013-05-17 | 2014-11-20 | Novozymes A/S | Polypeptides having alpha amylase activity |
EP3786269A1 (en) | 2013-06-06 | 2021-03-03 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
ES2891755T3 (es) | 2013-06-06 | 2022-01-31 | Pf Medicament | Anticuerpos anti-C10orf54 y utilizaciones de los mismos |
EP2816115A1 (en) | 2013-06-17 | 2014-12-24 | BASF Plant Science Company GmbH | Plants having one or more enhanced yield-related traits and a method for making the same |
WO2014202793A1 (en) | 2013-06-21 | 2014-12-24 | Novozymes A/S | Production of polypeptides without secretion signal in bacillus |
AR096601A1 (es) | 2013-06-21 | 2016-01-20 | Novartis Ag | Anticuerpos del receptor 1 de ldl oxidado similar a lectina y métodos de uso |
UY35620A (es) | 2013-06-21 | 2015-01-30 | Novartis Ag | Anticuerpos del receptor 1 de ldl oxidado similar a lectina y métodos de uso |
FI3013956T3 (fi) | 2013-06-27 | 2023-05-23 | Novozymes As | Subtilaasivariantteja ja niitä koodittavia polynukleotideja |
US20160145596A1 (en) | 2013-06-27 | 2016-05-26 | Novozymes A/S | Subtilase Variants and Polynucleotides Encoding Same |
WO2015001017A2 (en) | 2013-07-04 | 2015-01-08 | Novozymes A/S | Polypeptides having anti-redeposition effect and polynucleotides encoding same |
WO2015004102A1 (en) | 2013-07-09 | 2015-01-15 | Novozymes A/S | Polypeptides with lipase activity and polynucleotides encoding same |
WO2015006105A1 (en) | 2013-07-09 | 2015-01-15 | Board Of Trustees Of Michigan State University | Transgenic plants produced with a k-domain, and methods and expression cassettes related thereto |
US11459579B2 (en) | 2013-07-09 | 2022-10-04 | Board Of Trustees Of Michigan State University | Transgenic plants produced with a K-domain, and methods and expression cassettes related thereto |
US9951323B2 (en) | 2013-07-17 | 2018-04-24 | Novozymes A/S | Pullulanase chimeras and polynucleotides encoding same |
CN105408492A (zh) | 2013-07-25 | 2016-03-16 | 巴斯夫酶有限责任公司 | 肌醇六磷酸酶 |
CN105358684A (zh) | 2013-07-29 | 2016-02-24 | 诺维信公司 | 蛋白酶变体以及对其进行编码的多核苷酸 |
EP3339436B1 (en) | 2013-07-29 | 2021-03-31 | Henkel AG & Co. KGaA | Detergent composition comprising protease variants |
RU2670946C9 (ru) | 2013-07-29 | 2018-11-26 | Новозимс А/С | Варианты протеазы и кодирующие их полинуклеотиды |
DK3027733T3 (en) | 2013-07-31 | 2018-12-10 | Novozymes As | Preparation of 3-Hydroxypropionic Acid in Recombinant Yeast Expressing an Insect Aspartate-1 Decarboxylase |
ES2761587T3 (es) | 2013-08-07 | 2020-05-20 | Friedrich Miescher Institute For Biomedical Res | Nuevo método de cribado para el tratamiento de la ataxia de Friedreich |
WO2015021139A2 (en) | 2013-08-08 | 2015-02-12 | Pioneer Hi-Bred International, Inc. | Insecticidal polypeptides having broad spectrum activity and uses thereof |
UY35696A (es) | 2013-08-09 | 2015-03-27 | Athenix Corp | ?molécula de adn recombinante que comprende al gen de toxina axmi440, vector, célula huésped, plantas, composiciones y métodos relacionados?. |
WO2015038262A2 (en) | 2013-08-09 | 2015-03-19 | Athenix Corp. | Axmi281 toxin gene and methods for its use |
WO2015022429A1 (en) | 2013-08-15 | 2015-02-19 | Novozymes A/S | Polypeptides having beta-1,3-galactanase activity and polynucleotides encoding same |
EA030896B1 (ru) | 2013-08-16 | 2018-10-31 | Пайонир Хай-Бред Интернэшнл, Инк. | Инсектицидные белки и способы их применения |
US10395758B2 (en) | 2013-08-30 | 2019-08-27 | 10X Genomics, Inc. | Sequencing methods |
US20160201073A1 (en) | 2013-09-11 | 2016-07-14 | Pioneer Hi-Bred International, Inc. | Plant regulatory elements and methods of use thereof |
BR112016005543B1 (pt) | 2013-09-13 | 2022-03-08 | Pioneer Hi-Bred International, Inc | Polipeptídeo pip-72 recombinante, construto de dna, método de obtenção de planta transgênica, célula hospedeira, composição, proteína de fusão, método para controlar uma população de praga de inseto, método para inibir o crescimento ou matar uma praga de inseto, método para controlar uma infestação de insetos em uma planta transgênica, método para identificar em uma amostra biológica uma sequência de nucleotídeos, método para identificar em uma amostra um polipeptídeo pip-72 |
DK3046628T3 (da) | 2013-09-19 | 2020-02-10 | Univ Leland Stanford Junior | Fremgangsmåder og sammensætninger til fremstilling af hepatocyt-lignende celler |
WO2015048016A2 (en) | 2013-09-24 | 2015-04-02 | E. I. Du Pont De Nemours And Company | Fasciated inflorescence (fin) sequences and methods of use |
WO2015048572A1 (en) | 2013-09-27 | 2015-04-02 | Codexis, Inc. | Automated screening of enzyme variants |
WO2015050959A1 (en) | 2013-10-01 | 2015-04-09 | Yale University | Anti-kit antibodies and methods of use thereof |
WO2015049370A1 (en) | 2013-10-03 | 2015-04-09 | Novozymes A/S | Detergent composition and use of detergent composition |
WO2015059133A1 (en) | 2013-10-22 | 2015-04-30 | Novozymes A/S | Cellobiose dehydrogenase variants and polynucleotides encoding same |
WO2015073555A1 (en) | 2013-11-13 | 2015-05-21 | Codexis, Inc. | Engineered imine reductases and methods for the reductive amination of ketone and amine compounds |
WO2015077525A1 (en) | 2013-11-25 | 2015-05-28 | Bayer Cropscience Lp | Use of axmi-011 for the control of hemipteran insects |
EP2876156A1 (en) | 2013-11-26 | 2015-05-27 | Commissariat A L'energie Atomique Et Aux Energies Alternatives | New enzymes and method for preparing hydroxylated L-lysine or L-ornithine and analogs thereof |
CN105764330B (zh) | 2013-11-27 | 2019-04-30 | 纳幕尔杜邦公司 | 与对非生物胁迫的响应相关联的基因座 |
CN105793418A (zh) | 2013-11-29 | 2016-07-20 | 诺维信公司 | 过氧合酶变体 |
US9309314B2 (en) | 2013-12-03 | 2016-04-12 | Agency For Science, Technology And Research (A*Star) | Polypeptides, nucleic acids and uses thereof |
UA122475C2 (uk) | 2013-12-09 | 2020-11-10 | Атенікс Корп. | Ген токсину ахмі486 та спосіб його застосування |
KR102268532B1 (ko) | 2013-12-11 | 2021-06-24 | 노보자임스 에이/에스 | 큐티나아제 변이체 및 이를 암호화하는 폴리뉴클레오티드 |
US9824068B2 (en) | 2013-12-16 | 2017-11-21 | 10X Genomics, Inc. | Methods and apparatus for sorting data |
EP2886656A1 (en) | 2013-12-18 | 2015-06-24 | Commissariat A L'energie Atomique Et Aux Energies Alternatives | New enzyme and method for preparing 4-hydroxyl benzyl alcohol and derivatives thereof |
DK3083936T3 (en) | 2013-12-19 | 2018-10-22 | Danisco Us Inc | USE OF HYDROPHOBINES TO INCREASE GAS TRANSFER IN AEROBE FERMENTATION PROCESSES |
WO2015091989A1 (en) | 2013-12-20 | 2015-06-25 | Novozymes A/S | Polypeptides having protease activity and polynucleotides encoding same |
EP3087088B1 (en) | 2013-12-23 | 2022-05-25 | University Of Rochester | Methods and compositions for ribosomal synthesis of macrocyclic peptides |
NZ630311A (en) | 2013-12-27 | 2016-03-31 | Celgene Corp | Romidepsin formulations and uses thereof |
EP2896698A1 (en) | 2014-01-17 | 2015-07-22 | BASF Plant Science Company GmbH | Plants having one or more enhanced yield-related traits and a method for making the same |
CN105849121B (zh) | 2014-01-22 | 2020-12-29 | 诺维信公司 | 具有脂肪酶活性的多肽和编码它们的多核苷酸 |
HUE056192T2 (hu) | 2014-01-22 | 2022-01-28 | Novozymes As | Pullulanázvariánsok és azokat kódoló polinukleotidok |
RU2701434C2 (ru) | 2014-01-24 | 2019-09-26 | Нгм Биофармасьютикалс, Инк. | Связывающие белки и способы их применения |
EP3099799B1 (en) | 2014-01-28 | 2019-05-15 | Dice Molecules SV. LLC | Arrays of monoliths with attached recognition compounds |
WO2015116680A1 (en) | 2014-01-30 | 2015-08-06 | Two Blades Foundation | Plants with enhanced resistance to phytophthora |
BR112016018103B1 (pt) | 2014-02-07 | 2024-01-16 | E.I. Du Pont De Nemours And Company | Polipeptídeo e seu uso, polinucleotídeo, composição, proteína de fusão, método para controlar uma população, método para inibir o crescimento, método para controlar a infestação, método para obtenção de uma planta ou célula vegetal, construto |
BR112016018287A2 (pt) | 2014-02-07 | 2017-10-10 | Du Pont | proteínas inseticidas e métodos para uso das mesmas |
EP2910640B1 (en) | 2014-02-25 | 2018-12-05 | Biopract GmbH | A method for improving substrate degradation in agricultural biogas plants |
GB201403775D0 (en) | 2014-03-04 | 2014-04-16 | Kymab Ltd | Antibodies, uses & methods |
EA201691827A1 (ru) | 2014-03-12 | 2017-01-30 | Новартис Аг | Конкретные участки для модификации антител с целью получения иммуноконъюгатов |
CN106103721B (zh) | 2014-03-12 | 2020-01-03 | 诺维信公司 | 具有脂肪酶活性的多肽和编码它们的多核苷酸 |
WO2015143144A1 (en) | 2014-03-19 | 2015-09-24 | Novozymes A/S | Method for enhancing activity of an x143 polypeptide |
EP4163354A3 (en) | 2014-03-19 | 2023-08-30 | Novozymes A/S | Polypeptides having phospholipase c activity and polynucleotides encoding same |
EP3126479A1 (en) | 2014-04-01 | 2017-02-08 | Novozymes A/S | Polypeptides having alpha amylase activity |
EP3126509A1 (en) | 2014-04-01 | 2017-02-08 | DuPont Nutrition Biosciences ApS | Method for increasing crude palm oil yields |
CN106536556B (zh) | 2014-04-04 | 2020-02-07 | 生态学有限公司 | 结合lgr5的人源化抗体 |
EP3550015B1 (en) | 2014-04-10 | 2021-11-10 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
AU2015243445B2 (en) | 2014-04-10 | 2020-05-28 | 10X Genomics, Inc. | Fluidic devices, systems, and methods for encapsulating and partitioning reagents, and applications of same |
DK3129457T3 (en) | 2014-04-11 | 2018-09-17 | Novozymes As | detergent |
EP3131921B1 (en) | 2014-04-15 | 2020-06-10 | Novozymes A/S | Polypeptides with lipase activity and polynucleotides encoding same |
US9605252B2 (en) | 2014-04-16 | 2017-03-28 | Codexis, Inc. | Engineered tyrosine ammonia lyase |
WO2015158800A1 (en) | 2014-04-17 | 2015-10-22 | Boehringer Ingelheim Rcv Gmbh & Co Kg | Recombinant host cell for expressing proteins of interest |
EP3132028B1 (en) | 2014-04-17 | 2023-10-25 | Boehringer Ingelheim RCV GmbH & Co KG | Recombinant host cell engineered to overexpress helper proteins |
US10053702B2 (en) | 2014-04-22 | 2018-08-21 | E I Du Pont De Nemours And Company | Plastidic carbonic anhydrase genes for oil augmentation in seeds with increased DGAT expression |
WO2015171603A1 (en) | 2014-05-06 | 2015-11-12 | Two Blades Foundation | Methods for producing plants with enhanced resistance to oomycete pathogens |
CA2948491C (en) | 2014-05-09 | 2024-01-16 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Vaccines against genital herpes simplex infections |
EP3143135B1 (en) | 2014-05-15 | 2019-04-10 | Novozymes A/S | Compositions comprising polypeptides having phospholipase c activity and use thereof |
US10023852B2 (en) | 2014-05-27 | 2018-07-17 | Novozymes A/S | Lipase variants and polynucleotides encoding same |
CA2950273C (en) | 2014-05-30 | 2022-06-21 | Novozymes A/S | Variants of gh family 11 xylanase and polynucleotides encoding same |
EP2952584A1 (en) | 2014-06-04 | 2015-12-09 | Boehringer Ingelheim RCV GmbH & Co KG | Improved protein production |
CN106414729A (zh) | 2014-06-12 | 2017-02-15 | 诺维信公司 | α‑淀粉酶变体以及对其进行编码的多核苷酸 |
WO2015189816A1 (en) | 2014-06-13 | 2015-12-17 | Friedrich Miescher Institute For Biomedical Research | New treatment against influenza virus |
EP2957571B1 (en) | 2014-06-17 | 2018-08-15 | Centre National De La Recherche Scientifique (Cnrs) | Monoclonal anti-pvhl antibodies and uses thereof |
JP6655074B2 (ja) | 2014-06-20 | 2020-02-26 | ジェネンテック, インコーポレイテッド | シャガシンに基づく足場組成物、方法及び使用 |
EP3160991A2 (en) | 2014-06-25 | 2017-05-03 | Novartis AG | Compositions and methods for long acting proteins |
WO2015200659A1 (en) | 2014-06-25 | 2015-12-30 | Novozymes A/S | Xylanase variants and polynucleotides encoding same |
EP3160990A2 (en) | 2014-06-25 | 2017-05-03 | Novartis AG | Compositions and methods for long acting proteins |
KR20170023979A (ko) | 2014-06-26 | 2017-03-06 | 10엑스 제노믹스, 인크. | 핵산 서열 조립을 위한 프로세스 및 시스템 |
EP4053292A1 (en) | 2014-06-26 | 2022-09-07 | 10X Genomics, Inc. | Methods of analyzing nucleic acids from individual cells or cell populations |
WO2016001319A1 (en) | 2014-07-03 | 2016-01-07 | Novozymes A/S | Improved stabilization of non-protease enzyme |
EP3164486B1 (en) | 2014-07-04 | 2020-05-13 | Novozymes A/S | Subtilase variants and polynucleotides encoding same |
US10550381B2 (en) | 2014-07-04 | 2020-02-04 | Novozymes A/S | Variant proteases and amylases having enhanced storage stability |
DK3167052T3 (da) | 2014-07-09 | 2020-02-10 | Codexis Inc | P450-bm3-varianter med forbedret aktivitet |
WO2016020791A1 (en) | 2014-08-05 | 2016-02-11 | Novartis Ag | Ckit antibody drug conjugates |
EP3194437B1 (en) | 2014-08-07 | 2021-01-20 | Novartis AG | Angiopoietin-like 4 (angptl4) antibodies and methods of use |
DK3177642T3 (da) | 2014-08-07 | 2022-02-21 | Novartis Ag | Angiopoietin-lignende 4-antistoffer og fremgangsmåder til anvendelse deraf |
US20170218384A1 (en) | 2014-08-08 | 2017-08-03 | Pioneer Hi-Bred International, Inc. | Ubiquitin promoters and introns and methods of use |
KR20170040249A (ko) | 2014-08-12 | 2017-04-12 | 노파르티스 아게 | 항-cdh6 항체 약물 접합체 |
US20170267980A1 (en) | 2014-08-20 | 2017-09-21 | Novozymes A/S | Xyloglucan Endotransglycosylase variants and Polynucleotides Encoding Same |
EP3778891A1 (en) | 2014-08-27 | 2021-02-17 | New England Biolabs, Inc. | Synthon formation |
US9963687B2 (en) | 2014-08-27 | 2018-05-08 | New England Biolabs, Inc. | Fusion polymerase and method for using the same |
US11390898B2 (en) | 2014-09-05 | 2022-07-19 | Novozymes A/S | Polypeptides having cellobiohydrolase activity and polynucleotides encoding same |
WO2016040788A1 (en) | 2014-09-11 | 2016-03-17 | Promega Corporation | Luciferase sequences utilizing infrared-emitting substrates to produce enhanced luminescence |
CA2956487A1 (en) | 2014-09-12 | 2016-03-17 | E. I. Du Pont De Nemours And Company | Generation of site-specific-integration sites for complex trait loci in corn and soybean, and methods of use |
EP3197557A1 (en) | 2014-09-24 | 2017-08-02 | Friedrich Miescher Institute for Biomedical Research | Lats and breast cancer |
MA41044A (fr) | 2014-10-08 | 2017-08-15 | Novartis Ag | Compositions et procédés d'utilisation pour une réponse immunitaire accrue et traitement contre le cancer |
CA2963558C (en) | 2014-10-16 | 2023-04-04 | Pioneer Hi-Bred International, Inc. | Insecticidal proteins and methods for their use |
UA125168C2 (uk) | 2014-10-16 | 2022-01-26 | Піонір Хай-Бред Інтернешнл, Інк. | ВАРІАНТНИЙ ПОЛІПЕПТИД Cry1B |
CA2963550A1 (en) | 2014-10-16 | 2016-04-21 | Pioneer Hi-Bred International, Inc. | Insecticidal polypeptides having broad spectrum activity and uses thereof |
GB201418713D0 (en) | 2014-10-21 | 2014-12-03 | Kymab Ltd | Bindings Proteins |
EP3209788B1 (en) | 2014-10-23 | 2019-06-05 | Novozymes A/S | Glucoamylase variants and polynucleotides encoding same |
EP3172329A1 (en) | 2014-10-24 | 2017-05-31 | Danisco US Inc. | Method for producing alcohol by use of a tripeptidyl peptidase |
DK3209773T3 (da) | 2014-10-24 | 2020-06-15 | Dupont Nutrition Biosci Aps | Prolintolerante tripeptidylpeptidaser og anvendelser deraf |
WO2016069939A1 (en) | 2014-10-29 | 2016-05-06 | 10X Genomics, Inc. | Methods and compositions for targeted nucleic acid sequencing |
US9975122B2 (en) | 2014-11-05 | 2018-05-22 | 10X Genomics, Inc. | Instrument systems for integrated sample processing |
WO2016073610A1 (en) | 2014-11-07 | 2016-05-12 | Novozymes A/S | Xylanase based bleach boosting |
US10005836B2 (en) | 2014-11-14 | 2018-06-26 | Novartis Ag | Antibody drug conjugates |
US10287562B2 (en) | 2014-11-20 | 2019-05-14 | Novoszymes A/S | Alicyclobacillus variants and polynucleotides encoding same |
WO2016085916A1 (en) | 2014-11-25 | 2016-06-02 | Codexis, Inc. | Engineered imine reductases and methods for the reductive amination of ketone and amine compounds |
WO2016087327A1 (en) | 2014-12-01 | 2016-06-09 | Novozymes A/S | Polypeptides having pullulanase activity comprising the x25, x45 and cbm41 domains |
EP3227438B1 (en) | 2014-12-02 | 2024-03-27 | Novozymes A/S | Laccase variants and polynucleotides encoding same |
EP4339282A2 (en) | 2014-12-04 | 2024-03-20 | Novozymes A/S | Liquid cleaning compositions comprising protease variants |
CN107075493B (zh) | 2014-12-04 | 2020-09-01 | 诺维信公司 | 枯草杆菌酶变体以及编码它们的多核苷酸 |
US10457921B2 (en) | 2014-12-05 | 2019-10-29 | Novozymes A/S | Lipase variants and polynucleotides encoding same |
ES2934940T3 (es) | 2014-12-11 | 2023-02-28 | Pf Medicament | Anticuerpos anti-C10orf54 y utilizaciones de los mismos |
MA41142A (fr) | 2014-12-12 | 2017-10-17 | Amgen Inc | Anticorps anti-sclérostine et utilisation de ceux-ci pour traiter des affections osseuses en tant qu'élements du protocole de traitement |
CA2969672A1 (en) | 2014-12-12 | 2016-06-16 | Syngenta Participations Ag | Compositions and methods for controlling plant pests |
CA2971425A1 (en) | 2014-12-16 | 2016-06-23 | Pioneer Hi-Bred International, Inc. | Restoration of male fertility in wheat |
WO2016096996A1 (en) | 2014-12-16 | 2016-06-23 | Novozymes A/S | Polypeptides having n-acetyl glucosamine oxidase activity |
ES2813727T3 (es) | 2014-12-19 | 2021-03-24 | Novozymes As | Variantes de proteasa y polinucleótidos que las codifican |
WO2016100910A1 (en) | 2014-12-19 | 2016-06-23 | Novozymes A/S | Recombinant host cells for the production of 3-hydroxypropionic acid |
UY36449A (es) | 2014-12-19 | 2016-07-29 | Novartis Ag | Composiciones y métodos para anticuerpos dirigidos a bmp6 |
WO2016097352A1 (en) | 2014-12-19 | 2016-06-23 | Novozymes A/S | Protease variants and polynucleotides encoding same |
WO2016095856A1 (en) | 2014-12-19 | 2016-06-23 | Novozymes A/S | Compositions comprising polypeptides having xylanase activity and polypeptides having arabinofuranosidase activity |
LT3237621T (lt) | 2014-12-22 | 2023-09-25 | Codexis, Inc. | Žmogaus alfa-galaktozidazės variantai |
CA2972969A1 (en) | 2015-01-12 | 2016-07-21 | 10X Genomics, Inc. | Processes and systems for preparing nucleic acid sequencing libraries and libraries prepared using same |
EP3245605B1 (en) | 2015-01-13 | 2022-04-20 | 10X Genomics, Inc. | Systems and methods for visualizing structural variation and phasing information |
EP3262062A1 (en) | 2015-02-04 | 2018-01-03 | Pioneer Hi-Bred International, Inc. | Novel bt toxin receptors and methods of use |
AU2016219488A1 (en) | 2015-02-09 | 2017-09-14 | Bioconsortia, Inc. | Agriculturally beneficial microbes, microbial compositions, and consortia |
WO2016130578A1 (en) | 2015-02-09 | 2016-08-18 | 10X Genomics, Inc. | Systems and methods for determining structural variation and phasing using variant call data |
US10696953B2 (en) | 2015-02-10 | 2020-06-30 | Codexis, Inc. | Ketoreductase polypeptides for the synthesis of chiral compounds |
KR20170117403A (ko) | 2015-02-12 | 2017-10-23 | 디에스엠 아이피 어셋츠 비.브이. | 소과 동물에서 사료 소화율을 개선시키는 방법 |
WO2016138148A1 (en) | 2015-02-24 | 2016-09-01 | 10X Genomics, Inc. | Methods for targeted nucleic acid sequence coverage |
EP3262407B1 (en) | 2015-02-24 | 2023-08-30 | 10X Genomics, Inc. | Partition processing methods and systems |
US10557127B2 (en) | 2015-02-24 | 2020-02-11 | Novozymes A/S | Cellobiohydrolase variants and polynucleotides encoding same |
WO2016138315A1 (en) | 2015-02-25 | 2016-09-01 | Danisco Us Inc | Alpha-glucosidase, compositions & methods |
CN107406821B (zh) | 2015-02-27 | 2021-10-15 | 诺维信公司 | 用于生产3-羟基丙酸的突变宿主细胞 |
MX2017011194A (es) | 2015-03-03 | 2018-04-10 | Kymab Ltd | Anticuerpos, usos y métodos. |
WO2016144688A1 (en) | 2015-03-11 | 2016-09-15 | Pioneer Hi Bred International Inc | Insecticidal combinations of pip-72 and methods of use |
EP3268483A1 (en) | 2015-03-11 | 2018-01-17 | Genencor International B.V. | Enzymatic activity of lytic polysaccharide monooxygenase |
EP3842451A1 (en) | 2015-03-12 | 2021-06-30 | MedImmune, LLC | Method of purifying albumin-fusion proteins |
CN107429207A (zh) | 2015-03-19 | 2017-12-01 | 诺维信公司 | 一种酿造方法 |
EP3070103A1 (en) | 2015-03-19 | 2016-09-21 | Institut Hospitalier Universitaire De Strasbourg | Anti-Claudin 1 monoclonal antibodies for the prevention and treatment of hepatocellular carcinoma |
US11492632B2 (en) | 2015-03-19 | 2022-11-08 | Pioneer Hi-Bred International, Inc. | Methods and compositions for accelerated trait introgression |
WO2016164596A2 (en) | 2015-04-07 | 2016-10-13 | Novozymes A/S | Methods for selecting enzymes having lipase activity |
WO2016164583A2 (en) | 2015-04-07 | 2016-10-13 | Novozymes A/S | Methods for selecting enzymes having enhanced activity |
US20180105772A1 (en) | 2015-04-10 | 2018-04-19 | Novozymes A/S | Detergent composition |
WO2016162556A1 (en) | 2015-04-10 | 2016-10-13 | Novozymes A/S | Laundry method, use of dnase and detergent composition |
EP3283504A1 (en) | 2015-04-17 | 2018-02-21 | Agbiome, Inc. | Pesticidal genes and methods of use |
CA2981088A1 (en) | 2015-04-22 | 2016-10-27 | AgBiome, Inc. | Pesticidal genes and methods of use |
US20180142251A1 (en) | 2015-05-06 | 2018-05-24 | Pioneer Hi-Bred International, Inc. | Methods and compositions for the production of unreduced, non-recombined gametes and clonal offspring |
KR102604503B1 (ko) | 2015-05-07 | 2023-11-20 | 코덱시스, 인코포레이티드 | 페니실린-g 아실라아제 |
AU2016259703B2 (en) | 2015-05-08 | 2021-12-23 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
US20180142224A1 (en) | 2015-05-08 | 2018-05-24 | Novozymes A/S | Alpha-amylase variants having improved performance and stability |
CN107750275A (zh) | 2015-05-08 | 2018-03-02 | 诺维信公司 | α‑淀粉酶变体以及编码它们的多核苷酸 |
CN107709564B (zh) | 2015-05-09 | 2021-11-02 | 双刃基金会 | 来自少花龙葵的抗晚疫病基因及使用方法 |
CN108064233B (zh) | 2015-05-19 | 2022-07-15 | 先锋国际良种公司 | 杀昆虫蛋白及其使用方法 |
JP6867302B2 (ja) | 2015-05-21 | 2021-04-28 | フル スペクトラム ジェネティクス, インコーポレイテッド | タンパク質の特徴を改善する方法 |
WO2016188459A1 (en) | 2015-05-27 | 2016-12-01 | Novozymes A/S | Polypeptides having cellobiohydrolase activity and polynucleotides encoding same |
WO2016196202A1 (en) | 2015-05-29 | 2016-12-08 | Novozymes A/S | Polypeptides having protease activity and polynucleotides encoding same |
EP3960864A3 (en) | 2015-06-03 | 2022-06-15 | Agbiome, Inc. | Pesticidal genes and methods of use |
WO2016193420A1 (en) | 2015-06-04 | 2016-12-08 | Novozymes A/S | Use of m4 metalloprotease in wort production |
PE20180041A1 (es) | 2015-06-05 | 2018-01-09 | Novartis Ag | Anticuerpos dirigidos a la proteina morfogenetica osea (bmp9) y metodos a partir de estos |
EP3310908B1 (en) | 2015-06-16 | 2020-08-05 | Novozymes A/S | Polypeptides with lipase activity and polynucleotides encoding same |
CA2985490A1 (en) | 2015-06-17 | 2016-12-22 | E.I. Du Pont De Nemours And Company | Plant regulatory elements and methods of use thereof |
US20190194315A1 (en) | 2015-06-17 | 2019-06-27 | Novartis Ag | Antibody drug conjugates |
CA2981342A1 (en) | 2015-06-18 | 2016-12-22 | Novozymes A/S | Polypeptides having trehalase activity and the use thereof in process of producing fermentation products |
EP3106508B1 (en) | 2015-06-18 | 2019-11-20 | Henkel AG & Co. KGaA | Detergent composition comprising subtilase variants |
US11162089B2 (en) | 2015-06-18 | 2021-11-02 | Novozymes A/S | Subtilase variants and polynucleotides encoding same |
WO2016209708A1 (en) | 2015-06-22 | 2016-12-29 | AgBiome, Inc. | Pesticidal genes and methods of use |
DK3313999T3 (da) | 2015-06-24 | 2021-08-02 | Genencor Int Bv | Polypeptider med demethyleringsaktivitet |
TW201713775A (zh) | 2015-06-25 | 2017-04-16 | 亞斯科生物科學公司 | 用於自複雜的異源群集中分析微生物品系、預測及識別其機能性關係及交互作用,且依據前述選擇並合成微生物系集之方法、裝置及系統 |
US9938558B2 (en) | 2015-06-25 | 2018-04-10 | Ascus Biosciences, Inc. | Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon |
US10632157B2 (en) | 2016-04-15 | 2020-04-28 | Ascus Biosciences, Inc. | Microbial compositions and methods of use for improving fowl production |
US10851399B2 (en) | 2015-06-25 | 2020-12-01 | Native Microbials, Inc. | Methods, apparatuses, and systems for microorganism strain analysis of complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon |
US20180317514A1 (en) | 2015-06-26 | 2018-11-08 | Novozymes A/S | Method for Producing a Coffee Extract |
EP3313990A4 (en) | 2015-06-26 | 2019-01-23 | Novozymes A/S | BIOLOGICAL FINISHING TREATMENT SYSTEM |
WO2016207373A1 (en) | 2015-06-26 | 2016-12-29 | Novozymes A/S | Polypeptides having peroxygenase activity |
JOP20200312A1 (ar) | 2015-06-26 | 2017-06-16 | Novartis Ag | الأجسام المضادة للعامل xi وطرق الاستخدام |
US11473073B2 (en) | 2015-06-26 | 2022-10-18 | Dupont Nutrition Biosciences Aps | Aminopeptidases for protein hydrolyzates |
EP3317407B1 (en) | 2015-07-01 | 2021-05-19 | Novozymes A/S | Methods of reducing odor |
US10945449B2 (en) | 2015-07-02 | 2021-03-16 | Novozymes A/S | Animal feed compositions and uses thereof |
CN114292829A (zh) | 2015-07-06 | 2022-04-08 | 诺维信公司 | 脂肪酶变体以及编码它们的多核苷酸 |
CN108271374B (zh) | 2015-07-07 | 2021-09-21 | 科德克希思公司 | 具有改进的活性的新颖p450-bm3变体 |
WO2017019491A1 (en) | 2015-07-24 | 2017-02-02 | Novozymes Inc. | Polypeptides having beta-xylosidase activity and polynucleotides encoding same |
US10577594B2 (en) | 2015-07-24 | 2020-03-03 | Novozymes, Inc. | Polypeptides having arabinofuranosidase activity and polynucleotides encoding same |
CA2993188A1 (en) | 2015-07-25 | 2017-02-02 | Bioconsortia, Inc. | Agriculturally beneficial microbes, microbial compositions, and consortia |
EP3331914A1 (en) | 2015-08-03 | 2018-06-13 | Novartis AG | Methods of treating fgf21-associated disorders |
EP3331352B1 (en) | 2015-08-06 | 2022-07-06 | Pioneer Hi-Bred International, Inc. | Plant derived insecticidal proteins and methods for their use |
JP7007261B2 (ja) | 2015-08-20 | 2022-01-24 | アルブミディクス リミティド | アルブミン変異体及びコンジュゲート |
US20180265902A1 (en) | 2015-08-24 | 2018-09-20 | Novozymes A/S | Beta-Alanine Aminotransferases For The Production of 3-Hydroxypropionic Acid |
EP3347466B1 (en) | 2015-09-08 | 2024-01-03 | Cold Spring Harbor Laboratory | Genetic copy number determination using high throughput multiplex sequencing of smashed nucleotides |
DK3347377T3 (da) | 2015-09-09 | 2021-05-10 | Novartis Ag | Tymisk stromal lymfopoietin (TSLP)-bindende antistoffer og fremgangsmåder til anvendelse af antistofferne |
TWI799366B (zh) | 2015-09-15 | 2023-04-21 | 美商建南德克公司 | 胱胺酸結骨架平臺 |
JP6956709B2 (ja) | 2015-09-22 | 2021-11-02 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | Ompgバリアント |
EP3353195B1 (en) | 2015-09-22 | 2021-11-10 | Novozymes A/S | Polypeptides having cellobiohydrolase activity and polynucleotides encoding same |
AU2016332725A1 (en) | 2015-09-29 | 2018-03-22 | Celgene Corporation | PD-1 binding proteins and methods of use thereof |
WO2017062343A1 (en) | 2015-10-06 | 2017-04-13 | Pierce Biotechnology, Inc. | Devices and methods for producing nucleic acids and proteins |
WO2017060505A1 (en) | 2015-10-07 | 2017-04-13 | Novozymes A/S | Polypeptides |
WO2017062790A1 (en) | 2015-10-09 | 2017-04-13 | Two Blades Foundation | Cold shock protein receptors and methods of use |
WO2017064253A1 (en) | 2015-10-14 | 2017-04-20 | Novozymes A/S | Polypeptides having protease activity and polynucleotides encoding same |
DK3362574T3 (da) | 2015-10-14 | 2021-10-11 | Novozymes As | Glucoamylasevarianter og polynukleotider, der koder for dem |
WO2017066510A1 (en) | 2015-10-14 | 2017-04-20 | Novozymes A/S | Cleaning of water filtration membranes |
WO2017064269A1 (en) | 2015-10-14 | 2017-04-20 | Novozymes A/S | Polypeptide variants |
WO2017070219A1 (en) | 2015-10-20 | 2017-04-27 | Novozymes A/S | Lytic polysaccharide monooxygenase (lpmo) variants and polynucleotides encoding same |
CA2996749C (en) | 2015-10-28 | 2023-10-10 | Novozymes A/S | Detergent composition comprising amylase and protease variants |
WO2017072669A1 (en) | 2015-10-28 | 2017-05-04 | Friedrich Miescher Institute For Biomedical Research | Tenascin-w and biliary tract cancers |
ITUB20155272A1 (it) | 2015-11-02 | 2017-05-02 | Scuola Normale Superiore | Intracellular antibody |
CN108770333B (zh) | 2015-11-03 | 2022-12-09 | 双刃基金会 | 小麦条锈病抗性基因及其使用方法 |
BR112018007796A2 (pt) | 2015-11-06 | 2018-10-30 | Du Pont | plantas de soja, partes de plantas de soja ou sementes de soja, método para selecionar uma célula de soja, métodos de seleção de uma célula de soja e de produção de um locus e molécula de ácido nucleico |
WO2017089366A1 (en) | 2015-11-24 | 2017-06-01 | Novozymes A/S | Polypeptides having protease activity and polynucleotides encoding same |
WO2017095698A1 (en) | 2015-11-30 | 2017-06-08 | Pioneer Hi-Bred International, Inc. | Plant regulatory elements and methods of use thereof |
US10870838B2 (en) | 2015-12-01 | 2020-12-22 | Novozymes A/S | Methods for producing lipases |
CN115369161A (zh) | 2015-12-04 | 2022-11-22 | 10X 基因组学有限公司 | 用于核酸分析的方法和组合物 |
WO2017100376A2 (en) | 2015-12-07 | 2017-06-15 | Zymergen, Inc. | Promoters from corynebacterium glutamicum |
US10035995B2 (en) | 2015-12-07 | 2018-07-31 | Eastman Chemical Company | CALB variants |
JP2018537099A (ja) | 2015-12-07 | 2018-12-20 | ノボザイムス アクティーゼルスカブ | ベータ−グルカナーゼ活性を有するポリペプチド、これをコードするポリヌクレオチド、ならびにクリーニング組成物中でのおよび洗剤組成物中でのこの使用 |
US9988624B2 (en) | 2015-12-07 | 2018-06-05 | Zymergen Inc. | Microbial strain improvement by a HTP genomic engineering platform |
US11208649B2 (en) | 2015-12-07 | 2021-12-28 | Zymergen Inc. | HTP genomic engineering platform |
EP3858996B1 (en) | 2015-12-07 | 2022-08-03 | Zymergen Inc. | Microbial strain improvement by a htp genomic engineering platform |
UY37030A (es) | 2015-12-18 | 2017-07-31 | Novartis Ag | Anticuerpos dirigidos a cd32b y métodos de uso de los mismos |
WO2017105987A1 (en) | 2015-12-18 | 2017-06-22 | Pioneer Hi-Bred International, Inc. | Insecticidal proteins and methods for their use |
CA3222614A1 (en) | 2015-12-22 | 2017-06-29 | AgBiome, Inc. | Pesticidal genes and methods of use |
BR112018012851A2 (pt) | 2015-12-22 | 2018-12-26 | Albumedix Ltd | cepas de expressão de proteína melhoradas |
JP6871252B2 (ja) | 2015-12-22 | 2021-05-12 | パイオニア ハイ−ブレッド インターナショナル, インコーポレイテッド | 組織優先的プロモーターおよびその使用方法 |
MX2018007485A (es) | 2015-12-30 | 2018-08-01 | Novozymes As | Variantes de enzimas y polinucleotidos que las codifican. |
CA3010505A1 (en) | 2016-01-07 | 2017-07-13 | Ascus Biosciences, Inc. | Methods for improving milk production by administration of microbial consortia |
ES2847155T3 (es) | 2016-01-21 | 2021-08-02 | Novartis Ag | Moléculas multiespecíficas que fijan como objetivo CLL-1 |
CN108884451A (zh) | 2016-01-29 | 2018-11-23 | 诺维信公司 | β-葡聚糖酶变体以及编码它们的多核苷酸 |
JP6735348B2 (ja) | 2016-02-11 | 2020-08-05 | 10エックス ジェノミクス, インコーポレイテッド | 全ゲノム配列データのデノボアセンブリのためのシステム、方法及び媒体 |
GB201602535D0 (en) | 2016-02-12 | 2016-03-30 | Univ Edinburgh | Improved flu vaccine yield |
US11685911B2 (en) | 2016-02-16 | 2023-06-27 | Monaghan Mushroom S Group | Fungal polypeptides having lysozyme activity |
EP3419992B1 (en) | 2016-02-22 | 2020-11-18 | Danisco US Inc. | Fungal high-level protein production system |
US10988749B2 (en) | 2016-02-23 | 2021-04-27 | Da Volterra | Beta-lactamase variants |
PT3420078T (pt) | 2016-02-23 | 2022-07-13 | Da Volterra | Variantes da beta-lactamase |
BR112018015589A2 (pt) | 2016-02-25 | 2019-10-01 | Dupont Nutrition Biosci Aps | método para produzir hidrolisado de proteína que emprega uma tripeptidil peptidase de aspergillus fumigatus |
ES2880331T3 (es) | 2016-02-29 | 2021-11-24 | Genia Tech Inc | Variantes de polimerasa |
US10738293B2 (en) | 2016-03-02 | 2020-08-11 | Novozymes A/S | Cellobiohydrolase variants and polynucleotides encoding same |
GB201604124D0 (en) | 2016-03-10 | 2016-04-27 | Ucb Biopharma Sprl | Pharmaceutical formulation |
CA3018081A1 (en) | 2016-03-22 | 2017-09-28 | Bionomics Limited | Administration of an anti-lgr5 monoclonal antibody |
DK3433358T3 (da) | 2016-03-24 | 2022-09-26 | Novozymes As | Cellobiohydrolasevarianter og polynukleotider, der koder for dem |
US9988641B2 (en) | 2016-04-05 | 2018-06-05 | Corn Products Development, Inc. | Compositions and methods for producing starch with novel functionality |
CN109312333A (zh) | 2016-04-07 | 2019-02-05 | 诺维信公司 | 选择具有蛋白酶活性的酶的方法 |
CA3012362A1 (en) | 2016-04-14 | 2017-10-19 | Pioneer Hi-Bred International, Inc. | Insecticidal polypeptides having improved activity spectrum and uses thereof |
EP3442548A4 (en) | 2016-04-15 | 2020-02-26 | Ascus Biosciences, Inc. | METHOD FOR IMPROVING AGRICULTURAL PRODUCTION OF POULTRY BY ADMINISTERING MICROBIAL CONSORTIES OR PURIFIED STRAINS THEREOF |
US11028407B2 (en) | 2016-04-19 | 2021-06-08 | Pioneer Hi-Bred International, Inc. | Insecticidal combinations of polypeptides having improved activity spectrum and uses thereof |
JP7138567B2 (ja) | 2016-04-27 | 2022-09-16 | ノバルティス アーゲー | 成長分化因子15に対する抗体およびそれらの使用 |
BR112018072282A2 (pt) | 2016-04-29 | 2019-02-12 | Novozymes A/S | composições detergentes e usos das mesmas |
CA3022497A1 (en) | 2016-04-29 | 2017-11-02 | Defensin Therapeutics Aps | Treatment of liver, biliary tract and pancreatic disorders |
CN109415421B (zh) | 2016-05-03 | 2023-02-28 | 诺维信公司 | α-淀粉酶变体以及编码它们的多核苷酸 |
US11008585B2 (en) | 2016-05-04 | 2021-05-18 | Pioneer Hi-Bred International, Inc. | Insecticidal proteins and methods for their use |
EP3452587B1 (en) | 2016-05-05 | 2021-09-08 | Codexis, Inc. | Penicillin-g acylases |
MX2018013556A (es) | 2016-05-09 | 2019-03-14 | Novozymes As | Polipeptidos variantes con rendimiento mejorado y uso de los mismos. |
WO2017197338A1 (en) | 2016-05-13 | 2017-11-16 | 10X Genomics, Inc. | Microfluidic systems and methods of use |
EP3246401A1 (en) | 2016-05-20 | 2017-11-22 | Commissariat À L'Énergie Atomique Et Aux Énergies Alternatives | New fatty acid decarboxylase and its uses |
EP3464580A1 (en) | 2016-05-24 | 2019-04-10 | Novozymes A/S | Compositions comprising polypeptides having galactanase activity and polypeptides having beta-galactosidase activity |
US10927359B2 (en) | 2016-05-24 | 2021-02-23 | Novozymes A/S | Compositions comprising polypeptides having galactanase activity and polypeptides having beta-galactosidase activity |
US11058129B2 (en) | 2016-05-24 | 2021-07-13 | Novozymes A/S | Animal feed additives |
US10808268B2 (en) | 2016-05-24 | 2020-10-20 | Novozymes A/S | Polypeptides having alpha-galactosidase activity and polynucleotides encoding same |
TW201802121A (zh) | 2016-05-25 | 2018-01-16 | 諾華公司 | 抗因子XI/XIa抗體之逆轉結合劑及其用途 |
WO2017205535A1 (en) | 2016-05-27 | 2017-11-30 | Novozymes, Inc. | Polypeptides having endoglucanase activity and polynucleotides encoding same |
US20190218479A1 (en) | 2016-05-31 | 2019-07-18 | Novozymes A/S | Stabilized Liquid Peroxide Compositions |
CN109715792A (zh) | 2016-06-03 | 2019-05-03 | 诺维信公司 | 枯草杆菌酶变体和对其进行编码的多核苷酸 |
WO2017211803A1 (en) | 2016-06-07 | 2017-12-14 | Novozymes A/S | Co-expression of heterologous polypeptides to increase yield |
US10184117B2 (en) | 2016-06-09 | 2019-01-22 | Codexis, Inc. | Biocatalysts and methods for hydroxylation of chemical compounds |
WO2017216724A1 (en) | 2016-06-15 | 2017-12-21 | Novartis Ag | Methods for treating disease using inhibitors of bone morphogenetic protein 6 (bmp6) |
KR20190018512A (ko) | 2016-06-15 | 2019-02-22 | 코덱시스, 인코포레이티드 | 조작된 베타-글루코시다아제 및 글루코실화 방법 |
WO2017215790A1 (en) | 2016-06-17 | 2017-12-21 | National Hellenic Research Foundation | Systems for recombinant protein production |
EP3475430B1 (en) | 2016-06-24 | 2022-06-01 | Pioneer Hi-Bred International, Inc. | Plant regulatory elements and methods of use thereof |
EP3478827A1 (en) | 2016-06-30 | 2019-05-08 | Novozymes A/S | Lipase variants and compositions comprising surfactant and lipase variant |
US10544411B2 (en) | 2016-06-30 | 2020-01-28 | Zymergen Inc. | Methods for generating a glucose permease library and uses thereof |
JP2019519242A (ja) | 2016-06-30 | 2019-07-11 | ザイマージェン インコーポレイテッド | 細菌ヘモグロビンライブラリーを生成するための方法およびその使用 |
WO2018005411A1 (en) | 2016-07-01 | 2018-01-04 | Pioneer Hi-Bred International, Inc. | Insecticidal proteins from plants and methods for their use |
WO2018002379A2 (en) | 2016-07-01 | 2018-01-04 | Novozymes A/S | Enzymatic preparation of indigo dyes and in situ dyeing process |
WO2018002261A1 (en) | 2016-07-01 | 2018-01-04 | Novozymes A/S | Detergent compositions |
JP2019522988A (ja) | 2016-07-05 | 2019-08-22 | ノボザイムス アクティーゼルスカブ | ペクチン酸リアーゼ変異体およびこれをコードするポリヌクレオチド |
EP3481948B1 (en) | 2016-07-08 | 2023-11-01 | Novozymes A/S | Xylanase variants and polynucleotides encoding same |
CN109415709A (zh) | 2016-07-08 | 2019-03-01 | 诺维信公司 | 具有木聚糖酶活性的多肽以及编码其的多核苷酸 |
WO2018007573A1 (en) | 2016-07-08 | 2018-01-11 | Novozymes A/S | Detergent compositions with galactanase |
CA3027272C (en) | 2016-07-13 | 2022-06-21 | The Procter & Gamble Company | Bacillus cibi dnase variants and uses thereof |
EP4357453A2 (en) | 2016-07-18 | 2024-04-24 | Novozymes A/S | Lipase variants, polynucleotides encoding same and the use thereof |
EP3487997B1 (en) | 2016-07-20 | 2021-03-24 | Novozymes A/S | Heat-stable metagenomic carbonic anhydrases and their use |
WO2018015303A1 (en) | 2016-07-21 | 2018-01-25 | Novozymes A/S | Serine protease variants and polynucleotides encoding same |
CN109642225A (zh) | 2016-07-21 | 2019-04-16 | 诺维信公司 | 丝氨酸蛋白酶变体以及对其进行编码的多核苷酸 |
WO2018015444A1 (en) | 2016-07-22 | 2018-01-25 | Novozymes A/S | Crispr-cas9 genome editing with multiple guide rnas in filamentous fungi |
WO2018026868A1 (en) | 2016-08-01 | 2018-02-08 | Novozymes, Inc. | Polypeptides having endoglucanase activity and polynucleotides encoding same |
CN109563451A (zh) | 2016-08-24 | 2019-04-02 | 汉高股份有限及两合公司 | 包含gh9内切葡聚糖酶变体i的洗涤剂组合物 |
CN109844110B (zh) | 2016-08-24 | 2023-06-06 | 诺维信公司 | 黄原胶裂解酶变体以及编码它们的多核苷酸 |
EP3504331A1 (en) | 2016-08-24 | 2019-07-03 | Henkel AG & Co. KGaA | Detergent compositions comprising xanthan lyase variants i |
WO2018037062A1 (en) | 2016-08-24 | 2018-03-01 | Novozymes A/S | Gh9 endoglucanase variants and polynucleotides encoding same |
CN109863162B (zh) | 2016-08-26 | 2023-03-17 | 科德克希思公司 | 工程化亚胺还原酶和用于酮和胺化合物的还原胺化的方法 |
WO2018048915A1 (en) | 2016-09-06 | 2018-03-15 | AgBiome, Inc. | Pesticidal genes and methods of use |
JP2019534858A (ja) | 2016-09-09 | 2019-12-05 | ジェネンテック, インコーポレイテッド | Frizzledの選択的ペプチド阻害剤 |
EP3512941B1 (en) | 2016-09-16 | 2021-03-24 | DuPont Nutrition Biosciences ApS | Acetolactate decarboxylase variants having improved specific activity |
JP2019534859A (ja) | 2016-09-19 | 2019-12-05 | セルジーン コーポレイション | Pd−1結合タンパク質を使用して白斑を治療する方法 |
WO2018053405A1 (en) | 2016-09-19 | 2018-03-22 | Celgene Corporation | Methods of treating immune disorders using pd-1 binding proteins |
MX2019003063A (es) | 2016-09-20 | 2019-10-14 | 22Nd Century Ltd Llc | Promotores específicos de tricoma para la manipulación de cannabinoides y otros compuestos en tricomas glandulares. |
EP3519547A1 (en) | 2016-09-29 | 2019-08-07 | Novozymes A/S | Spore containing granule |
US10889830B2 (en) | 2016-09-30 | 2021-01-12 | Dow Agrosciences Llc | Binary insecticidal Cry toxins |
EP3532592A1 (en) | 2016-10-25 | 2019-09-04 | Novozymes A/S | Detergent compositions |
US11021716B2 (en) | 2016-11-01 | 2021-06-01 | Pioneer Hi-Bred International, Inc. | Insecticidal proteins and methods for their use |
WO2018085370A1 (en) | 2016-11-02 | 2018-05-11 | Novozymes A/S | Processes for reducing production of primeverose during enzymatic saccharification of lignocellulosic material |
US11779604B2 (en) | 2016-11-03 | 2023-10-10 | Kymab Limited | Antibodies, combinations comprising antibodies, biomarkers, uses and methods |
WO2018089860A1 (en) | 2016-11-11 | 2018-05-17 | 2D Genomics Inc. | Methods for processing nucleic acid samples |
EP3541954A1 (en) | 2016-11-21 | 2019-09-25 | Novozymes A/S | Yeast cell extract assisted construction of dna molecules |
AU2017365169B2 (en) | 2016-11-23 | 2022-07-21 | BASF Agricultural Solutions Seed US LLC | Axmi669 and Axmi991 toxin genes and methods for their use |
WO2018098124A1 (en) | 2016-11-23 | 2018-05-31 | Novozymes A/S | Polypeptides having protease activity and polynucleotides encoding same |
US20210292723A1 (en) | 2016-11-29 | 2021-09-23 | Novozymes A/S | Alpha-Amylase Variants and Polynucleotides Encoding Same |
WO2018099965A1 (en) | 2016-11-30 | 2018-06-07 | Novozymes A/S | Method of baking |
BR112019011612A2 (pt) | 2016-12-06 | 2020-08-18 | Novozymes A/S | processos melhorados para a produção de etanol a partir de substratos celulósicos que contêm xilose com o uso de cepas de levedura geneticamente modificadas |
KR20190108106A (ko) | 2016-12-13 | 2019-09-23 | 디펜신 테라퓨틱스 에이피에스 | 폐의 염증 상태를 치료하는 방법 |
BR112019012339A2 (pt) | 2016-12-14 | 2019-11-26 | Pioneer Hi Bred Int | polipeptídeo inseticida recombinante, composição, construto de dna, célula hospedeira, planta transgênica, método para inibir o crescimento ou extermínio de uma praga de inseto ou população de praga, polipeptídeo ipd093 quimérico e proteína de fusão |
CA3047121A1 (en) | 2016-12-16 | 2018-06-21 | Two Blades Foundation | Late blight resistance genes and methods of use |
EP3534872B1 (en) | 2016-12-20 | 2022-03-23 | Colgate-Palmolive Company | Two-phase oral care whitening compositions |
AU2017382576B2 (en) | 2016-12-20 | 2020-08-27 | Colgate-Palmolive Company | Oral care composition and methods for whitening teeth |
EP3559234B1 (en) | 2016-12-20 | 2021-10-27 | Novozymes A/S | Recombinant yeast strains for pentose fermentation |
CA3040739A1 (en) | 2016-12-20 | 2018-06-28 | Colgate-Palmolive Company | Oral care compositions and methods for whitening teeth |
CA3046226A1 (en) | 2016-12-22 | 2018-06-28 | Pioneer Hi-Bred International, Inc. | Insecticidal proteins and methods for their use |
AU2017382305A1 (en) | 2016-12-22 | 2019-07-18 | BASF Agricultural Solutions Seed US LLC | Use of CRY14 for the control of nematode pests |
US10815525B2 (en) | 2016-12-22 | 2020-10-27 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10011872B1 (en) | 2016-12-22 | 2018-07-03 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10550429B2 (en) | 2016-12-22 | 2020-02-04 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
IL267538B1 (en) | 2016-12-23 | 2024-01-01 | Novartis Ag | Antibodies against factor XI and methods for use in preventing, treating, managing or reducing the risk of thromboembolic disorder or stroke in a patient |
EP3558370A2 (en) | 2016-12-23 | 2019-10-30 | Novartis AG | Methods of treatment with anti-factor xi/xia antibodies |
CA3048246A1 (en) | 2016-12-28 | 2018-07-05 | Ascus Biosciences, Inc. | Methods, apparatuses, and systems for analyzing complete microorganism strains in complex heterogeneous communities, determining functional relationships and interactions thereof, and identifying and synthesizing bioreactive modificators based thereon |
WO2018129029A1 (en) | 2017-01-04 | 2018-07-12 | Immunogen, Inc. | Met antibodies and immunoconjugates and uses thereof |
CA3048475A1 (en) | 2017-01-05 | 2018-07-12 | Codexis, Inc. | Penicillin-g acylases |
WO2018136611A1 (en) | 2017-01-18 | 2018-07-26 | Bayer Cropscience Lp | Use of bp005 for the control of plant pathogens |
EP3571303A1 (en) | 2017-01-18 | 2019-11-27 | Basf Agricultural Solutions Seed Us Llc | Bp005 toxin gene and methods for its use |
WO2018140214A1 (en) | 2017-01-24 | 2018-08-02 | Pioneer Hi-Bred International, Inc. | Nematicidal protein from pseudomonas |
BR112019015582A2 (pt) | 2017-01-30 | 2020-03-10 | AgBiome, Inc. | Genes pesticidas e métodos de uso |
EP4029939B1 (en) | 2017-01-30 | 2023-06-28 | 10X Genomics, Inc. | Methods and systems for droplet-based single cell barcoding |
MX2019009093A (es) | 2017-02-01 | 2019-12-05 | Procter & Gamble | Composiciones de limpieza que comprenden variantes de amilasa. |
DK3577219T3 (da) | 2017-02-01 | 2023-11-13 | Novozymes As | Alfa-amylase-varianter |
JOP20190187A1 (ar) | 2017-02-03 | 2019-08-01 | Novartis Ag | مترافقات عقار جسم مضاد لـ ccr7 |
EP3577229A4 (en) | 2017-02-03 | 2020-12-23 | Codexis, Inc. | MANIPULATED GLYCOSYL TRANSFERASES AND METHOD FOR STEVIOL GLYCOSIDE GLUCOSYLATION |
MX2019009498A (es) | 2017-02-08 | 2019-10-02 | Novartis Ag | Anticuerpos mimeticos de fgf21 y usos de los mismos. |
CA3052794A1 (en) | 2017-02-08 | 2018-08-16 | Pioneer Hi-Bred International, Inc. | Insecticidal combinations of plant derived insecticidal proteins and methods for their use |
NZ755628A (en) | 2017-02-13 | 2023-09-29 | Codexis Inc | Engineered phenylalanine ammonia lyase polypeptides |
AU2018222787B2 (en) | 2017-02-20 | 2023-05-25 | Novozymes A/S | Lipolytic enzyme for use in baking |
CN110603322A (zh) | 2017-03-07 | 2019-12-20 | 丹尼斯科美国公司 | 热稳定的葡糖淀粉酶及其使用方法 |
JP7189145B2 (ja) | 2017-03-29 | 2022-12-13 | ベーリンガー インゲルハイム エルツェーファウ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト | 改変された膜脂質組成を有するリコンビナントホスト細胞 |
US11053483B2 (en) | 2017-03-31 | 2021-07-06 | Novozymes A/S | Polypeptides having DNase activity |
EP3601550A1 (en) | 2017-03-31 | 2020-02-05 | Novozymes A/S | Polypeptides having dnase activity |
CN110651039A (zh) | 2017-03-31 | 2020-01-03 | 诺维信公司 | 具有rna酶活性的多肽 |
WO2018185618A1 (en) | 2017-04-03 | 2018-10-11 | Novartis Ag | Anti-cdh6 antibody drug conjugates and anti-gitr antibody combinations and methods of treatment |
CN110651029B (zh) | 2017-04-04 | 2022-02-15 | 诺维信公司 | 糖基水解酶 |
EP3607039A1 (en) | 2017-04-04 | 2020-02-12 | Novozymes A/S | Polypeptides |
US20200109352A1 (en) | 2017-04-04 | 2020-04-09 | Novozymes A/S | Polypeptide compositions and uses thereof |
BR112019021380A2 (pt) | 2017-04-11 | 2020-05-05 | Agbiome Inc | genes pesticidas e métodos de uso |
EP3610027A1 (en) | 2017-04-11 | 2020-02-19 | Novozymes A/S | Glucoamylase variants and polynucleotides encoding same |
IL270068B (en) | 2017-04-24 | 2022-06-01 | Tesaro Inc | Manufacturing methods of Niraprib |
BR112019022201A2 (pt) | 2017-04-24 | 2020-05-12 | Dupont Nutrition Biosciences Aps | Métodos para modular a atividade de uma endonuclease cas, para aumentar a especificidade de uma endonuclease cas e complexo polinucleotídico guia, para aumentar a frequência de recombinação homóloga e para ativação ou repressão gênica, célula e célula vegetal |
JP7045725B2 (ja) | 2017-04-27 | 2022-04-01 | コデクシス, インコーポレイテッド | ケトレダクターゼポリペプチドおよびポリヌクレオチド |
CN110913702A (zh) | 2017-04-28 | 2020-03-24 | 埃斯库斯生物科技股份公司 | 利用微生物的人造生物集合在反刍动物中用于支持谷物加强剂和/或能量加强剂饮食的方法 |
EP3619304A1 (en) | 2017-05-05 | 2020-03-11 | Novozymes A/S | Compositions comprising lipase and sulfite |
WO2018206300A1 (en) | 2017-05-08 | 2018-11-15 | Novozymes A/S | Mannanase variants and polynucleotides encoding same |
CA3058095A1 (en) | 2017-05-08 | 2018-11-15 | Novozymes A/S | Mannanase variants and polynucleotides encoding same |
WO2018206535A1 (en) | 2017-05-08 | 2018-11-15 | Novozymes A/S | Carbohydrate-binding domain and polynucleotides encoding the same |
CA3062550A1 (en) | 2017-05-08 | 2018-11-15 | Codexis, Inc. | Engineered ligase variants |
CA3063200A1 (en) | 2017-05-11 | 2018-11-15 | Pioneer Hi-Bred International, Inc. | Insecticidal proteins and methods for their use |
EP3625715A4 (en) | 2017-05-19 | 2021-03-17 | 10X Genomics, Inc. | DATA SET ANALYSIS SYSTEMS AND METHODS |
EP3625351A1 (en) | 2017-05-19 | 2020-03-25 | Zymergen Inc. | Genomic engineering of biosynthetic pathways leading to increased nadph |
WO2018215936A1 (en) | 2017-05-24 | 2018-11-29 | Novartis Ag | Antibody-cytokine engrafted proteins and methods of use in the treatment of cancer |
EP3630162A1 (en) | 2017-05-24 | 2020-04-08 | Novartis AG | Antibody-cytokine engrafted proteins and methods of use |
JOP20190271A1 (ar) | 2017-05-24 | 2019-11-21 | Novartis Ag | بروتينات مطعّمة بسيتوكين- الجسم المضاد وطرق الاستخدام للاضطرابات المتعلقة بالمناعة |
WO2018215937A1 (en) | 2017-05-24 | 2018-11-29 | Novartis Ag | Interleukin-7 antibody cytokine engrafted proteins and methods of use in the treatment of cancer |
US20180340169A1 (en) | 2017-05-26 | 2018-11-29 | 10X Genomics, Inc. | Single cell analysis of transposase accessible chromatin |
UA126971C2 (uk) | 2017-05-26 | 2023-03-01 | Піонір Хай-Бред Інтернешнл, Інк. | Інсектицидний поліпептид з поліпшеним спектром активності і його застосування |
SG11201901822QA (en) | 2017-05-26 | 2019-03-28 | 10X Genomics Inc | Single cell analysis of transposase accessible chromatin |
WO2018220116A1 (en) | 2017-05-31 | 2018-12-06 | Novozymes A/S | Xylose fermenting yeast strains and processes thereof for ethanol production |
EP3630989A1 (en) | 2017-06-02 | 2020-04-08 | Novozymes A/S | Improved yeast for ethanol production |
EP3635110A2 (en) | 2017-06-06 | 2020-04-15 | Zymergen, Inc. | A high-throughput (htp) genomic engineering platform for improving saccharopolyspora spinosa |
JP7227162B2 (ja) | 2017-06-06 | 2023-02-21 | ザイマージェン インコーポレイテッド | 真菌株を改良するためのhtpゲノム操作プラットフォーム |
JP2020524494A (ja) | 2017-06-06 | 2020-08-20 | ザイマージェン インコーポレイテッド | ハイスループットトランスポゾン変異誘発 |
ES2875579T3 (es) | 2017-06-06 | 2021-11-10 | Zymergen Inc | Plataforma de ingeniería genómica de HTP para mejorar Escherichia coli |
WO2018224544A1 (en) | 2017-06-08 | 2018-12-13 | Novozymes A/S | Compositions comprising polypeptides having cellulase activity and amylase activity, and uses thereof in cleaning and detergent compositions |
JP7122009B2 (ja) | 2017-06-14 | 2022-08-19 | コデクシス, インコーポレイテッド | 産業上の生体触媒作用のための操作されたトランスアミナーゼポリペプチド |
WO2018229715A1 (en) | 2017-06-16 | 2018-12-20 | Novartis Ag | Compositions comprising anti-cd32b antibodies and methods of use thereof |
JP7282693B2 (ja) | 2017-06-20 | 2023-05-29 | アルブミディクス リミティド | 改良されたタンパク質発現株 |
US11499144B2 (en) | 2017-06-22 | 2022-11-15 | Novozymes A/S | Xylanase variants and polynucleotides encoding same |
US11643642B2 (en) | 2017-06-27 | 2023-05-09 | Codexis, Inc. | Penicillin-g acylases |
EP4015524A1 (en) | 2017-06-28 | 2022-06-22 | Novozymes A/S | Polypeptides having trehalase activity and polynucleotides encoding same |
KR20200023455A (ko) | 2017-06-30 | 2020-03-04 | 코덱시스, 인코포레이티드 | T7 rna 폴리머라제 변이체 |
WO2019002356A1 (en) | 2017-06-30 | 2019-01-03 | Novozymes A/S | ENZYMATIC SUSPENSION COMPOSITION |
CA3066767A1 (en) | 2017-06-30 | 2019-01-03 | Codexis, Inc. | T7 rna polymerase variants |
EP4085919A3 (en) | 2017-07-21 | 2023-02-08 | Novartis AG | Compositions and methods to treat cancer |
CN110770283A (zh) | 2017-07-24 | 2020-02-07 | 诺维信公司 | 湿磨中的gh5和gh30 |
US11261458B2 (en) | 2017-07-28 | 2022-03-01 | Two Blades Foundation | Potyvirus resistance genes and methods of use |
CA3071862A1 (en) | 2017-08-03 | 2019-02-07 | AgBiome, Inc. | Pesticidal genes and methods of use |
WO2019030165A1 (en) | 2017-08-08 | 2019-02-14 | Novozymes A/S | POLYPEPTIDES HAVING TREHALASE ACTIVITY AND THEIR USE IN A PRODUCTION PROCESS OF FERMENTATION PRODUCTS |
WO2019040335A1 (en) | 2017-08-19 | 2019-02-28 | University Of Rochester | MICHELOLID DERIVATIVES, PREPARATION METHODS AND THEIR USE AS ANTICANCER AND ANTI-INFLAMMATORY AGENTS |
US11525128B2 (en) | 2017-08-24 | 2022-12-13 | Novozymes A/S | GH9 endoglucanase variants and polynucleotides encoding same |
EP3673060A1 (en) | 2017-08-24 | 2020-07-01 | Henkel AG & Co. KGaA | Detergent composition comprising xanthan lyase variants ii |
WO2019038057A1 (en) | 2017-08-24 | 2019-02-28 | Novozymes A/S | VARIANTS OF XANTHANE LYASE AND POLYNUCLEOTIDES ENCODING THE SAME |
US11624059B2 (en) | 2017-08-24 | 2023-04-11 | Henkel Ag & Co. Kgaa | Detergent compositions comprising GH9 endoglucanase variants II |
CN111132553A (zh) | 2017-08-29 | 2020-05-08 | 诺维信公司 | 表达抗老化/保鲜淀粉酶的面包酵母 |
US11377650B2 (en) | 2017-08-31 | 2022-07-05 | Novozymes A/S | Polypeptides having D-psicose 3 epimerase activity and polynucleotides encoding same |
EP3675646A1 (en) | 2017-09-01 | 2020-07-08 | Novozymes A/S | Animal feed additives comprising polypeptide having protease activity and uses thereof |
US11744263B2 (en) | 2017-09-01 | 2023-09-05 | Novozymes A/S | Animal feed additives comprising a polypeptide having protease activity and uses thereof |
WO2019046703A1 (en) | 2017-09-01 | 2019-03-07 | Novozymes A/S | METHODS OF ENHANCING GENOME EDITION IN FUNGI |
WO2019052907A2 (en) | 2017-09-07 | 2019-03-21 | Total Raffinage Chimie | METHOD FOR DETECTING THE HYDROGEN PEROXIDE CONVERSION ACTIVITY OF AN ENZYME |
WO2019047199A1 (en) | 2017-09-11 | 2019-03-14 | Danisco Us Inc. | GLUCOAMYLASE AND METHODS OF USE THEREOF |
AU2018337756A1 (en) | 2017-09-25 | 2020-04-02 | Pioneer Hi-Bred, International, Inc. | Tissue-preferred promoters and methods of use |
WO2019067390A1 (en) | 2017-09-27 | 2019-04-04 | The Procter & Gamble Company | DETERGENT COMPOSITIONS CONTAINING LIPASES |
CA3073362A1 (en) | 2017-09-27 | 2019-04-04 | Novozymes A/S | Lipase variants and microcapsule compositions comprising such lipase variants |
EP3692147A1 (en) | 2017-10-02 | 2020-08-12 | Novozymes A/S | Polypeptides having mannanase activity and polynucleotides encoding same |
WO2019068715A1 (en) | 2017-10-02 | 2019-04-11 | Novozymes A/S | POLYPEPTIDES HAVING MANNANASE ACTIVITY AND POLYNUCLEOTIDES ENCODING THESE POLYPEPTIDES |
WO2019070883A1 (en) | 2017-10-04 | 2019-04-11 | Novozymes A/S | POLYPEPTIDES WITH PROTEASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME |
US20200165626A1 (en) | 2017-10-13 | 2020-05-28 | Pioneer Hi-Bred International, Inc. | Virus-induced gene silencing technology for insect control in maize |
BR112020007707A2 (pt) | 2017-10-18 | 2021-01-26 | Ascus Biosciences, Inc. | melhoria de produção de ave por administração de um bioconjunto sintético de micróbios ou cepas purificadas dos mesmos |
CN111417726A (zh) | 2017-10-23 | 2020-07-14 | 诺维信公司 | 通过与前肽共表达改善蛋白酶的表达 |
US20210040205A1 (en) | 2017-10-25 | 2021-02-11 | Novartis Ag | Antibodies targeting cd32b and methods of use thereof |
CN111247246A (zh) | 2017-10-25 | 2020-06-05 | 达·沃尔泰拉公司 | β-内酰胺酶变体 |
US20230416706A1 (en) | 2017-10-27 | 2023-12-28 | Novozymes A/S | Dnase Variants |
CN111386340A (zh) | 2017-10-27 | 2020-07-07 | 宝洁公司 | 包含多肽变体的洗涤剂组合物 |
DE102017125560A1 (de) | 2017-11-01 | 2019-05-02 | Henkel Ag & Co. Kgaa | Reinigungszusammensetzungen, die dispersine iii enthalten |
DE102017125558A1 (de) | 2017-11-01 | 2019-05-02 | Henkel Ag & Co. Kgaa | Reinigungszusammensetzungen, die dispersine i enthalten |
DE102017125559A1 (de) | 2017-11-01 | 2019-05-02 | Henkel Ag & Co. Kgaa | Reinigungszusammensetzungen, die dispersine ii enthalten |
CN111511389A (zh) | 2017-11-07 | 2020-08-07 | 科德克希思公司 | 转谷氨酰胺酶变体 |
WO2019092201A2 (en) | 2017-11-10 | 2019-05-16 | Defensin Therapeutics Aps | Maturation of mucosal defense and gut/lung function in the preterm infant |
US20200318086A1 (en) | 2017-11-10 | 2020-10-08 | Novozymes A/S | Temperature-sensitive cas9 protein |
CN111989400A (zh) | 2017-11-14 | 2020-11-24 | 丹尼斯科美国公司 | α-淀粉酶、组合物和方法 |
SG11201913654QA (en) | 2017-11-15 | 2020-01-30 | 10X Genomics Inc | Functionalized gel beads |
US10829815B2 (en) | 2017-11-17 | 2020-11-10 | 10X Genomics, Inc. | Methods and systems for associating physical and genetic properties of biological particles |
WO2019096903A1 (en) | 2017-11-20 | 2019-05-23 | Novozymes A/S | New galactanases (ec 3.2.1.89) for use in soy processing |
MX2020005370A (es) | 2017-11-24 | 2020-10-19 | Defensin Therapeutics Aps | Prevencion y tratamiento de enfermedad de injerto contra hospedero con defensinas. |
WO2019108619A1 (en) | 2017-11-28 | 2019-06-06 | Two Blades Foundation | Methods and compositions for enhancing the disease resistance of plants |
EP3720954A1 (en) | 2017-12-04 | 2020-10-14 | Novozymes A/S | Lipase variants and polynucleotides encoding same |
DK3720956T3 (da) | 2017-12-08 | 2023-09-04 | Novozymes As | Alfa-amylasevarianter og polynukleotider, der koder for dem |
JP2021505167A (ja) | 2017-12-08 | 2021-02-18 | ノボザイムス アクティーゼルスカブ | α−アミラーゼ変異体及びそれをコードするポリヌクレオチド |
US11015180B2 (en) | 2017-12-13 | 2021-05-25 | Codexis, Inc. | Carboxyesterase polypeptides for amide coupling |
JP7401435B2 (ja) | 2017-12-13 | 2023-12-19 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド | カルボキシエステラーゼ生体触媒 |
EP4122947A1 (en) | 2017-12-19 | 2023-01-25 | Pioneer Hi-Bred International, Inc. | Insecticidal polypeptides and uses thereof |
EP3728574A1 (en) | 2017-12-20 | 2020-10-28 | Basf Se | Nucleases and methods for making and using them |
EP3728333A1 (en) | 2017-12-22 | 2020-10-28 | Novozymes A/S | Wheat milling process and gh8 xylanases |
WO2019126479A1 (en) | 2017-12-22 | 2019-06-27 | AgBiome, Inc. | Pesticidal genes and methods of use |
US11173136B2 (en) | 2018-01-10 | 2021-11-16 | Brightseed, Inc. | Method for modulating metabolism |
US11732271B2 (en) | 2018-01-12 | 2023-08-22 | The Sainsbury Laboratory | Stem rust resistance genes and methods of use |
EP3746545A1 (en) | 2018-01-29 | 2020-12-09 | Novozymes A/S | Microorganisms with improved nitrogen utilization for ethanol production |
WO2019154954A1 (en) | 2018-02-08 | 2019-08-15 | Novozymes A/S | Lipase variants and compositions thereof |
CN111868239A (zh) | 2018-02-08 | 2020-10-30 | 诺维信公司 | 脂肪酶、脂肪酶变体及其组合物 |
US11905518B2 (en) | 2018-02-12 | 2024-02-20 | Curators Of The University Of Missouri | Small auxin upregulated (SAUR) gene for the improvement of root system architecture, waterlogging tolerance, drought resistance and yield in plants and methods of uses |
US20190264140A1 (en) | 2018-02-28 | 2019-08-29 | The Procter & Gamble Company | Methods of cleaning |
US11525151B2 (en) | 2018-03-09 | 2022-12-13 | Danisco Us Inc. | Glucoamylases and methods of use, thereof |
EP3765185B1 (en) | 2018-03-13 | 2023-07-19 | Novozymes A/S | Microencapsulation using amino sugar oligomers |
WO2019183183A1 (en) | 2018-03-20 | 2019-09-26 | Zymergen Inc. | A htp platform for the genetic engineering of chinese hamster ovary cells |
CN112154153A (zh) | 2018-03-28 | 2020-12-29 | 百时美施贵宝公司 | 白介素-2/白介素-2受体α融合蛋白以及使用方法 |
EP3775190A1 (en) | 2018-03-29 | 2021-02-17 | Novozymes A/S | Mannanase variants and polynucleotides encoding same |
KR20200138254A (ko) | 2018-03-30 | 2020-12-09 | 암젠 인크 | C-말단 항체 변이체 |
EP3775271A1 (en) | 2018-04-06 | 2021-02-17 | 10X Genomics, Inc. | Systems and methods for quality control in single cell processing |
BR112020020285A2 (pt) | 2018-04-06 | 2021-01-19 | Braskem S.A. | Mutantes de enzima dependentes de nadh para converter acetona em isopropanol |
US11377648B2 (en) | 2018-04-09 | 2022-07-05 | Novozymes A/S | Polypeptides having alpha-amylase activity and polynucleotides encoding same |
US11661592B2 (en) | 2018-04-19 | 2023-05-30 | Novozymes A/S | Stabilized endoglucanase variants |
WO2019201785A1 (en) | 2018-04-19 | 2019-10-24 | Novozymes A/S | Stabilized cellulase variants |
BR112020021445A2 (pt) | 2018-04-20 | 2021-01-19 | AgBiome, Inc. | Genes pesticidas e métodos de uso |
US11708571B2 (en) | 2018-05-17 | 2023-07-25 | Bp Corporation North America Inc. | Production of 2-keto-3-deoxy-d-gluconic acid in filamentous fungi |
CA3096516A1 (en) | 2018-05-22 | 2019-11-28 | Pioneer Hi-Bred International, Inc. | Plant regulatory elements and methods of use thereof |
TW202015726A (zh) | 2018-05-30 | 2020-05-01 | 瑞士商諾華公司 | Entpd2抗體、組合療法、及使用該等抗體和組合療法之方法 |
BR112020022593A2 (pt) | 2018-05-31 | 2021-02-09 | Novozymes A/S | método para tratar polpa de dissolução, polpa de dissolução, fibra têxtil ou celulose derivatizada, e, uso de uma monoxigenase lítica de polissacarídeo. |
EP3802611A2 (en) | 2018-06-01 | 2021-04-14 | Novartis AG | Binding molecules against bcma and uses thereof |
KR20210089629A (ko) | 2018-06-05 | 2021-07-16 | 라이프에디트 테라퓨틱스, 인크. | Rna-가이드된 뉴클레아제 및 그의 활성 단편 및 변이체 및 사용 방법 |
EP3810750A4 (en) | 2018-06-06 | 2022-03-23 | Zymergen, Inc. | MANIPULATION OF GENES INVOLVED IN SIGNAL TRANSDUCTION TO CONTROL FUNGAL MORPHOLOGY DURING FERMENTATION AND PRODUCTION |
WO2019241132A1 (en) | 2018-06-12 | 2019-12-19 | Codexis, Inc. | Engineered tyrosine ammonia lyase |
WO2020002494A1 (en) | 2018-06-27 | 2020-01-02 | Boehringer Ingelheim Rcv Gmbh & Co Kg | Means and methods for increased protein expression by use of transcription factors |
WO2020005933A1 (en) | 2018-06-28 | 2020-01-02 | Pioneer Hi-Bred International, Inc. | Methods for selecting transformed plants |
WO2020002575A1 (en) | 2018-06-28 | 2020-01-02 | Novozymes A/S | Polypeptides having pectin lyase activity and polynucleotides encoding same |
CA3105609A1 (en) | 2018-07-04 | 2020-01-09 | Danisco Us Inc | Glucoamylases and methods of use, thereof |
KR20210031933A (ko) | 2018-07-09 | 2021-03-23 | 코덱시스, 인코포레이티드 | 조작된 포스포펜토뮤타제 변이체 효소 |
CA3103718A1 (en) | 2018-07-09 | 2020-01-16 | Codexis, Inc. | Engineered purine nucleoside phosphorylase variant enzymes |
WO2020014048A1 (en) | 2018-07-09 | 2020-01-16 | Codexis, Inc. | Engineered deoxyribose-phosphate aldolases |
JP2021530216A (ja) | 2018-07-09 | 2021-11-11 | コデクシス, インコーポレイテッド | 操作されたパントテン酸キナーゼ改変体酵素 |
SG11202012138XA (en) | 2018-07-09 | 2021-01-28 | Codexis Inc | Engineered galactose oxidase variant enzymes |
WO2020014306A1 (en) | 2018-07-10 | 2020-01-16 | Immunogen, Inc. | Met antibodies and immunoconjugates and uses thereof |
CA3105916A1 (en) | 2018-07-12 | 2020-01-16 | Codexis, Inc. | Engineered phenylalanine ammonia lyase polypeptides |
MX2021000786A (es) | 2018-07-20 | 2021-06-15 | Pf Medicament | Receptor para supresor de ig del dominio v de activación de células t (vista). |
AU2019309683A1 (en) | 2018-07-25 | 2021-02-11 | Novozymes A/S | Enzyme-expressing yeast for ethanol production |
KR20210040408A (ko) | 2018-07-30 | 2021-04-13 | 코덱시스, 인코포레이티드 | 조작된 글리코실트랜스퍼라제 및 스테비올 글리코시드 글루코실화 방법 |
EP3829608B1 (en) | 2018-08-01 | 2024-01-10 | Board of Supervisors of Louisiana State University and Agricultural and Mechanical College | Compositions comprising herpes simplex virus-1 for use in methods of treating and preventing cancer |
MX2021002290A (es) | 2018-08-29 | 2021-04-28 | Pioneer Hi Bred Int | Proteinas insecticidas y metodos para su uso. |
US11473076B2 (en) | 2018-08-31 | 2022-10-18 | Novozymes A/S | Animal feed additives and compositions comprising an S8 serine protease |
AU2019334672A1 (en) | 2018-09-07 | 2021-03-25 | Basf Plant Science Company Gmbh | Improved method for the production of high levels of PUFA in plants |
US20220025391A1 (en) | 2018-09-07 | 2022-01-27 | Basf Plant Science Company Gmbh | Improved method for the production of high levels of pufa in plants |
EP3847262A1 (en) | 2018-09-07 | 2021-07-14 | Basf Plant Science Company GmbH | Improved method for the production of high levels of pufa in plants |
CN113056476A (zh) | 2018-10-03 | 2021-06-29 | 诺维信公司 | 具有α-甘露聚糖降解活性的多肽以及编码它们的多核苷酸 |
EP3864164A1 (en) | 2018-10-08 | 2021-08-18 | Novozymes A/S | Enzyme-expressing yeast for ethanol production |
UY38407A (es) | 2018-10-15 | 2020-05-29 | Novartis Ag | Anticuerpos estabilizadores de trem2 |
BR112021008186A2 (pt) | 2018-10-29 | 2021-08-17 | Codexis, Inc. | dna polimerase projetada, sequência polinucleotídica, vetor de expressão, célula hospedeira, composição, sistema de ensaio de alto rendimento, e, métodos para produção de um polipeptídeo de dna polimerase projetado em uma célula hospedeira e para determinação de fidelidade de alto rendimento de uma dna polimerase. |
WO2020089811A1 (en) | 2018-10-31 | 2020-05-07 | Novartis Ag | Dc-sign antibody drug conjugates |
EP3874051A1 (en) | 2018-10-31 | 2021-09-08 | Novozymes A/S | Genome editing by guided endonuclease and single-stranded oligonucleotide |
WO2020092487A1 (en) | 2018-10-31 | 2020-05-07 | Pioneer Hi-Bred International, Inc. | Compositions and methods for ochrobactrum-mediated plant transformation |
US11066663B2 (en) | 2018-10-31 | 2021-07-20 | Zymergen Inc. | Multiplexed deterministic assembly of DNA libraries |
US20220025348A1 (en) | 2018-12-12 | 2022-01-27 | Novozymes A/S | Polypeptides Having Xylanase Activity And Polynucleotides Encoding Same |
SG11202105668PA (en) | 2018-12-14 | 2021-06-29 | Codexis Inc | Engineered tyrosine ammonia lyase |
US11427813B2 (en) | 2018-12-20 | 2022-08-30 | Codexis, Inc. | Human alpha-galactosidase variants |
CN113195541A (zh) | 2018-12-21 | 2021-07-30 | 诺华股份有限公司 | 针对pmel17的抗体及其缀合物 |
WO2020127796A2 (en) | 2018-12-21 | 2020-06-25 | Novozymes A/S | Polypeptides having peptidoglycan degrading activity and polynucleotides encoding same |
EP3883537A1 (en) | 2018-12-27 | 2021-09-29 | Colgate-Palmolive Company | Oral care compositions |
SG11202106977PA (en) | 2018-12-27 | 2021-07-29 | Lifeedit Therapeutics Inc | Polypeptides useful for gene editing and methods of use |
CN113302294A (zh) | 2019-01-31 | 2021-08-24 | 诺维信公司 | 具有木聚糖酶活性的多肽及其用于改善动物饲料营养质量的用途 |
EP3917571A4 (en) | 2019-01-31 | 2022-10-12 | Agency For Science, Technology And Research | CNX/ERP57 INHIBITOR FOR USE IN THE TREATMENT OR PREVENTION OF CANCER |
KR20210136997A (ko) | 2019-03-08 | 2021-11-17 | 지머젠 인코포레이티드 | 미생물에서 반복적 게놈 편집 |
US11053515B2 (en) | 2019-03-08 | 2021-07-06 | Zymergen Inc. | Pooled genome editing in microbes |
CA3123457A1 (en) | 2019-03-11 | 2020-09-17 | Pioneer Hi-Bred International, Inc. | Methods for clonal plant production |
US20220235341A1 (en) | 2019-03-21 | 2022-07-28 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
AU2020248645A1 (en) | 2019-03-27 | 2021-10-28 | Tigatx, Inc. | Engineered IgA antibodies and methods of use |
WO2020198408A1 (en) | 2019-03-27 | 2020-10-01 | Pioneer Hi-Bred International, Inc. | Plant explant transformation |
CN113874392A (zh) | 2019-03-28 | 2021-12-31 | 丹尼斯科美国公司 | 工程化抗体 |
WO2020198496A1 (en) | 2019-03-28 | 2020-10-01 | Pioneer Hi-Bred International, Inc. | Modified agrobacterium strains and use thereof for plant transformation |
WO2020201403A1 (en) | 2019-04-03 | 2020-10-08 | Novozymes A/S | Polypeptides having beta-glucanase activity, polynucleotides encoding same and uses thereof in cleaning and detergent compositions |
EP3953462A1 (en) | 2019-04-10 | 2022-02-16 | Novozymes A/S | Polypeptide variants |
BR112021020439A2 (pt) | 2019-04-12 | 2022-05-24 | Novozymes As | Variantes estabilizadas de glicosídeo hidrolase |
WO2020229191A1 (en) | 2019-05-15 | 2020-11-19 | Novozymes A/S | Temperature-sensitive rna-guided endonuclease |
EP3972993A1 (en) | 2019-05-21 | 2022-03-30 | Novartis AG | Variant cd58 domains and uses thereof |
CA3140142A1 (en) | 2019-05-21 | 2020-11-26 | Novartis Ag | Trispecific binding molecules against bcma and uses thereof |
EP3972998A1 (en) | 2019-05-21 | 2022-03-30 | Novartis AG | Cd19 binding molecules and uses thereof |
CN114040972A (zh) | 2019-06-24 | 2022-02-11 | 宝洁公司 | 包含淀粉酶变体的清洁组合物 |
US20220251528A1 (en) | 2019-06-24 | 2022-08-11 | Novozymes A/S | Alpha-Amylase Variants |
WO2020264237A1 (en) | 2019-06-27 | 2020-12-30 | Two Blades Foundation | Engineered atrlp23 pattern recognition receptors and methods of use |
WO2021001400A1 (en) | 2019-07-02 | 2021-01-07 | Novozymes A/S | Lipase variants and compositions thereof |
WO2021013464A1 (en) | 2019-07-25 | 2021-01-28 | Novozymes A/S | Filamentous fungal expression system |
WO2021021458A1 (en) | 2019-07-26 | 2021-02-04 | Novozymes A/S | Microorganisms with improved nitrogen transport for ethanol production |
WO2021018751A1 (en) | 2019-07-26 | 2021-02-04 | Novozymes A/S | Enzymatic treatment of paper pulp |
CA3148593A1 (en) | 2019-07-29 | 2021-02-04 | Brightseed, Inc. | Method for improving digestive health |
CA3143527A1 (en) | 2019-08-06 | 2021-02-11 | Novozymes A/S | Fusion proteins for improved enzyme expression |
BR112022002695A2 (pt) | 2019-08-12 | 2022-08-23 | Lifeedit Therapeutics Inc | Nucleases guiadas por rna, fragmentos ativos e variantes das mesmas e métodos de uso |
JP2022545465A (ja) | 2019-08-22 | 2022-10-27 | ビーエーエスエフ ソシエタス・ヨーロピア | アミラーゼバリアント |
EP4031661A1 (en) | 2019-09-16 | 2022-07-27 | Novozymes A/S | Polypeptides having beta-glucanase activity and polynucleotides encoding same |
TW202124446A (zh) | 2019-09-18 | 2021-07-01 | 瑞士商諾華公司 | 與entpd2抗體之組合療法 |
US20220348651A1 (en) | 2019-09-18 | 2022-11-03 | Novartis Ag | Entpd2 antibodies, combination therapies, and methods of using the antibodies and combination therapies |
CA3152705A1 (en) | 2019-10-02 | 2021-04-08 | Abbott Diabetes Care Inc. | Detection of analytes by protein switches |
US20220340843A1 (en) | 2019-10-03 | 2022-10-27 | Novozymes A/S | Polypeptides comprising at least two carbohydrate binding domains |
MX2022005682A (es) | 2019-11-11 | 2022-08-08 | Brightseed Inc | Extracto, producto consumible y método para enriquecer metabolito bioactivo en un extracto. |
EP3821946A1 (en) | 2019-11-12 | 2021-05-19 | Université de Strasbourg | Anti-claudin-1 monoclonal antibodies for the prevention and treatment of fibrotic diseases |
US20230002794A1 (en) | 2019-12-10 | 2023-01-05 | Novozymes A/S | Microorganism for improved pentose fermentation |
JP2023506305A (ja) | 2019-12-19 | 2023-02-15 | ノボザイムス アクティーゼルスカブ | キシラナーゼバリアント及びそれをコードするポリヌクレオチド |
CN115485387A (zh) | 2019-12-19 | 2022-12-16 | 巴斯夫欧洲公司 | 增加精细化学品生产中的时空产率、碳转化效率和碳底物灵活性 |
MX2022007361A (es) | 2019-12-19 | 2022-07-19 | Novozymes As | Variantes de alfa-amilasas. |
JP2023507365A (ja) | 2019-12-19 | 2023-02-22 | ザ プロクター アンド ギャンブル カンパニー | α-アミラーゼ活性を有するポリペプチドを含む洗浄組成物 |
US20220411773A1 (en) | 2019-12-20 | 2022-12-29 | Novozymes A/S | Polypeptides having proteolytic activity and use thereof |
BR112022011895A2 (pt) | 2019-12-20 | 2022-09-06 | Basf Se | Diminuição da toxidez de terpenos e aumento da produção potencial em microrganismos |
EP4085133A1 (en) | 2019-12-30 | 2022-11-09 | Lifeedit Therapeutics, Inc. | Rna-guided nucleases and active fragments and variants thereof and methods of use |
EP4093188A1 (en) | 2020-01-24 | 2022-11-30 | Novozymes A/S | Mutants of a filamentous fungal cell having increased productivity in the production of a polypeptide |
WO2021152123A1 (en) | 2020-01-31 | 2021-08-05 | Novozymes A/S | Mannanase variants and polynucleotides encoding same |
WO2021152120A1 (en) | 2020-01-31 | 2021-08-05 | Novozymes A/S | Mannanase variants and polynucleotides encoding same |
EP4103703A2 (en) | 2020-02-10 | 2022-12-21 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
EP4103709A2 (en) | 2020-02-10 | 2022-12-21 | Novozymes A/S | Polypeptides having alpha-amylase activity and polynucleotides encoding same |
WO2021163015A1 (en) | 2020-02-10 | 2021-08-19 | Novozymes A/S | Process for producing ethanol from raw starch using alpha-amylase variants |
JP2023513314A (ja) | 2020-02-13 | 2023-03-30 | ザイマージェン インコーポレイテッド | メタゲノムライブラリーおよび天然物発見プラットフォーム |
WO2021168399A1 (en) * | 2020-02-21 | 2021-08-26 | Regents Of The University Of Minnesota | Novel methods for creating alpha-n-methylated polypeptides |
US20230220366A1 (en) | 2020-02-26 | 2023-07-13 | Novozymes A/S | Polypeptide Variants |
WO2021202463A1 (en) | 2020-03-30 | 2021-10-07 | Danisco Us Inc | Anti-rsv antibodies |
WO2021202473A2 (en) | 2020-03-30 | 2021-10-07 | Danisco Us Inc | Engineered antibodies |
US20230143128A1 (en) | 2020-04-08 | 2023-05-11 | Novozymes A/S | Carbohydrate binding module variants |
JP2023521772A (ja) | 2020-04-10 | 2023-05-25 | コデクシス, インコーポレイテッド | 操作されたトランスアミナーゼポリペプチド |
CN115867651A (zh) | 2020-04-17 | 2023-03-28 | 丹尼斯科美国公司 | 葡糖淀粉酶及其使用方法 |
WO2021214059A1 (en) | 2020-04-21 | 2021-10-28 | Novozymes A/S | Cleaning compositions comprising polypeptides having fructan degrading activity |
TW202208626A (zh) | 2020-04-24 | 2022-03-01 | 美商生命編輯公司 | Rna引導核酸酶及其活性片段與變體,以及使用方法 |
US20230181756A1 (en) | 2020-04-30 | 2023-06-15 | Novartis Ag | Ccr7 antibody drug conjugates for treating cancer |
WO2021220218A1 (en) | 2020-05-01 | 2021-11-04 | Novartis Ag | Immunoglobulin variants |
CN116096758A (zh) | 2020-05-01 | 2023-05-09 | 诺华股份有限公司 | 工程化免疫球蛋白 |
CA3173882A1 (en) | 2020-05-11 | 2021-11-18 | Alexandra Briner CRAWLEY | Rna-guided nucleic acid binding proteins and active fragments and variants thereof and methods of use |
WO2021245064A1 (en) | 2020-06-04 | 2021-12-09 | Isobionics B.V. | Synthetic santalene synthases |
US20230287383A1 (en) | 2020-07-03 | 2023-09-14 | Engenes Biotech Gmbh | PYRROLYSYL-tRNA SYNTHETASE VARIANTS AND USES THEREOF |
BR112022027035A2 (pt) | 2020-07-14 | 2023-04-11 | Pioneer Hi Bred Int | Proteínas inseticidas e métodos para uso das mesmas |
KR20230049100A (ko) | 2020-07-15 | 2023-04-12 | 라이프에디트 테라퓨틱스, 인크. | 우라실 안정화 단백질 및 그의 활성 단편 및 변이체 및 사용 방법 |
US11479779B2 (en) | 2020-07-31 | 2022-10-25 | Zymergen Inc. | Systems and methods for high-throughput automated strain generation for non-sporulating fungi |
EP4192232A2 (en) | 2020-08-10 | 2023-06-14 | E. I. du Pont de Nemours and Company | Compositions and methods for enhancing resistance to northern leaf blight in maize |
CN116096903A (zh) | 2020-08-10 | 2023-05-09 | 先锋国际良种公司 | 植物调节元件及其使用方法 |
KR20230050402A (ko) | 2020-08-13 | 2023-04-14 | 노보자임스 에이/에스 | 피타제 변이체 및 이를 암호화하는 폴리뉴클레오티드 |
US20230313209A1 (en) | 2020-08-18 | 2023-10-05 | Novozymes A/S | Dispersins expressed with amylase signal peptides |
US20230313165A1 (en) | 2020-08-25 | 2023-10-05 | Novozymes A/S | Variants of a family 44 xyloglucanase |
EP4204552A1 (en) | 2020-08-28 | 2023-07-05 | Codexis, Inc. | Engineered amylase variants |
CA3186910A1 (en) | 2020-08-28 | 2022-03-03 | Rolf Thomas Lenhard | Protease variants with improved solubility |
JP2023539632A (ja) | 2020-08-28 | 2023-09-15 | コデクシス, インコーポレイテッド | 操作されたプロテアーゼバリアント |
WO2022056254A2 (en) | 2020-09-11 | 2022-03-17 | LifeEDIT Therapeutics, Inc. | Dna modifying enzymes and active fragments and variants thereof and methods of use |
AU2021340243A1 (en) | 2020-09-14 | 2023-05-04 | Aesculus Bio Aps | Defensin fragment derived lipopeptides for treatment of drug-resistant microorganisms |
CN116249780A (zh) | 2020-09-30 | 2023-06-09 | 先锋国际良种公司 | 单子叶植物叶外植体的快速转化 |
WO2022074037A2 (en) | 2020-10-07 | 2022-04-14 | Novozymes A/S | Alpha-amylase variants |
CN116529375A (zh) | 2020-10-13 | 2023-08-01 | 诺维信公司 | 用于提高蛋白质产量的糖基转移酶变体 |
EP4237525A1 (en) | 2020-10-28 | 2023-09-06 | Novozymes A/S | Use of lipoxygenase |
EP4237552A2 (en) | 2020-10-29 | 2023-09-06 | Novozymes A/S | Lipase variants and compositions comprising such lipase variants |
WO2022090564A1 (en) | 2020-11-02 | 2022-05-05 | Novozymes A/S | Glucoamylase variants and polynucleotides encoding same |
WO2022090555A1 (en) | 2020-11-02 | 2022-05-05 | Novozymes A/S | Leader peptides and polynucleotides encoding the same |
EP4240491A1 (en) | 2020-11-06 | 2023-09-13 | Novartis AG | Cd19 binding molecules and uses thereof |
MX2023005234A (es) | 2020-11-06 | 2023-05-18 | Novartis Ag | Terapia de combinacion de agente anti-cd19 y agente de direccionamiento a celulas b para el tratamiento de neoplasias malignas de celulas b. |
WO2022106404A1 (en) | 2020-11-18 | 2022-05-27 | Novozymes A/S | Combination of proteases |
WO2022106400A1 (en) | 2020-11-18 | 2022-05-27 | Novozymes A/S | Combination of immunochemically different proteases |
WO2022115524A2 (en) | 2020-11-24 | 2022-06-02 | AgBiome, Inc. | Pesticidal genes and methods of use |
MX2023006010A (es) | 2020-11-24 | 2023-06-08 | Novartis Ag | Anticuerpos anti-cd48, conjugados de anticuerpo-farmaco, y usos de los mismos. |
WO2022125960A1 (en) | 2020-12-11 | 2022-06-16 | Willow Biosciences, Inc. | Recombinant acyl activating enzyme (aae) genes for enhanced biosynthesis of cannabinoids and cannabinoid precursors |
WO2022129166A1 (en) | 2020-12-15 | 2022-06-23 | Novozymes A/S | Mutated host cells with reduced cell motility |
US11898174B2 (en) | 2020-12-18 | 2024-02-13 | Codexis, Inc. | Engineered uridine phosphorylase variant enzymes |
EP4015626A1 (en) | 2020-12-18 | 2022-06-22 | Isobionics B.V. | Enzymes and methods for fermentative production of monoterpene esters |
WO2022147463A2 (en) | 2020-12-31 | 2022-07-07 | Alamar Biosciences, Inc. | Binder molecules with high affinity and/ or specificity and methods of making and use thereof |
CN112725331B (zh) * | 2021-01-25 | 2021-07-20 | 深圳市狂风生命科技有限公司 | 一种高通量突变体文库的构建方法 |
US20240124805A1 (en) | 2021-01-28 | 2024-04-18 | Novozymes A/S | Lipase with low malodor generation |
WO2022171780A2 (en) | 2021-02-12 | 2022-08-18 | Novozymes A/S | Alpha-amylase variants |
AR124921A1 (es) | 2021-02-18 | 2023-05-17 | Novozymes As | Polipéptidos inactivos que contienen hemo |
EP4047088A1 (en) | 2021-02-22 | 2022-08-24 | Basf Se | Amylase variants |
JP2024508766A (ja) | 2021-02-22 | 2024-02-28 | ベーアーエスエフ・エスエー | アミラーゼバリアント |
WO2022189521A1 (en) | 2021-03-12 | 2022-09-15 | Novozymes A/S | Polypeptide variants |
WO2022194673A1 (en) | 2021-03-15 | 2022-09-22 | Novozymes A/S | Dnase variants |
EP4060036A1 (en) | 2021-03-15 | 2022-09-21 | Novozymes A/S | Polypeptide variants |
WO2022197512A1 (en) | 2021-03-15 | 2022-09-22 | The Procter & Gamble Company | Cleaning compositions containing polypeptide variants |
CN117295817A (zh) | 2021-03-22 | 2023-12-26 | 生命编辑制药股份有限公司 | Dna修饰酶及其活性片段和变体以及使用方法 |
EP4314222A1 (en) | 2021-03-26 | 2024-02-07 | Novozymes A/S | Detergent composition with reduced polymer content |
US11913036B2 (en) | 2021-04-02 | 2024-02-27 | Codexis, Inc. | Engineered acetate kinase variant enzymes |
CA3214975A1 (en) | 2021-04-02 | 2022-10-06 | Codexis, Inc. | Engineered cyclic gmp-amp synthase (cgas) variant enzymes |
CN117120600A (zh) | 2021-04-02 | 2023-11-24 | 科德克希思公司 | 工程化腺苷酸激酶变体酶 |
IL305922A (en) | 2021-04-02 | 2023-11-01 | Codexis Inc | Transgenic enzymes of variant guanylate kinase |
EP4322761A1 (en) | 2021-04-12 | 2024-02-21 | Novozymes A/S | Method for producing a meat analogue product |
WO2022221720A1 (en) | 2021-04-16 | 2022-10-20 | Novartis Ag | Antibody drug conjugates and methods for making thereof |
AR125794A1 (es) | 2021-05-06 | 2023-08-16 | Agbiome Inc | Genes plaguicidas y métodos de uso |
EP4336997A1 (en) | 2021-05-11 | 2024-03-20 | Two Blades Foundation | Methods for preparing a library of plant disease resistance genes for functional testing for disease resistance |
BR112023024706A2 (pt) | 2021-05-27 | 2024-02-15 | Novozymes As | Reguladores da transcrição e polinucleotídeos que os codificam |
WO2022261003A1 (en) | 2021-06-07 | 2022-12-15 | Novozymes A/S | Engineered microorganism for improved ethanol fermentation |
WO2022261394A1 (en) | 2021-06-11 | 2022-12-15 | LifeEDIT Therapeutics, Inc. | Rna polymerase iii promoters and methods of use |
EP4355868A1 (en) | 2021-06-16 | 2024-04-24 | Novozymes A/S | Method for controlling slime in a pulp or paper making process |
WO2023285348A1 (en) | 2021-07-13 | 2023-01-19 | Novozymes A/S | Recombinant cutinase expression |
WO2023288294A1 (en) | 2021-07-16 | 2023-01-19 | Novozymes A/S | Compositions and methods for improving the rainfastness of proteins on plant surfaces |
WO2023010083A2 (en) | 2021-07-30 | 2023-02-02 | Willow Biosciences, Inc. | Recombinant prenyltransferase polypeptides engineered for enhanced biosynthesis of cannabinoids |
CN117795087A (zh) | 2021-08-02 | 2024-03-29 | 巴斯夫欧洲公司 | 用紫罗兰亚基乙烷合酶进行的芳香化合物的新颖生产 |
WO2023023621A1 (en) | 2021-08-19 | 2023-02-23 | Willow Biosciences, Inc. | Recombinant olivetolic acid cyclase polypeptides engineered for enhanced biosynthesis of cannabinoids |
CA3233676A1 (en) | 2021-09-30 | 2023-04-06 | The Sainsbury Laboratory | Plant disease resistance genes against stem rust and methods of use |
WO2023061928A1 (en) | 2021-10-12 | 2023-04-20 | Novozymes A/S | Endoglucanase with improved stability |
CA3234874A1 (en) | 2021-10-15 | 2023-04-20 | Martijn Scheffers | Glucoamylase variants and methods for use thereof |
WO2023064955A1 (en) | 2021-10-15 | 2023-04-20 | Cytomx Therapeutics, Inc. | Activatable anti-cd3, anti-egfr, heteromultimeric bispecific polypeptide complex |
WO2023064929A1 (en) | 2021-10-15 | 2023-04-20 | Cytomx Therapeutics, Inc. | Activatable polypeptide complex |
TW202330611A (zh) | 2021-10-15 | 2023-08-01 | 美商賽特艾克斯生物製藥公司 | 可活化之多肽複合物 |
WO2023069921A1 (en) | 2021-10-19 | 2023-04-27 | Epimeron Usa, Inc. | Recombinant thca synthase polypeptides engineered for enhanced biosynthesis of cannabinoids |
WO2023107943A1 (en) | 2021-12-07 | 2023-06-15 | AgBiome, Inc. | Pesticidal genes and methods of use |
WO2023104846A1 (en) | 2021-12-10 | 2023-06-15 | Novozymes A/S | Improved protein production in recombinant bacteria |
WO2023118436A1 (en) | 2021-12-22 | 2023-06-29 | Novozymes A/S | Method of producing a milk-based product |
WO2023118565A1 (en) | 2021-12-23 | 2023-06-29 | Novozymes A/S | Reduction of residual dna in microbial fermentation products |
WO2023131901A1 (en) | 2022-01-07 | 2023-07-13 | Johnson & Johnson Enterprise Innovation Inc. | Materials and methods of il-1beta binding proteins |
WO2023139557A1 (en) | 2022-01-24 | 2023-07-27 | LifeEDIT Therapeutics, Inc. | Rna-guided nucleases and active fragments and variants thereof and methods of use |
WO2023152220A1 (en) | 2022-02-10 | 2023-08-17 | Novozymes A/S | Improved expression of recombinant proteins |
WO2023161245A1 (en) | 2022-02-22 | 2023-08-31 | Novozymes A/S | Oral care composition comprising enzymes |
WO2023165507A1 (en) | 2022-03-02 | 2023-09-07 | Novozymes A/S | Use of xyloglucanase for improvement of sustainability of detergents |
EP4242303A1 (en) | 2022-03-08 | 2023-09-13 | Novozymes A/S | Fusion polypeptides with deamidase inhibitor and deamidase domains |
WO2023170177A1 (en) | 2022-03-08 | 2023-09-14 | Novozymes A/S | Fusion polypeptides with deamidase inhibitor and deamidase domains |
WO2023173084A1 (en) | 2022-03-11 | 2023-09-14 | University Of Rochester | Cyclopeptibodies and uses thereof |
TW202400658A (zh) | 2022-04-26 | 2024-01-01 | 瑞士商諾華公司 | 靶向il—13和il—18的多特異性抗體 |
WO2023225459A2 (en) | 2022-05-14 | 2023-11-23 | Novozymes A/S | Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections |
WO2023222648A2 (en) | 2022-05-17 | 2023-11-23 | Novozymes A/S | Process for reducing free fatty acids |
WO2023247348A1 (en) | 2022-06-21 | 2023-12-28 | Novozymes A/S | Mannanase variants and polynucleotides encoding same |
WO2023247514A1 (en) | 2022-06-22 | 2023-12-28 | Novozymes A/S | Recombinant mannanase expression |
WO2023247664A2 (en) | 2022-06-24 | 2023-12-28 | Novozymes A/S | Lipase variants and compositions comprising such lipase variants |
WO2024003143A1 (en) | 2022-06-30 | 2024-01-04 | Novozymes A/S | Mutanases and oral care compositions comprising same |
WO2024012912A1 (en) | 2022-07-15 | 2024-01-18 | Novozymes A/S | Polypeptides having deamidase inhibitor activity |
WO2024015953A1 (en) | 2022-07-15 | 2024-01-18 | Danisco Us Inc. | Methods for producing monoclonal antibodies |
WO2024013727A1 (en) | 2022-07-15 | 2024-01-18 | Janssen Biotech, Inc. | Material and methods for improved bioengineered pairing of antigen-binding variable regions |
EP4311430A1 (en) | 2022-07-28 | 2024-01-31 | Limagrain Europe | Chlorotoluron tolerance gene and methods of use thereof |
WO2024026406A2 (en) | 2022-07-29 | 2024-02-01 | Vestaron Corporation | Next Generation ACTX Peptides |
WO2024033133A2 (en) | 2022-08-11 | 2024-02-15 | Basf Se | Enzyme compositions comprising an amylase |
WO2024033134A1 (en) | 2022-08-11 | 2024-02-15 | Basf Se | Enzyme compositions comprising protease, mannanase, and/or cellulase |
WO2024033901A1 (en) | 2022-08-12 | 2024-02-15 | LifeEDIT Therapeutics, Inc. | Rna-guided nucleases and active fragments and variants thereof and methods of use |
WO2024040020A1 (en) | 2022-08-15 | 2024-02-22 | Absci Corporation | Quantitative affinity activity specific cell enrichment |
WO2024044596A1 (en) | 2022-08-23 | 2024-02-29 | AgBiome, Inc. | Pesticidal genes and methods of use |
WO2024042489A1 (en) | 2022-08-25 | 2024-02-29 | LifeEDIT Therapeutics, Inc. | Chemical modification of guide rnas with locked nucleic acid for rna guided nuclease-mediated gene editing |
WO2024056643A1 (en) | 2022-09-15 | 2024-03-21 | Novozymes A/S | Fungal signal peptides |
EP4273249A2 (en) | 2023-07-07 | 2023-11-08 | Novozymes A/S | Improved expression of recombinant proteins |
Family Cites Families (154)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4994379A (en) * | 1983-03-09 | 1991-02-19 | Cetus Corporation | Modified signal peptides |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US5422266A (en) | 1984-12-31 | 1995-06-06 | University Of Georgia Research Foundation, Inc. | Recombinant DNA vectors capable of expressing apoaequorin |
US4683202A (en) * | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US5176995A (en) * | 1985-03-28 | 1993-01-05 | Hoffmann-La Roche Inc. | Detection of viruses by amplification and hybridization |
US4965188A (en) * | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
DE3546807C2 (zh) * | 1985-03-30 | 1991-03-28 | Marc Genf/Geneve Ch Ballivet | |
US4959312A (en) | 1985-05-31 | 1990-09-25 | The University Of Tennessee Research Corporation | Full spectrum mutagenesis |
ATE93541T1 (de) * | 1985-07-03 | 1993-09-15 | Genencor Int | Hybride polypeptide und verfahren zu deren herstellung. |
US5866363A (en) | 1985-08-28 | 1999-02-02 | Pieczenik; George | Method and means for sorting and identifying biological information |
US4800159A (en) * | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
DK311186D0 (da) * | 1986-06-30 | 1986-06-30 | Novo Industri As | Enzymer |
US5824469A (en) * | 1986-07-17 | 1998-10-20 | University Of Washington | Method for producing novel DNA sequences with biological activity |
US5763192A (en) | 1986-11-20 | 1998-06-09 | Ixsys, Incorporated | Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique |
US4994368A (en) * | 1987-07-23 | 1991-02-19 | Syntex (U.S.A.) Inc. | Amplification method for polynucleotide assays |
US4994367A (en) | 1988-10-07 | 1991-02-19 | East Carolina University | Extended shelf life platelet preparations and process for preparing the same |
FR2641793B1 (fr) * | 1988-12-26 | 1993-10-01 | Setratech | Procede de recombinaison in vivo de sequences d'adn presentant des mesappariements de bases |
DD282028A5 (de) | 1989-02-16 | 1990-08-29 | Akad Wissenschaften Ddr | Verfahren zur herstellung einer thermostabilen, hybriden bacillus-beta-1,3-1,4-glukanase |
US5043272A (en) * | 1989-04-27 | 1991-08-27 | Life Technologies, Incorporated | Amplification of nucleic acid sequences using oligonucleotides of random sequence as primers |
US5106727A (en) * | 1989-04-27 | 1992-04-21 | Life Technologies, Inc. | Amplification of nucleic acid sequences using oligonucleotides of random sequences as primers |
US5556750A (en) * | 1989-05-12 | 1996-09-17 | Duke University | Methods and kits for fractionating a population of DNA molecules based on the presence or absence of a base-pair mismatch utilizing mismatch repair systems |
CA2016841C (en) * | 1989-05-16 | 1999-09-21 | William D. Huse | A method for producing polymers having a preselected activity |
CA2016842A1 (en) * | 1989-05-16 | 1990-11-16 | Richard A. Lerner | Method for tapping the immunological repertoire |
IT1231157B (it) * | 1989-07-20 | 1991-11-19 | Crc Ricerca Chim | Nuovi geni ibridi funzionali di bacillus thuringiensis ottenuti mediante ricombinazione in vivo. |
US5574205A (en) | 1989-07-25 | 1996-11-12 | Cell Genesys | Homologous recombination for universal donor cells and chimeric mammalian hosts |
US5023171A (en) * | 1989-08-10 | 1991-06-11 | Mayo Foundation For Medical Education And Research | Method for gene splicing by overlap extension using the polymerase chain reaction |
WO1991006570A1 (en) * | 1989-10-25 | 1991-05-16 | The University Of Melbourne | HYBRID Fc RECEPTOR MOLECULES |
US5071743A (en) | 1989-10-27 | 1991-12-10 | Her Majesty The Queen In Right Of Canada, As Represented By The National Research Council Of Canada | Process for conducting site-directed mutagenesis |
DE3936258C1 (zh) | 1989-10-31 | 1991-04-25 | Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften Ev, 3400 Goettingen, De | |
WO1991007506A1 (en) * | 1989-11-08 | 1991-05-30 | The United States Of America, Represented By The Secretary, United States Department Of Commerce | A method of synthesizing double-stranded dna molecules |
JP4251406B2 (ja) * | 1990-04-05 | 2009-04-08 | クレア,ロベルト | ウォーク―スルー突然変異誘発 |
WO1991016427A1 (en) | 1990-04-24 | 1991-10-31 | Stratagene | Methods for phenotype creation from multiple gene populations |
US5877402A (en) | 1990-05-01 | 1999-03-02 | Rutgers, The State University Of New Jersey | DNA constructs and methods for stably transforming plastids of multicellular plants and expressing recombinant proteins therein |
US5851813A (en) * | 1990-07-12 | 1998-12-22 | President And Fellows Of Harvard College | Primate lentivirus antigenic compositions |
US5571208A (en) | 1990-07-13 | 1996-11-05 | Caspers; Carl A. | Reinforced prosthetic polyurethane hypobaric sleeve |
DK0540693T3 (da) | 1990-07-24 | 1999-09-13 | Hoffmann La Roche | Reduktion af ikke-specifik amplifikation under in vitro-nukleinsyreamplifikation under anvendelse af modificerede nukleinsy |
US5169764A (en) | 1990-08-08 | 1992-12-08 | Regeneron Pharmaceuticals, Inc. | Multitrophic and multifunctional chimeric neurotrophic factors, and nucleic acids and plasmids encoding the chimeras |
US5264563A (en) * | 1990-08-24 | 1993-11-23 | Ixsys Inc. | Process for synthesizing oligonucleotides with random codons |
ATE174598T1 (de) * | 1990-08-24 | 1999-01-15 | Ixsys Inc | Verfahren zur herstellung von oligonukleotiden mit regellosen codonen |
US5871974A (en) * | 1990-09-28 | 1999-02-16 | Ixsys Inc. | Surface expression libraries of heteromeric receptors |
US5698426A (en) * | 1990-09-28 | 1997-12-16 | Ixsys, Incorporated | Surface expression libraries of heteromeric receptors |
IL99553A0 (en) * | 1990-09-28 | 1992-08-18 | Ixsys Inc | Compositions containing oligonucleotides linked to expression elements,a kit for the preparation of vectors useful for the expression of a diverse population of random peptides and methods utilizing the same |
US5770434A (en) * | 1990-09-28 | 1998-06-23 | Ixsys Incorporated | Soluble peptides having constrained, secondary conformation in solution and method of making same |
US5858725A (en) * | 1990-10-10 | 1999-01-12 | Glaxo Wellcome Inc. | Preparation of chimaeric antibodies using the recombinant PCR strategy |
US5234824A (en) * | 1990-11-13 | 1993-08-10 | Specialty Laboratories, Inc. | Rapid purification of DNA |
US5187083A (en) * | 1990-11-13 | 1993-02-16 | Specialty Laboratories, Inc. | Rapid purification of DNA |
US5489523A (en) * | 1990-12-03 | 1996-02-06 | Stratagene | Exonuclease-deficient thermostable Pyrococcus furiosus DNA polymerase I |
JP3298879B2 (ja) * | 1990-12-20 | 2002-07-08 | イグジス,インコーポレイテッド | 結合タンパク質の最適化 |
US5795747A (en) * | 1991-04-16 | 1998-08-18 | Evotec Biosystems Gmbh | Process for manufacturing new biopolymers |
DE4112440C1 (zh) * | 1991-04-16 | 1992-10-22 | Diagen Institut Fuer Molekularbiologische Diagnostik Gmbh, 4000 Duesseldorf, De | |
WO1992018846A1 (en) * | 1991-04-17 | 1992-10-29 | Bemis Manufacturing Company | Method and apparatus for data point analysis |
US5514568A (en) * | 1991-04-26 | 1996-05-07 | Eli Lilly And Company | Enzymatic inverse polymerase chain reaction |
US5512463A (en) * | 1991-04-26 | 1996-04-30 | Eli Lilly And Company | Enzymatic inverse polymerase chain reaction library mutagenesis |
ES2091976T3 (es) | 1991-06-20 | 1996-11-16 | Hoffmann La Roche | Metodos perfeccionados para la amplificacion del acido nucleico. |
WO1993000103A1 (en) * | 1991-06-21 | 1993-01-07 | The Wistar Institute Of Anatomy And Biology | Chimeric envelope proteins for viral targeting |
JP3442774B2 (ja) | 1991-07-01 | 2003-09-02 | バーレックス ラボラトリーズ,インコーポレイティド | 新規な突然変異誘発法および組成物 |
US6071889A (en) | 1991-07-08 | 2000-06-06 | Neurospheres Holdings Ltd. | In vivo genetic modification of growth factor-responsive neural precursor cells |
US5223408A (en) * | 1991-07-11 | 1993-06-29 | Genentech, Inc. | Method for making variant secreted proteins with altered properties |
GB9115364D0 (en) * | 1991-07-16 | 1991-08-28 | Wellcome Found | Antibody |
US5279952A (en) * | 1991-08-09 | 1994-01-18 | Board Of Regents, The University Of Texas System | PCR-based strategy of constructing chimeric DNA molecules |
WO1993006213A1 (en) * | 1991-09-23 | 1993-04-01 | Medical Research Council | Production of chimeric antibodies - a combinatorial approach |
GB9125979D0 (en) * | 1991-12-06 | 1992-02-05 | Wellcome Found | Antibody |
FR2685004A1 (fr) * | 1991-12-11 | 1993-06-18 | Pasteur Institut | Procede de generation d'une diversite structurale et fonctionnelle dans une sequence peptidique. |
CA2127126A1 (en) * | 1992-01-30 | 1993-08-05 | Helen M. Wilks | Chiral synthesis with modified enzymes |
US5773267A (en) | 1992-02-07 | 1998-06-30 | Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University | D29 shuttle phasmids and uses thereof |
GB9202796D0 (en) * | 1992-02-11 | 1992-03-25 | Wellcome Found | Antiviral antibody |
US5843643A (en) | 1992-02-21 | 1998-12-01 | Ratner; Paul L. | Site-specific transfection of eukaryotic cells using polypeptide-linked recombinant nucleic acid |
JPH07507995A (ja) * | 1992-03-02 | 1995-09-07 | バイオジェン,インコーポレイテッド | トロンビンレセプターアンタゴニスト |
WO1993019170A1 (en) | 1992-03-16 | 1993-09-30 | Jacob Nathaniel Wohlstadter | Selection methods |
JP3507073B2 (ja) | 1992-03-24 | 2004-03-15 | ケンブリッジ アンティボディー テクノロジー リミティド | 特異的結合対の成員の製造方法 |
US5316935A (en) | 1992-04-06 | 1994-05-31 | California Institute Of Technology | Subtilisin variants suitable for hydrolysis and synthesis in organic media |
PT786257E (pt) | 1992-06-03 | 2003-12-31 | Genentech Inc | Variantes de glicosilacao do activador de plasminogenio tissular com propriedades terapeuticas meloradas |
JPH06509947A (ja) * | 1992-06-15 | 1994-11-10 | シティ・オブ・ホープ | キメラ抗cea抗体 |
ATE210726T1 (de) * | 1992-07-10 | 2001-12-15 | Energy Biosystems Corp | Für einen entschwefelungs-biokatalysator kodierende, rekombinante dna |
US6107062A (en) * | 1992-07-30 | 2000-08-22 | Inpax, Inc. | Antisense viruses and antisense-ribozyme viruses |
FR2694754B1 (fr) | 1992-08-12 | 1994-09-16 | Bio Merieux | Fragments d'ADN de mycobactéries, amorces d'amplification, sondes d'hybridation, réactifs et procédé de détection de détection de mycobactéries. |
US5837821A (en) * | 1992-11-04 | 1998-11-17 | City Of Hope | Antibody construct |
JPH08505524A (ja) * | 1992-11-10 | 1996-06-18 | イグジス, インコーポレイティッド | 溶液中で拘束された二次コンホメーションを有する可溶性ペプチド、およびその製造方法 |
US5360728A (en) * | 1992-12-01 | 1994-11-01 | Woods Hole Oceanographic Institution (W.H.O.I.) | Modified apoaequorin having increased bioluminescent activity |
JP3720353B2 (ja) * | 1992-12-04 | 2005-11-24 | メディカル リサーチ カウンシル | 多価および多重特異性の結合タンパク質、それらの製造および使用 |
US5571708A (en) | 1993-04-19 | 1996-11-05 | Bristol-Myers Squibb Company | Thrombin-activatable plasminogen activator |
IT1264712B1 (it) * | 1993-07-13 | 1996-10-04 | Eniricerche Spa | Metodo di sintesi biologica di peptidi |
US5498531A (en) | 1993-09-10 | 1996-03-12 | President And Fellows Of Harvard College | Intron-mediated recombinant techniques and reagents |
US5474920A (en) | 1993-11-23 | 1995-12-12 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University | Modified thermo-resistant DNA polymerases |
US5556772A (en) * | 1993-12-08 | 1996-09-17 | Stratagene | Polymerase compositions and uses thereof |
DE4343591A1 (de) * | 1993-12-21 | 1995-06-22 | Evotec Biosystems Gmbh | Verfahren zum evolutiven Design und Synthese funktionaler Polymere auf der Basis von Formenelementen und Formencodes |
US5928905A (en) * | 1995-04-18 | 1999-07-27 | Glaxo Group Limited | End-complementary polymerase reaction |
US6395547B1 (en) * | 1994-02-17 | 2002-05-28 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
US6165793A (en) | 1996-03-25 | 2000-12-26 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
US5837458A (en) | 1994-02-17 | 1998-11-17 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
US6117679A (en) | 1994-02-17 | 2000-09-12 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
US5834252A (en) | 1995-04-18 | 1998-11-10 | Glaxo Group Limited | End-complementary polymerase reaction |
US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
US6995017B1 (en) | 1994-02-17 | 2006-02-07 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
US6335160B1 (en) * | 1995-02-17 | 2002-01-01 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
US5521077A (en) * | 1994-04-28 | 1996-05-28 | The Leland Stanford Junior University | Method of generating multiple protein variants and populations of protein variants prepared thereby |
EP0714980A1 (en) | 1994-12-02 | 1996-06-05 | Institut Pasteur | Hypermutagenesis |
WO1996017056A1 (en) | 1994-12-02 | 1996-06-06 | Institut Pasteur | Hypermutagenesis |
US5514588A (en) | 1994-12-13 | 1996-05-07 | Exxon Research And Engineering Company | Surfactant-nutrients for bioremediation of hydrocarbon contaminated soils and water |
US5629179A (en) * | 1995-03-17 | 1997-05-13 | Novagen, Inc. | Method and kit for making CDNA library |
KR100501838B1 (ko) * | 1995-04-24 | 2005-07-21 | 큐비스트 파마슈티컬즈 인코포레이티드 | 새로운 대사 경로를 만들고 이를 스크리닝하는 방법 |
US6004788A (en) | 1995-07-18 | 1999-12-21 | Diversa Corporation | Enzyme kits and libraries |
US6168919B1 (en) | 1996-07-17 | 2001-01-02 | Diversa Corporation | Screening methods for enzymes and enzyme kits |
US5958672A (en) * | 1995-07-18 | 1999-09-28 | Diversa Corporation | Protein activity screening of clones having DNA from uncultivated microorganisms |
US6057103A (en) | 1995-07-18 | 2000-05-02 | Diversa Corporation | Screening for novel bioactivities |
US6030779A (en) | 1995-07-18 | 2000-02-29 | Diversa Corporation | Screening for novel bioactivities |
WO1997007205A1 (en) * | 1995-08-11 | 1997-02-27 | Novo Nordisk A/S | Method for preparing polypeptide variants |
US5962258A (en) | 1995-08-23 | 1999-10-05 | Diversa Corporation | Carboxymethyl cellulase fromthermotoga maritima |
FR2738840B1 (fr) | 1995-09-19 | 1997-10-31 | Rhone Poulenc Rorer Sa | Souches de levures genetiquement modifiees |
US6051409A (en) | 1995-09-25 | 2000-04-18 | Novartis Finance Corporation | Method for achieving integration of exogenous DNA delivered by non-biological means to plant cells |
US5756316A (en) * | 1995-11-02 | 1998-05-26 | Genencor International, Inc. | Molecular cloning by multimerization of plasmids |
US5830696A (en) * | 1996-12-05 | 1998-11-03 | Diversa Corporation | Directed evolution of thermophilic enzymes |
US6358709B1 (en) | 1995-12-07 | 2002-03-19 | Diversa Corporation | End selection in directed evolution |
US6238884B1 (en) | 1995-12-07 | 2001-05-29 | Diversa Corporation | End selection in directed evolution |
US6352842B1 (en) | 1995-12-07 | 2002-03-05 | Diversa Corporation | Exonucease-mediated gene assembly in directed evolution |
US5965408A (en) * | 1996-07-09 | 1999-10-12 | Diversa Corporation | Method of DNA reassembly by interrupting synthesis |
US5962283A (en) | 1995-12-07 | 1999-10-05 | Diversa Corporation | Transminases and amnotransferases |
US5814473A (en) | 1996-02-09 | 1998-09-29 | Diversa Corporation | Transaminases and aminotransferases |
US5939250A (en) * | 1995-12-07 | 1999-08-17 | Diversa Corporation | Production of enzymes having desired activities by mutagenesis |
US6361974B1 (en) | 1995-12-07 | 2002-03-26 | Diversa Corporation | Exonuclease-mediated nucleic acid reassembly in directed evolution |
US20030215798A1 (en) | 1997-06-16 | 2003-11-20 | Diversa Corporation | High throughput fluorescence-based screening for novel enzymes |
US6171820B1 (en) | 1995-12-07 | 2001-01-09 | Diversa Corporation | Saturation mutagenesis in directed evolution |
AU1367897A (en) * | 1996-01-10 | 1997-08-01 | Novo Nordisk A/S | A method for in vivo production of a mutant library in cells |
US5942430A (en) | 1996-02-16 | 1999-08-24 | Diversa Corporation | Esterases |
US5958751A (en) | 1996-03-08 | 1999-09-28 | Diversa Corporation | α-galactosidase |
US6096548A (en) * | 1996-03-25 | 2000-08-01 | Maxygen, Inc. | Method for directing evolution of a virus |
US5783431A (en) * | 1996-04-24 | 1998-07-21 | Chromaxome Corporation | Methods for generating and screening novel metabolic pathways |
US5789228A (en) | 1996-05-22 | 1998-08-04 | Diversa Corporation | Endoglucanases |
US5877001A (en) | 1996-06-17 | 1999-03-02 | Diverso Corporation | Amidase |
US5763239A (en) | 1996-06-18 | 1998-06-09 | Diversa Corporation | Production and use of normalized DNA libraries |
US5939300A (en) | 1996-07-03 | 1999-08-17 | Diversa Corporation | Catalases |
US6093873A (en) | 1996-08-19 | 2000-07-25 | Institut National De La Sante Et De La Recherche Medicale | Genetically engineered mice containing alterations in the gene encoding RXR |
US5834458A (en) | 1996-10-09 | 1998-11-10 | Eli Lilly And Company | Heterocyclic compounds and their use |
CN1208456C (zh) * | 1996-12-20 | 2005-06-29 | 诺维信公司 | 体内重组 |
US6326204B1 (en) | 1997-01-17 | 2001-12-04 | Maxygen, Inc. | Evolution of whole cells and organisms by recursive sequence recombination |
IL130635A0 (en) * | 1997-01-17 | 2000-06-01 | Maxygen Inc | Evolution of whole cells and organisms by recursive sequence recombination |
EP1015575B1 (en) * | 1997-03-18 | 2010-05-19 | Novozymes A/S | Shuffling of heterologous dna sequences |
IL131966A0 (en) * | 1997-03-18 | 2001-03-19 | Novo Industri As | An in vitro method for construction of a dna library |
JP4263248B2 (ja) * | 1997-03-18 | 2009-05-13 | ノボザイムス アクティーゼルスカブ | Dnaのシャッフリングによるライブラリーの作成方法 |
US5948653A (en) | 1997-03-21 | 1999-09-07 | Pati; Sushma | Sequence alterations using homologous recombination |
US6153410A (en) * | 1997-03-25 | 2000-11-28 | California Institute Of Technology | Recombination of polynucleotide sequences using random or defined primers |
US6051049A (en) | 1997-05-29 | 2000-04-18 | Exothermic Distribution Corporation | Utilization of strontium aluminate in steelmaking |
US5948666A (en) | 1997-08-06 | 1999-09-07 | Diversa Corporation | Isolation and identification of polymerases |
US5876997A (en) | 1997-08-13 | 1999-03-02 | Diversa Corporation | Phytase |
CA2313380C (en) | 1997-12-08 | 2008-12-30 | California Institute Of Technology | Method for creating polynucleotide and polypeptide sequences |
US6087341A (en) | 1998-02-12 | 2000-07-11 | The Board Of Trustees Of The Leland Standford Junior University | Introduction of nucleic acid into skin cells by topical application |
US6365408B1 (en) | 1998-06-19 | 2002-04-02 | Maxygen, Inc. | Methods of evolving a polynucleotides by mutagenesis and recombination |
JP2003503005A (ja) | 1998-07-28 | 2003-01-28 | カリフォルニア インスティチュート オブ テクノロジー | 機能的真核生物タンパク質の発現 |
WO2000009727A2 (en) | 1998-08-12 | 2000-02-24 | Maxygen, Inc. | Dna shuffling to produce herbicide selective crops |
JP2002537758A (ja) | 1998-09-29 | 2002-11-12 | マキシジェン, インコーポレイテッド | コドン変更された遺伝子のシャッフリング |
US6376246B1 (en) | 1999-02-05 | 2002-04-23 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
US6397053B1 (en) * | 1999-12-30 | 2002-05-28 | Koninklijke Philips Electronics N.V. (Kpenv) | Reduction of power consumption with increased standby time in wireless communications device |
US20050084907A1 (en) | 2002-03-01 | 2005-04-21 | Maxygen, Inc. | Methods, systems, and software for identifying functional biomolecules |
US20090312196A1 (en) | 2008-06-13 | 2009-12-17 | Codexis, Inc. | Method of synthesizing polynucleotide variants |
-
1994
- 1994-02-17 US US08/198,431 patent/US5605793A/en not_active Expired - Lifetime
-
1995
- 1995-02-17 EP EP98122040A patent/EP0934999B1/en not_active Revoked
- 1995-02-17 DK DK98122040T patent/DK0934999T3/da active
- 1995-02-17 DE DE0934999T patent/DE934999T1/de active Pending
- 1995-02-17 AU AU29714/95A patent/AU703264C/en not_active Ceased
- 1995-02-17 WO PCT/US1995/002126 patent/WO1995022625A1/en active IP Right Grant
- 1995-02-17 EP EP95911826.6A patent/EP0752008B2/en not_active Expired - Lifetime
- 1995-02-17 AT AT95911826T patent/ATE216722T1/de active
- 1995-02-17 ES ES98122040T patent/ES2165652T3/es not_active Expired - Lifetime
- 1995-02-17 CA CA002182393A patent/CA2182393C/en not_active Expired - Fee Related
- 1995-02-17 US US08/537,874 patent/US5830721A/en not_active Expired - Lifetime
- 1995-02-17 EP EP01123328A patent/EP1205547A3/en not_active Withdrawn
- 1995-02-17 EP EP01100962A patent/EP1094108A3/en not_active Withdrawn
- 1995-02-17 DE DE1094108T patent/DE1094108T1/de active Pending
- 1995-02-17 RU RU96118426/13A patent/RU2157851C2/ru active
- 1995-02-17 DE DE69526497T patent/DE69526497T2/de not_active Expired - Lifetime
- 1995-02-17 DE DE0752008T patent/DE752008T1/de active Pending
- 1995-02-17 ES ES95911826T patent/ES2176324T3/es not_active Expired - Lifetime
- 1995-02-17 DK DK95911826T patent/DK0752008T3/da active
- 1995-02-17 CN CN95191679A patent/CN1145641A/zh active Pending
- 1995-02-17 DE DE69525084T patent/DE69525084T2/de not_active Expired - Fee Related
- 1995-02-17 AT AT98122040T patent/ATE211761T1/de not_active IP Right Cessation
- 1995-02-17 JP JP7521977A patent/JPH10500561A/ja active Pending
- 1995-11-30 US US08/564,955 patent/US5811238A/en not_active Expired - Lifetime
-
1998
- 1998-06-19 US US09/100,856 patent/US6132970A/en not_active Expired - Lifetime
- 1998-08-12 US US09/133,508 patent/US6287861B1/en not_active Expired - Lifetime
-
1999
- 1999-01-15 US US09/232,863 patent/US6277638B1/en not_active Expired - Lifetime
- 1999-01-15 US US09/231,253 patent/US6420175B1/en not_active Expired - Fee Related
-
2000
- 2000-02-10 US US09/501,698 patent/US6297053B1/en not_active Expired - Lifetime
- 2000-07-03 JP JP2000201673A patent/JP3393848B2/ja not_active Expired - Fee Related
- 2000-11-15 US US09/713,920 patent/US6602986B1/en not_active Expired - Fee Related
- 2000-11-21 US US09/718,764 patent/US6576467B1/en not_active Expired - Fee Related
- 2000-11-28 US US09/724,958 patent/US6444468B1/en not_active Expired - Fee Related
-
2002
- 2002-07-15 JP JP2002206303A patent/JP3485560B2/ja not_active Expired - Fee Related
- 2002-12-17 JP JP2002365621A patent/JP2003174881A/ja not_active Withdrawn
-
2003
- 2003-07-18 US US10/623,036 patent/US7288375B2/en not_active Expired - Fee Related
-
2004
- 2004-06-11 JP JP2004174720A patent/JP4067516B2/ja not_active Expired - Fee Related
-
2006
- 2006-06-15 AU AU2006202542A patent/AU2006202542A1/en not_active Abandoned
-
2007
- 2007-07-09 JP JP2007180396A patent/JP2007244399A/ja not_active Withdrawn
- 2007-08-22 US US11/843,351 patent/US20080261833A1/en not_active Abandoned
-
2009
- 2009-09-11 US US12/557,519 patent/US7981614B2/en not_active Expired - Fee Related
-
2010
- 2010-01-22 AU AU2010200270A patent/AU2010200270A1/en not_active Abandoned
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101258244B (zh) * | 2005-08-08 | 2012-02-15 | 基因技术股份公司 | 用于在体内进行蛋白质的选择性进化的方法 |
US10202608B2 (en) | 2006-08-31 | 2019-02-12 | Gen9, Inc. | Iterative nucleic acid assembly using activation of vector-encoded traits |
US10457935B2 (en) | 2010-11-12 | 2019-10-29 | Gen9, Inc. | Protein arrays and methods of using and making the same |
US11845054B2 (en) | 2010-11-12 | 2023-12-19 | Gen9, Inc. | Methods and devices for nucleic acids synthesis |
US11084014B2 (en) | 2010-11-12 | 2021-08-10 | Gen9, Inc. | Methods and devices for nucleic acids synthesis |
US10982208B2 (en) | 2010-11-12 | 2021-04-20 | Gen9, Inc. | Protein arrays and methods of using and making the same |
US11702662B2 (en) | 2011-08-26 | 2023-07-18 | Gen9, Inc. | Compositions and methods for high fidelity assembly of nucleic acids |
US10308931B2 (en) | 2012-03-21 | 2019-06-04 | Gen9, Inc. | Methods for screening proteins using DNA encoded chemical libraries as templates for enzyme catalysis |
US10081807B2 (en) | 2012-04-24 | 2018-09-25 | Gen9, Inc. | Methods for sorting nucleic acids and multiplexed preparative in vitro cloning |
US10927369B2 (en) | 2012-04-24 | 2021-02-23 | Gen9, Inc. | Methods for sorting nucleic acids and multiplexed preparative in vitro cloning |
US11072789B2 (en) | 2012-06-25 | 2021-07-27 | Gen9, Inc. | Methods for nucleic acid assembly and high throughput sequencing |
US10662424B2 (en) | 2012-12-06 | 2020-05-26 | Agilent Technologies, Inc. | Molecular fabrication |
US11549106B2 (en) | 2012-12-06 | 2023-01-10 | Agilent Technologies, Inc. | Molecular fabrication |
CN104837994A (zh) * | 2012-12-06 | 2015-08-12 | 安捷伦科技有限公司 | 分子制造 |
CN105934541B (zh) * | 2013-11-27 | 2019-07-12 | Gen9股份有限公司 | 核酸文库及其制造方法 |
CN105934541A (zh) * | 2013-11-27 | 2016-09-07 | Gen9股份有限公司 | 核酸文库及其制造方法 |
WO2016058127A1 (zh) * | 2014-10-14 | 2016-04-21 | 深圳华大基因科技有限公司 | 一种转座酶打断核酸并加接头的方法和试剂 |
CN104805508B (zh) * | 2015-04-29 | 2017-07-14 | 江南大学 | 一种基于合成单链dna文库进化代谢途径的方法 |
CN104805508A (zh) * | 2015-04-29 | 2015-07-29 | 江南大学 | 一种基于合成单链dna文库进化代谢途径的方法 |
CN110366593A (zh) * | 2017-02-21 | 2019-10-22 | 苏黎世联邦理工学院 | Dna零件,途径和基因组的进化指导的多重dna装配 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1145641A (zh) | 通过随机片段化和重装配进行的dna诱变 | |
Patten et al. | Applications of DNA shuffling to pharmaceuticals and vaccines | |
CN1484698A (zh) | 具有c型类凝集素结构域的支架结构的蛋白质组合文库 | |
CN1277843C (zh) | 分枝杆菌比较基因组学作为鉴定分枝杆菌病的诊断、预防或治疗靶的工具 | |
CN111757937A (zh) | 腺苷碱基编辑器的用途 | |
CN1230990A (zh) | 用随机或确定的引物来重组多核苷酸序列 | |
CN1757724A (zh) | 具有独特特异性的多个重组位点在重组克隆中的用途 | |
CN1173878A (zh) | 双功能或双价抗体片段类似物 | |
CN1836041A (zh) | 浏览突变 | |
CN87105787A (zh) | 纯化的热稳定性酶以及用其进行扩增、检测和/或克隆核酸顺序的方法 | |
JPH05503000A (ja) | 新規の遺伝子及びポリペチドの無細胞合成並びに単離 | |
CN1956996A (zh) | 基于泛素蛋白的人工结合蛋白的生产 | |
CN85109740A (zh) | 能表达脱辅基水母发光蛋白(Apoaeq-uorin)的重组DNA载体 | |
McClain | Seven terminal steps in a biosynthetic pathway leading from DNA to transfer RNA | |
CN1529759A (zh) | 模块转染系统 | |
CN1264860C (zh) | 在遗传载体上表面展示蛋白的方法 | |
CN1449444A (zh) | 无细胞蛋白质合成用转录模型的设计、结构及使用其合成无细胞麦胚芽蛋白质的稀释批式法 | |
Oosting | Molecular biotechnology: from dna sequence to therapeutic protein | |
CN1204369A (zh) | 多功能性造血受体激动剂 | |
WO2001088196A2 (en) | Sequence based screening | |
CN1649626A (zh) | 可与触珠蛋白受体配体结合相互作用的分子的用途 | |
CN1289668C (zh) | 一种用于抗体改形的体外分子定向进化方法 | |
EP1670932B1 (en) | Libraries of recombinant chimeric proteins | |
CN1894272A (zh) | 蛋白质表达 | |
CN1498276A (zh) | 通过三螺旋相互作用纯化与检测双链dna靶序列的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |